IPA > Hazard Check > CLP-Tabelle 3.1

Tabelle 3.1 der CLP-Verordnung, Anhang VI

Zur Erläuterung der Hinweisnoten

Index-Nr. Bezeichnung CAS-Nr. Kategorie H-Satz Konzentrationsgrenzen Anmerk. Stand
Hinweis: Verwenden Sie die Schlüsselwörter 'nicht leer' und 'leer' (ohne Anführungszeichen) in Freitextfeldern, um nach Ergebnissen mit bzw. ohne Einträge zu suchen.
001-001-00-9 hydrogen 1333-74-0 Flam. Gas 1, Press. Gas H220 U CLP00/
001-002-00-4 aluminium lithium hydride 16853-85-3 Water-react. 1, Skin Corr. 1A H260, H314 CLP00/ATP01
001-003-00-X sodium hydride 7646-69-7 Water-react. 1 H260 CLP00/
001-004-00-5 calcium hydride 7789-78-8 Water-react. 1 H260 CLP00/
003-001-00-4 lithium 7439-93-2 Water-react. 1, Skin Corr. 1B H260, H314 CLP00/
003-002-00-X n-hexyllithium 21369-64-2 Water-react. 1, Pyr. Sol. 1, Skin Corr. 1A H260, H250, H314 CLP00/
003-003-00-5 (2-methylpropyl)lithium; isobutyllithium 920-36-5 Water-react. 1, Pyr. Liq. 1, Skin Corr. 1A, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H260, H250, H314, H336, H400, H410 ATP01/
004-001-00-7 beryllium 7440-41-7 Carc. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H350i, H330, H301, H372 **, H319, H335, H315, H317 CLP00/
004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex - Carc. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H350i, H330, H301, H372 **, H319, H335, H315, H317, H411 A CLP00/
004-003-00-8 beryllium oxide 1304-56-9 Carc. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H350i, H330, H301, H372 **, H319, H335, H315, H317 CLP00/
005-001-00-X boron trifluoride 7637-07-2 Press. Gas, Acute Tox. 2 *, Skin Corr. 1A H330, H314 U CLP00/
005-002-00-5 boron trichloride 10294-34-5 Press. Gas, Acute Tox. 2 *, Acute Tox. 2 *, Skin Corr. 1B H330, H300, H314 U CLP00/
005-003-00-0 boron tribromide 10294-33-4 Acute Tox. 2 *, Acute Tox. 2 *, Skin Corr. 1A H330, H300, H314 CLP00/
005-004-00-6 trialkylboranes - Pyr. Sol. 1, Skin Corr. 1B H250, H314 A CLP00/
005-004-01-3 trialkylboranes, liquid - Pyr. Liq. 1, Skin Corr. 1B H250, H314 A CLP00/
005-005-00-1 trimethyl borate 121-43-7 Flam. Liq. 3, Acute Tox. 4 * H226, H312 CLP00/
005-006-00-7 dibutyltin hydrogen borate 75113-37-0 Repr. 1B, Muta. 2, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H360FD, H341, H372**, H312, H302, H318, H317, H400, H410 CLP00/ATP01
005-007-00-2 boric acid; [1] boric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2] 10043-35-3 [1], 11113-50-1 [2] Repr. 1B H360FD Repr. 1B; H360FD: C ≥ 5,5 % ATP01/
005-008-00-8 diboron trioxide; boric oxide 1303-86-2 Repr. 1B H360FD Repr. 1B; H360FD: C ≥ 3,1 % ATP01/
005-009-00-3 tetrabutylammonium butyltriphenylborate 120307-06-4 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 118612-00-3 Carc. 2, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1 H351, H302, H315, H318 CLP00/
005-011-00-4 disodium tetraborate, anhydrous; boric acid, disodium salt; [1] tetraboron disodium heptaoxide, hydrate; [2] orthoboric acid, sodium salt [3] 1330-43-4 [1], 12267-73-1 [2], 13840-56-7 [3] Repr. 1B H360FD Repr. 1B; H360FD: C ≥ 4,5 % ATP01/
005-011-01-1 disodium tetraborate decahydrate; borax decahydrate 1303-96-4 Repr. 1B H360FD Repr. 1B; H360FD: C ≥ 8,5 % ATP01/
005-011-02-9 disodium tetraborate pentahydrate; borax pentahydrate 12179-04-3 Repr. 1B H360FD Repr. 1B; H360FD: C ≥ 6,5 % ATP01/
005-012-00-X diethyl{}{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}}ammonium butyltriphenylborate 141714-54-7 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
005-013-00-5 diethylmethoxyborane 7397-46-8 Pyr. Liq. 1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 4 H250, H332, H312, H302, H373**, H314, H317, H413 ATP01/
005-014-00-0 4-formylphenylboronic acid 87199-17-5 Skin Sens. 1 H317 ATP01/
005-015-00-6 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 140681-55-6 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H318, H317, H412 ATP01/
005-016-00-1 tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate - Aquatic Chronic 4 H413 ATP01/
005-017-00-7 sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; sodium peroxometaborate; perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate; [containing < 0.1 % (w/w) of particles with an aerodynamic d 15120-21-5 [1], 7632-04-4 [2], -, -, -, - Oxid. Sol. 2, Repr. 1B, Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H272, H360Df, H302, H335, H318 Repr. 1B; H360Df: C ≥ 9 %, Repr. 1B; H360D: 6,5 % ≤ C < 9 %, Eye Dam. 1; H318: C ≥ 22 %, Eye Irrit. 2; H319: 14 % ≤ C < 22 % ATP01/
005-017-01-4 sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; sodium peroxometaborate; perboric acid (HBO(O2)), sodium salt, monohydrate; sodium peroxoborate; [containing 0.1 % (w/w) of particles with an aerodynamic d 15120-21-5 [1], 7632-04-4 [2], -, -, -, - Oxid. Sol. 2, Repr. 1B, Acute Tox. 3 *, Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H272, H360Df, H331, H302, H335, H318 Repr. 1B; H360Df: C ≥ 9 %, Repr. 1B; H360D: 6,5 % ≤ C < 9 %, Eye Dam. 1; H318: C ≥ 22 %, Eye Irrit. 2; H319: 14 % ≤ C < 22 % ATP01/
005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0.1 % (w/w) of particles with an aerodynami 13517-20-9 [1], 37244-98-7 [2], 10486-00-7 [3], - Repr. 1B, STOT SE 3, Eye Dam. 1 H360Df, H335, H318 Repr. 1B; H360 Df: C ≥ 14 %, Repr. 1B; H360D: 10 % ≤ C < 14 %, Eye Dam. 1; H318: C ≥ 36 %, Eye Irrit. 2; H319: 22 % ≤ C < 36 % ATP01/
005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing 0.1 % (w/w) of particles with an aerodynam 13517-20-9 [1], 37244-98-7 [2], 10486-00-7 [3], - Repr. 1B, Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H360Df, H332, H335, H318 Repr. 1B; H360 Df: C ≥ 14 %, Repr. 1B; H360D: 10 % ≤ C < 14 %, Eye Dam. 1; H318: C ≥ 36 %, Eye Irrit. 2; H319: 22 % ≤ C < 36 % ATP01/
005-019-00-8 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing < 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 m] 11138-47-9 [1], 12040-72-1 [2], 10332-33-9 [3], - Oxid. Sol. 3, Repr. 1B, Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H272, H360Df, H302, H335, H318 Repr. 1B; H360Df: C ≥ 9 %, Repr. 1B; H360D: 6,5 % ≤ C < 9 %, Eye Dam. 1; H318: C ≥ 22 %, Eye Irrit. 2; H319: 14 % ≤ C < 22 %, STOT SE 3; H335: C ≥ 20 % ATP01/
005-019-01-5 perboric acid, sodium salt; [1] perboric acid, sodium salt, monohydrate; [2] perboric acid (HBO(O2)), sodium salt, monohydrate; [3] sodium peroxoborate; [containing 0.1 % (w/w) of particles with an aerodynamic diameter of below 50 m] 11138-47-9 [1], 12040-72-1 [2], 10332-33-9 [3], - Oxid. Sol. 3, Repr. 1B, Acute Tox. 3 *, Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H272, H360Df, H331, H302, H335, H318 Repr. 1B; H360Df: C ≥ 9 %, Repr. 1B; H360D: 6,5 % ≤ C < 9 %, Eye Dam. 1; H318: C ≥ 22 %, Eye Irrit. 2; H319: 14 % ≤ C < 22 % ATP01/
006-001-00-2 carbon monoxide 630-08-0 Flam. Gas 1, Press. Gas, Repr. 1A, Acute Tox. 3 *, STOT RE 1 H220, H360D ***, H331, H372 ** U CLP00/
006-002-00-8 phosgene; carbonyl chloride 75-44-5 Press. Gas, Acute Tox. 2 *, Skin Corr. 1B H330, H314 U CLP00/
006-003-00-3 carbon disulphide 75-15-0 Flam. Liq. 2, Repr. 2, STOT RE 1, Eye Irrit. 2, Skin Irrit. 2 H225, H361fd, H372 **, H319, H315 Repr. 2; H361fd: C ≥ 1 %, STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,2 % ≤C < 1 % CLP00/
006-004-00-9 calcium carbide 75-20-7 Water-react. 1 H260 T CLP00/
006-005-00-4 thiram (ISO); tetramethylthiuram disulphide 137-26-8 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H373 **, H319, H315, H317, H400, H410 M = 10: CLP00/
006-006-00-X hydrogen cyanide; hydrocyanic acid 74-90-8 Flam. Liq. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H224, H330, H400, H410 CLP00/
006-006-01-7 hydrogen cyanide ...%; hydrocyanic acid ...% 74-90-8 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 B CLP00/
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 A CLP00/ATP01
006-008-00-0 antu (ISO); 1-(1-naphthyl)-2-thiourea 86-88-4 Acute Tox. 2 *, Carc. 2 H300, H351 CLP00/
006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; Isolan 119-38-0 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate; 5,5-dimethyldihydroresorcinol dimethylcarbamate; Dimetan 122-15-6 Acute Tox. 3 * H301 CLP00/
006-011-00-7 carbaryl (ISO); 1-naphthyl methylcarbamate 63-25-2 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H351, H332, H302, H400 M=100: CLP00/ATP01
006-012-00-2 ziram (ISO); zinc bis dimethyldithiocarbamate 137-30-4 Acute Tox. 2 *, Acute Tox. 4 *, STOT RE 2 *, STOT SE 3, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H302, H373 **, H335, H318, H317, H400, H410 M = 100: CLP00/
006-013-00-8 metam-sodium (ISO); sodium methyldithiocarbamate 137-42-8 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H317, H400, H410 CLP00/
006-014-00-3 nabam (ISO); disodium ethylenebis(N,N'-dithiocarbamate) 142-59-6 Acute Tox. 4 *, STOT SE 3, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H335, H317, H410 CLP00/
006-015-00-9 diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea 330-54-1 Carc. 2, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H373**, H400, H410 M=10: CLP00/ATP01
006-016-00-4 propoxur (ISO); 2-isopropyloxyphenyl N-methylcarbamate; 2-isopropoxyphenyl methylcarbamate 114-26-1 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
006-017-00-X aldicarb (ISO); 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 116-06-3 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H311, H400, H410 CLP00/
006-018-00-5 aminocarb (ISO); 4-dimethylamino-3-tolyl methylcarbamate 2032-59-9 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 CLP00/
006-019-00-0 di-allate (ISO); S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 2303-16-4 Carc. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H400, H410 CLP00/
006-020-00-6 barban (ISO); 4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 101-27-9 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
006-021-00-1 linuron (ISO); 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 330-55-2 Repr. 1B, Carc. 2, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H351, H302, H373 **, H400, H410 CLP00/
006-022-00-7 decarbofuran (ISO); 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate 1563-67-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
006-023-00-2 mercaptodimethur (ISO); methiocarb (ISO); 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 2032-65-7 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
006-024-00-8 proxan-sodium (ISO); sodium O-isopropyldithiocarbonate 140-93-2 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Chronic 2 H302, H315, H411 CLP00/
006-025-00-3 allethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarb 584-79-2 [1], 28434-00-6 [2], 84030-86-4 [3] Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H400, H410 C CLP00/
006-026-00-9 carbofuran (ISO); 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 1563-66-2 Acute Tox. 2 *, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H400, H410 CLP00/
006-028-00-X dinobuton (ISO); 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 973-21-7 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
006-029-00-5 dioxacarb (ISO); 2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 6988-21-2 Acute Tox. 3 *, Aquatic Chronic 2 H301, H411 CLP00/
006-030-00-0 EPTC (ISO); S-ethyl dipropylthiocarbamate 759-94-4 Acute Tox. 4 * H302 CLP00/
006-031-00-6 formetanate (ISO); 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 22259-30-9 Acute Tox. 2 *, Acute Tox. 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H317, H400, H410 CLP00/
006-032-00-1 monolinuron (ISO); 3-(4-chlorophenyl)-1-methoxy-1-methylurea 1746-81-2 Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H400, H410 CLP00/
006-033-00-7 metoxuron (ISO); 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 19937-59-8 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
006-034-00-2 pebulate (ISO); N-butyl-N-ethyl-S-propylthiocarbamate 1114-71-2 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
006-035-00-8 pirimicarb (ISO); 5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate 23103-98-2 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
006-036-00-3 benzthiazuron (ISO); 1-benzothiazol-2-yl-3-methylurea 1929-88-0 Acute Tox. 4 * H302 CLP00/
006-037-00-9 promecarb (ISO); 3-isopropyl-5-methylphenyl N-methylcarbamate 2631-37-0 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
006-038-00-4 sulfallate (ISO); 2-chloroallyl N,N-dimethyldithiocarbamate 95-06-7 Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 CLP00/
006-039-00-X tri-allate (ISO); S-2,3,3-trichloroallyl diisopropylthiocarbamate 2303-17-5 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H317, H400, H410 CLP00/
006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate; monometilan 2532-43-6 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
006-041-00-0 dimethylcarbamoyl chloride 79-44-7 Carc. 1B, Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H350, H331, H302, H319, H335, H315 Carc. 1B; H350: C ≥ 0,001 % CLP00/
006-042-00-6 monuron (ISO); 3-(4-chlorophenyl)-1,1-dimethylurea 150-68-5 Carc. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H400, H410 CLP00/
006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; monuron-TCA 140-41-0 Carc. 2, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H319, H315, H400, H410 CLP00/
006-044-00-7 isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea 34123-59-6 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 M = 10: CLP00/
006-045-00-2 methomyl (ISO); 1-(methylthio)ethylideneamino N-methylcarbamate 16752-77-5 Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H400, H410 M=100: CLP00/ATP01
006-046-00-8 bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate 22781-23-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H312, H410 CLP00/
006-047-00-3 bufencarb (ISO); reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate 8065-36-9 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 CLP00/
006-048-00-9 ethiofencarb (ISO); 2-(ethylthiomethyl)phenyl N-methylcarbamate 29973-13-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
006-049-00-4 dixanthogen; O,O-diethyl dithiobis(thioformate) 502-55-6 Acute Tox. 4 * H302 CLP00/
006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate; fenuron-TCA 4482-55-7 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
006-051-00-5 ferbam (ISO); iron tris(dimethyldithiocarbamate) 14484-64-1 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H400, H410 CLP00/
006-052-00-0 formetanate hydrochloride; 3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 23422-53-9 Acute Tox. 2 *, Acute Tox. 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H317, H400, H410 CLP00/
006-053-00-6 isoprocarb (ISO); 2-isopropylphenyl N-methylcarbamate 2631-40-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
006-054-00-1 mexacarbate (ISO); 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 315-18-4 Acute Tox. 2 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H312, H400, H410 CLP00/
006-055-00-7 xylylcarb (ISO); 3,4-dimethylphenyl N-methylcarbamate; 3,4-xylyl methylcarbamate; MPMC 2425-10-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
006-056-00-2 metolcarb (ISO); m-tolyl methylcarbamate; MTMC 1129-41-5 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
006-057-00-8 nitrapyrin (ISO); 2-chloro-6-trichloromethylpyridine 1929-82-4 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
006-058-00-3 noruron (ISO); 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea 2163-79-3 Acute Tox. 4 * H302 CLP00/
006-059-00-9 oxamyl (ISO); N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate 23135-22-0 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 4 *, Aquatic Chronic 2 H330, H300, H312, H411 CLP00/
006-060-00-4 oxycarboxin (ISO); 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 5259-88-1 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; prothiocarb hydrochloride 19622-19-6 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
006-062-00-5 methyl 3,4-dichlorophenylcarbanilate; SWEP. 1918-18-9 Acute Tox. 4 * H302 CLP00/
006-063-00-0 thiobencarb (ISO); S-4-chlorobenzyl diethylthiocarbamate 28249-77-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
006-064-00-6 thiofanox (ISO); 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime 39196-18-4 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; triamid 15271-41-7 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Chronic 2 H300, H311, H411 CLP00/
006-066-00-7 vernolate (ISO); S-propyl dipropylthiocarbamate 1929-77-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
006-067-00-2 XMC; 3,5-xylyl methylcarbamate 2655-14-3 Acute Tox. 4 * H302 CLP00/
006-068-00-8 diazomethane 334-88-3 Carc. 1B H350 CLP00/
006-069-00-3 thiophanate-methyl (ISO); 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 23564-05-8 Muta. 2, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H332, H317, H400, H410 CLP00/
006-070-00-9 furmecyclox (ISO); N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide 60568-05-0 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 87731-18-8 Skin Sens. 1 H317 CLP00/
006-072-00-X prosulfocarb(ISO); S-benzyl N,N-dipropylthiocarbamate 52888-80-9 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
006-073-00-5 3-(dimethylamino)propylurea 31506-43-1 Eye Dam. 1 H318 CLP00/
006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 2094-99-7 Acute Tox. 2 *, Skin Corr. 1B, STOT RE 2 *, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H314, H373 **, H334, H317, H400, H410 CLP00/
006-076-00-1 mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt 8018-01-7 Repr. 2, Skin Sens. 1, Aquatic Acute 1 H361d***, H317, H400 M=10: CLP00/ATP01
006-077-00-7 maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) 12427-38-2 Repr. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d***, H332, H319, H317, H400, H410 M=10: CLP00/ATP01
006-078-00-2 zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric) 12122-67-7 STOT SE 3, Skin Sens. 1 H335, H317 CLP00/
006-079-00-8 disulfiram; tetraethylthiuramdisulfide 97-77-8 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H317, H400, H410 CLP00/
006-080-00-3 tetramethylthiuram monosulphide 97-74-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
006-081-00-9 zinc bis(dibutyldithiocarbamate) 136-23-2 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H317, H400, H410 CLP00/
006-082-00-4 zinc bis(diethyldithiocarbamate) 14324-55-1 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H315, H317, H400, H410 CLP00/
006-083-00-X butocarboxim (ISO); 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 34681-10-2 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H226, H331, H311, H301, H319, H400, H410 CLP00/
006-084-00-5 carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 55285-14-8 Acute Tox. 2 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H301, H317, H400, H410 CLP00/ATP01
006-085-00-0 fenobucarb (ISO); 2-butylphenyl methylcarbamate 3766-81-2 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
006-086-00-6 fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy) ethyl]carbamatefenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy) ethyl]carbamate 72490-01-8 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 M=1, M=10000 CLP00/ATP06
006-087-00-1 furathiocarb (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate 65907-30-4 Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H301, H373**, H319, H315, H317, H400, H410 M=100: CLP00/ATP01
006-088-00-7 benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- ß-alaninate 82560-54-1 Repr. 2, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H361f***, H331, H302, H400, H410 CLP00/ATP01
006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 88558-41-2 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H332, H318, H412 CLP00/
006-091-00-3 propineb (ISO); polymeric zinc propylenebis(dithiocarbamate) 9016-72-2 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1 H332, H373**, H317, H400 ATP01/
006-092-00-9 tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate 98737-29-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
006-093-00-4 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) - Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 ATP01/
006-094-00-X O-isobutyl-N-ethoxy carbonylthiocarbamate 103122-66-3 Flam. Liq. 3, Carc. 1B, Muta. 1B, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H226, H350, H340, H302, H373**, H317, H411 ATP01/
006-095-00-5 fosetyl-aluminium (ISO); aluminium triethyl triphosphonate 39148-24-8 Eye Dam. 1 H318 ATP01/
006-096-00-0 chlorpropham (ISO); isopropyl 3-chlorocarbanilate 101-21-3 Carc. 2, STOT RE 2 *, Aquatic Chronic 2 H351, H373**, H411 ATP01/
006-097-00-6 1-phenyl-3-(p-toluenesulfonyl)urea 13909-63-2 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 3 H302, H373**, H412 ATP01/
006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate 134575-17-0 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H302, H373**, H318, H317 ATP01/
006-099-00-7 N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate 232938-43-1 Aquatic Chronic 2 H411 ATP01/
006-101-00-6 reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] - Aquatic Chronic 4 H413 ATP01/
006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate - Carc. 1B, Muta. 1B, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H350, H340, H302, H373**, H317, H411 ATP01/
006-103-00-7 N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea - Eye Dam. 1, Resp. Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H334, H400, H410 M=100: ATP01/
007-001-00-5 ammonia, anhydrous 7664-41-7 Flam. Gas 2, Press. Gas, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1 H221, H331, H314, H400 U CLP00/
007-001-01-2 ammonia ....% 1336-21-6 Skin Corr. 1B, Aquatic Acute 1 H314, H400 STOT SE 3; H335: C ≥ 5 % B CLP00/
007-002-00-0 nitrogen dioxide; [1] dinitrogen tetraoxide [2] 10102-44-0 [1], 10544-72-6 [2] Press. Gas, Ox. Gas 1, Acute Tox. 2 *, Skin Corr. 1B H270, H330, H314 *, STOT SE 3; H335: C ≥ 0,5 % 5 CLP00/ATP01
007-003-00-6 chlormequat chloride (ISO); 2-chloroethyltrimethylammonium chloride 999-81-5 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
007-004-00-1 nitric acid ... % 7697-37-2 Ox. Liq. 2, Skin Corr. 1A H272, H314 Skin Corr. 1A; H314: C >= 20 %, Skin Corr. 1B; H314: 5 % <= C < 20 %, Ox. Liq. 2; H272: C >= 99 %, Ox. Liq 3; H272: 99% > C >= 65% B CLP00/ATP07
007-006-00-2 ethyl nitrite 109-95-5 Flam. Gas 1, Press. Gas, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H220, H332, H312, H302 U CLP00/
007-007-00-8 ethyl nitrate 625-58-1 Unst. Expl H200 CLP00/ATP01
007-008-00-3 hydrazine 302-01-2 Flam. Liq. 3, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H226, H350, H331, H311, H301, H314, H317, H400, H410 Skin Corr. 1B; H314: C ≥ 10 %, Skin Irrit. 2; H315: 3 % ≤ C < 10 %, Eye Irrit. 2; H319: 3 % ≤ C < 10 % CLP00/
007-009-00-9 dicyclohexylammonium nitrite 3129-91-7 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 * CLP00/
007-010-00-4 sodium nitrite 7632-00-0 Ox. Sol. 3, Acute Tox. 3 *, Aquatic Acute 1 H272, H301, H400 * CLP00/
007-011-00-X potassium nitrite 7758-09-0 Ox. Sol. 2, Acute Tox. 3 *, Aquatic Acute 1 H272, H301, H400 * CLP00/
007-012-00-5 N,N-dimethylhydrazine 57-14-7 Flam. Liq. 2, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Chronic 2 H225, H350, H331, H301, H314, H411 CLP00/
007-013-00-0 1,2-dimethylhydrazine 540-73-8 Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H350, H331, H311, H301, H411 Carc. 1B; H350: C ≥ 0,01 % CLP00/
007-014-00-6 salts of hydrazine - Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H331, H311, H301, H317, H400, H410 A CLP00/
007-015-00-1 O-ethylhydroxylamine 624-86-2 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H225, H331, H311, H301, H372 **, H319, H317, H400 CLP00/
007-016-00-7 butyl nitrite 544-16-1 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 * H225, H331, H301 CLP00/
007-017-00-2 isobutyl nitrite 542-56-3 Flam. Liq. 2, Carc. 1B, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H350, H341, H332, H302 CLP00/
007-018-00-8 sec-butyl nitrite 924-43-6 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H302 CLP00/
007-019-00-3 tert-butyl nitrite 540-80-7 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H302 CLP00/
007-020-00-9 pentyl nitrite; [1] `amyl nitrite , mixed isomers [2] 463-04-7 [1], 110-46-3 [2] Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H302 CLP00/
007-021-00-4 hydrazobenzene; 1,2-diphenylhydrazine 122-66-7 Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 CLP00/
007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) - Carc. 1B, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H350, H302, H314, H317, H412 CLP00/
007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate - Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
007-024-00-0 2-(decylthio)ethylammonium chloride 36362-09-1 STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H315, H318, H400, H410 CLP00/
007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 81880-96-8 Muta. 2, Acute Tox. 3 *, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H301, H372 **, H317, H400, H410 CLP00/
007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 122035-71-6 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 771478-66-1 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373 **, H314, H317, H400, H410 CLP00/
007-028-00-2 hydroxylammonium nitrate 13465-08-2 Expl. 1.1 ****, Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H201, H351, H311, H302, H373**, H319, H315, H317, H400 ATP01/
007-029-00-8 diethyldimethylammonium hydroxide 95500-19-9 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H312, H302, H314 ATP01/
008-001-00-8 oxygen 7782-44-7 Ox. Gas 1, Press. Gas H270 U CLP00/
008-003-00-9 hydrogen peroxide solution ... % 7722-84-1 Ox. Liq. 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H271, H332, H302, H314 Ox. Liq. 1; H271: C ≥ 70 %****, Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****, *, Skin Corr. 1A; H314: C ≥ 70 %, Skin Corr. 1B; H314: 50 % ≤ C < 70 %, Skin Irrit. 2; H315: 35 % ≤ C < 50 %, Eye Dam. 1; H318: 8 % ≤ C < 50 %, Eye Irrit. 2; H319: 5 % ≤ C < 8 %, STOT B CLP00/
009-001-00-0 fluorine 7782-41-4 Press. Gas, Ox. Gas 1, Acute Tox. 2 *, Skin Corr. 1A H270, H330, H314 CLP00/ATP01
009-002-00-6 hydrogen fluoride 7664-39-3 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Skin Corr. 1A H330, H310, H300, H314 CLP00/
009-003-00-1 hydrofluoric acid ... % 7664-39-3 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Skin Corr. 1A H330, H310, H300, H314 Skin Corr. 1A; H314: C ≥ 7 %, Skin Corr. 1B; H314: 1 % ≤ C < 7 %, Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % B CLP00/
009-004-00-7 sodium fluoride 7681-49-4 Acute Tox. 3 *, Eye Irrit. 2, Skin Irrit. 2 H301, H319, H315 CLP00/
009-005-00-2 potassium fluoride 7789-23-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
009-006-00-8 ammonium fluoride 12125-01-8 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
009-007-00-3 sodium bifluoride; sodium hydrogen difluoride 1333-83-1 Acute Tox. 3 *, Skin Corr. 1B H301, H314 *, Skin Corr. 1B; H314: C ≥ 1 %, Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %, Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % CLP00/
009-008-00-9 potassium bifluoride; potassium hydrogen difluoride 7789-29-9 Acute Tox. 3 *, Skin Corr. 1B H301, H314 *, Skin Corr. 1B; H314: C ≥ 1 %, Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %, Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % CLP00/
009-009-00-4 ammonium bifluoride; ammonium hydrogen difluoride 1341-49-7 Acute Tox. 3 *, Skin Corr. 1B H301, H314 *, Skin Corr. 1B; H314: C ≥ 1 %, Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %, Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % CLP00/
009-010-00-X fluoroboric acid ... % 16872-11-0 Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % B CLP00/
009-011-00-5 fluorosilicic acid ... % 16961-83-4 Skin Corr. 1B H314 B CLP00/
009-012-00-0 alkali fluorosilicates(Na); [1] alkali fluorosilicates(K); [2] alkali fluorosilicates(NH4) [3] 16893-85-9 [1], 16871-90-2 [2], 16919-19-0 [3] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 * A CLP00/
009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this annex - Acute Tox. 4 * H302 * A CLP00/
009-014-00-1 lead hexafluorosilicate 25808-74-6 Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H332, H302, H373 **, H400, H410 1 CLP00/
009-015-00-7 sulphuryl difluoride 2699-79-8 Press. Gas, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1 H331, H373 **, H400 U CLP00/
009-016-00-2 trisodium hexafluoroaluminate [1] trisodium hexafluoroaluminate (cryolite) [2] 13775-53-6 [1], 15096-52-3 [2] STOT RE 1, Acute Tox. 4 , Aquatic Chronic 2 H372, H332, H411 CLP00/ATP03
009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 12091-08-6 Flam. Sol. 1, Water-react. 1, Skin Corr. 1A, Acute Tox. 4 * H228, H270, H314, H332 T CLP00/
009-018-00-3 magnesium hexafluorosilicate 16949-65-8 Acute Tox. 3 * H301 * CLP00/
011-001-00-0 sodium 7440-23-5 Water-react. 1, Skin Corr. 1B H260, H314 CLP00/
011-002-00-6 sodium hydroxide; caustic soda 1310-73-2 Skin Corr. 1A H314 Skin Corr. 1A; H314: C ≥ 5 %, Skin Corr. 1B; H314: 2 % ≤ C < 5 %, Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % CLP00/
011-003-00-1 sodium peroxide 1313-60-6 Ox. Sol. 1, Skin Corr. 1A H271, H314 CLP00/
011-004-00-7 sodium azide 26628-22-8 Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H400, H410 CLP00/
011-005-00-2 sodium carbonate 497-19-8 Eye Irrit. 2 H319 CLP00/
011-006-00-8 sodium cyanate 917-61-3 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
011-007-00-3 propoxycarbazone-sodium 181274-15-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M = 10: CLP00/
012-001-00-3 magnesium powder (pyrophoric) 7439-95-4 Water-react. 1, Pyr. Sol. 1 H260, H250 T CLP00/
012-002-00-9 magnesium, powder or turnings - Flam. Sol. 1, Water-react. 2, Self-heat. 1 H228, H261, H252 T CLP00/
012-003-00-4 magnesium alkyls - Pyr. Liq. 1, Water-react. 1, Skin Corr. 1B H250, H260, H314 A CLP00/
012-004-00-X aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
013-001-00-6 aluminium powder (pyrophoric) 7429-90-5 Water-react. 2, Pyr. Sol. 1 H261, H250 T CLP00/
013-002-00-1 aluminium powder (stabilised) 7429-90-5 Water-react. 2, Flam. Sol. 1 H261, H228 T CLP00/ATP01
013-003-00-7 aluminium chloride, anhydrous 7446-70-0 Skin Corr. 1B H314 CLP00/
013-004-00-2 aluminium alkyls - Pyr. Liq. 1, Water-react. 1, Skin Corr. 1B H250, H260, H314 A CLP00/
013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 55426-95-4 Water-react. 1, Pyr. Liq. 1, Skin Corr. 1A H260, H250, H314 CLP00/
013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised - Flam. Liq. 3, Eye Dam. 1 H226, H318 CLP00/
013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) - Eye Dam. 1 H318 CLP00/
013-008-00-4 di-n-octylaluminium iodide 7585-14-0 Pyr. Liq. 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H250, H314, H400, H410 CLP00/
013-009-00-X sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5 - Flam. Sol. 1, Water-react. 1, Pyr. Sol. 1, Acute Tox. 4 *, Skin Corr. 1A H228, H260, H250, H332, H314 T CLP00/
013-010-00-5 hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide) 151841-65-5 Aquatic Chronic 2 H411 ATP01/
014-001-00-9 trichlorosilane 10025-78-2 Flam. Liq. 1, Pyr. Liq. 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H224, H250, H332, H302, H314 *, STOT SE 3; H335: C ≥ 1 % T CLP00/
014-002-00-4 silicon tetrachloride 10026-04-7 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 CLP00/
014-003-00-X dimethyldichlorosilane 75-78-5 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H225, H319, H335, H315 CLP00/
014-004-00-5 trichloro(methyl)silane; methyltrichlorosilane 75-79-6 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H225, H319, H335, H315 Skin Irrit. 2; H315: C ≥ 1 %, Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % CLP00/
014-005-00-0 tetraethyl silicate; ethyl silicate 78-10-4 Flam. Liq. 3, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H226, H332, H319, H335 CLP00/
014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride - Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
014-007-00-1 triethoxyisobutylsilane 17980-47-1 Skin Irrit. 2 H315 CLP00/
014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 85491-26-5 Aquatic Chronic 2 H411 CLP00/
014-009-00-2 isobutylisopropyldimethoxysilane 111439-76-0 Flam. Liq. 3, Acute Tox. 4 *, Skin Irrit. 2 H226, H332, H315 CLP00/
014-010-00-8 disodium metasilicate 6834-92-0 Skin Corr. 1B, STOT SE 3 H314, H335 CLP00/
014-011-00-3 cyclohexyldimethoxymethylsilane 17865-32-6 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
014-013-00-4 -hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) - Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H312, H302, H314, H411 CLP00/
014-014-00-X etacelasil (ISO); 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane 37894-46-5 Repr. 1B, Acute Tox. 4 *, STOT RE 2 * H360D ***, H302, H373 ** CLP00/
014-015-00-5 -trimethylsilanyl- -trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane)) 69430-40-6 Aquatic Chronic 4 H413 CLP00/
014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane - Aquatic Chronic 2 H411 CLP00/
014-017-00-6 flusilazole (ISO); bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane 85509-19-9 Carc. 2, Repr. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H351, H360D ***, H302, H411 CLP00/
014-018-00-1 octamethylcyclotetrasiloxane 556-67-2 Repr. 2, Aquatic Chronic 4 H361f ***, H413 CLP00/
014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole - Carc. 2, Repr. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H351, H360D ***, H302, H411 CLP00/
014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 53863-99-3 Acute Tox. 4 * H332 CLP00/
014-021-00-8 tris(isopropenyloxy)phenyl silane 52301-18-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) - Flam. Sol. 1, STOT SE 1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H228, H370 **, H332, H312, H302 T CLP00/
014-023-00-9 , -dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 125613-45-8 Aquatic Chronic 2 H411 CLP00/
014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 121626-74-2 Aquatic Chronic 2 H411 CLP00/
014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 102089-33-8 Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H302, H373 **, H315, H318, H412 CLP00/
014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 770722-36-6 Skin Corr. 1A H314 CLP00/
014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 770722-46-8 Skin Corr. 1A H314 CLP00/
014-028-00-6 -[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy- -[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 193159-06-7 Skin Sens. 1 H317 CLP00/
014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 156145-66-3 Repr. 2, Acute Tox. 4 *, STOT RE 2 * H361f ***, H302, H373 ** CLP00/
014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a- )-1H-inden-1-ylidene)dimethyl]hafnium 137390-08-0 Acute Tox. 2 * H300 CLP00/
014-031-00-2 bis(1-methylethyl)-dimethoxysilane 18230-61-0 Flam. Liq. 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H226, H315, H317, H412 CLP00/
014-032-00-8 dicyclopentyldimethoxysilane 126990-35-0 Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
014-033-00-3 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica 125804-20-8 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 ATP01/
014-034-00-9 3-hexylheptamethyltrisiloxane 1873-90-1 Acute Tox. 4 *, Aquatic Chronic 4 H332, H413 ATP01/
014-035-00-4 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane 10217-34-2 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
014-036-00-X (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane 105024-66-6 Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H360F***, H400, H410 M=1000: ATP01/
014-037-00-5 2-butanone-O,O',O''-(phenylsilylidyne)trioxime 34036-80-1 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H373**, H317, H412 ATP01/
014-038-00-0 S-(3-(triethoxysilyl)propyl)octanethioate 220727-26-4 Skin Sens. 1 H317 ATP01/
014-039-00-6 (2,3-dimethylbut-2-yl)-trimethoxysilane 142877-45-0 Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H315, H318, H412 ATP01/
014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane 201290-01-9 Acute Tox. 4 *, Skin Sens. 1 H302, H317 ATP01/
014-042-00-2 reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) - Eye Dam. 1 H318 ATP01/
014-043-00-8 reaction product of amorphous silica (50-85%), butyl (1-methylpropyl) magnesium (3-15%), tetraethyl orthosilicate (5-15%) and titanium tetrachloride (5-20%) - Aquatic Chronic 2 H411 ATP01/
014-044-00-3 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane - Aquatic Chronic 2 H411 ATP01/
014-045-00-9 magnesium sodium fluoride silicate - STOT RE 2 * H373** ATP01/
015-001-00-1 white phosphorus 12185-10-3 Pyr. Sol. 1, Acute Tox. 2 *, Acute Tox. 2 *, Skin Corr. 1A, Aquatic Acute 1 H250, H330, H300, H314, H400 CLP00/
015-002-00-7 red phosphorus 7723-14-0 Flam. Sol. 1, Aquatic Chronic 3 H228, H412 CLP00/
015-003-00-2 calcium phosphide; tricalcium diphosphide 1305-99-3 Water-react. 1, Acute Tox. 2, Acute Tox. 3, Acute Tox. 1, Eye Dam. 1, Aquatic Acute 1 H260, H300, H311, H330, H318, H400 M=100: CLP00/ATP07
015-004-00-8 aluminium phosphide 20859-73-8 Water-react. 1, Acute Tox. 2 , Acute Tox. 3 , Acute Tox. 1 , Aquatic Acute 1 H260, H300, H311, H330, H400 M=100: CLP00/ATP01/ATP05
015-005-00-3 magnesium phosphide; trimagnesium diphosphide 12057-74-8 Water-react. 1, Acute Tox. 2, Acute Tox. 3, Acute Tox. 1, Aquatic Acute 1 H260, H300, H311, H330, H400 M=100 CLP00/ATP01/ATP05
015-006-00-9 trizinc diphosphide; zinc phosphide 1314-84-7 Water-react. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H260, H300, H400, H410 M=100: T CLP00/ATP01
015-007-00-4 phosphorus trichloride 7719-12-2 Acute Tox. 2 *, Acute Tox. 2 *, STOT RE 2 *, Skin Corr. 1A H330, H300, H373 **, H314 CLP00/
015-008-00-X phosphorus pentachloride 10026-13-8 Acute Tox. 2 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B H330, H302, H373 **, H314 CLP00/
015-009-00-5 phosphoryl trichloride 10025-87-3 Acute Tox. 2 *, STOT RE 1, Acute Tox. 4 *, Skin Corr. 1A H330, H372 **, H302, H314 CLP00/
015-010-00-0 phosphorus pentoxide 1314-56-3 Skin Corr. 1A H314 CLP00/
015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 7664-38-2 Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % B CLP00/
015-012-00-1 tetraphosphorus trisulphide; phosphorus sesquisulphid 1314-85-8 Flam. Sol. 2, Water-react. 1, Acute Tox. 4 *, Aquatic Acute 1 H228, H260, H302, H400 T CLP00/
015-013-00-7 triethyl phosphate 78-40-0 Acute Tox. 4 * H302 CLP00/
015-014-00-2 tributyl phosphate 126-73-8 Carc. 2, Acute Tox. 4 *, Skin Irrit. 2 H351, H302, H315 CLP00/
015-015-00-8 tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-) 78-30-8 STOT SE 1, Aquatic Chronic 2 H370 **, H411 STOT SE 1; H370: C ≥ 1 %, STOT SE 2; H371: 0,2 % ≤ C < 1 % C CLP00/
015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-) 78-32-0 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H312, H302, H411 * C CLP00/
015-019-00-X dichlorvos (ISO); 2,2-dichlorovinyl dimethyl phosphate 62-73-7 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1 H330, H311, H301, H317, H400 M=1000: CLP00/ATP01
015-020-00-5 mevinphos (ISO); 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 7786-34-7 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 M = 10000: CLP00/
015-021-00-0 trichlorfon (ISO); dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 52-68-6 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 M = 1000: CLP00/
015-022-00-6 phosphamidon (ISO); 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate 13171-21-6 Muta. 2, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H341, H300, H311, H400, H410 CLP00/
015-023-00-1 pyrazoxon; diethyl 3-methylpyrazol-5-yl phosphate 108-34-9 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H330, H310, H300 CLP00/
015-024-00-7 triamiphos (ISO); 5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide 1031-47-6 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-025-00-2 TEPP (ISO); tetraethyl pyrophosphate 107-49-3 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1 H310, H300, H400 CLP00/
015-026-00-8 schradan (ISO); octamethylpyrophosphoramide 152-16-9 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-027-00-3 sulfotep (ISO); O,O,O,O-tetraethyl dithiopyrophosphate 3689-24-5 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 M = 1000: CLP00/
015-028-00-9 demeton-O (ISO); O,O-diethyl-O-2-ethylthioethyl phosphorothioate 298-03-3 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1 H310, H300, H400 CLP00/
015-029-00-4 demeton-S (ISO); diethyl-S-2-ethylthioethyl phosphorothioate 126-75-0 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-030-00-X demeton-O-methyl (ISO); O-2-ethylthioethyl O,O-dimethyl phosphorothioate 867-27-6 Acute Tox. 3 * H301 CLP00/
015-031-00-5 demeton-S-methyl (ISO); S-2-ethylthioethyl dimethyl phosphorothioate 919-86-8 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H311, H301, H411 CLP00/
015-032-00-0 prothoate (ISO); O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 2275-18-5 Acute Tox. 1, Acute Tox. 2 *, Aquatic Chronic 3 H310, H300, H412 CLP00/
015-033-00-6 phorate (ISO); O,O-diethyl ethylthiomethyl phosphorodithioate 298-02-2 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 M = 1000: CLP00/
015-034-00-1 parathion (ISO); O,O-diethyl O-4-nitrophenyl phosphorothioate 56-38-2 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H311, H372 **, H400, H410 M = 100: CLP00/
015-035-00-7 parathion - methyl (ISO); O,O-dimethyl O-4-nitrophenyl phosphorothioate 298-00-0 Flam. Liq. 3, Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H226, H330, H300, H311, H373 **, H400, H410 M = 100: CLP00/
015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate; EPN 2104-64-5 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
015-037-00-8 phenkapton (ISO); S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate 2275-14-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 CLP00/
015-038-00-3 coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 56-72-4 Acute Tox. 2 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H312, H400, H410 CLP00/
015-039-00-9 azinphos-methyl (ISO); O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 86-50-0 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H311, H317, H400, H410 CLP00/
015-040-00-4 diazinon (ISO); O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 333-41-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-041-00-X malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing 0.03 % isomalathion] 121-75-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 M=1000: CLP00/ATP01
015-042-00-5 chlorthion; O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate 500-28-7 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 M = 100: CLP00/
015-043-00-0 phosnichlor (ISO); O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate 5826-76-6 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 CLP00/
015-044-00-6 carbophenothion (ISO); 4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate 786-19-6 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 CLP00/
015-045-00-1 mecarbam (ISO); N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate 2595-54-2 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 CLP00/
015-046-00-7 oxydemeton-methyl; S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 301-12-2 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1 H311, H301, H400 CLP00/
015-047-00-2 ethion (ISO); O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate); diethion 563-12-2 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 M = 10000: CLP00/
015-048-00-8 fenthion (ISO); O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 55-38-9 Muta. 2, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H331, H312, H302, H372**, H400, H410 M=100: CLP00/ATP01
015-049-00-3 endothion (ISO); S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 2778-04-3 Acute Tox. 3 *, Acute Tox. 3 * H311, H301 CLP00/
015-050-00-9 thiometon (ISO); S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 640-15-3 Acute Tox. 3 *, Acute Tox. 4 * H301, H312 CLP00/
015-051-00-4 dimethoate (ISO); O,O-dimethyl methylcarbamoylmethyl phosphorodithioate 60-51-5 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
015-052-00-X fenchlorphos (ISO); O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 299-84-3 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
015-053-00-5 menazon (ISO); S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate 78-57-9 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
015-054-00-0 fenitrothion (ISO); O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate 122-14-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-055-00-6 naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 300-76-5 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1 H312, H302, H319, H315, H400 M = 1000: CLP00/
015-056-00-1 azinphos-ethyl (ISO); O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 2642-71-9 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 M=100: CLP00/ATP01
015-057-00-7 formothion (ISO); N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate 2540-82-1 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
015-058-00-2 morphothion (ISO); O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 144-41-2 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 CLP00/
015-059-00-8 vamidothion (ISO); O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 2275-23-2 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1 H301, H312, H400 CLP00/
015-060-00-3 disulfoton (ISO); O,O-diethyl 2-ethylthioethyl phosphorodithioate 298-04-4 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
015-061-00-9 dimefox (ISO); tetramethylphosphorodiamidic fluoride 115-26-4 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-062-00-4 mipafox (ISO); N,N'- di-isopropylphosphorodiamidic fluoride 371-86-8 STOT SE 1 H370 ** CLP00/
015-063-00-X dioxathion (ISO); 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 78-34-2 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H311, H400, H410 M = 1000: CLP00/
015-064-00-5 bromophos-ethyl (ISO); O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 4824-78-6 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 CLP00/
015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate 2703-37-9 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Chronic 2 H330, H310, H300, H411 CLP00/
015-066-00-6 omethoate (ISO); O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate 1113-02-6 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1 H301, H312, H400 CLP00/
015-067-00-1 phosalone (ISO); S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate 2310-17-0 Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H332, H312, H317, H400, H410 M=1000: CLP00/ATP01
015-068-00-7 dichlofenthion (ISO); O-,4-dichlorophenyl O,O-diethyl phosphorothioate 97-17-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-069-00-2 methidathion (ISO); 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 950-37-8 Acute Tox. 2 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H312, H400, H410 CLP00/
015-070-00-8 cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 3734-95-0 Acute Tox. 2 *, Acute Tox. 3 * H300, H311 CLP00/
015-071-00-3 chlorfenvinphos (ISO); 2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate 470-90-6 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 CLP00/
015-072-00-9 monocrotophos (ISO); dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 6923-22-4 Muta. 2, Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H341, H330, H300, H311, H400, H410 CLP00/
015-073-00-4 dicrotophos (ISO); (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 141-66-2 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 CLP00/
015-074-00-X crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 299-86-5 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate 2635-50-9 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
015-076-00-0 potasan; O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate 299-45-6 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 M = 1000: CLP00/
015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate 7076-53-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
015-078-00-1 demeton-S-methylsulphon (ISO); S-2-ethylsulphonylethyl dimethyl phosphorothioate 17040-19-6 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Chronic 2 H301, H312, H411 CLP00/
015-079-00-7 acephate (ISO); O,S-dimethyl acetylphosphoramidothioate 30560-19-1 Acute Tox. 4 * H302 CLP00/
015-080-00-2 amidithion (ISO); 2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 919-76-6 Acute Tox. 4 * H302 CLP00/
015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 3244-90-4 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
015-082-00-3 azothoate (ISO); O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 5834-96-8 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 CLP00/
015-083-00-9 bensulide (ISO); O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 741-58-2 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-084-00-4 chlorpyrifos (ISO); O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 2921-88-2 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 M = 10000: CLP00/
015-085-00-X chlorphonium chloride (ISO); tributyl (2,4-dichlorobenzyl) phosphonium chloride 115-78-6 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H301, H312, H319, H315 CLP00/
015-086-00-5 coumithoate (ISO); O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate 572-48-5 Acute Tox. 3 * H301 CLP00/
015-087-00-0 cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate 2636-26-2 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
015-088-00-6 dialifos (ISO); 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 10311-84-9 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 CLP00/
015-089-00-1 ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 116-01-8 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
015-090-00-7 fensulfothion (ISO); O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 115-90-2 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
015-091-00-2 fonofos (ISO); O-ethyl phenyl ethylphosphonodithioate 944-22-9 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
015-092-00-8 phosacetim (ISO); O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 4104-14-7 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
015-093-00-3 leptophos (ISO); O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 21609-90-5 Acute Tox. 3 *, STOT SE 1, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H370 **, H312, H400, H410 CLP00/
015-094-00-9 mephosfolan (ISO); diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 950-10-7 Acute Tox. 1, Acute Tox. 2 *, Aquatic Chronic 2 H310, H300, H411 CLP00/
015-095-00-4 methamidophos (ISO); O,S-dimethyl phosphoramidothioate 10265-92-6 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1 H330, H300, H311, H400 CLP00/
015-096-00-X oxydisulfoton (ISO); O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate 2497-07-6 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 M = 10: CLP00/
015-097-00-5 phenthoate (ISO); ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 2597-03-7 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 M = 100: CLP00/
015-098-00-0 trichloronate (ISO); O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 327-98-0 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 CLP00/
015-099-00-6 pirimiphos-ethyl (ISO); O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 23505-41-1 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 CLP00/
015-100-00-X phoxim (ISO); -(diethoxyphosphinothioylimino) phenylacetonitrile 14816-18-3 Repr. 2, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f***, H302, H317, H400, H410 M=1000: CLP00/ATP01
015-101-00-5 phosmet (ISO); O,O-dimethyl phthalimidomethyl S-phosphorodithioate 732-11-6 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 M = 100: CLP00/
015-102-00-0 tris(2-chloroethyl)phosphate 115-96-8 Carc. 2, Repr. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H351, H360F***, H302, H411 CLP00/ATP01
015-103-00-6 phosphorus tribromide 7789-60-8 Skin Corr. 1B, STOT SE 3 H314, H335 CLP00/
015-104-00-1 diphosphorus pentasulphide; phosphorus pentasulphide 1314-80-3 Flam. Sol. 1, Water-react. 1, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H228, H260, H332, H302, H400 T CLP00/
015-105-00-7 triphenyl phosphite 101-02-0 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 Skin Irrit. 2; H315: C ≥ 5 %, Eye Irrit. 2; H319: C ≥ 5 % CLP00/
015-106-00-2 hexamethylphosphoric triamide; hexamethylphosphoramide 680-31-9 Carc. 1B, Muta. 1B H350, H340 Carc. 1B; H350: C ≥ 0,01 % CLP00/
015-107-00-8 ethoprophos (ISO); ethyl-S,S-dipropyl phosphorodithioate 13194-48-4 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H301, H317, H400, H410 CLP00/
015-108-00-3 bromophos (ISO); O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 2104-96-3 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M = 100: CLP00/
015-109-00-9 crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 7700-17-6 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 M = 10: CLP00/
015-110-00-4 cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate 13067-93-1 Acute Tox. 3 *, STOT SE 1, Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 2 H301, H370 **, H312, H319, H411 CLP00/
015-111-00-X phosfolan (ISO); diethyl 1,3-dithiolan-2-ylidenephosphoramidate 947-02-4 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-112-00-5 thionazin (ISO); O,O-diethyl O-pyrazin-2-yl phosphorothioate 297-97-2 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-113-00-0 tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate 57018-04-9 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
015-114-00-6 chlormephos (ISO); S-chloromethyl O,O-diethyl phosphorodithioate 24934-91-6 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M=10: CLP00/ATP01
015-115-00-1 chlorthiophos (ISO); [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates] 21923-23-9 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 M=1000: CLP00/ATP01
015-116-00-7 demephion-O (ISO); O,O-dimethyl O-2-methylthioethyl phosphorothioate 682-80-4 Acute Tox. 2 *, Acute Tox. 3 * H300, H311 CLP00/
015-117-00-2 demephion-S (ISO); O,O-dimethyl S-2-methylthioethyl phosphorothioate 2587-90-8 Acute Tox. 2 *, Acute Tox. 3 * H300, H311 CLP00/
015-118-00-8 demeton 8065-48-3 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1 H310, H300, H400 CLP00/
015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate 3254-63-5 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-120-00-9 ditalimfos (ISO); O,O-diethyl phthalimidophosphonothioate 5131-24-8 Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
015-121-00-4 edifenphos (ISO); O-ethyl S,S-diphenyl phosphorodithioate 17109-49-8 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H312, H317, H400, H410 CLP00/
015-122-00-X etrimfos (ISO); O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate 38260-54-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M = 10: CLP00/
015-123-00-5 fenamiphos (ISO); ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 22224-92-6 Acute Tox. 2, Acute Tox. 2, Acute Tox. 2, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H300, H310, H330, H319, H400, H410 M = 100, M = 100 CLP00/ATP05
015-124-00-0 fosthietan (ISO); diethyl 1,3-dithietan-2-ylidenephosphoramidate 21548-32-3 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
015-125-00-6 glyphosine (ISO); N,N-bis(phosphonomethyl)glycine 2439-99-8 Eye Dam. 1 H318 CLP00/
015-126-00-1 heptenophos (ISO); 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 23560-59-0 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 M = 100: CLP00/
015-127-00-7 iprobenfos (ISO); S-benzyl diisopropyl phosphorothioate 26087-47-8 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
015-128-00-2 IPSP; S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate 5827-05-4 Acute Tox. 1, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H301, H400, H410 M = 100: CLP00/
015-129-00-8 isofenphos (ISO); O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 25311-71-1 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 M = 100: CLP00/
015-130-00-3 isothioate (ISO); S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate 36614-38-7 Acute Tox. 3 *, Acute Tox. 3 * H311, H301 CLP00/
015-131-00-9 isoxathion (ISO); O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 18854-01-8 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 CLP00/
015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione 953-17-3 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 M = 1000: CLP00/
015-133-00-X piperophos (ISO); S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate 24151-93-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M = 10: CLP00/
015-134-00-5 pirimiphos-methyl (ISO); O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate 29232-93-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-135-00-0 profenofos (ISO); O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate 41198-08-7 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 M = 1000: CLP00/
015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO) 31218-83-4 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 M = 100: CLP00/
015-137-00-1 pyrazophos (ISO); O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 13457-18-6 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H400, H410 CLP00/
015-138-00-7 quinalphos (ISO); O,O-diethyl-O-quinoxalin-2-yl phosphorothioate 13593-03-8 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 M = 1000: CLP00/
015-139-00-2 terbufos (ISO); S-tert-butylthiomethyl O,O-diethylphosphorodithioate 13071-79-9 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 M = 1000: CLP00/
015-140-00-8 triazophos (ISO); O,O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate 24017-47-8 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H312, H400, H410 M=100: CLP00/ATP01
015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers - Skin Corr. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H314, H302, H400, H410 CLP00/
015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate - Flam. Liq. 2, Eye Irrit. 2, Aquatic Chronic 2 H225, H319, H411 T CLP00/
015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers - Acute Tox. 4 * H302 CLP00/
015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 87025-52-3 Skin Corr. 1B H314 CLP00/
015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) - Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H315, H318, H317, H411 CLP00/
015-148-00-1 2-(diphosphonomethyl)succinic acid 51395-42-7 Skin Corr. 1B, Skin Sens. 1 H314, H317 CLP00/
015-149-00-7 reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide - Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 CLP00/
015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 86608-70-0 Acute Tox. 4 *, Eye Dam. 1, STOT RE 2 *, Aquatic Chronic 3 H302, H318, H373 **, H412 CLP00/
015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate - Aquatic Chronic 2 H411 CLP00/
015-152-00-3 dioxabenzofos (ISO); 2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide 3811-49-2 Acute Tox. 3 *, Acute Tox. 3 *, STOT SE 1, Aquatic Chronic 2 H311, H301, H370 **, H411 CLP00/
015-153-00-9 isazofos (ISO); O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate 42509-80-8 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H311, H301, H373 **, H317, H400, H410 CLP00/
015-154-00-4 ethephon; 2-chloroethylphosphonic acid 16672-87-0 Acute Tox. 3, Acute Tox. 4, Acute Tox. 4, Skin Corr. 1C, Aquatic Chronic 2 H311, H332, H302, H314, H411 CLP00/ATP06
015-155-00-X glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate 77182-82-2 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 * H360Fd, H332, H312, H302, H373** CLP00/ATP01
015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] methacrifos (ISO); methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 30864-28-9 [1], 62610-77-9 [2] Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
015-157-00-0 phosphonic acid; [1] phosphorous acid [2] 13598-36-2 [1], 10294-56-1 [2] Acute Tox. 4 *, Skin Corr. 1A H302, H314 CLP00/
015-158-00-6 ( -cyclopentadienyl)( -cumenyl)iron(1+)hexafluorophosphate(1-) 32760-80-8 Aquatic Chronic 3 H412 CLP00/
015-159-00-1 hydroxyphosphonoacetic acid 23783-26-8 Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1 H302, H373 **, H314, H317 CLP00/
015-160-00-7 vanadyl pyrophosphate 58834-75-6 Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H319, H317, H412 CLP00/
015-161-00-2 divanadyl pyrophosphate 65232-89-5 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped - Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Aquatic Chronic 2 H332, H373 **, H318, H411 CLP00/
015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 145052-34-2 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 36669-85-9 Aquatic Chronic 3 H412 CLP00/
015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 80693-00-1 Aquatic Chronic 4 H413 CLP00/
015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 14657-64-8 Eye Dam. 1 H318 CLP00/
015-168-00-0 fosthiazate (ISO); (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate 98886-44-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H312, H317, H400, H410 CLP00/
015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate - Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H314, H317, H400, H410 CLP00/
015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate; 1-octane-N,N,N-trimethylammonium di-octylphosphate; 1-octane-N,N,N-trimethylammonium octylphosphate - Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 CLP00/
015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate - Aquatic Chronic 2 H411 CLP00/
015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate - Flam. Liq. 3, Skin Corr. 1B, Aquatic Chronic 2 H226, H314, H411 CLP00/
015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 117291-73-3 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 82857-68-9 Acute Tox. 3 *, Eye Dam. 1, Aquatic Chronic 2 H301, H318, H411 CLP00/
015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 35000-38-5 Acute Tox. 3 *, STOT RE 2 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H301, H373 **, H319, H317, H411 CLP00/
015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 116163-96-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 83623-61-4 STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H373 **, H318, H317 CLP00/
015-178-00-5 (R)- -phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 25383-07-7 Repr. 2, Aquatic Chronic 2 H361f ***, H411 CLP00/
015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 166242-53-1 Carc. 2, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H373 **, H314, H317, H400, H410 CLP00/
015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 137590-32-0 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
015-181-00-1 phosphine 7803-51-2 Flam. Gas 1, Press. Gas, Acute Tox. 2 *, Skin Corr. 1B, Aquatic Acute 1 H220, H330, H314, H400 U CLP00/
015-182-00-7 tetraisopropyldichloromethylenebisphosphonate 10596-22-2 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H302, H319, H317 ATP01/
015-183-00-2 (1-hydroxydodecylidene)diphosphonic acid 16610-63-2 Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 ATP01/
015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex - Aquatic Chronic 2 H411 A CLP00/
015-186-00-9 chlorpyrifos-methyl (ISO),; O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 5598-13-0 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M = 10000: CLP00/
015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 162881-26-7 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 154862-43-8 Aquatic Chronic 4 H413 ATP01/
015-191-00-6 dodecyldiphenyl phosphate 27460-02-2 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 ATP01/
015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate 139189-30-3 Skin Sens. 1 H317 ATP01/ATP06
015-193-00-7 triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) 332350-93-3 Acute Tox. 3 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H318, H400, H410 ATP01/
015-194-00-2 tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate 220689-12-3 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
015-195-00-8 reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate - Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H319, H317, H412 ATP01/
015-196-00-3 reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate - Carc. 1B, Muta. 1B, Skin Sens. 1 H350, H340, H317 ATP01/
015-197-00-9 bis(2,4,4-trimethylpentyl)dithiophosphonic acid 107667-02-7 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H226, H331, H302, H314, H411 ATP01/
015-198-00-4 (4-phenylbutyl)phosphinic acid 86552-32-1 Carc. 2, Eye Dam. 1 H351, H318 ATP01/
016-001-00-4 hydrogen sulphide 7783-06-4 Flam. Gas 1, Press. Gas, Acute Tox. 2 *, Aquatic Acute 1 H220, H330, H400 U CLP00/
016-002-00-X barium sulphide 21109-95-5 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H332, H302, H400 CLP00/
016-003-00-5 barium polysulphides 50864-67-0 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H319, H335, H315, H400 CLP00/
016-004-00-0 calcium sulphide 20548-54-3 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H319, H335, H315, H400 CLP00/
016-005-00-6 calcium polysulphides 1344-81-6 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H319, H335, H315, H400 CLP00/
016-006-00-1 dipotassium sulphide; potassium sulphide 1312-73-8 Skin Corr. 1B, Aquatic Acute 1 H314, H400 CLP00/
016-007-00-7 potassium polysulphides 37199-66-9 Skin Corr. 1B, Aquatic Acute 1 H314, H400 CLP00/
016-008-00-2 ammonium polysulphides 9080-17-5 Skin Corr. 1B, Aquatic Acute 1 H314, H400 EUH031: C ≥ 1 % CLP00/
016-009-00-8 disodium sulfide; sodium sulfide 1313-82-2 Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1 H311, H302, H314, H400 CLP00/ATP01
016-010-00-3 sodium polysulphides 1344-08-7 Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1 H301, H314, H400 CLP00/
016-011-00-9 sulphur dioxide 7446-09-5 Press. Gas, Acute Tox. 3 *, Skin Corr. 1B H331, H314 * U 5 CLP00/
016-012-00-4 disulphur dichloride; sulfur monochloride 10025-67-9 Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1A, Aquatic Acute 1 H301, H332, H314, H400 STOT SE 3; H335: C ≥ 1 % CLP00/
016-013-00-X sulphur dichloride 10545-99-0 Skin Corr. 1B, STOT SE 3, Aquatic Acute 1 H314, H335, H400 STOT SE 3; H335: C ≥ 5 % CLP00/
016-014-00-5 sulphur tetrachloride 13451-08-6 Skin Corr. 1B, Aquatic Acute 1 H314, H400 STOT SE 3; H335: C ≥ 5 % CLP00/
016-015-00-0 thionyl dichloride; thionyl chloride 7719-09-7 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H332, H302, H314 STOT SE 3; H335: C ≥ 1 % CLP00/
016-016-00-6 sulphuryl chloride 7791-25-5 Skin Corr. 1B, STOT SE 3 H314, H335 CLP00/
016-017-00-1 chlorosulphonic acid 7790-94-5 Skin Corr. 1A, STOT SE 3 H314, H335 CLP00/
016-018-00-7 fluorosulphonic acid 7789-21-1 Acute Tox. 4 *, Skin Corr. 1A H332, H314 CLP00/
016-019-00-2 oleum ... % SO3 - Skin Corr. 1A, STOT SE 3 H314, H335 B CLP00/
016-020-00-8 sulphuric acid ... % 7664-93-9 Skin Corr. 1A H314 Skin Corr. 1A; H314: C ≥ 15 %, Skin Irrit. 2; H315: 5 % ≤ C < 15 %, Eye Irrit. 2; H319: 5 % ≤ C < 15 % B CLP00/
016-021-00-3 methanethiol; methyl mercaptan 74-93-1 Flam. Gas 1, Press. Gas, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H220, H331, H400, H410 U CLP00/
016-022-00-9 ethanethiol; ethyl mercaptan 75-08-1 Flam. Liq. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H225, H332, H400, H410 CLP00/
016-023-00-4 dimethyl sulphate 77-78-1 Carc. 1B, Muta. 2, Acute Tox. 2 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1 H350, H341, H330, H301, H314, H317 Carc. 1B; H350: C ≥ 0,01 %, Muta. 2; H341: C ≥ 0,01 %, STOT SE 3; H335: C ≥ 5 % CLP00/
016-024-00-X dimexano (ISO); bis(methoxythiocarbonyl) disulphide 1468-37-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
016-025-00-5 disul (ISO); 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; 2,4-DES 149-26-8 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1 H302, H315, H318 CLP00/
016-026-00-0 sulphamidic acid; sulphamic acid; sulfamic acid 5329-14-6 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H319, H315, H412 CLP00/
016-027-00-6 diethyl sulphate 64-67-5 Carc. 1B, Muta. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H350, H340, H332, H312, H302, H314 CLP00/
016-028-00-1 sodium dithionite; sodium hydrosulphite 7775-14-6 Self-heat. 1, Acute Tox. 4 * H251, H302 CLP00/
016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 - Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % CLP00/
016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 104-15-4 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 STOT SE 3; H335: C ≥ 20 % CLP00/
016-031-00-8 tetrahydrothiophene-1,1-dioxide; sulpholane 126-33-0 Acute Tox. 4 * H302 CLP00/
016-032-00-3 1,3-propanesultone; 1,2-oxathiolane 2,2-dioxide 1120-71-4 Carc. 1B, Acute Tox. 4 *, Acute Tox. 4 * H350, H312, H302 Carc. 1B; H350: C ≥ 0,01 % CLP00/
016-033-00-9 dimethylsulfamoylchloride 13360-57-1 Carc. 1B, Acute Tox. 2 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H350, H330, H312, H302, H314 CLP00/
016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 81898-60-4 Skin Sens. 1 H317 CLP00/
016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate - Eye Irrit. 2 H319 CLP00/
016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate - Resp. Sens. 1, Aquatic Chronic 2 H334, H411 CLP00/
016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 85153-93-1 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 86393-35-3 Skin Sens. 1 H317 CLP00/
016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate - Skin Sens. 1 H317 CLP00/
016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate - Eye Irrit. 2 H319 CLP00/
016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate - Acute Tox. 4 * H332 CLP00/
016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 85665-97-0 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 CLP00/
016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate - Skin Sens. 1 H317 CLP00/
016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 108624-00-6 Skin Sens. 1 H317 CLP00/
016-046-00-X sodium hydrogensulphate 7681-38-1 Eye Dam. 1 H318 CLP00/
016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 85665-96-9 Skin Sens. 1 H317 CLP00/
016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate - Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
016-049-00-6 calcium octadecylxylenesulphonate - Skin Corr. 1B, Aquatic Chronic 2 H314, H411 CLP00/
016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat - Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 106359-91-5 Skin Sens. 1 H317 CLP00/
016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 102561-46-6 Acute Tox. 4 *, Aquatic Chronic 2 H332, H411 CLP00/
016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H315, H317, H413 CLP00/
016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate - Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Sens. 1 H331, H372 **, H302, H319, H335, H317 CLP00/
016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) - Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
016-056-00-4 potassium hydrogensulphate 7646-93-7 Skin Corr. 1B, STOT SE 3 H314, H335 CLP00/
016-057-00-X styrene-4-sulfonyl chloride 2633-67-2 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H315, H318, H317 CLP00/
016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H315, H317, H412 CLP00/
016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 17339-60-5 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H317, H400, H410 CLP00/
016-060-00-6 diammonium peroxodisulphate; ammonium persulphate 7727-54-0 Ox. Sol. 3, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1 H272, H302, H319, H335, H315, H334, H317 CLP00/
016-061-00-1 dipotassium peroxodisulphate; potassium persulphate 7727-21-1 Ox. Sol. 3, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1 H272, H302, H319, H335, H315, H334, H317 CLP00/
016-062-00-7 bensultap (ISO); 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane 17606-31-4 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
016-063-00-2 sodium metabisulphite 7681-57-4 Acute Tox. 4 *, Eye Dam. 1 H302, H318 CLP00/
016-064-00-8 sodium hydrogensulphite %; sodium bisulphite % 7631-90-5 Acute Tox. 4 * H302 B CLP00/
016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 84057-97-6 Aquatic Chronic 2 H411 CLP00/
016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 116912-62-0 Aquatic Chronic 3 H412 CLP00/
016-067-00-4 (4-methylphenyl)mesitylene sulfonate 67811-06-7 Aquatic Chronic 4 H413 CLP00/
016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 155160-86-4 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 141915-64-2 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone - Aquatic Chronic 4 H413 CLP00/
016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 136248-03-8 Skin Sens. 1 H317 CLP00/
016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 112195-27-4 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 10591-85-2 Aquatic Chronic 4 H413 CLP00/
016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene - Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H315, H318, H317, H411 CLP00/
016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 41481-66-7 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 131538-00-6 Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H400, H410 CLP00/
016-077-00-9 2-chloro-p-toluenesulfochloride 42413-03-6 Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H314, H317, H412 CLP00/
016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 56187-04-3 Aquatic Chronic 4 H413 CLP00/
016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 16695-22-0 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 31361-99-6 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide - Muta. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H341, H302, H319, H317, H411 CLP00/
016-082-00-6 ethoxysulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea 126801-58-9 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
016-083-00-1 acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester 135158-54-2 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H317, H400, H410 CLP00/
016-084-00-7 prosulfuron (ISO); 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea 94125-34-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=100: CLP00/ATP01
016-085-00-2 flazasulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea 104040-78-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 109125-56-6 Eye Dam. 1 H318 CLP00/
016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; propylene carbonate 104558-95-4 Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H319, H317, H400, H410 CLP00/
016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 71297-11-5 Aquatic Chronic 3 H412 CLP00/
016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene - Self-react. C ****, Aquatic Chronic 4 H242, H413 CLP00/
016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 14653-91-9 Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H302, H335, H318 CLP00/
016-091-00-5 C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
016-092-00-0 reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol - Repr. 1A, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f, H315, H317, H400, H410 ATP01/
016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 140698-96-0 Self-react. C ****, Carc. 2 H242, H351 CLP00/
016-094-00-1 sulfur 7704-34-9 Skin Irrit. 2 H315 ATP01/
016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydr - Self-react. C ****, Carc. 2 H242, H351 CLP00/
016-096-00-2 thifensulfuron-methyl (ISO); methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate 79277-27-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride 32047-53-3 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H302, H314, H317, H412 ATP01/
017-001-00-7 chlorine 7782-50-5 Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H331, H319, H335, H315, H400 M=100: CLP00/ATP01
017-002-00-2 hydrogen chloride 7647-01-0 Press. Gas, Acute Tox. 3 *, Skin Corr. 1A H331, H314 U 5 CLP00/
017-002-01-X hydrochloric acid ... % - Skin Corr. 1B, STOT SE 3 H314, H335 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 %, STOT SE 3; H335: C ≥ 10 % B CLP00/
017-003-00-8 barium chlorate 13477-00-4 Ox. Sol. 1, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H271, H332, H302, H411 CLP00/
017-004-00-3 potassium chlorate 3811-04-9 Ox. Sol. 1, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H271, H332, H302, H411 CLP00/
017-005-00-9 sodium chlorate 7775-09-9 Ox. Sol. 1, Acute Tox. 4 *, Aquatic Chronic 2 H271, H302, H411 CLP00/
017-006-00-4 perchloric acid ... % 7601-90-3 Ox. Liq. 1, Skin Corr. 1A H271, H314 Skin Corr. 1A; H314: C ≥ 50 %, Skin Corr. 1B; H314: 10 % ≤ C < 50 %, Skin Irrit. 2; H315: 1 % ≤ C < 10 %, Eye Irrit. 2; H319: 1 % ≤ C < 10 %, Ox. Liq. 1; H271: C > 50 %, Ox. Liq. 2; H272: C ≤ 50 % B CLP00/
017-007-00-X barium perchlorate 13465-95-7 Ox. Sol. 1, Acute Tox. 4 *, Acute Tox. 4 * H271, H332, H302 CLP00/
017-008-00-5 potassium perchlorate 7778-74-7 Ox. Sol. 1, Acute Tox. 4 * H271, H302 CLP00/
017-009-00-0 ammonium perchlorate; [containing 80 % of 0-30 µm particles] 7790-98-9 Expl. 1.1, Ox. Sol. 1 H201, H271 T CLP00/ATP01
017-009-01-8 ammonium perchlorate; [containing < 80 % of 0-30 µm particles] - ATP01/
017-010-00-6 sodium perchlorate 7601-89-0 Ox. Sol. 1, Acute Tox. 4 * H271, H302 CLP00/
017-011-00-1 sodium hypochlorite, solution ... % Cl active 7681-52-9 Skin Corr. 1B, Aquatic Acute 1 H314, H400 EUH031: C ≥ 5 % B CLP00/
017-012-00-7 calcium hypochlorite 7778-54-3 Ox. Sol. 2, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1 H272, H302, H314, H400 Skin Corr. 1B; H314: C ≥ 5 %, Skin Irrit. 2; H; 315: 1 % ≤ C < 5 %, Eye Dam. 1; H318: 3 % ≤ C < 5 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %, STOT SE 3; H335: C ≥ 3 %, M=10: T CLP00/ATP01
017-013-00-2 calcium chloride 10043-52-4 Eye Irrit. 2 H319 CLP00/
017-014-00-8 ammonium chloride 12125-02-9 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 61807-67-8 Acute Tox. 4 *, Skin Corr. 1A, Skin Sens. 1 H302, H314, H317 CLP00/
017-016-00-9 methyltriphenylphosphonium chloride 1031-15-8 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H312, H302, H315, H318, H411 CLP00/
017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 120086-58-0 Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 CLP00/
017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride - Aquatic Chronic 2 H411 CLP00/
017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 54417-53-7 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
017-020-00-0 ethyl propoxy aluminium chloride 13014-29-4 Water-react. 1, Skin Corr. 1A H260, H314 CLP00/
017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 136920-10-0 Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H317, H400, H410 CLP00/
017-023-00-7 [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides 197179-61-6 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
017-026-00-3 chlorine dioxide 10049-04-4 Press. Gas, Ox. Gas 1, Acute Tox. 2 *, Skin Corr. 1B, Aquatic Acute 1 H270, H330, H314, H400 M=10: 5 CLP00/ATP01
017-026-01-0 chlorine dioxide ... % 10049-04-4 Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1 H301, H314, H400 Skin Corr. 1B; H314: C ≥ 5 %, Skin Irrit. 2; H315: 1 % ≤ C < 5 %, Eye Dam. 1; H318: 3 % ≤ C < 5 %, Eye Irrit. 2; H319: 0,3 % ≤ C < 3 %, STOT SE 3; H335: C ≥ 3 %, M=10: B CLP00/ATP01
019-001-00-2 potassium 7440-09-7 Water-react. 1, Skin Corr. 1B H260, H314 CLP00/
019-002-00-8 potassium hydroxide; caustic potash 1310-58-3 Acute Tox. 4 *, Skin Corr. 1A H302, H314 Skin Corr. 1A; H314: C ≥ 5 %, Skin Corr. 1B; H314: 2 % ≤ C < 5 %, Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % CLP00/
019-003-00-3 potassium (E,E)-hexa-2,4-dienoate 24634-61-5 Eye Irrit. 2 H319 ATP07
020-001-00-X calcium 7440-70-2 Water-react. 2 H261 CLP00/
020-002-00-5 calcium cyanide 592-01-8 Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H400, H410 CLP00/
020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydro - Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 CLP00/
022-001-00-5 titanium tetrachloride 7550-45-0 Skin Corr. 1B H314 CLP00/
022-002-00-0 titanium(4+) oxalate - Eye Dam. 1 H318 CLP00/
022-003-00-6 bis( 5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 125051-32-3 Flam. Sol. 1, Repr. 2, STOT RE 2 *, Aquatic Chronic 2 H228, H361f ***, H373 **, H411 T CLP00/
022-004-00-1 potassium titanium oxide (K2Ti6O13) 12056-51-8 Carc. 2 H351 ATP01/
022-005-00-7 [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5- )-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)- N][(1,2,3,4- )-1,3-pentadiene]-titanium 169104-71-6 Flam. Sol. 1****, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 4 H228, H314, H317, H413 ATP01/
023-001-00-8 divanadium pentaoxide; vanadium pentoxide 1314-62-1 Muta. 2, Repr. 2, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Aquatic Chronic 2 H341, H361d ***, H372 **, H332, H302, H335, H411 CLP00/
024-001-00-0 chromium (VI) trioxide 1333-82-0 Ox. Sol. 1, Carc. 1A, Muta. 1B, Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Skin Corr. 1A, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H271, H350, H340, H361f ***, H330, H311, H301, H372 **, H314, H334, H317, H400, H410 STOT SE 3; H335: C ≥ 1 % CLP00/
024-002-00-6 potassium dichromate 7778-50-9 Ox. Sol. 2, Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H272, H350, H340, H360FD, H330, H301, H372 **, H312, H314, H334, H317, H400, H410 STOT SE 3; H335: C ≥ 5 % 3 CLP00/
024-003-00-1 ammonium dichromate 7789-09-5 Ox. Sol. 2 ****, Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H272, H350, H340, H360FD, H330, H301, H372 **, H312, H314, H334, H317, H400, H410 STOT SE 3; H335: C ≥ 5 %, Resp. Sens.; H334: C ≥ 0,2 %, Skin Sens.; H317: C ≥ 0,2 % G 3 CLP00/
024-004-00-7 sodium dichromate 10588-01-9 Ox. Sol. 2, Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 1, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H272, H350, H340, H360FD, H330, H301, H312, H372**, H314, H334, H317, H400, H410 Resp. Sens. 1; H334: C ≥ 0,2 %, Skin Sens. 1; H317: C ≥ 0,2 %, STOT SE 3; H335: C ≥ 5 % CLP00/ATP01
024-005-00-2 chromyl dichloride; chromic oxychloride 14977-61-8 Ox. Liq. 1, Carc. 1B, Muta. 1B, Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H271, H350i, H340, H314, H317, H400, H410 Skin Corr. 1A; H314: C ≥ 10 %, Skin Corr. 1B; H314: 5 % ≤ C < 10 %, Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %, STOT SE 3; H335: 0,5 % ≤ C < 5 %, Skin Sens. 1; H317: C ≥ 0,5 % T 3 CLP00/
024-006-00-8 potassium chromate 7789-00-6 Carc. 1B, Muta. 1B, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H340, H319, H335, H315, H317, H400, H410 Skin Sens. 1; H317: C ≥ 0,5 % 3 CLP00/
024-007-00-3 zinc chromates including zinc potassium chromate - Carc. 1A, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H317, H400, H410 A CLP00/
024-008-00-9 calcium chromate 13765-19-0 Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 CLP00/
024-009-00-4 strontium chromate 7789-06-2 Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 CLP00/
024-010-00-X dichromium tris(chromate); chromium III chromate; chromic chromate 24613-89-6 Ox. Sol. 1, Carc. 1B, Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H271, H350, H314, H317, H400, H410 T CLP00/
024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 109125-51-1 Self-react. C ****, Aquatic Acute 1, Aquatic Chronic 1 H242, H400, H410 CLP00/
024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) - Muta. 2 H341 CLP00/
024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 93952-24-0 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H332, H318, H411 CLP00/
024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 88377-66-6 STOT RE 2 *, Aquatic Chronic 4 H373 **, H413 CLP00/
024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex - Carc. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H317, H400, H410 A CLP00/
024-018-00-3 sodium chromate 7775-11-3 Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H340, H360FD, H330, H301, H372 **, H312, H314, H334, H317, H400, H410 Resp. Sens.; H334: C ≥ 0,2 %, Skin Sens.; H317: C ≥ 0,2 % 3 CLP00/
024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {}{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}}-{}{6''-[1-(phenylcarbamoyl)ethylazo]- - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III) - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
024-021-00-X potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) - Eye Dam. 1 H318 ATP01/
025-001-00-3 manganese dioxide 1313-13-9 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 CLP00/
025-002-00-9 potassium permanganate 7722-64-7 Ox. Sol. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H272, H302, H400, H410 CLP00/
025-003-00-4 manganese sulphate 7785-87-7 STOT RE 2 *, Aquatic Chronic 2 H373 **, H411 CLP00/
025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 116633-53-5 Aquatic Chronic 2 H411 CLP00/
025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-); tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-); pentasodium [29H,31H-phthalocyanine-C,C,C,C, - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
026-001-00-6 ( -cumene)-( -cyclopentadienyl)iron(II) hexafluoroantimonate 100011-37-8 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
026-002-00-1 ( -cumene)-( -cyclopentadienyl)iron(II) trifluoromethane-sulfonate 117549-13-0 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
026-003-00-7 iron (II) sulfate 7720-78-7 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H302, H319, H315 ATP01/
026-003-01-4 iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; ferrous sulfate heptahydrate 7782-63-0 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H302, H319, H315 Skin Irrit. 2; H315: C ≥ 25 % ATP01/
026-004-00-2 potassium ferrite 12160-44-0 Skin Corr. 1B, Skin Sens. 1 H314, H317 ATP01/
027-001-00-9 cobalt 7440-48-4 Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 4 H334, H317, H413 CLP00/
027-002-00-4 cobalt oxide 1307-96-6 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 M=10: CLP00/ATP01
027-003-00-X cobalt sulfide 1317-42-6 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M=10: CLP00/ATP01
027-004-00-5 cobalt dichloride 7646-79-9 Carc. 1B, Muta. 2, Repr. 1B, Acute Tox. 4 *, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360F***, H302, H334, H317, H400, H410 Carc. 1B; H350i: C ≥ 0,01 %, M=10: 1 CLP00/ATP01
027-005-00-0 cobalt sulfate 10124-43-3 Carc. 1B, Muta. 2, Repr. 1B, Acute Tox. 4 *, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360F***, H302, H334, H317, H400, H410 Carc. 1B; H350i: C ≥ 0,01 %, M=10: 1 CLP00/ATP01
027-006-00-6 cobalt acetate 71-48-7 Carc. 1B, Muta. 2, Repr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360F***, H334, H317, H400, H410 Carc. 1B; H350i: C ≥ 0,01 %, M=10: 1 ATP01/
027-007-00-1 zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex - Eye Dam. 1, Aquatic Chronic 2 H318, H411 ATP01/
027-008-00-7 complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O, 2<n<3) - Skin Sens. 1 H317 ATP01/
027-009-00-2 cobalt nitrate 10141-05-6 Carc. 1B, Muta. 2, Repr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360F***, H334, H317, H400, H410 Carc. 1B; H350i: C ≥ 0,01 %, M=10: 1 ATP01/
027-010-00-8 cobalt carbonate 513-79-1 Carc. 1B, Muta. 2, Repr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360F***, H334, H317, H400, H410 Carc. 1B; H350i: C ≥ 0,01 %, M=10: 1 ATP01/
028-001-00-1 tetracarbonylnickel; nickel tetracarbonyl 13463-39-3 Flam. Liq. 2, Carc. 2, Repr. 1B, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H225, H351, H360D ***, H330, H400, H410 CLP00/
028-002-00-7 nickel 7440-02-0 Carc. 2, STOT RE 1, Skin Sens. 1 H351, H372**, H317 S 7 CLP00/ATP01
028-002-01-4 nickel powder; [particle diameter < 1 mm] 7440-02-0 Carc. 2, STOT RE 1, Skin Sens. 1, Aquatic Chronic 3 H351, H372**, H317, H412 ATP01/
028-003-00-2 nickel monoxide; [1] nickel oxide; [2] bunsenite [3] 1313-99-1 [1], 11099-02-8 [2], 34492-97-2 [3] Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Chronic 4 H350i, H372**, H317, H413 CLP00/ATP01
028-004-00-8 nickel dioxide 12035-36-8 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Chronic 4 H350i, H372**, H317, H413 CLP00/ATP01
028-005-00-3 dinickel trioxide 1314-06-3 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Chronic 4 H350i, H372**, H317, H413 CLP00/ATP01
028-006-00-9 nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] 16812-54-7 [1], 11113-75-0 [2], 1314-04-1 [3], - Carc. 1A, Muta. 2, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H372**, H317, H400, H410 CLP00/ATP01
028-007-00-4 trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] 12035-72-2 [1], 12035-71-1 [2] Carc. 1A, Muta. 2, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H372**, H317, H400, H410 CLP00/ATP01
028-008-00-X nickel dihydroxide; [1] nickel hydroxide [2] 12054-48-7 [1], 11113-74-9 [2] Carc. 1A, Repr. 1B, Muta. 2, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H360D***, H341, H372**, H332, H302, H315, H334, H317, H400, H410 CLP00/ATP01
028-009-00-5 nickel sulfate 7786-81-4 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H332, H302, H315, H334, H317, H400, H410 STOT RE 1; H373: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Irrit. 2; H315: C ≥ 20 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP01
028-010-00-0 nickel carbonate; basic nickel carbonate; carbonic acid, nickel (2+) salt; [1] carbonic acid, nickel salt; [2] [µ-[carbonato(2-)-O:O ]] dihydroxy trinickel; [3] [carbonato(2-)] tetrahydroxytrinickel [4] 3333-67-3 [1], 16337-84-1 [2], 65405-96-1 [3], 12607-70-4 [4] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H332, H302, H315, H334, H317, H400, H410 CLP00/ATP01
028-011-00-6 nickel dichloride 7718-54-9 Carc. 1A, Muta. 2, Repr. 1B, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H331, H301, H372**, H315, H334, H317, H400, H410 STOT RE. 1; H373: C ≥ 1 %, STOT RE. 2; H373: 0,1 % < C < 1 %, Skin Irrit. 2; H315: C ≥ 20 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: ATP01/
028-012-00-1 nickel dinitrate; [1] nitric acid, nickel salt [2] 13138-45-9 [1], 14216-75-2 [2] Ox. Sol. 2, Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H272, H350i, H341, H360D***, H372**, H332, H302, H318, H315, H317, H400, H410 STOT RE. 1; H373: C ≥ 1 %, STOT RE. 2; H373: 0,1 % < C < 1 %, Skin Irrit. 2; H315: C ≥ 20 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: ATP01/
028-013-00-7 nickel matte 69012-50-6 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-014-00-2 slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate 92129-57-2 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H332, H302, H315, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: ATP01/
028-015-00-8 slimes and sludges, copper electrolyte refining, decopperised 94551-87-8 Carc. 1A, Muta. 2, Repr. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 CLP00/ATP02
028-016-00-3 nickel diperchlorate; perchloric acid, nickel(II) salt 13637-71-3 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H314, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-017-00-9 nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] 13842-46-1 [1], 15699-18-0 [2] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H332, H302, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-018-00-4 nickel bis(sulfamidate); nickel sulfamate 13770-89-3 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-019-00-X nickel bis(tetrafluoroborate) 14708-14-6 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-021-00-0 nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] 3349-06-2 [1], 15843-02-4 [2], 68134-59-8 [3] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-022-00-6 nickel di(acetate); [1] nickel acetate [2] 373-02-4 [1], 14998-37-9 [2] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H332, H302, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: E H ATP01/
028-024-00-7 nickel dibenzoate 553-71-9 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-025-00-2 nickel bis(4-cyclohexylbutyrate) 3906-55-6 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: ATP01/
028-026-00-8 nickel(II) stearate; nickel(II) octadecanoate 2223-95-2 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-027-00-3 nickel dilactate 16039-61-5 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-028-00-9 nickel(II) octanoate 4995-91-9 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Skin Corr. 1A, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H314, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-029-00-4 nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] 10028-18-9 [1], 13462-88-9 [2], 13462-90-3 [3], 11132-10-8 [4] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-030-00-X nickel hexafluorosilicate 26043-11-8 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-031-00-5 nickel selenate 15060-62-5 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-032-00-0 nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nick 14332-34-4 [1], 18718-11-1 [2], 10381-36-9 [3], 14448-18-1 [4], 14507-36-9 [5], 36026-88-7 [6], 17169-61-8 [7], 19372-20-4 [8] Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-033-00-6 diammonium nickel hexacyanoferrate 74195-78-1 Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-034-00-1 nickel dicyanide 557-19-7 Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-035-00-7 nickel chromate 14721-18-7 Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-036-00-2 nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] 21784-78-1 [1], 13775-54-7 [2], 31748-25-1 [3], 37321-15-6 [4], 12519-85-6 [5] Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-037-00-8 dinickel hexacyanoferrate 14874-78-3 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-038-00-3 trinickel bis(arsenate); nickel(II) arsenate 13477-70-8 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H372**, H317, H400, H410 CLP00/ATP02
028-039-00-9 nickel oxalate; [1] oxalic acid, nickel salt [2] 547-67-1 [1], 20543-06-0 [2] Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-040-00-4 nickel telluride 12142-88-0 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-041-00-X trinickel tetrasulfide 12137-12-1 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-042-00-5 trinickel bis(arsenite) 74646-29-0 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-043-00-0 cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] 68186-89-0 [1], 58591-45-0 [2], 12737-30-3 [3] Carc. 1A, STOT RE 1, Skin Sens. 1 H350i, H372**, H317 CLP00/ATP02
028-044-00-6 nickel tin trioxide; nickel stannate 12035-38-0 Carc. 1A, STOT RE 1, Skin Sens. 1 H350i, H372**, H317 CLP00/ATP02
028-045-00-1 nickel triuranium decaoxide 15780-33-3 Carc. 1A, STOT RE 1, Skin Sens. 1 H350i, H372**, H317 CLP00/ATP02
028-046-00-7 nickel dithiocyanate 13689-92-4 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-047-00-2 nickel dichromate 15586-38-6 Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-048-00-8 nickel(II) selenite 10101-96-9 Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-049-00-3 nickel selenide 1314-05-2 Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-050-00-9 silicic acid, lead nickel salt 68130-19-8 Carc. 1A, Repr. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H360Df, H372**, H317, H400, H410 CLP00/ATP02
028-051-00-4 nickel diarsenide; [1] nickel arsenide [2] 12068-61-0 [1], 27016-75-7 [2] Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-052-00-X nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 68610-24-2 Carc. 1A, STOT RE 1, Skin Sens. 1 H350i, H372**, H317 CLP00/ATP02
028-053-00-5 nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] 67952-43-6 [1], 14550-87-9 [2], 71720-48-4 [3] Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %1, M=1: CLP00/ATP02
028-054-00-0 nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic ac 16083-14-0 [1], 3349-08-4 [2], 39819-65-3 [3], 18721-51-2 [4], 18283-82-4 [5], 22605-92-1 [6], 4454-16-4 [7], 7580-31-6 [8], 93983-68-7 [9], 29317-63-3 [10], 27637-46-3 [11], 84852-37-9 [12], 93920-10-6 [13], 85508-43-6 [14], 85508-44-7 [15], 51818-56-5 [ Carc. 1A, Muta. 2, Repr. 1B, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H341, H360D***, H372**, H334, H317, H400, H410 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,1 % ≤ C < 1 %, Skin Sens. 1; H317: C ≥ 0,01 %, M=1: CLP00/ATP02
028-055-00-6 nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] 7757-95-1 [1], 15851-52-2 [2], 15852-21-8 [3], 68130-36-9 [4] Carc. 1A, STOT RE 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H334, H317, H400, H410 CLP00/ATP02
028-056-00-1 nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] 12007-00-0 [1], 12007-01-1 [2], 12007-02-2 [3], 12619-90-8 [4], 12059-14-2 [5], 12201-89-7 [6], 12035-64-2 [7], 65229-23-4 [8] Carc. 1A, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H372**, H317, H400, H410 CLP00/ATP02
028-057-00-7 dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten 12004-35-2 [1], 12035-39-1 [2], 12653-76-8 [3], 52502-12-2 [4], 68016-03-5 [5], 70692-93-2 [6], 14177-55-0 [7], 14177-51-6 [8], 68515-84-4 [9], 12031-65-1 [10], 12673-58-4 [11] Carc. 1A, STOT RE 1, Skin Sens. 1 H350i, H372**, H317 CLP00/ATP02
028-058-00-2 cobalt lithium nickel oxide - Carc. 1A, Acute Tox. 2 *, STOT RE 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350i, H330, H372**, H317, H400, H410 ATP01/
029-001-00-4 copper chloride; copper (I) chloride; cuprous chloride 7758-89-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
029-002-00-X dicopper oxide; copper (I) oxide 1317-39-1 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
029-003-00-5 Naphthenic acids, copper salts; copper naphthenate 1338-02-9 Flam. Liq. 3, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H226, H302, H400, H410 CLP00/
029-004-00-0 copper sulphate 7758-98-7 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H315, H400, H410 CLP00/
029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid - Eye Irrit. 2 H319 CLP00/
029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 89797-01-3 Skin Sens. 1 H317 G CLP00/
029-008-00-2 copper(II) methanesulfonate 54253-62-2 Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H318, H400, H410 CLP00/
029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 93971-95-0 Aquatic Chronic 3 H412 CLP00/
029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 101408-30-4 Skin Sens. 1 H317 CLP00/
029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 150522-10-4 Skin Corr. 1B H314 CLP00/
029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 124719-24-0 Eye Dam. 1 H318 CLP00/
029-013-00-X trisodium(2-( -(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 130201-51-3 Eye Dam. 1 H318 CLP00/ATP01
029-014-00-5 reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex; 2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex 171866-24-3 STOT RE 2 *, Aquatic Chronic 2 H373**, H411 ATP01/
030-001-00-1 zinc powder - zinc dust (pyrophoric) 7440-66-6 Water-react. 1, Pyr. Sol. 1, Aquatic Acute 1, Aquatic Chronic 1 H260, H250, H400, H410 T CLP00/
030-001-01-9 zinc powder - zinc dust (stabilised) 7440-66-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
030-003-00-2 zinc chloride 7646-85-7 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H400, H410 STOT SE 3; H335: C ≥ 5 % CLP00/
030-004-00-8 dimethylzinc; [1] diethylzinc [2] 544-97-8 [1], 557-20-0 [2] Pyr. Liq. 1, Water-react. 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H250, H260, H314, H400, H410 CLP00/
030-005-00-3 diamminediisocyanatozinc - Acute Tox. 4 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1 H302, H318, H334, H317, H400 CLP00/
030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1] zinc sulphate (anhydrous) [2] 7446-19-7 [1], 7733-02-0 [2] Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H318, H400, H410 CLP00/
030-007-00-4 bis(3,5-di-tert-butylsalicylato-O1,O2)zinc 42405-40-3 Flam. Sol. 1, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H228, H302, H400, H410 T CLP00/
030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 113036-91-2 Acute Tox. 4 *, Aquatic Chronic 2 H332, H411 CLP00/
030-009-00-5 zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate - Eye Dam. 1, Aquatic Chronic 2 H318, H411 ATP01/
030-010-00-0 2-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt - Aquatic Chronic 2 H411 ATP01/
030-011-00-6 trizinc bis(orthophosphate) 7779-90-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide 169314-88-9 Aquatic Chronic 4 H413 ATP01/
030-013-00-7 zinc oxide 1314-13-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate - Aquatic Chronic 2 H411 ATP01/
031-001-00-4 gallium arsenide 1303-00-0 Repr. 1B, Carc. 1B, STOT RE 1 H360F, H350, H372 (respiratory and haematopoietic systems) ATP07
033-001-00-X arsenic 7440-38-2 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H400, H410 CLP00/
033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H400, H410 * A 1 CLP00/
033-003-00-0 diarsenic trioxide; arsenic trioxide 1327-53-3 Carc. 1A, Acute Tox. 2 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H300, H314, H400, H410 CLP00/
033-004-00-6 diarsenic pentaoxide; arsenic pentoxide; arsenic oxide 1303-28-2 Carc. 1A, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H331, H301, H400, H410 CLP00/
033-005-00-1 arsenic acid and its salts with the exception of those specified elsewhere in this Annex - Carc. 1A, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H331, H301, H400, H410 A CLP00/ATP01
033-006-00-7 arsine 7784-42-1 Flam. Gas 1, Press. Gas, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H220, H330, H373 **, H400, H410 U CLP00/
033-007-00-2 tert-butylarsine 4262-43-5 Pyr. Liq. 1, Acute Tox. 2 * H250, H330 CLP00/
034-001-00-2 selenium 7782-49-2 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 4 H331, H301, H373 **, H413 CLP00/
034-002-00-8 selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H373**, H400, H410 A CLP00/ATP01
034-003-00-3 sodium selenite 10102-18-8 Acute Tox. 2 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Chronic 2 H300, H331, H317, H411 CLP00/
035-001-00-5 bromine 7726-95-6 Acute Tox. 2 *, Skin Corr. 1A, Aquatic Acute 1 H330, H314, H400 CLP00/
035-002-00-0 hydrogen bromide 10035-10-6 Press. Gas, Skin Corr. 1A, STOT SE 3 H314, H335 U CLP00/
035-002-01-8 hydrobromic acid ... % - Skin Corr. 1B, STOT SE 3 H314, H335 Skin Corr. 1B; H314: C ≥ 40 %, Skin Irrit. 2; H315: 10 % ≤ C < 40 %, Eye Irrit. 2; H319: 10 % ≤ C < 40 %, STOT SE 3; H335: C ≥ 10 % B CLP00/
035-003-00-6 potassium bromate 7758-01-2 Ox. Sol. 1, Carc. 1B, Acute Tox. 3 * H271, H350, H301 CLP00/
035-004-00-1 2-hydroxyethylammonium perbromide - Ox. Sol. 2 ****, Acute Tox. 4 *, Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1 H272, H302, H314, H317, H400 CLP00/
040-001-00-3 zirconium powder (pyrophoric) 7440-67-7 Water-react. 1, Pyr. Sol. 1 H260, H250 T CLP00/
040-002-00-9 zirconium powder (non pyrophoric) - Self-heat. 1 H251 T CLP00/
040-003-00-4 reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr : DTBS = 1.0 : 1.0 to 1.0 : 1.5 226996-19-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
042-001-00-9 molybdenum trioxide 1313-27-5 Carc. 2, Eye Irrit. 2, STOT SE 3 H351, H319, H335 CLP00/ATP01
042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa- -oxotetra- 3-oxodi- 5-oxotetradecaoxooctamolybdate(4-) 117342-25-3 Acute Tox. 3 *, Eye Dam. 1 H331, H318 CLP00/ATP01
042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 116810-46-9 Flam. Sol. 1, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H228, H318, H400, H410 T CLP00/
042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H315, H317, H411 CLP00/
042-005-00-0 reaction mass of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
046-001-00-X tetraammine palladium (II) hydrogen carbonate 134620-00-1 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H318, H317, H400, H410 ATP01/
047-001-00-2 silver nitrate 7761-88-8 Ox. Sol. 2, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H272, H314, H400, H410 CLP00/ATP01
047-002-00-8 polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 * A 1 CLP00/
048-002-00-0 cadmium (non-pyrophoric); [1] cadmium oxide (non-pyrophoric) [2] 7440-43-9 [1], 1306-19-0 [2] Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H361fd, H330, H372 **, H400, H410 CLP00/
048-003-00-6 cadmium diformate; cadmiumformate 4464-23-7 Acute Tox. 3 *, Acute Tox. 3 *, Carc. 2, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H351, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,25 % CLP00/
048-004-00-1 cadmium cyanide 542-83-6 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Carc. 2, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H351, H373 **, H400, H410 STOT RE 2; H373: C ≥ 0,1 %, EUH032: C ≥ 1 % CLP00/
048-005-00-7 cadmiumhexafluorosilicate(2-); cadmium fluorosilica 17010-21-8 Acute Tox. 3 *, Acute Tox. 3 *, Carc. 2, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H351, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,1 % CLP00/
048-006-00-2 cadmium fluoride 7790-79-6 Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H340, H360FD, H330, H301, H372 **, H400, H410 Carc. 1B; H350: C ≥ 0,01 %, * oral, STOT RE 1; H372: C ≥ 7 %, STOT RE 2: 0,1 % ≤ C < 7 % CLP00/
048-007-00-8 cadmium iodide 7790-80-9 Acute Tox. 3 *, Acute Tox. 3 *, Carc. 2, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H351, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,1 % CLP00/
048-008-00-3 cadmium chloride 10108-64-2 Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H340, H360FD, H330, H301, H372 **, H400, H410 Carc. 1B; H350: C ≥ 0,01 %, * oral, STOT RE 1; H372: C ≥ 7 %, STOT RE 2; H373: 0,1 % ≤ C < 7 % CLP00/
048-009-00-9 cadmium sulphate 10124-36-4 Carc. 1B, Muta. 1B, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H340, H360FD, H330, H301, H372 **, H400, H410 Carc. 1B; H350: C ≥ 0,01 %, * oral, STOT RE 1; H372: C ≥ 7 %, STOT RE 2; H373: 0,1 % ≤ C < 7 % CLP00/
048-010-00-4 cadmium sulphide 1306-23-6 Carc. 1B, Muta. 2, Repr. 2, STOT RE 1, Acute Tox. 4 *, Aquatic Chronic 4 H350, H341, H361fd, H372 **, H302, H413 *, STOT RE 1; H372: C ≥ 10 %, STOT RE 2; H373: 0,1 % ≤ C < 10 % 1 CLP00/
048-011-00-X cadmium (pyrophoric) 7440-43-9 Pyr. Sol. 1, Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H250, H350, H341, H361fd, H330, H372 **, H400, H410 CLP00/
050-001-00-5 tin tetrachloride; stannic chloride 7646-78-8 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 STOT SE 3; H335: C ≥ 5 % CLP00/
050-002-00-0 cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide 13121-70-5 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 M=1000: CLP00/ATP01
050-003-00-6 fentin acetate (ISO); triphenyltin acetate 900-95-8 Carc. 2, Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H361d***, H330, H311, H301, H372**, H335, H315, H318, H400, H410 M=10: CLP00/ATP01
050-004-00-1 fentin hydroxide (ISO); triphenyltin hydroxide 76-87-9 Carc. 2, Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H361d***, H330, H311, H301, H372**, H335, H315, H318, H400, H410 M=10: CLP00/ATP01
050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 * A 1 CLP00/
050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 * A 1 CLP00/
050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 * A 1 CLP00/
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex - Repr. 1B, Acute Tox. 3, Acute Tox. 4 *, STOT RE 1, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H360FD, H301, H312, H372**, H319, H315, H400, H410 *, STOT RE 1; H372: C >= 1 %, STOT RE 2; H373: 0,25 % <= C < 1 %, Skin Irrit. 2; H315: C >= 1 %, Eye Irrit. 2; H319: C >= 1 %, M=10: A 1 CLP00/ATP07
050-009-00-9 fluorotripentylstannane; [1] hexapentyldistannoxane [2] 20153-49-5 [1], 25637-27-8 [2] Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 * 1 CLP00/
050-010-00-4 fluorotrihexylstannane 20153-50-8 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 * 1 CLP00/
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 *, M=100: A 1 CLP00/ATP01
050-012-00-5 tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3] 1449-55-4 [1], 3091-32-5 [2], 7067-44-9 [3] Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 * A 1 CLP00/
050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex - Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 4 H319, H335, H315, H413 Skin Irrit. 2; H315: C ≥ 1 %, Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % A 1 CLP00/
050-017-00-2 fenbutatin oxide (ISO); bis(tris(2-methyl-2-phenylpropyl)tin)oxide 13356-08-6 Acute Tox. 2 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H330, H319, H315, H400, H410 CLP00/
050-018-00-8 tin(II) methanesulphonate 53408-94-9 Skin Corr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H314, H302, H317, H411 CLP00/ATP01
050-019-00-3 azocyclotin (ISO); 1-(tricyclohexylstannyl)-1H-1,2,4-triazole 41083-11-8 Acute Tox. 2 *, Acute Tox. 3 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H301, H335, H315, H318, H400, H410 CLP00/
050-020-00-9 trioctylstannane 869-59-0 STOT RE 1, Skin Irrit. 2, Aquatic Chronic 4 H372 **, H315, H413 CLP00/
050-021-00-4 dichlorodioctyl stannane 3542-36-7 Acute Tox. 3 *, STOT RE 1, Aquatic Chronic 3 H331, H372**, H412 ATP01/
050-022-00-X dibutyltin dichloride; (DBTC) 683-18-1 Muta. 2, Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H341, H360FD, H330, H301, H312, H372**, H314, H400, H410 Skin Corr. 1B; H314: C ≥ 5 %, Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %, Eye Dam. 1; H318: 3 % ≤ C < 5 %, Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %, M=10: ATP01/
050-023-00-5 reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane - STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373**, H400, H410 M=10: ATP01/
050-024-00-0 reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane - STOT RE 1, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H372**, H302, H315, H318, H317, H400, H410 ATP01/
051-001-00-8 antimony trichloride 10025-91-9 Skin Corr. 1B, Aquatic Chronic 2 H314, H411 STOT SE 3; H335: C ≥ 5 % CLP00/
051-002-00-3 antimony pentachloride 7647-18-9 Skin Corr. 1B, Aquatic Chronic 2 H314, H411 STOT SE 3; H335: C ≥ 5 % CLP00/
051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H332, H302, H411 * A 1 CLP00/
051-004-00-4 antimony trifluoride 7783-56-4 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H331, H311, H301, H411 CLP00/
051-005-00-X antimony trioxide 1309-64-4 Carc. 2 H351 CLP00/
051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 71786-70-4 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
053-001-00-3 iodine 7553-56-2 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H332, H312, H400 CLP00/
053-002-00-9 hydrogen iodide 10034-85-2 Press. Gas, Skin Corr. 1A H314 Skin Corr. 1A; H314: C ≥ 10 %, Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %, Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %, Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %, STOT SE 3; H335: C ≥ 0,02 % U 5 CLP00/
053-002-01-6 hydriodic acid ... % - Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % B CLP00/
053-003-00-4 iodoxybenzene 696-33-3 CLP00/ATP01
053-004-00-X calcium iodoxybenzoate - C CLP00/ATP01
053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 178233-72-2 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373 **, H400, H410 CLP00/
056-001-00-1 barium peroxide 1304-29-6 Ox. Sol. 2, Acute Tox. 4 *, Acute Tox. 4 * H272, H332, H302 CLP00/
056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 * H332, H302 * A 1 CLP00/
056-003-00-2 barium carbonate 513-77-9 Acute Tox. 4 * H302 CLP00/
056-004-00-8 barium chloride 10361-37-2 Acute Tox. 3 *, Acute Tox. 4 * H301, H332 CLP00/
064-001-00-8 gadolinium(III)sulfite trihydrate 51285-81-5 Aquatic Chronic 2 H411 ATP01/
072-001-00-4 hafnium tetra-n-butoxide 22411-22-9 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
074-001-00-X hexasodium tungstate hydrate 12141-67-2 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione - Flam. Liq. 2, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H225, H332, H314, H317, H400, H410 CLP00/
076-001-00-5 osmium tetraoxide; osmic acid 20816-12-0 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Skin Corr. 1B H330, H310, H300, H314 CLP00/
078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H318, H334, H317 A CLP00/
078-002-00-6 diammonium tetrachloroplatinate 13820-41-2 Acute Tox. 3 *, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H315, H318, H334, H317 CLP00/
078-003-00-1 disodium tetrachloroplatinate 10026-00-3 Acute Tox. 3 *, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H315, H318, H334, H317 CLP00/
078-004-00-7 dipotassium tetrachloroplatinate 10025-99-7 Acute Tox. 3 *, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H315, H318, H334, H317 CLP00/
078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H318, H334, H317 A CLP00/
078-006-00-8 disodium hexachloroplatinate 16923-58-3 Acute Tox. 3 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H318, H334, H317 CLP00/
078-007-00-3 dipotassium hexachloroplatinate 16921-30-5 Acute Tox. 3 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H318, H334, H317 CLP00/
078-008-00-9 diammonium hexachloroplatinate 16919-58-7 Acute Tox. 3 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H301, H318, H334, H317 CLP00/
078-009-00-4 hexachloroplatinic acid 16941-12-1 Acute Tox. 3 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1 H301, H314, H334, H317 CLP00/
078-010-00-X tetraammine platinum (II) hydrogen carbonate 123439-82-7 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
078-011-00-5 hydroxydisulfito platinum(II) acid 61420-92-6 Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1A, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H373, H314, H334, H317, H412 ATP01/
078-012-00-0 platinum(IV) nitrate/nitric acid solution - Skin Corr. 1A, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 ATP01/
080-001-00-0 mercury 7439-97-6 Repr. 1B, Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H360D***, H330, H372**, H400, H410 CLP00/ATP01
080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,1 % A 1 CLP00/
080-003-00-1 dimercury dichloride; mercurous chloride; calomel 10112-91-1 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H315, H400, H410 CLP00/
080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,1 % A 1 CLP00/
080-005-00-2 mercury difulminate; mercuric fulminate; fulminate of mercury 628-86-4 Unst. Expl., Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H200, H331, H311, H301, H373 **, H400, H410 CLP00/
080-005-01-X mercury difulminate; mercuric fulminate; fulminate of mercury [ 20 % phlegmatiser] 628-86-4 Expl. 1.1, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H201, H331, H311, H301, H373 **, H400, H410 CLP00/
080-006-00-8 dimercury dicyanide oxide; mercuric oxycyanide 1335-31-5 Expl. 1.1, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H201, H331, H311, H301, H373**, H400, H410 CLP00/ATP01
080-007-00-3 dimethylmercury; [1] diethylmercury [2] 593-74-8 [1], 627-44-1 [2] Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H373 **, H400, H410 *, STOT RE 2; H373: C ≥ 0,05 % 1 CLP00/
080-008-00-9 phenylmercury nitrate; [1] phenylmercury hydroxide; [2] basic phenylmercury nitrate [3] 55-68-5 [1], 100-57-2 [2], 8003-05-2 [3] Acute Tox. 3 *, STOT RE 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H301, H372 **, H314, H400, H410 CLP00/
080-009-00-4 2-methoxyethylmercury chloride 123-88-6 Acute Tox. 3 *, STOT RE 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H301, H372 **, H314, H400, H410 CLP00/
080-010-00-X mercury dichloride; mercuric chloride 7487-94-7 Muta. 2, Repr. 2, Acute Tox. 2 *, STOT RE 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H341, H361f***, H300, H372**, H314, H400, H410 CLP00/ATP01
080-011-00-5 phenylmercury acetate 62-38-4 Acute Tox. 3 *, STOT RE 1, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H301, H372 **, H314, H400, H410 CLP00/
081-001-00-3 thallium 7440-28-0 Acute Tox. 2 *, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 4 H330, H300, H373 **, H413 CLP00/
081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 2 H330, H300, H373 **, H411 A CLP00/
081-003-00-4 dithallium sulphate; thallic sulphate 7446-18-6 Acute Tox. 2 *, STOT RE 1, Skin Irrit. 2, Aquatic Chronic 2 H300, H372 **, H315, H411 CLP00/
082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex - Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H332, H302, H373 **, H400, H410 Repr. 2; H361f: C ≥ 2,5 %, *, STOT RE 2; H373: C ≥ 0,5 % A 1 CLP00/
082-002-00-1 lead alkyls - Repr. 1A, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H330, H310, H300, H373 **, H400, H410 Repr. 1A; H360D: C ≥ 0,1 %, *, STOT RE 2; H373: C ≥ 0,05 % A 1 CLP00/
082-003-00-7 lead diazide; lead azide 13424-46-9 Unst. Expl., Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H200, H360Df, H332, H302, H373 **, H400, H410 1 CLP00/
082-003-01-4 lead diazide; lead azide [ 20 % phlegmatiser] 13424-46-9 Expl. 1.1, Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H201, H360Df, H332, H302, H373 **, H400, H410 1 CLP00/
082-004-00-2 lead chromate 7758-97-6 Carc. 1B, Repr. 1A, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H350, H360Df, H373**, H400, H410 1 CLP00/ATP01
082-005-00-8 lead di(acetate) 301-04-2 Repr. 1A, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H373 **, H400, H410 1 CLP00/
082-006-00-3 trilead bis(orthophosphate) 7446-27-7 Repr. 1A, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H373 **, H400, H410 1 CLP00/
082-007-00-9 lead acetate, basic 1335-32-6 Carc. 2, Repr. 1A, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H360Df, H373 **, H400, H410 1 CLP00/
082-008-00-4 lead(II) methanesulphonate 17570-76-2 Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1 H360Df, H332, H302, H373 **, H315, H318 1 CLP00/
082-009-00-X lead sulfochromate yellow; C.I. Pigment Yellow 34; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 1344-37-2 Carc. 1B, Repr. 1A, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H350, H360Df, H373**, H400, H410 1 CLP00/ATP01
082-010-00-5 lead chromate molybdate sulfate red; C.I. Pigment Red 104; [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 12656-85-8 Carc. 1B, Repr. 1A, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H350, H360Df, H373**, H400, H410 1 CLP00/ATP01
082-011-00-0 lead hydrogen arsenate 7784-40-9 Carc. 1A, Repr. 1A, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H360Df, H331, H301, H373 **, H400, H410 1 CLP00/
082-012-00-6 barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped 199876-46-5 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 2 H302, H373**, H411 ATP01/
092-001-00-8 uranium 7440-61-1 Acute Tox. 2 *, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 4 H330, H300, H373 **, H413 CLP00/
092-002-00-3 uranium compounds with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 2 *, STOT RE 2, Aquatic Chronic 2 H330, H300, H373**, H411 A CLP00/ATP01
601-001-00-4 methane 74-82-8 Flam. Gas 1, Press. Gas H220 U CLP00/
601-002-00-X ethane 74-84-0 Flam. Gas 1, Press. Gas H220 U CLP00/
601-003-00-5 propane 74-98-6 Flam. Gas 1, Press. Gas H220 U CLP00/
601-004-00-0 butane; [1] and isobutane [2] 106-97-8 [1], 75-28-5 [2] Flam. Gas 1, Press. Gas H220 C U CLP00/
601-004-01-8 butane (containing 0,1 % butadiene (203-450-8)); [1] isobutane (containing 0,1 % butadiene (203-450-8)) [2] 106-97-8 [1], 75-28-5 [2] Flam. Gas 1, Press. Gas, Carc. 1A, Muta. 1B H220, H350, H340 C S U CLP00/
601-005-00-6 2,2-dimethylpropane; neopentane 463-82-1 Flam. Gas 1, Press. Gas, Aquatic Chronic 2 H220, H411 U CLP00/
601-006-00-1 pentane; isopentane; 2-methylbutane 109-66-0, - Flam. Liq. 2, Asp. Tox. 1, STOT SE 3, Aquatic Chronic 2 H225, H304, H336, H411 C CLP00/
601-007-00-7 hexane (containing < 5 % n-hexane (203-777-6)); 2-methylpentane; [1] 3-methylpentane; [2] 2,2-dimethylbutane; [3] 2,3-dimethylbutane [4] 107-83-5 [1], 96-14-0 [2], 75-83-2 [3], 79-29-8 [4] Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Chronic 2 H225, H304, H315, H336, H411 C CLP00/ATP01
601-008-00-2 heptane; n-heptane; [1] 2,4-dimethylpentane; [2] 2,2,3-trimethylbutane; [3] 3,3-dimethylpentane; [4] 2,3-dimethylpentane; [5] 3-methylhexane; [6] 2,2-dimethylpentane; [7] 2-methylhexane; [8] 3-ethylpentane; [9] isoheptane; [10] 142-82-5 [1], 108-08-7 [2], 464-06-2 [3], 562-49-2 [4], 565-59-3 [5], 589-34-4 [6], 590-35-2 [7], 591-76-4 [8], 617-78-7 [9], 31394-54-4 [10] Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H225, H304, H315, H336, H400, H410 C CLP00/ATP01
601-009-00-8 octane; n-octane; [1] 2,2,4-trimethylpentane; [2] 2,3,3-trimethylpentane; [3] 3,3-dimethylhexane; [4] 2,2,3-trimethylpentane; [5] 2,3,4-trimethylpentane; [6] 3,4-dimethylhexane; [7] 2,3-dimethylhexane; [8] 2,4-dimethylhexane; [9] 4-methylheptane 111-65-9 [1], 540-84-1 [2], 560-21-4 [3], 563-16-6 [4], 564-02-3 [5], 565-75-3 [6], 583-48-2 [7], 584-94-1 [8], 589-43-5 [9], 589-53-7 [10], 589-81-1 [11], 590-73-8 [12], 592-13-2 [13], 592-27-8 [14], 594-82-1 [15], 609-26-7 [16], 619-99-8 [17], 1067-08-9 Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H225, H304, H315, H336, H400, H410 C CLP00/ATP01
601-010-00-3 ethylene 74-85-1 Flam. Gas 1, Press. Gas, STOT SE 3 H220, H336 U CLP00/
601-011-00-9 propene; propylene 115-07-1 Flam. Gas 1, Press. Gas H220 U CLP00/
601-012-00-4 but-1-ene; [1] butene, mixed-1-and-2-isomers; [2] 2-methylpropene; [3] (Z)-but-2-ene; [4] (E)-but-2-ene [5] 106-98-9 [1], 107-01-7 [2], 115-11-7 [3], 590-18-1 [4], 624-64-6 [5] Flam. Gas 1, Press. Gas H220 C U CLP00/
601-013-00-X 1,3-butadiene; buta-1,3-diene 106-99-0 Flam. Gas 1, Press. Gas, Carc. 1A, Muta. 1B H220, H350, H340 D U CLP00/
601-014-00-5 isoprene (stabilised); 2-methyl-1,3-butadiene 78-79-5 Flam. Liq. 1, Carc. 1B, Muta. 2, Aquatic Chronic 3 H224, H350, H341, H412 D CLP00/
601-015-00-0 acetylene; ethyne 74-86-2 Flam. Gas 1, Press. Gas H220 U CLP00/ATP04
601-016-00-6 cyclopropane 75-19-4 Flam. Gas 1, Press. Gas H220 U CLP00/
601-017-00-1 cyclohexane 110-82-7 Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H225, H304, H315, H336, H400, H410 CLP00/
601-018-00-7 methylcyclohexane 108-87-2 Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Chronic 2 H225, H304, H315, H336, H411 CLP00/
601-019-00-2 1,4-dimethylcyclohexane 589-90-2 Flam. Liq. 2, Asp. Tox. 1, Skin Irrit. 2, STOT SE 3, Aquatic Chronic 2 H225, H304, H315, H336, H411 CLP00/
601-020-00-8 benzene 71-43-2 Flam. Liq. 2, Carc. 1A, Muta. 1B, STOT RE 1, Asp. Tox. 1, Eye Irrit. 2, Skin Irrit. 2 H225, H350, H340, H372 **, H304, H319, H315 E CLP00/
601-021-00-3 toluene 108-88-3 Flam. Liq. 2, Repr. 2, Asp. Tox. 1, STOT RE 2 *, Skin Irrit. 2, STOT SE 3 H225, H361d ***, H304, H373 **, H315, H336 CLP00/
601-022-00-9 o-xylene; [1] p-xylene; [2] m-xylene; [3] xylene [4] 95-47-6 [1], 106-42-3 [2], 108-38-3 [3], 1330-20-7 [4] Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2 H226, H332, H312, H315 * C CLP00/
601-023-00-4 ethylbenzene 100-41-4 Flam. Liq. 2, Acute Tox. 4 *, STOT RE 2, Asp. Tox. 1 H225, H332, H373 (Hörorgane), H304 CLP00/ATP06
601-024-00-X cumene; [1] propylbenzene [2] 98-82-8 [1], 103-65-1 [2] Flam. Liq. 3, Asp. Tox. 1, STOT SE 3, Aquatic Chronic 2 H226, H304, H335, H411 C CLP00/
601-025-00-5 mesitylene; 1,3,5-trimethylbenzene 108-67-8 Flam. Liq. 3, STOT SE 3, Aquatic Chronic 2 H226, H335, H411 STOT SE 3; H335: C ≥ 25 % CLP00/
601-026-00-0 styrene 100-42-5 Flam. Liq. 3, Repr. 2, Acute Tox. 4*, STOT RE 1, Skin Irrit. 2, Eye Irrit. 2 H226, H361d, H332, H372 (Hörorgane), H315, H319 * D CLP00/ATP06
601-027-00-6 2-phenylpropene; -methylstyrene 98-83-9 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, Aquatic Chronic 2 H226, H319, H335, H411 STOT SE 3; H335: C ≥ 25 % CLP00/
601-028-00-1 2-methylstyrene; 2-vinyltoluene 611-15-4 Acute Tox. 4 *, Aquatic Chronic 2 H332, H411 CLP00/
601-029-00-7 dipentene; limonene; [1] (R)-p-mentha-1,8-diene; d-limonene; [2] (S)-p-mentha-1,8-diene; l-limonene; [3] trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4] (±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 138-86-3 [1], 5989-27-5 [2], 5989-54-8 [3], 6876-12-6 [4], 7705-14-8 [5] Flam. Liq. 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H226, H315, H317, H400, H410 C CLP00/
601-030-00-2 cyclopentane 287-92-3 Flam. Liq. 2, Aquatic Chronic 3 H225, H412 CLP00/
601-031-00-8 2,4,4-trimethylpent-1-ene 107-39-1 Flam. Liq. 2, Aquatic Chronic 2 H225, H411 CLP00/
601-032-00-3 benzo[a]pyrene; benzo[def]chrysene 50-32-8 Carc. 1B, Muta. 1B, Repr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H340, H360FD, H317, H400, H410 Carc. 1B; H350: C ≥ 0,01 % CLP00/
601-033-00-9 benz[a]anthracene 56-55-3 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 M=100: CLP00/ATP01
601-034-00-4 benz[e]acephenanthrylene 205-99-2 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
601-035-00-X benzo[j]fluoranthene 205-82-3 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
601-036-00-5 benzo[k]fluoranthene 207-08-9 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
601-037-00-0 n-hexane 110-54-3 Flam. Liq. 2, Repr. 2, Asp. Tox. 1, STOT RE 2 *, Skin Irrit. 2, STOT SE 3, Aquatic Chronic 2 H225, H361f ***, H304, H373 **, H315, H336, H411 STOT RE 2; H373: C ≥ 5 % CLP00/
601-041-00-2 dibenz[a,h]anthracene 53-70-3 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 Carc. 1B; H350: C ≥ 0,01 %, M=100: CLP00/ATP01
601-042-00-8 biphenyl; diphenyl 92-52-4 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H400, H410 CLP00/
601-043-00-3 1,2,4-trimethylbenzene 95-63-6 Flam. Liq. 3, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H226, H332, H319, H335, H315, H411 CLP00/
601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 77-73-6 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H225, H332, H302, H319, H335, H315, H411 CLP00/
601-045-00-4 1,2,3,4-tetrahydronaphthalene 119-64-2 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H319, H315, H411 CLP00/
601-046-00-X 7-methylocta-1,6-diene 42152-47-6 Flam. Liq. 3, Aquatic Acute 1, Aquatic Chronic 1 H226, H400, H410 CLP00/
601-047-00-5 m-mentha-1,3(8)-diene 17092-80-7 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
601-048-00-0 chrysene 218-01-9 Carc. 1B, Muta. 2, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H400, H410 CLP00/
601-049-00-6 benzo[e]pyrene 192-97-2 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
601-051-00-7 4-phenylbut-1-ene 768-56-9 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
601-052-00-2 naphthalene 91-20-3 Carc. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H400, H410 CLP00/
601-053-00-8 nonylphenol; [1] 4-nonylphenol, branched [2] 25154-52-3 [1], 84852-15-3 [2] Repr. 2, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H361fd, H302, H314, H400, H410 CLP00/
601-054-00-3 reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes 132983-41-6 Eye Irrit. 2, Aquatic Chronic 4 H319, H413 CLP00/
601-056-00-4 reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane 73807-39-3 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 156679-41-3 Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H317, H400, H410 CLP00/
601-058-00-5 di-L-para-menthene 83648-84-4 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 15768-07-7 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H319, H315, H411 CLP00/
601-060-00-6 1,2-bis[4-fluoro-6-{}{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 155522-09-1 Skin Sens. 1 H317 CLP00/
601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl] -(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) - Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H314, H317, H411 CLP00/
601-062-00-7 reaction mass of: branched triacontane; branched dotriacontane; branched tetratriacontane; branched hexatriacontane 151006-59-6 Aquatic Chronic 4 H413 CLP00/
601-063-00-2 reaction mass of isomers of branched tetracosane 151006-61-0 Acute Tox. 4 *, Aquatic Chronic 4 H332, H413 CLP00/
601-064-00-8 branched hexatriacontane 151006-62-1 Aquatic Chronic 4 H413 CLP00/
601-065-00-3 reaction mass of: (1' ,3' ,6' )-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); (1' ,3'ß,6' )-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/ATP01
601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone 78531-60-9 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
601-067-00-4 triethyl arsenate 15606-95-8 Carc. 1A, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H331, H301, H400, H410 CLP00/
601-068-00-X 1,2-diacetoxybut-3-ene 18085-02-4 Acute Tox. 4 * H302 CLP00/
601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 287933-44-2 Aquatic Chronic 3 H412 CLP00/
601-070-00-0 reaction mass of: branched icosane; branched docosane; branched tetracosane 151006-58-5 Acute Tox. 4 *, Aquatic Chronic 4 H332, H413 ATP01/
601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 20627-73-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
601-072-00-1 reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane 52783-21-8 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 ATP01/
601-073-00-7 1-bromo-3,5-difluorobenzene 461-96-1 Flam. Liq. 3, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H226, H302, H373 **, H315, H317, H400, H410 CLP00/
601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2 - Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H319, H315, H411 CLP00/
601-075-00-8 4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane 151882-81-4 Carc. 2 H351 ATP01/
601-076-00-3 ethynyl cyclopropane 6746-94-7 Flam. Liq. 2, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H225, H315, H318, H412 ATP01/
601-077-00-9 reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane 196965-91-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
601-078-00-4 reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane - Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 ATP01/
601-079-00-X reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H315, H317, H413 ATP01/
601-080-00-5 reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
601-081-00-0 cyclohexadeca-1,9-diene 4277-06-9 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H315, H317, H413 ATP01/
601-082-00-6 reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 ATP01/
601-083-00-1 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene 22094-83-3 Asp. Tox. 1, Skin Irrit. 2, Aquatic Chronic 4 H304, H315, H413 ATP01/
601-084-00-7 reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) - Asp. Tox. 1, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H304, H315, H400, H410 ATP01/
601-085-00-2 isopentane; 2-methylbutane 78-78-4 Flam. Liq. 1, Asp. Tox. 1, STOT SE 3, Aquatic Chronic 2 H224, H304, H336, H411 CLP00/
602-001-00-7 chloromethane; methyl chloride 74-87-3 Flam. Gas 1, Press. Gas, Carc. 2, STOT RE 2 * H220, H351, H373 ** U CLP00/
602-002-00-2 bromomethane; methylbromide 74-83-9 Press. Gas, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Ozone 1 H341,H331, H301, H373, **, H319, H335, H315, H400, H420 U CLP00/ATP02
602-003-00-8 dibromomethane 74-95-3 Acute Tox. 4 *, Aquatic Chronic 3 H332, H412 * CLP00/
602-004-00-3 dichloromethane; methylene chloride 75-09-2 Carc. 2 H351 CLP00/
602-005-00-9 methyl iodide; iodomethane 74-88-4 Carc. 2, Acute Tox. 4 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT SE 3, Skin Irrit. 2 H351, H312, H331, H301, H335, H315 CLP00/
602-006-00-4 trichloromethane; chloroform 67-66-3 Carc. 2, Repr. 2, Acute Tox. 3, Acute Tox. 4, STOT RE 1, Eye Irrit. 2, Skin Irrit. 2 H351, H361d, H331, H302, H372, H319, H315 CLP00/ATP05
602-007-00-X bromoform; tribromomethane 75-25-2 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H331, H302, H319, H315, H411 CLP00/ATP01
602-008-00-5 carbon tetrachloride; tetrachloromethane 56-23-5 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Aquatic Chronic 3, Ozone 1 H351, H331, H311, H301, H372 **, H412, H420 *, STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,2 % ≤ C < 1 % CLP00/ATP02
602-009-00-0 chloroethane 75-00-3 Flam. Gas 1, Press. Gas, Carc. 2, Aquatic Chronic 3 H220, H351, H412 U CLP00/
602-010-00-6 1,2-dibromoethane 106-93-4 Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H350, H331, H311, H301, H319, H335, H315, H411 * CLP00/
602-011-00-1 1,1-dichloroethane 75-34-3 Flam. Liq. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Chronic 3 H225, H302, H319, H335, H412 * CLP00/
602-012-00-7 1,2-dichloroethane; ethylene dichloride 107-06-2 Flam. Liq. 2, Carc. 1B, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H225, H350, H302, H319, H335, H315 CLP00/
602-013-00-2 1,1,1-trichloroethane; methyl chloroform 71-55-6 Acute Tox. 4 *, Ozone 1 H332, H420 F CLP00/ATP02
602-014-00-8 1,1,2-trichloroethane 79-00-5 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H351, H332, H312, H302 * CLP00/
602-015-00-3 1,1,2,2-tetrachloroethane 79-34-5 Acute Tox. 2 *, Acute Tox. 1, Aquatic Chronic 2 H330, H310, H411 CLP00/
602-016-00-9 1,1,2,2-tetrabromoethane 79-27-6 Acute Tox. 2 *, Eye Irrit. 2, Aquatic Chronic 3 H330, H319, H412 CLP00/
602-017-00-4 pentachloroethane 76-01-7 Carc. 2, STOT RE 1, Aquatic Chronic 2 H351, H372 **, H411 STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,2 % ≤ C < 1 % CLP00/
602-018-00-X 1-chloropropane; [1] 2-chloropropane [2] 540-54-5 [1], 75-29-6 [2] Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H312, H302 C CLP00/
602-019-00-5 1-bromopropane; n-propyl bromide 106-94-5 Flam. Liq. 2, Repr. 1B, STOT RE 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, STOT SE 3 H225, H360FD, H373 **, H319, H335, H315, H336 CLP00/
602-020-00-0 1,2-dichloropropane; propylene dichloride 78-87-5 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H302 CLP00/
602-021-00-6 1,2-dibromo-3-chloropropane 96-12-8 Carc. 1B, Muta. 1B, Repr. 1A, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H350, H340, H360F ***, H301, H373 **, H412 CLP00/
602-022-00-1 1-chloropentane; [1] 2-chloropentane; [2] 3-chloropentane [3] 543-59-9 [1], 625-29-6 [2], 616-20-6 [3] Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H312, H302 C CLP00/
602-023-00-7 vinyl chloride; chloroethylene 75-01-4 Press. Gas, Flam. Gas 1, Carc. 1A H220, H350 D U CLP00/
602-024-00-2 bromoethylene 593-60-2 Press. Gas, Flam. Gas 1, Carc. 1B H220, H350 U CLP00/
602-025-00-8 1,1-dichloroethylene; vinylidene chloride 75-35-4 Flam. Liq. 1, Carc. 2, Acute Tox. 4 * H224, H351, H332 * D CLP00/
602-026-00-3 1,2-dichloroethylene; [1] cis-dichloroethylene; [2] trans-dichloroethylene [3] 540-59-0 [1], 156-59-2 [2], 156-60-5 [3] Flam. Liq. 2, Acute Tox. 4 *, Aquatic Chronic 3 H225, H332, H412 * C CLP00/
602-027-00-9 trichloroethylene; trichloroethene 79-01-6 Carc. 1B, Muta. 2, Eye Irrit. 2, Skin Irrit. 2, STOT SE 3, Aquatic Chronic 3 H350, H341, H319, H315, H336, H412 CLP00/
602-028-00-4 tetrachloroethylene 127-18-4 Carc. 2, Aquatic Chronic 2 H351, H411 CLP00/
602-029-00-X 3-chloropropene; allyl chloride 107-05-1 Flam. Liq. 2, Carc. 2, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H225, H351, H341, H332, H312, H302, H373 **, H319, H335, H315, H400 D CLP00/
602-030-00-5 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] 542-75-6 [1], 10061-01-5 [2] Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Asp. Tox. 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H226, H311, H301, H332, H304, H319, H335, H315, H317, H400, H410 C D CLP00/ATP01
602-031-00-0 1,1-dichloropropene 563-58-6 Flam. Liq. 2, Acute Tox. 3 *, Aquatic Chronic 3 H225, H301, H412 CLP00/
602-032-00-6 3-chloro-2-methylpropene 563-47-3 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H225, H332, H302, H314, H317, H411 CLP00/
602-033-00-1 chlorobenzene 108-90-7 Flam. Liq. 3, Acute Tox. 4 *, Aquatic Chronic 2 H226, H332, H411 * CLP00/
602-034-00-7 1,2-dichlorobenzene; o-dichlorobenzene 95-50-1 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H315, H400, H410 * CLP00/
602-035-00-2 1,4-dichlorobenzene; p-dichlorobenzene 106-46-7 Carc. 2, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H319, H400, H410 CLP00/
602-036-00-8 chloroprene (stabilised); 2-chlorobuta-1,3-diene (stabilised) 126-99-8 Flam. Liq. 2, Carc. 1B, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H225, H350, H332, H302, H373 **, H319, H335, H315 D CLP00/
602-037-00-3 -chlorotoluene; benzyl chloride 100-44-7 Carc. 1B, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H350, H331, H302, H373 **, H335, H315, H318 CLP00/
602-038-00-9 , , -trichlorotoluene; benzotrichloride 98-07-7 Carc. 1B, Acute Tox. 3 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H350, H331, H302, H335, H315, H318 CLP00/
602-039-00-4 polychlorobiphenyls; PCB 1336-36-3 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H400, H410 STOT RE 2; H373: C ≥ 0,005 % C CLP00/
602-040-00-X 2-chlorotoluene; [1] 3-chlorotoluene; [2] 4-chlorotoluene; [3] chlorotoluene [4] 95-49-8 [1], 108-41-8 [2], 106-43-4 [3], 25168-05-2 [4] Acute Tox. 4 *, Aquatic Chronic 2 H332, H411 C CLP00/
602-041-00-5 penthachloronaphthalene 1321-64-8 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H319, H315, H400, H410 C CLP00/
602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex - Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H301, H312, H400, H410 A C CLP00/
602-043-00-6 lindane (ISO); -HCH or -BHC; -1,2,3,4,5,6-hexachlorocyclohexane 58-89-9 Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Lact., Aquatic Acute 1, Aquatic Chronic 1 H301, H332, H312, H373 **, H362, H400, H410 M=10: CLP00/
602-044-00-1 camphechlor (ISO); toxaphene 8001-35-2 Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H301, H312, H335, H315, H400, H410 CLP00/
602-045-00-7 DDT (ISO); clofenotane (INN); dicophane; 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane 50-29-3 Carc. 2, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H301, H372 **, H400, H410 CLP00/
602-046-00-2 heptachlor (ISO); 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 76-44-8 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H311, H301, H373 **, H400, H410 CLP00/
602-047-00-8 chlordane (ISO); 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 57-74-9 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H312, H302, H400, H410 CLP00/
602-048-00-3 aldrin (ISO) 309-00-2 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H311, H301, H372 **, H400, H410 CLP00/
602-049-00-9 dieldrin (ISO) 60-57-1 Carc. 2, Acute Tox. 1, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H310, H301, H372 **, H400, H410 CLP00/
602-050-00-4 isodrin; (1 ,4 ,4aß,5ß,8ß,8aß)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene 465-73-6 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 M=100: CLP00/ATP01
602-051-00-X endrin (ISO); 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 72-20-8 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H311, H400, H410 CLP00/
602-052-00-5 endosulfan (ISO); 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite 115-29-7 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H312, H400, H410 CLP00/ATP01
602-053-00-0 isobenzan (ISO); 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 297-78-9 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1 H310, H300, H400 CLP00/
602-054-00-6 3-iodpropene; allyl iodide 556-56-9 Flam. Liq. 2, Skin Corr. 1B H225, H314 CLP00/ATP01
602-055-00-1 bromoethane; ethyl bromide 74-96-4 Flam. Liq. 2, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 * H225, H351, H332, H302 CLP00/
602-056-00-7 , , -trifluorotoluene; benzotrifluoride 98-08-8 Flam. Liq. 2, Aquatic Chronic 2 H225, H411 CLP00/
602-057-00-2 -bromotoluene; benzyl bromide 100-39-0 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 CLP00/
602-058-00-8 , -dichlorotoluene; benzylidene chloride; benzal chloride 98-87-3 Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H351, H331, H302, H335, H315, H318 CLP00/
602-059-00-3 1-chlorobutane; butyl chloride 109-69-3 Flam. Liq. 2 H225 CLP00/
602-060-00-9 bromobenzene 108-86-1 Flam. Liq. 3, Skin Irrit. 2, Aquatic Chronic 2 H226, H315, H411 CLP00/
602-061-00-4 hexafluoropropene; hexafluoropropylene 116-15-4 Press. Gas, Acute Tox. 4 *, STOT SE 3 H332, H335 U CLP00/
602-062-00-X 1,2,3-trichloropropane 96-18-4 Carc. 1B, Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H350, H360F ***, H332, H312, H302 D CLP00/
602-063-00-5 heptachlor epoxide; 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 1024-57-3 Carc. 2, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H301, H373 **, H400, H410 CLP00/
602-064-00-0 1,3-dichloro-2-propanol 96-23-1 Carc. 1B, Acute Tox. 3 *, Acute Tox. 4 * H350, H301, H312 CLP00/
602-065-00-6 hexachlorobenzene 118-74-1 Carc. 1B, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H372 **, H400, H410 CLP00/
602-066-00-1 tetrachloro-p-benzoquinone 118-75-2 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 CLP00/
602-067-00-7 1,3-dichlorbenzene 541-73-1 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
602-068-00-2 ethylene bis(trichloroacetate) 2514-53-6 Skin Irrit. 2 H315 CLP00/
602-069-00-8 dichloroacetylene 7572-29-4 Unst. Expl., Carc. 2, STOT RE 2 * H200, H351, H373 ** CLP00/
602-070-00-3 3-chloro-4,5, , , -pentafluorotoluene 77227-99-7 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H226, H332, H302, H400 CLP00/
602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 99688-47-8 STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H317, H400, H410 CLP00/
602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) 76253-60-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
602-073-00-X 1,4-dichlorobut-2-ene 764-41-0 Carc. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H330, H311, H301, H314, H400, H410 Carc. 1B; H350: C ≥ 0,01 %, STOT SE 3; H335: C ≥ 5 % CLP00/
602-074-00-5 pentachlorobenzene 608-93-5 Flam. Sol. 1, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H228, H302, H400, H410 T CLP00/
602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 22432-68-4 Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B H330, H302, H314 CLP00/
602-076-00-6 2,3,4-trichlorobut-1-ene 2431-50-7 Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H331, H302, H319, H335, H315, H400, H410 Carc. 2; H351: C ≥ 0,1 % CLP00/ATP01
602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; mirex 2385-85-5 Carc. 2, Repr. 2, Lact., Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H361fd, H362, H312, H302, H400, H410 CLP00/
602-078-00-7 hexachlorocyclopentadiene 77-47-4 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H330, H311, H302, H314, H400, H410 CLP00/
602-079-00-2 2,3-dichloropropene; 2,3-dichloropropylene 78-88-6 Flam. Liq. 2, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H225, H341, H332, H312, H302, H335, H315, H318, H412 CLP00/
602-080-00-8 alkanes, C10-13, chloro; chlorinated paraffins, C10-13 85535-84-8 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/ATP01
602-081-00-3 2-chloro-4,5-difluorobenzoic acid - Acute Tox. 4 *, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H312, H302, H318, H317 CLP00/
602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 109678-33-3 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 32534-81-9 STOT RE 2 *, Lact., Aquatic Acute 1, Aquatic Chronic 1 H373 **, H362, H400, H410 CLP00/
602-084-00-X 1,1-dichloro-1-fluoroethane 1717-00-6 Aquatic Chronic 3, Ozone 1 H412, H420 CLP00/ATP02
602-085-00-5 2-bromopropane 75-26-3 Flam. Liq. 2, Repr. 1A, STOT RE 2 * H225, H360F ***, H373 ** CLP00/
602-086-00-0 trifluoroiodomethane; trifluoromethyl iodide 2314-97-8 Muta. 2 H341 CLP00/
602-087-00-6 1,2,4-trichlorobenzene 120-82-1 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H400, H410 CLP00/
602-088-00-1 2,3-dibromopropan-1-ol; 2,3-dibromo-1-propanol 96-13-9 Carc. 1B, Repr. 2, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H350, H361f ***, H311, H332, H302, H412 CLP00/
602-089-00-7 4-bromo-2-chlorofluorobenzene 60811-21-4 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H400, H410 CLP00/
602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 121626-73-1 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
602-091-00-8 1,3-dichloro-4-fluorobenzene 1435-48-9 Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, H302, H373 **, H315, H411 CLP00/
602-092-00-3 1-bromo-3,4,5-trifluorobenzene 138526-69-9 Flam. Liq. 3, Carc. 2, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H226, H351, H315, H318, H411 CLP00/
602-093-00-9 , , ,4-tetrachlorotoluene; p-chlorobenzotrichloride 5216-25-1 Carc. 1B, Repr. 2, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2 H350, H361f ***, H372 **, H312, H302, H335, H315 CLP00/
602-094-00-4 diphenylether; octabromo derivate 32536-52-0 Repr. 1B H360Df CLP00/
602-095-00-X alkanes, C14-17, chloro; chlorinated paraffins, C14-17 85535-85-9 Lact., Aquatic Acute 1, Aquatic Chronic 1 H362, H400, H410 ATP01/
602-096-00-5 malachite green hydrochloride; [1] malachite green oxalate [2] 569-64-2 [1], 2437-29-8 [2] Repr. 2, Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H302, H318, H400, H410 CLP00/
602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 148757-89-5 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
602-098-00-6 2-(3-bromophenoxy)tetrahydro-2H-pyran 57999-49-2 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
602-099-00-1 3-(4-fluorophenyl)-2-methylpropionylchloride - Skin Corr. 1A, Acute Tox. 4 *, Aquatic Chronic 3 H314, H302, H412 ATP01/
602-100-00-5 reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane - Aquatic Chronic 3 H412 ATP01/
602-101-00-0 2-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate 141772-37-4 STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373**, H317, H400, H410 ATP01/
602-102-00-6 1,1,1,3,3-pentafluorobutane 406-58-6 Flam. Liq. 2 H225 ATP01/
602-103-00-1 1-(chlorophenylmethyl)-2-methylbenzene 41870-52-4 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 ATP01/
602-104-00-7 1,1,2,2,3,3,4-heptafluorocyclopentane 15290-77-4 Aquatic Chronic 3 H412 ATP01/
602-105-00-2 sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate 102061-82-5 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
602-106-00-8 2-bromo-4,6-difluoroaniline 444-14-4 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 ATP01/
602-107-00-3 3,3,4,4-tetrafluoro-4-iodo-1-butene 33831-83-3 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Chronic 2 H302, H315, H411 ATP01/
602-108-00-9 (2,3,5,6-tetrafluorophenyl)methanol 4084-38-2 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H302, H319, H317 ATP01/
603-001-00-X methanol 67-56-1 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT SE 1 H225, H331, H311, H301, H370 ** *, STOT SE 1; H370: C ≥ 10 %, STOT SE 2; H371: 3 % ≤ C < 10 % CLP00/
603-002-00-5 ethanol; ethyl alcohol 64-17-5 Flam. Liq. 2 H225 CLP00/
603-003-00-0 propan-1-ol; n-propanol 71-23-8 Flam. Liq. 2, Eye Dam. 1, STOT SE 3 H225, H318, H336 CLP00/
603-004-00-6 butan-1-ol; n-butanol 71-36-3 Flam. Liq. 3, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, STOT SE 3 H226, H302, H335, H315, H318, H336 CLP00/
603-005-00-1 2-methylpropan-2-ol; tert-butyl alcohol 75-65-0 Flam. Liq. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H225, H332, H319, H335 CLP00/ATP01
603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex - Flam. Liq. 3, Acute Tox. 4 *, STOT SE 3 H226, H332, H335 C CLP00/
603-007-00-2 2-methylbutan-2-ol; tert-pentanol 75-85-4 Flam. Liq. 2, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2 H225, H332, H335, H315 CLP00/
603-008-00-8 4-methylpentan-2-ol; methyl isobutyl carbinol 108-11-2 Flam. Liq. 3, STOT SE 3 H226, H335 STOT SE 3; H335: C ≥ 25 % CLP00/
603-009-00-3 cyclohexanol 108-93-0 Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2 H332, H302, H335, H315 CLP00/
603-010-00-9 2-methylcyclohexanol, mixed isomers; [1] cis-2-methylcyclohexanol; [2] trans-2-methylcyclohexanol [3] 583-59-5 [1], 7443-70-1 [2], 7443-52-9 [3] Acute Tox. 4 * H332 C CLP00/
603-011-00-4 2-methoxyethanol; ethylene glycol monomethyl ether 109-86-4 Flam. Liq. 3, Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H226, H360FD, H332, H312, H302 CLP00/
603-012-00-X 2-ethoxyethanol; ethylene glycol monoethyl ether 110-80-5 Flam. Liq. 3, Repr. 1B, Acute Tox. 3, Acute Tox. 4 H226, H360FD, H331, H302 CLP00/ATP03
603-013-00-5 2-isopropoxyethanol; ethylene glycol monoisopropyl ether 109-59-1 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2 H332, H312, H319 CLP00/
603-014-00-0 2-butoxyethanol; ethylene glycol monobutyl ether; butyl cellosolve 111-76-2 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H332, H312, H302, H319, H315 CLP00/
603-015-00-6 allyl alcohol 107-18-6 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H225, H331, H311, H301, H319, H335, H315, H400 CLP00/
603-016-00-1 4-hydroxy-4-methylpentan-2-one; diacetone alcohol 123-42-2 Eye Irrit. 2 H319 Eye Irrit. 2; H319: C ≥ 10 % CLP00/
603-018-00-2 furfuryl alcohol 98-00-0 Carc. 2, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, STOT SE 3 H351, H331, H312, H302, H373**, H319, H335 CLP00/ATP01
603-019-00-8 dimethyl ether 115-10-6 Flam. Gas 1, Press. Gas H220 U CLP00/
603-020-00-3 ethyl methyl ether 540-67-0 Flam. Gas 1, Press. Gas H220 U CLP00/
603-021-00-9 methyl vinyl ether 107-25-5 Flam. Gas 1, Press. Gas H220 D U CLP00/
603-022-00-4 diethyl ether; ether 60-29-7 Flam. Liq. 1, Acute Tox. 4 *, STOT SE 3 H224, H302, H336 CLP00/
603-023-00-X ethylene oxide; oxirane 75-21-8 Press. Gas, Flam. Gas 1, Carc. 1B, Muta. 1B, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H220, H350, H340, H331, H319, H335, H315 CLP00/ATP01
603-024-00-5 1,4-dioxane 123-91-1 Flam. Liq. 2, Carc. 2, Eye Irrit. 2, STOT SE 3 H225, H351, H319, H335 D CLP00/
603-025-00-0 tetrahydrofuran 109-99-9 Flam. Liq. 2, Carc. 2, Eye Irrit. 2, STOT SE 3 H225, H351, H319, H335, EUH019 Eye Irrit. 2; H319: C ≥ 25 %, STOT SE 3; H335: C ≥ 25 % CLP00/ATP03
603-026-00-6 1-chloro-2,3-epoxypropane; epichlorhydrin 106-89-8 Flam. Liq. 3, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1 H226, H350, H331, H311, H301, H314, H317 * CLP00/
603-027-00-1 ethanediol; ethylene glycol 107-21-1 Acute Tox. 4 * H302 CLP00/
603-028-00-7 2-chloroethanol; ethylene chlorohydrin 107-07-3 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H330, H310, H300 CLP00/
603-029-00-2 bis(2-chloroethyl) ether 111-44-4 Carc. 2, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H351, H330, H310, H300 CLP00/ATP01
603-030-00-8 2-aminoethanol; ethanolamine 141-43-5 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H332, H312, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
603-031-00-3 1,2-dimethoxyethane; ethylene glycol dimethyl ether; EGDME 110-71-4 Flam. Liq. 2, Repr. 1B, Acute Tox. 4 * H225, H360FD, H332 CLP00/
603-032-00-9 ethylene dinitrate; ethylene glycol dinitrate 628-96-6 Unst. Expl., Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 H200, H330, H310, H300, H373** CLP00/ATP01
603-033-00-4 oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate 693-21-0 Unst. Expl, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 3 H200, H330, H310, H300, H373 **, H412 CLP00/
603-033-01-1 oxydiethylene dinitrate; diethylene glycol dinitrate; digol dinitrate; [>25 % phlegmatiser] 693-21-0 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 3 H201, H330, H310, H300, H373 **, H412 CLP00/
603-034-00-X glycerol trinitrate; nitroglycerine 55-63-0 Unst. Expl., Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 2 H200, H330, H310, H300, H373 **, H411 CLP00/
603-034-01-7 glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser] 55-63-0 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 2 H201, H330, H310, H300, H373 **, H411 CLP00/
603-035-00-5 pentaerythritol tetranitrate; P.E.T.N. 78-11-5 Unst. Expl. H200 CLP00/
603-035-01-2 pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.; [>20 % phlegmatiser] 78-11-5 Expl. 1.1 H201 T CLP00/
603-036-00-0 mannitol hexanitrate; nitromannite 15825-70-4 Unst. Expl. H200 CLP00/
603-036-01-8 mannitol hexanitrate; nitromannite; [>40 % phlegmatiser] 15825-70-4 Expl. 1.1 H201 CLP00/
603-037-00-6 cellulose nitrate; nitrocellulose - Expl. 1.1 H201 T CLP00/ATP01
603-038-00-1 allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether 106-92-3 Flam. Liq. 3, Carc. 2, Muta. 2, Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H226, H351, H341, H361f ***, H332, H302, H335, H315, H318, H317, H412 CLP00/
603-039-00-7 butyl glycidyl ether; butyl 2,3-epoxypropyl ether 2426-08-6 Flam. Liq. 3, Carc. 2, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Sens. 1, Aquatic Chronic 3 H226, H351, H341, H332, H302, H335, H317, H412 CLP00/
603-040-00-2 sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3] 124-41-4 [1], 865-33-8 [2], 865-34-9 [3] Self-heat 1, Skin Corr. 1B H251, H314 T CLP00/
603-041-00-8 potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2] 917-58-8 [1], 141-52-6 [2] Self-heat 1, Skin Corr. 1B H251, H314 T CLP00/
603-042-00-3 aluminium-tri-isopropoxide 555-31-7 Flam. Sol. 1 H228 T CLP00/
603-043-00-9 triarimol (ISO); 2,4-dichloro- -(pyrimidin-5-yl) benzhydryl alcohol 26766-27-8 Acute Tox. 4 * H302 CLP00/
603-044-00-4 dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol 115-32-2 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H315, H317, H400, H410 CLP00/
603-045-00-X diisopropyl ether; [1] dipropyl ether [2] 108-20-3 [1], 111-43-3 [2] Flam. Liq. 2, STOT SE 3 H225, H336 C CLP00/
603-046-00-5 bis(chloromethyl) ether; oxybis(chloromethane) 542-88-1 Flam. Liq. 2, Carc. 1A, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 * H225, H350, H330, H311, H302 Carc. 1A; H350: C ≥ 0,001 % CLP00/ATP01
603-047-00-0 2-dimethylaminoethanol; N,N-dimethylethanolamine 108-01-0 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H226, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
603-048-00-6 2-diethylaminoethanol; N,N-diethylethanolamine 100-37-8 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H226, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
603-049-00-1 chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol 80-06-8 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
603-050-00-7 1-(2-Butoxypropoxy)propan-2-ol 24083-03-2 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
603-051-00-2 2-ethylbutan-1-ol 97-95-0 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
603-052-00-8 3-butoxypropan-2-ol; propylene glycol monobutyl ether 5131-66-8 Eye Irrit. 2, Skin Irrit. 2 H319, H315 CLP00/
603-053-00-3 2-methylpentane-2,4-diol 107-41-5 Eye Irrit. 2, Skin Irrit. 2 H319, H315 CLP00/
603-054-00-9 di-n-butyl ether; dibutyl ether 142-96-1 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 3 H226, H319, H335, H315, H412 STOT SE 3; H335: C ≥ 10 % CLP00/
603-055-00-4 propylene oxide; 1,2-epoxypropane; methyloxirane 75-56-9 Flam. Liq. 1, Carc. 1B, Muta. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H224, H350, H340, H332, H312, H302, H319, H335, H315 CLP00/
603-056-00-X [(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2] 2,3-epoxypropyl o-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4] 2186-24-5 [1], 2186-25-6 [2], 2210-79-9 [3], 26447-14-3 [4] Muta. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H341, H315, H317, H411 C CLP00/
603-057-00-5 benzyl alcohol 100-51-6 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 CLP00/
603-058-00-0 1,3-propylene oxide 503-30-0 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H312, H302 CLP00/
603-059-00-6 hexan-1-ol 111-27-3 Acute Tox. 4 * H302 CLP00/
603-060-00-1 2,2'-bioxirane; 1,2:3,4-diepoxybutane 1464-53-5 Carc. 1B, Muta. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B H350, H340, H330, H311, H301, H314 CLP00/
603-061-00-7 tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol 97-99-4 Repr. 1B, Eye Irrit. 2 H360Df, H319 CLP00/ATP06
603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 104-80-3 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 STOT SE 3; H335: C ≥ 10 % CLP00/
603-063-00-8 2,3-epoxypropan-1-ol; glycidol; oxiranemethanol 556-52-5 Carc. 1B, Muta. 2, Repr. 1B, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H350, H341, H360F ***, H331, H312, H302, H319, H335, H315 CLP00/
603-064-00-3 1-methoxy-2-propanol; monopropylene glycol methyl ether 107-98-2 Flam. Liq. 3, STOT SE 3 H226, H336 CLP00/ATP01
603-065-00-9 resorcinol diglycidyl ether; 1,3-bis(2,3-epoxypropoxy)benzene 101-90-6 Carc. 2, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H351, H341, H312, H302, H319, H315, H317, H412 CLP00/
603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide 106-87-6 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H351, H331, H311, H301 * CLP00/ATP01
603-067-00-X phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether; 1,2-epoxy-3-phenoxypropane 122-60-1 Carc. 1B, Muta. 2, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H350, H341, H332, H335, H315, H317, H412 CLP00/
603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether 130014-35-6 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 CLP00/
603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 90-72-2 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H302, H319, H315 CLP00/
603-070-00-6 2-amino-2-methylpropanol 124-68-5 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H319, H315, H412 CLP00/
603-071-00-1 2,2'-iminodiethanol; diethanolamine 111-42-2 Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1 H302, H373 **, H315, H318 CLP00/
603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether 2425-79-8 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H332, H312, H319, H315, H317 CLP00/
603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 1675-54-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 Eye Irrit. 2; H319: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 % CLP00/
603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight 700) 25068-38-6 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H319, H315, H317, H411 Eye Irrit. 2; H319: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 % CLP00/
603-075-00-3 chlormethyl methyl ether; chlorodimethyl ether 107-30-2 Flam. Liq. 2, Carc. 1A, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H225, H350, H332, H312, H302 CLP00/
603-076-00-9 but-2-yne-1,4-diol; 2-butyne-1,4-diol 110-65-6 Skin Corr. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1 H314, H331, H301, H312, H373 **, H317 Skin Corr. 1B; H314: C ≥ 50 %, Skin Irrit. 2; H315: 25 % ≤ C < 50 %, Eye Irrit. 2; H319: 25 % ≤ C < 50 % D CLP00/
603-077-00-4 1-dimethylaminopropan-2-ol; dimepranol (INN) 108-16-7 Flam. Liq. 3, Acute Tox. 4 *, Skin Corr. 1B H226, H302, H314 CLP00/
603-078-00-X prop-2-yn-1-ol; propargyl alcohol 107-19-7 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Chronic 2 H226, H331, H311, H301, H314, H411 CLP00/
603-079-00-5 2,2'-(methylimino)diethanol; N-methyldiethanolamine 105-59-9 Eye Irrit. 2 H319 CLP00/
603-080-00-0 2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol 109-83-1 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
603-081-00-6 2,2'-thiodiethanol; thiodiglycol 111-48-8 Eye Irrit. 2 H319 CLP00/
603-082-00-1 1-aminopropan-2-ol; isopropanolamine 78-96-6 Skin Corr. 1B H314 CLP00/
603-083-00-7 1,1'-iminodipropan-2-ol; di-isopropanolamine 110-97-4 Eye Irrit. 2 H319 CLP00/
603-084-00-2 styrene oxide; (epoxyethyl)benzene; phenyloxirane 96-09-3 Carc. 1B, Acute Tox. 4 *, Eye Irrit. 2 H350, H312, H319 CLP00/
603-085-00-8 bronopol (INN); 2-bromo-2-nitropropane-1,3-diol 52-51-7 Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1 H312, H302, H335, H315, H318, H400 M=10: CLP00/ATP01
603-086-00-3 ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol 23947-60-6 Acute Tox. 4 * H312 CLP00/
603-087-00-9 2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol 94-96-2 Eye Dam. 1 H318 CLP00/
603-088-00-4 2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide 3547-33-9 Eye Dam. 1 H318 CLP00/
603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol - Skin Corr. 1A, Acute Tox. 4 * H314, H302 CLP00/
603-090-00-5 2-(2-bromoethoxy)anisole 4463-59-6 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 87172-89-2 Acute Tox. 4 *, Eye Dam. 1 H302, H318 CLP00/
603-092-00-6 2-methyl-4-phenylpentanol 92585-24-5 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
603-093-00-1 cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane 87818-31-3 Acute Tox. 4 *, Aquatic Chronic 2 H332, H411 CLP00/
603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 17557-23-2 Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
603-095-00-2 2-(propyloxy)ethanol; EGPE 2807-30-9 Acute Tox. 4 *, Eye Irrit. 2 H312, H319 CLP00/
603-096-00-8 2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether 112-34-5 Eye Irrit. 2 H319 CLP00/
603-097-00-3 1,1',1''-nitrilotripropan-2-ol; triisopropanolamine 122-20-3 Eye Irrit. 2 H319 CLP00/ATP05
603-098-00-9 2-phenoxyethanol 122-99-6 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 93633-79-5 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
603-100-00-8 1,2-dimethoxypropane 7778-85-0 Flam. Liq. 2 H225 CLP00/
603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) - Eye Irrit. 2 H319 CLP00/
603-102-00-9 1,2-epoxybutane 106-88-7 Flam. Liq. 2, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Irrit. 2 H225, H351, H302, H312, H332, H335, H315, H319 CLP00/ATP07
603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 68609-97-2 Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
603-104-00-X fenarimol (ISO); 2,4'-dichloro- -(pyrimidin-5-yl)benzhydryl alcohol 60168-88-9 Repr. 2, Lact., Aquatic Chronic 2 H361fd, H362, H411 CLP00/
603-105-00-5 furan 110-00-9 Flam. Liq. 1, Carc. 1B, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Aquatic Chronic 3 H224, H350, H341, H332, H302, H373 **, H315, H412 CLP00/
603-106-00-0 2-methoxypropanol 1589-47-5 Flam. Liq. 3, Repr. 1B, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H226, H360D ***, H335, H315, H318 CLP00/
603-107-00-6 2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether 111-77-3 Repr. 2 H361d *** CLP00/
603-108-00-1 2-methylpropan-1-ol; iso-butanol 78-83-1 Flam. Liq. 3, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, STOT SE 3 H226, H335, H315, H318, H336 CLP00/
603-109-00-7 reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane - Aquatic Chronic 4 H413 ATP01/
603-110-00-2 reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane 166301-21-9 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 ATP01/
603-111-00-8 reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane - Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 ATP01/
603-112-00-3 cyclopentyl 2-phenylethyl ether - Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 ATP01/
603-113-00-9 6-glycidyloxynapht-1-yl oxymethyloxirane 27610-48-6 Muta. 2, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H341, H312, H315, H317, H412 ATP01/
603-114-00-4 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene 26912-64-1 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
603-115-00-X reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) - STOT RE 2 *, Aquatic Chronic 4 H373**, H413 ATP01/
603-116-00-5 (Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride 138271-16-6 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
603-117-00-0 propan-2-ol; isopropyl alcohol; isopropanol 67-63-0 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 CLP00/
603-118-00-6 6-dimethylaminohexan-1-ol 1862-07-3 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 3 H302, H314, H412 CLP00/
603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
603-120-00-7 2-methyl-5-phenylpentanol 25634-93-9 Eye Irrit. 2, Skin Irrit. 2 H319, H315 CLP00/
603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 114565-66-1 Carc. 2, Skin Sens. 1, Aquatic Chronic 4 H351, H317, H413 CLP00/
603-122-00-8 sodium 2-ethylhexanolate 38411-13-1 Flam. Sol. 1, Skin Corr. 1B, Aquatic Chronic 3 H228, H314, H412 T CLP00/
603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 122760-84-3 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H315, H317, H411 CLP00/
603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 84563-49-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol 89544-40-1 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 100418-33-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 CLP00/
603-127-00-5 butan-2-ol; [1] (S)-butan-2-ol; [2] (R)-butan-2-ol; [3] (±)-butan-2-ol [4] 78-92-2 [1], 4221-99-2 [2], 14898-79-4 [3], 15892-23-6 [4] Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, STOT SE 3 H226, H319, H335, H336 C CLP00/ATP01
603-128-00-0 2-(phenylmethoxy)naphthalene 613-62-7 Aquatic Chronic 4 H413 CLP00/
603-129-00-6 1-tert-butoxypropan-2-ol 57018-52-7 Flam. Liq. 3, Eye Dam. 1 H226, H318 CLP00/
603-130-00-1 reaction mass of isomers of: -((dimethyl)biphenyl)- -hydroxypoly(oxyethylene) - Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) - Eye Dam. 1 H318 CLP00/
603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 63187-91-7 Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H315, H318, H412 CLP00/
603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) - Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. - Aquatic Chronic 4 H413 CLP00/
603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 104226-19-9 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol - Eye Dam. 1 H318 CLP00/
603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene; (alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol 103694-68-4 Aquatic Chronic 3 H412 CLP00/
603-139-00-0 bis(2-methoxyethyl) ether 111-96-6 Flam. Liq. 3, Repr. 1B H226, H360FD CLP00/
603-140-00-6 2,2' -oxybisethanol; diethylene glycol 111-46-6 Acute Tox. 4 * H302 CLP00/
603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane - Aquatic Chronic 3 H412 CLP00/
603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 116230-20-7 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1 H312, H302, H373 **, H315, H318 CLP00/
603-143-00-2 R-2,3-epoxy-1-propanol 57044-25-4 Self-react. C ****, Carc. 1B, Muta. 2, Repr. 1B, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H242, H350, H341, H360F ***, H331, H312, H302, H314 CLP00/
603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol 111850-00-1 Aquatic Chronic 2 H411 CLP00/
603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 129228-11-1 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 83016-70-0 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 3 H302, H314, H412 CLP00/
603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 105812-81-5 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 17351-75-6 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 63767-86-2 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H319, H315, H411 CLP00/
603-150-00-0 (±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 107898-54-4 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol - Aquatic Chronic 3 H412 CLP00/
603-152-00-1 2-(4-tert-butylphenyl)ethanol 5406-86-0 Repr. 2, STOT RE 2 *, Eye Dam. 1, Aquatic Chronic 2 H361f ***, H373 **, H318, H411 CLP00/
603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 104333-00-8 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 139504-68-0 Aquatic Chronic 2 H411 CLP00/
603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 89544-48-9 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 143747-72-2 Aquatic Chronic 4 H413 CLP00/
603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
603-159-00-X 2-cyclododecylpropan-1-ol 118562-73-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
603-160-00-5 1,2-diethoxypropane 10221-57-5 Flam. Liq. 2 H225 CLP00/
603-161-00-0 1,3-diethoxypropane 3459-83-4 Flam. Liq. 3 H226 CLP00/
603-162-00-6 [2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- -(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 144736-29-8 Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H314, H317, H411 CLP00/
603-163-00-1 2-phenyl-1,3-propanediol 1570-95-2 Eye Dam. 1 H318 CLP00/
603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 133909-99-6 Aquatic Chronic 4 H413 CLP00/
603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3 - Muta. 2, Skin Sens. 1 H341, H317 CLP00/
603-166-00-8 R-1-chloro-2,3-epoxypropane 51594-55-9 Flam. Liq. 3, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1 H226, H350, H331, H311, H301, H314, H317 CLP00/
603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 6390-69-8 Aquatic Chronic 4 H413 CLP00/
603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 70445-33-9 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 109887-53-8 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol 67739-11-1 Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
603-171-00-5 5-thiazolylmethanol 38585-74-9 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 773058-82-5 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 57280-22-5 Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 83926-73-2 Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
603-175-00-7 2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol 112-59-4 Acute Tox. 4 *, Eye Dam. 1 H312, H318 CLP00/
603-176-00-2 1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme 112-49-2 Repr. 1B H360Df CLP00/
603-177-00-8 1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEA [2] 1569-02-4 [1], 54839-24-6 [2] Flam. Liq. 3, STOT SE 3 H226, H336 CLP00/
603-178-00-3 2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol 112-25-4 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 CLP00/
603-179-00-9 ergocalciferol (ISO); Vitamin D2 50-14-6 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1 H330, H311, H301, H372 ** CLP00/
603-180-00-4 colecalciferol; Vitamin D3 67-97-0 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1 H330, H311, H301, H372 ** CLP00/
603-181-00-X tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane 1634-04-4 Flam. Liq. 2, Skin Irrit. 2 H225, H315 CLP00/
603-182-00-5 reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide - Skin Sens. 1 H317 ATP01/
603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutyl ether; butoxytriethylene glycol 143-22-6 Eye Dam. 1 H318 Eye Dam. 1; H318: C ≥ 30 %, Eye Irrit. 2; H319: 20 % ≤ C < 30 % CLP00/
603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 146925-83-9 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 99817-36-4 Acute Tox. 3 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H318, H317, H400, H410 CLP00/
603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 79944-37-9 Skin Sens. 1 H317 CLP00/
603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 163661-77-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
603-188-00-8 reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol - Aquatic Chronic 2 H411 CLP00/
603-190-00-9 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane 62406-73-9 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 ATP01/
603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 137658-79-8 Aquatic Chronic 4 H413 CLP00/
603-192-00-X (E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol 125474-34-2 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 ATP01/
603-193-00-5 disodium 9,10-anthracenedioxide 46492-07-3 Skin Corr. 1A H314 ATP01/
603-194-00-0 2-(2-aminoethylamino)ethanol; (AEEA) 111-41-1 Repr. 1B, Skin Corr. 1B, Skin Sens. 1, H360Fd, H361, H314, H317 STOT SE 3; H335: C ≥ 5 % ATP01/
603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 154825-62-4 Aquatic Chronic 3 H412 CLP00/
603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 41340-36-7 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 2 H302, H373 **, H411 CLP00/
603-197-00-7 tebuconazole (ISO); 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 107534-96-3 Repr. 2, Acute Tox. 4, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H302, H400, H410 M=1 , M=10 CLP00/ATP07
603-199-00-8 etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole 153233-91-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M = 100: CLP00/
603-200-00-1 1-pentanol; [1] 3-pentanol [2] 71-41-0 [1], 584-02-1 [2] Flam. Liq. 3, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2 H226, H332, H335, H315 ATP01/
603-201-00-7 (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol - Skin Irrit. 2, Aquatic Chronic 4 H315, H413 ATP01/
603-202-00-2 4,4,5,5,5-pentafluoropentan-1-ol 148043-73-6 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
603-203-00-8 (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane - Skin Irrit. 2 H315 ATP01/
603-204-00-3 reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane - Aquatic Chronic 3 H412 ATP01/
603-205-00-9 (1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride 172015-79-1 STOT RE 1, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H372**, H302, H318, H317, H412 ATP01/
603-206-00-4 2,2-dichloro-1,3-benzodioxol 2032-75-9 Flam. Liq. 3, Skin Corr. 1A, Acute Tox. 4 *, Skin Sens. 1 H226, H314, H302, H317 ATP01/
603-207-00-X 2-isobutyl-2-isopropyl-1,3-dimethoxypropane 129228-21-3 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
603-208-00-5 1,2-diethoxyethane 629-14-1 Flam. Liq. 2, Repr. 1A, Eye Irrit. 2 H225, H360Df, H319 ATP01/
603-209-00-0 spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95% of (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-deoxy-2,3,4-tri-O-methyl- -l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-ß-d- - [1], 131929-60-7 [2], 131929-63-0 [3], - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=10: ATP01/
603-210-00-6 2,4-diethyl-1,5-pentanediol 57987-55-0 Eye Dam. 1 H318 ATP01/
603-211-00-1 2,3-epoxypropyltrimethylammonium chloride ...%; glycidyl trimethylammonium chloride ...% 3033-77-0 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H350, H341, H361f***, H312, H302, H373**, H318, H317, H412 B ATP01/
603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) 1222-05-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
603-213-00-2 2-methoxy-2-methylbutane; tert-amyl methyl ether 994-05-8 Flam. Liq. 2, Acute Tox. 4 *, STOT SE 3 H225, H302, H336 ATP01/
603-214-00-8 1,1-diisopropoxycyclohexane 1132-95-2 Skin Corr. 1B H314 ATP01/
603-215-00-3 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) 162241-33-0 Expl. 1.1****, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H201, H302, H373**, H318, H317, H400, H410 ATP01/
603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol 7480-35-5 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
603-217-00-4 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite 161717-32-4 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
603-220-00-0 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol 72955-94-3 Aquatic Chronic 4 H413 ATP01/
603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0.1 % 4-chloroaniline (EC No 203-401-0)] 214353-17-0 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H302, H314, H411 ATP01/
603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing 0.1 % 4-chloroaniline (EC No 203-401-0)] 214353-17-0 Carc. 1B, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H350, H302, H314, H411 ATP01/
603-222-00-1 (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane 118058-74-5 Eye Irrit. 2 H319 ATP01/
603-223-00-7 2-cyclopentylidene cyclopentanol; 1,1'-bi(cyclopentyliden)-2-ol 6261-30-9 Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H315, H318, H412 ATP01/
603-224-00-2 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane 297730-93-9 Aquatic Chronic 4 H413 ATP01/
603-225-00-8 erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl- -L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-ß-d-xylohexapiranosyl)oxy)oxacyclot 13127-18-9 Aquatic Chronic 2 H411 ATP01/
603-226-00-3 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol 1440-00-2 Aquatic Chronic 3 H412 ATP01/
603-227-00-9 -hydro- -[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: -hydro- -((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxy 203574-04-3 ****, Aquatic Acute 1, Aquatic Chronic 1 ****, H400, H410 ATP01/
603-228-00-4 (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
603-229-00-X sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate - Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 ATP01/
603-230-00-5 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan - Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 4 H315, H318, H413 ATP01/
603-231-00-0 (S)-1,1-diphenyl-1,2-propanediol - Aquatic Chronic 3 H412 ATP01/
603-232-00-6 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane - Aquatic Chronic 4 H413 ATP01/
603-233-00-1 reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a- - Aquatic Chronic 2 H411 ATP01/
603-234-00-7 (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
604-001-00-2 phenol; carbolic acid; monohydroxybenzene; phenylalcohol 108-95-2 Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Skin Corr. 1B H341, H331, H311, H301, H373 **, H314 *, Skin Corr. 1B; H314: C ≥ 3 %, Skin Irrit. 2; H315: 1 % ≤ C < 3 %, Eye Irrit. 2; H319: 1 % ≤ C < 3 % CLP00/
604-002-00-8 pentachlorophenol 87-86-5 Carc. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H330, H311, H301, H319, H335, H315, H400, H410 CLP00/
604-003-00-3 sodium pentachlorophenolate; [1] potassium pentachlorophenolate [2] 131-52-2 [1], 7778-73-6 [2] Carc. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H330, H311, H301, H319, H335, H315, H400, H410 CLP00/
604-004-00-9 m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] 108-39-4 [1], 95-48-7 [2], 106-44-5 [3], 1319-77-3 [4] Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B H311, H301, H314 * C CLP00/
604-005-00-4 1,4-dihydroxybenzene; hydroquinone; quinol 123-31-9 Carc. 2, Muta. 2, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H351, H341, H302, H318, H317, H400 M=10: CLP00/ATP01
604-006-00-X 3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7] 95-65-8 [1], 95-87-4 [2], 105-67-9 [3], 526-75-0 [4], 576-26-1 [5], 1300-71-6 [6], 71975-58-1 [7] Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Chronic 2 H311, H301, H314, H411 C CLP00/
604-007-00-5 2-naphthol 135-19-3 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H332, H302, H400 CLP00/
604-008-00-0 2-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4] 95-57-8 [1], 106-48-9 [2], 108-43-0 [3], 25167-80-0 [4] Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H332, H312, H302, H411 C CLP00/
604-009-00-6 pyrogallol; 1,2,3-trihydroxybenzene 87-66-1 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H341, H332, H312, H302, H412 * CLP00/
604-010-00-1 resorcinol; 1,3-benzenediol 108-46-3 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1 H302, H319, H315, H400 * CLP00/
604-011-00-7 2,4-dichlorophenol 120-83-2 Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H311, H302, H314, H411 CLP00/
604-012-00-2 4-chloro-o-cresol; 4-chloro-2-methyl phenol 1570-64-5 Acute Tox. 3 *, Skin Corr. 1A, Aquatic Acute 1 H331, H314, H400 STOT SE 3; H335: C ≥ 1 % CLP00/
604-013-00-8 2,3,4,6-tetrachlorophenol 58-90-2 Acute Tox. 3 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H301, H319, H315, H400, H410 *, Eye Irrit. 2; H319: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 % CLP00/
604-014-00-3 chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol 59-50-7 Acute Tox. 4 *, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H312, H302, H318, H317, H400 * CLP00/
604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene 70-30-4 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H301, H400, H410 * CLP00/
604-016-00-4 1,2-dihydroxybenzene; pyrocatechol 120-80-9 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H312, H302, H319, H315 CLP00/
604-017-00-X 2,4,5-trichlorophenol 95-95-4 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H315, H400, H410 *, Eye Irrit. 2; H319: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 % CLP00/
604-018-00-5 2,4,6-trichlorophenol 88-06-2 Carc. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H319, H315, H400, H410 CLP00/
604-019-00-0 dichlorophen (ISO) 97-23-4 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H400, H410 CLP00/
604-020-00-6 2-phenylphenol (ISO); biphenyl-2-ol; 2-hydroxybiphenyl 90-43-7 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H319, H335, H315, H400 CLP00/
604-021-00-1 sodium 2-biphenylate; 2-phenylphenol, sodium salt 132-27-4 Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1 H302, H335, H315, H318, H400 CLP00/
604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 22961-82-6 Eye Dam. 1 H318 CLP00/
604-023-00-2 2,4-dichloro-3-ethylphenol - Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 CLP00/
604-024-00-8 4,4-isobutylethylidenediphenol 6807-17-6 Repr. 1B, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H360F ***, H319, H400, H410 CLP00/
604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone - Aquatic Chronic 2 H411 CLP00/
604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) - Aquatic Chronic 2 H411 CLP00/
604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
604-028-00-X 4-amino-3-fluorophenol 399-95-1 Carc. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H350, H302, H317, H411 CLP00/
604-029-00-5 1-naphtol 90-15-3 Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H312, H302, H335, H315, H318 CLP00/
604-030-00-0 bisphenol A; 4,4'-isopropylidenediphenol 80-05-7 Repr. 2, STOT SE 3, Eye Dam. 1, Skin Sens. 1 H361f***, H335, H318, H317 CLP00/ATP01
604-031-00-6 guaiacol 90-05-1 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H302, H319, H315 CLP00/
604-032-00-1 thymol 89-83-8 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H302, H314, H411 CLP00/
604-033-00-7 isobutyl but-3-enoate 24342-03-8 Flam. Liq. 3 H226 CLP00/
604-034-00-2 4,4'-thiodi-o-cresol 24197-34-0 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol - Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 90884-29-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
604-037-00-9 3,5-xylenol; 3,5-dimethylphenol 108-68-9 Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B H311, H301, H314 CLP00/
604-038-00-4 4-chloro-3,5-dimethylphenol; [1] chloroxylenol [2] 88-04-0 [1], 1321-23-9 [2] Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H302, H319, H315, H317 CLP00/
604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl 66441-23-4 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
604-040-00-5 fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide 72178-02-0 Acute Tox. 4 * H302 CLP00/
604-041-00-0 acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid; [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2] 50594-66-6 [1], 62476-59-9 [2] Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H318, H400, H410 CLP00/
604-042-00-6 4-nitrosophenol 104-91-6 Muta. 2, Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H341, H302, H318, H411 CLP00/
604-043-00-1 monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether 103-16-2 Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
604-044-00-7 mequinol; 4-methoxyphenol; hydroquinone monomethyl ether 150-76-5 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H302, H319, H317 CLP00/
604-045-00-2 2,3,5-trimethylhydroquinone 700-13-0 Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H335, H315, H318, H317, H400, H410 CLP00/
604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 95235-30-6 Aquatic Chronic 2 H411 CLP00/
604-047-00-3 4-(4-tolyloxy)biphenyl 51601-57-1 STOT RE 2 *, Aquatic Chronic 4 H373 **, H413 CLP00/
604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 27955-94-8 Aquatic Chronic 2 H411 CLP00/
604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 93589-69-6 Aquatic Chronic 2 H411 CLP00/
604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 87113-78-8 Aquatic Chronic 3 H412 CLP00/
604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 103597-45-1 Aquatic Chronic 4 H413 CLP00/
604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 157661-93-3 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 85954-11-6 Carc. 2, Skin Sens. 1 H351, H317 CLP00/ATP01
604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 99610-72-7 Flam. Sol. 2, Repr. 2, Acute Tox. 4 * H228, H361f ***, H302 CLP00/
604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 - Aquatic Chronic 2 H411 CLP00/
604-058-00-3 1,2-bis(3-methylphenoxy)ethane 54914-85-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
604-059-00-9 2-n-hexadecylhydroquinone - STOT RE 2 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H373 **, H315, H317, H413 CLP00/
604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 3236-71-3 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 CLP00/
604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H315, H317, H412 CLP00/
604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol - Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
604-063-00-0 5,6-dihydroxyindole 3131-52-0 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 147315-50-2 Aquatic Chronic 4 H413 CLP00/
604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 111850-25-0 Aquatic Chronic 2 H411 CLP00/
604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propy - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 90274-24-1 Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1 H332, H302, H317 CLP00/
604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 51390-14-8 Skin Corr. 1B, Aquatic Chronic 2 H314, H411 CLP00/
604-070-00-9 triclosan; 2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol 3380-34-5 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 M = 100: CLP00/
604-071-00-4 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol 110726-28-8 Aquatic Chronic 4 H413 ATP01/
604-072-00-X 1,2-bis(phenoxymethyl)benzene 10403-74-4 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
604-073-00-5 (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol 82413-20-5 Carc. 2, Repr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H360F***, H317, H400, H410 ATP01/
604-074-00-0 tetrabromobisphenol-A; 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol 79-94-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol 140-66-9 Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 M=10: ATP01/
604-076-00-1 phenolphthalein 77-09-8 Carc. 1B, Muta. 2, Repr. 2 H350, H341, H361f*** Carc. 1A; H350: C ≥ 1 % ATP01/
604-077-00-7 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol 98809-58-6 Aquatic Chronic 4 H413 ATP01/
604-079-00-8 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol 13595-25-0 Repr. 2, Skin Sens. 1, Aquatic Chronic 2 H361f***, H317, H411 ATP01/
604-080-00-3 4-fluoro-3-trifluoromethylphenol 61721-07-1 Acute Tox. 4 *, Skin Corr. 1A, Skin Sens. 1, Aquatic Chronic 2 H332, H314, H317, H411 ATP01/
604-081-00-9 1,1-bis(4-hydroxyphenyl)-1-phenylethane 1571-75-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
604-082-00-4 2-chloro-6-fluoro-phenol 2040-90-6 Muta. 1B, Repr. 2, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H340, H361f***, H302, H314, H317, H411 ATP01/
604-083-00-X 4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol 260408-02-4 Aquatic Chronic 4 H413 ATP01/
604-084-00-5 1-ethoxy-2,3-difluorobenzene 121219-07-6 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
604-087-00-1 reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1 - Pyr. Sol. 1, Aquatic Chronic 4 H250, H413 ATP01/
604-089-00-2 2-methyl-5-tert-butylthiophenol - Flam. Liq. 3, Repr. 2, STOT RE 2 *, Asp. Tox. 1, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H226, H361d***, H373**, H304, H319, H315, H317, H336, H400, H410 ATP01/
604-092-00-9 phenol, dodecyl-, branched [1]; phenol, 2-dodecyl-, branched; phenol, 3-dodecyl-, branched; phenol, 4-dodecyl-, branched; phenol, (tetrapropenyl) derivatives [2] 121158-58-5 [1], 74499-35-7 [2] Skin Corr. 1C, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 M=10, M=10 ATP07
605-001-00-5 formaldehyde % 50-00-0 Carc. 1B, Muta. 2, Acute Tox. 3*, Acute Tox. 3*, Acute Tox. 3*, Skin Corr. 1B, Skin Sens. 1 H350, H341, H301, H311, H331, H314, H317 *, Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % STOT SE 3; H335: C ≥ 5 % Skin Sens. 1; H317: C ≥ 0,2 % B D CLP00/ATP06
605-002-00-0 1,3,5-trioxan; trioxymethylene 110-88-3 Flam. Sol. 1, Repr. 2, STOT SE 3 H228, H361d ***, H335 T CLP00/
605-003-00-6 acetaldehyde; ethanal 75-07-0 Flam. Liq. 1, Carc. 2, Eye Irrit. 2, STOT SE 3 H224, H351, H319, H335 CLP00/
605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde 123-63-7 Flam. Liq. 3 H226 CLP00/ATP01
605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde 108-62-3 Flam. Sol. 2, Acute Tox. 4 * H228, H302 CLP00/ATP01
605-006-00-2 butyraldehyde 123-72-8 Flam. Liq. 2 H225 CLP00/
605-007-00-8 1,1-dimethoxyethane; dimethyl acetal 534-15-6 Flam. Liq. 2 H225 CLP00/
605-008-00-3 acrolein; prop-2-enal; acrylaldehyde 107-02-8 Flam. Liq. 2, Acute Tox. 1, Acute Tox. 2, Acute Tox. 3, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H225, H330, H300, H311, H314, H400, H410 Skin Corr. 1B; H314: C ≥ 0,1 %, M=100, M=1 D CLP00/ATP05/ATP06
605-009-00-9 crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] 4170-30-3 [1], 123-73-9 [2] Flam. Liq. 2, Muta. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1 H225, H341, H330, H311, H301, H373 **, H335, H315, H318, H400 CLP00/
605-010-00-4 2-furaldehyde 98-01-1 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H351, H331, H301, H312, H319, H335, H315 CLP00/ATP01
605-011-00-X 2-chlorobenzaldehyde; o-chlorobenzaldehyde 89-98-5 Skin Corr. 1B H314 CLP00/
605-012-00-5 benzaldehyde 100-52-7 Acute Tox. 4 * H302 CLP00/
605-013-00-0 chloralose (INN); (R)-1,2-O-(2,2,2-trichloroethylidene)- -D-glucofuranose; glucochloralose; anhydroglucochloral 15879-93-3 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 CLP00/
605-014-00-6 chloral hydrate; 2,2,2-trichloroethane-1,1-diol 302-17-0 Acute Tox. 3 *, Eye Irrit. 2, Skin Irrit. 2 H301, H319, H315 CLP00/
605-015-00-1 1,1-diethoxyethane; acetal 105-57-7 Flam. Liq. 2, Eye Irrit. 2, Skin Irrit. 2 H225, H319, H315 CLP00/
605-016-00-7 glyoxal %; ethandial % 107-22-2 Muta. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H341, H332, H319, H315, H317 * B CLP00/
605-017-00-2 1,3-dioxolane 646-06-0 Flam. Liq. 2 H225 CLP00/
605-018-00-8 propanal; propionaldehyde 123-38-6 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H225, H319, H335, H315 CLP00/
605-019-00-3 citral 5392-40-5 Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
605-020-00-9 safrole; 5-allyl-1,3-benzodioxole 94-59-7 Carc. 1B, Muta. 2, Acute Tox. 4 * H350, H341, H302 CLP00/
605-021-00-4 formaldehyde, reaction products with butylphenol 91673-30-2 Skin Sens. 1 H317 CLP00/
605-022-00-X glutaral; glutaraldehyde; 1,5-pentanedial 111-30-8 Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1 H331, H301, H314, H334, H317, H400 *, Skin Corr. 1B; H314: C ≥ 10 %, Skin Irrit. 2; H315: 0,5 % ≤ C < 10 %, Eye Dam. ; H318: 2 % ≤ C < 10 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %, STOT SE; H335: C ≥ 0,5 %, Skin Sens. 1; H317: C ≥ 0,5 % CLP00/
605-023-00-5 5-chloro-2-(4-chlorophenoxy)phenol 3380-30-1 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
605-024-00-0 2-bromo-5-hydroxy-4-methoxybenzaldehyde 2973-59-3 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
605-025-00-6 chloroacetaldehyde 107-20-0 Carc. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1 H351, H330, H311, H301, H314, H400 STOT SE 3; H335: C ≥ 5 % CLP00/
605-026-00-1 2,5,7,7-tetramethyloctanal 114119-97-0 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H315, H317, H411 CLP00/
605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
605-028-00-2 ß-methyl-3-(1-methylethyl)-benzenepropanal 125109-85-5 Aquatic Chronic 2 H411 CLP00/
605-029-00-8 2-cyclohexylpropanal 2109-22-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 3353-51-3 Skin Sens. 1 H317 CLP00/
605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate; water(Incl - Skin Sens. 1 H317 CLP00/
605-032-00-4 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal 93957-50-7 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
605-033-00-X reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal 32480-08-3 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 ATP01/
605-034-00-5 reaction mass of: (1RS,2RS,3SR,6RS,9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,3RS,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS,2RS,4SR,6RS,8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
605-035-00-0 (E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal 177964-68-0 Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H319, H317, H413 ATP01/
605-036-00-6 2-bromomalonaldehyde 2065-75-0 Acute Tox. 4 *, Eye Dam. 1 H302, H318 ATP01/
605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde 120578-03-2 Aquatic Chronic 4 H413 ATP01/
605-038-00-7 3-methyl-5-phenylpentan-1-al 55066-49-4 Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H302, H315, H317, H411 ATP01/
605-039-00-2 3,4-dihydroxy-5-nitrobenzaldehyde 116313-85-0 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H302, H318, H317 ATP01/
606-001-00-8 acetone; propan-2-one; propanone 67-64-1 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 CLP00/
606-002-00-3 butanone; ethyl methyl ketone 78-93-3 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 CLP00/
606-003-00-9 heptan-3-one; butyl ethyl ketone 106-35-4 Flam. Liq. 3, Acute Tox. 4 *, Eye Irrit. 2 H226, H332, H319 CLP00/
606-004-00-4 4-methylpentan-2-one; isobutyl methyl ketone 108-10-1 Flam. Liq. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H225, H332, H319, H335 CLP00/
606-005-00-X 2,6-dimethylheptan-4-one; di-isobutyl ketone 108-83-8 Flam. Liq. 3, STOT SE 3 H226, H335 STOT SE 3; H335: C ≥ 10 % CLP00/
606-006-00-5 pentan-3-one; diethyl ketone 96-22-0 Flam. Liq. 2, STOT SE 3, STOT SE 3 H225, H335, H336 CLP00/
606-007-00-0 3-methylbutan-2-one; methyl isopropyl ketone 563-80-4 Flam. Liq. 2 H225 CLP00/
606-009-00-1 4-methylpent-3-en-2-one; mesityl oxide 141-79-7 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H226, H332, H312, H302 * CLP00/
606-010-00-7 cyclohexanone 108-94-1 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
606-011-00-2 2-methylcyclohexanone 583-60-8 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
606-012-00-8 3,5,5-trimethylcyclohex-2-enone; isophorone 78-59-1 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H351, H312, H302, H319, H335 STOT SE 3; H335: C ≥ 10 % CLP00/
606-013-00-3 p-benzoquinone; quinone 106-51-4 Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1 H331, H301, H319, H335, H315, H400 M=10: CLP00/ATP01
606-014-00-9 chlorophacinone (ISO); 2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione 3691-35-8 Acute Tox. 1, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H331, H372 **, H400, H410 CLP00/
606-016-00-X pindone (ISO); 2-pivaloylindan-1,3-dione 83-26-1 Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H372 **, H400, H410 CLP00/
606-017-00-5 diketene; diketen 674-82-8 Flam. Liq. 3, Acute Tox. 4 * H226, H332 D CLP00/
606-018-00-0 dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone 117-80-6 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H315, H400, H410 CLP00/
606-019-00-6 chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one 143-50-0 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H311, H301, H400, H410 CLP00/
606-020-00-1 5-methylheptan-3-one 541-85-5 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3 H226, H319, H335 STOT SE 3; H335: C ≥ 10 % CLP00/
606-021-00-7 N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone 872-50-4 Repr. 1B, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H360D***, H319, H335, H315 Repr. 1B; H360D: C ≥ 5 %, STOT SE 3; H335: C ≥ 10 % CLP00/ATP01
606-022-00-2 1-phenyl-3-pyrazolidone 92-43-3 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
606-023-00-8 4-methoxy-4-methylpentan-2-one 107-70-0 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
606-024-00-3 heptan-2-one; methyl amyl ketone 110-43-0 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 * H226, H332, H302 CLP00/
606-025-00-9 cyclopentanone 120-92-3 Flam. Liq. 3, Eye Irrit. 2, Skin Irrit. 2 H226, H319, H315 CLP00/
606-026-00-4 5-methylhexan-2-one; isoamyl methyl ketone 110-12-3 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
606-027-00-X heptan-4-one; di-n-propyl ketone 123-19-3 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
606-028-00-5 2,4-dimethylpentan-3-one; di-isopropyl ketone 565-80-0 Flam. Liq. 2, Acute Tox. 4 * H225, H332 CLP00/
606-029-00-0 pentane-2,4-dione; acetylacetone 123-54-6 Flam. Liq. 3, Acute Tox. 4 * H226, H302 CLP00/
606-030-00-6 hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone 591-78-6 Flam. Liq. 3, Repr. 2, STOT RE 1, STOT SE 3 H226, H361f ***, H372 **, H336 CLP00/
606-031-00-1 3-propanolide; 1,3-propiolactone 57-57-8 Carc. 1B, Acute Tox. 2 *, Eye Irrit. 2, Skin Irrit. 2 H350, H330, H319, H315 CLP00/
606-032-00-7 hexachloroacetone 116-16-5 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole 20354-26-1 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H312, H302, H319, H315, H411 CLP00/
606-034-00-8 metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one 21087-64-9 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=10: CLP00/ATP01
606-035-00-3 chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon 1698-60-8 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
606-036-00-9 quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one 2439-01-2 Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f ***, H332, H312, H302, H373 **, H319, H317, H400, H410 CLP00/
606-037-00-4 triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone 43121-43-3 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
606-038-00-X diphacinone (ISO); 2-diphenylacetylindan-1,3-dione 82-66-6 Acute Tox. 2 *, STOT RE 1 H300, H372 ** CLP00/
606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one - Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H400, H410 CLP00/
606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 55845-90-4 Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 71868-10-5 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
606-042-00-1 acetophenone 98-86-2 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
606-043-00-7 2,4-di-tert-butylcyclohexanone 13019-04-0 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
606-044-00-2 2,4,6-trimethylbenzophenone 954-16-5 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H400, H410 CLP00/
606-045-00-8 oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 19666-30-9 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 3100-36-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 119313-12-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one - Aquatic Chronic 4 H413 CLP00/
606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 78531-61-0 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 72453-58-8 Aquatic Chronic 2 H411 CLP00/
606-051-00-0 4-pentylcyclohexanone 61203-83-6 Aquatic Chronic 2 H411 CLP00/
606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 54574-82-2 Aquatic Chronic 3 H412 CLP00/
606-053-00-1 flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-( , , -trifluoro-m-tolyl)furan-3(2H)-one 96525-23-4 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-054-00-7 isoxaflutole (ISO); 5-cyclopropyl-1,2-oxazol-4-yl , , -trifluoro-2-mesyl-p-tolyl ketone 141112-29-0 Repr. 2, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H400, H410 M=10 , M=100 CLP00/ATP07
606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 92836-10-7 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 2 H302, H373 **, H411 CLP00/
606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 116412-83-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-057-00-3 4-propylcyclohexanone 40649-36-3 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 CLP00/
606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 21983-80-2 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
606-059-00-4 2,4-difluoro- -(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 86386-75-6 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H302, H318, H317 CLP00/
606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 66938-41-8 Muta. 2, Aquatic Acute 1, Aquatic Chronic 1 H341, H400, H410 CLP00/
606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 61571-06-0 Repr. 1B, Eye Dam. 1, Aquatic Chronic 3 H360D ***, H318, H412 CLP00/
606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 112704-51-5 Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 7093-55-2 Aquatic Chronic 4 H413 CLP00/
606-065-00-7 1-(4-morpholinophenyl)butan-1-one - Aquatic Chronic 2 H411 CLP00/
606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 164058-20-2 Aquatic Chronic 2 H411 CLP00/
606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3, 96792-67-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 1638-05-7 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H373 **, H317, H412 CLP00/
606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 154171-76-3 Aquatic Chronic 2 H411 CLP00/
606-070-00-4 butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one 138164-12-2 Repr. 2, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H361fd, H302, H315, H400, H410 CLP00/
606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 13258-43-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 719-86-8 STOT RE 2 *, Aquatic Chronic 2 H373 **, H411 CLP00/
606-073-00-0 4,4'-bis(dimethylamino)benzophenone; Michler's ketone 90-94-8 Carc. 1B, Muta. 2, Eye Dam. 1 H350, H341, H318 CLP00/
606-074-00-6 reaction mass of: (1R*,2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 65855-02-9 Acute Tox. 4 * H302 CLP00/
606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 136465-99-1 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 104872-06-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-078-00-8 1-octylazepin-2-one 59227-88-2 Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H314, H317, H411 CLP00/
606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 4299-07-4 Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 CLP00/
606-081-00-4 (3ß, 5 , 6ß)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 4229-69-0 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
606-082-00-X reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane - STOT RE 1, Skin Sens. 1, Aquatic Chronic 3 H372 **, H317, H412 CLP00/
606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 137193-60-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H319, H315, H317, H412 CLP00/
606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 484-33-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 79200-56-9 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H302, H318, H317 CLP00/
606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 56973-87-6 Aquatic Chronic 2 H411 CLP00/
606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 137234-87-8 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 74338-72-0 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone 12223-77-7 Aquatic Chronic 4 H413 CLP00/
606-090-00-3 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone 73096-98-7 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 118289-55-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
606-093-00-X 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one 95885-13-5 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
606-094-00-5 N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)-isobenzofuran]-3'-one - Aquatic Chronic 4 H413 ATP01/
606-095-00-0 (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one 49805-30-3 Acute Tox. 4 *, Skin Sens. 1 H302, H317 ATP01/
606-096-00-6 3-(6-O-(6-desoxy- -l-mannopyranosyl-O-( -d-glucopyranosyl)-(ß-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one 130603-71-3 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
606-097-00-1 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone 23911-85-5 Aquatic Chronic 4 H413 ATP01/
606-098-00-7 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione 158574-65-3 Aquatic Chronic 4 H413 ATP01/
606-099-00-2 5-methoxy-4'-(trifluoromethyl)valerophenone 61718-80-7 Aquatic Chronic 2 H411 ATP01/
606-100-00-6 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one 94723-86-1 Repr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H360F***, H302, H317, H412 ATP01/
606-101-00-1 reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methox 165038-51-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
606-102-00-7 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone 79876-59-8 Aquatic Chronic 2 H411 ATP01/
606-103-00-2 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone - Skin Sens. 1 H317 ATP01/
606-104-00-8 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone 78531-59-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
606-105-00-3 3,4,3',4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione 226065-73-2 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
606-106-00-9 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone 83626-30-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
606-107-00-4 8-azaspiro[4.5]decane-7,9-dione 1075-89-4 Acute Tox. 3 *, Aquatic Chronic 2 H301, H411 ATP01/
606-108-00-X 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone 756-13-8 Aquatic Chronic 3 H412 ATP01/
606-109-00-5 2-(4-methyl-3-pentenyl)anthraquinone 71308-16-2 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 4 H302, H317, H314 ATP01/
606-110-00-0 5-ethoxy-5H-furan-2-one 2833-30-9 Skin Corr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1 H314, H312, H302, H373**, H317 ATP01/
606-111-00-6 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one 67014-36-2 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
606-112-00-1 (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one 1668-86-6 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 3 H302, H319, H412 ATP01/
606-113-00-7 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one 272460-97-6 Eye Dam. 1, Aquatic Chronic 4 H318, H314 ATP01/
606-114-00-2 4,4',5,5',6,6',7,7'-octachloro-(2,2')biisoindolyl-1,1',3,3'-tetraone 67887-47-2 Aquatic Chronic 4 H413 ATP01/
606-115-00-8 profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one 139001-49-3 Carc. 2, Repr. 2, Skin Sens. 1 H351, H361d, H317 ATP01/
606-116-00-3 tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one 149979-41-9 Carc. 2, Repr. 2 H351, H361fd ATP01/
606-117-00-9 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one 7078-98-0 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
606-118-00-4 N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine 52870-46-9 Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H400, H410 ATP01/
606-119-00-X (E)-3-methyl-5-cyclopentadecen-1-one - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
606-120-00-5 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one 114625-74-0 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
606-121-00-0 (+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) 133636-82-5 Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 ATP01/
606-122-00-6 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one 114341-88-7 Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H315, H318, H317, H400, H410 ATP01/
606-123-00-1 4-hexadecyl-1-phenylpyrazolidin-3-one - Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
606-124-00-7 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione 161462-35-7 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373**, H400, H410 ATP01/
606-125-00-2 1-benzylimidazolidine-2,4-dione 6777-05-5 Acute Tox. 4 * H302 ATP01/
606-126-00-8 1,4-bis(2,3-dihydroxypropylamino)anthraquinone 99788-75-7 Aquatic Chronic 2 H411 ATP01/
606-128-00-9 2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione 148935-94-8 Aquatic Chronic 4 H413 ATP01/
606-129-00-4 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 156732-13-7 Aquatic Chronic 4 H413 ATP01/
606-130-00-X 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone 56309-94-5 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
606-131-00-5 cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione 5571-36-8 Repr. 1B, STOT RE 2 *, Aquatic Chronic 2 H360F***, H373**, H411 ATP01/
606-132-00-0 (6ß)-6,19-epoxyandrost-4-ene-3,17-dione 6563-83-3 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
606-134-00-1 androsta-1,4,9(11)-triene-3,17-dione 15375-21-0 Repr. 2 H361f*** ATP01/
606-135-00-7 cyclohexadecanone 2550-52-9 Aquatic Chronic 4 H413 ATP01/
606-136-00-2 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone 133413-70-4 Eye Irrit. 2, Aquatic Chronic 4 H319, H413 ATP01/
606-137-00-8 trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione 211387-26-7 Aquatic Chronic 4 H413 ATP01/
606-138-00-3 (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone 141645-23-0 Flam. Liq. 3, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H226, H302, H373**, H315, H318, H317, H400, H410 M=10: ATP01/
606-139-00-9 (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one 124379-29-9 Aquatic Chronic 4 H413 ATP01/
606-140-00-4 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one 474510-57-1 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373**, H400, H410 ATP01/
606-141-00-X sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate - Eye Irrit. 2 H319 ATP01/
606-142-00-5 reaction mass of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one - Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 ATP01/
606-148-00-8 carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1] d-arvone; (5S)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [2] l-carvone; (5R)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one [3] 99-49-0 [1], 2244-16-8 [2], 6485-40-1 [3] Skin Sens. 1 H317 ATP07
606-149-00-3 tembotrione (ISO); 2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione 335104-84-2 Repr. 2, STOT Re 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d, H373 (eyes, kidneys, liver) H317, H400, H410 M=100, M=10 ATP07
607-001-00-0 formic acid % 64-18-6 Skin Corr. 1A H314 Skin Corr. 1A; H314: C ≥ 90 %, Skin Corr. 1B; H314: 10 % ≤ C < 90 %, Skin Irrit. 2; H315: 2 % ≤ C < 10 %, Eye Irrit. 2; H319: 2 % ≤ C < 10 % B CLP00/
607-002-00-6 acetic acid % 64-19-7 Flam. Liq. 3, Skin Corr. 1A H226, H314 Skin Corr. 1A; H314: C ≥ 90 %, Skin Corr. 1B; H314: 25 % ≤ C < 90 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % B CLP00/
607-003-00-1 chloroacetic acid 79-11-8 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Aquatic Acute 1 H331, H311, H301, H314, H400 STOT SE 3; H335: C ≥ 5 % CLP00/ATP01
607-004-00-7 TCA (ISO); trichloroacetic acid 76-03-9 Skin Corr. 1A, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 STOT SE 3; H335: C ≥ 1 % CLP00/
607-005-00-2 TCA-sodium (ISO); sodium trichloroacetate 650-51-1 STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H335, H400, H410 CLP00/
607-006-00-8 oxalic acid 144-62-7 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 * CLP00/
607-007-00-3 salts of oxalic acid with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 * H312, H302 * A CLP00/ATP01
607-008-00-9 acetic anhydride 108-24-7 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H226, H332, H302, H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 5 % ≤ C < 25 %, Eye Dam. 1; H318: 5 % ≤ C < 25 %, Eye Irrit. 2; H319: 1 % ≤ C < 5 %, STOT SE 3; H335: C ≥ 5 % CLP00/
607-009-00-4 phthalic anhydride 85-44-9 Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H302, H335, H315, H318, H334, H317 CLP00/
607-010-00-X propionic anhydride 123-62-6 Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H315: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 % CLP00/
607-011-00-5 acetyl chloride 75-36-5 Flam. Liq. 2, Skin Corr. 1B H225, H314 CLP00/
607-012-00-0 benzoyl chloride 98-88-4 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H332, H312, H302, H314, H317 CLP00/ATP01
607-013-00-6 dimethyl carbonate 616-38-6 Flam. Liq. 2 H225 CLP00/
607-014-00-1 methyl formate 107-31-3 Flam. Liq. 1, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H224, H332, H302, H319, H335 CLP00/
607-015-00-7 ethyl formate 109-94-4 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H225, H332, H302, H319, H335 CLP00/
607-016-00-2 propyl formate; [1] isopropyl formate [2] 110-74-7 [1], 625-55-8 [2] Flam. Liq. 2, Eye Irrit. 2, STOT SE 3, STOT SE 3 H225, H319, H335, H336 C CLP00/
607-017-00-8 butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] 592-84-7 [1], 762-75-4 [2], 542-55-2 [3] Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H335 C CLP00/
607-018-00-3 isopentyl formate; [1] pentyl formate; [2] 2-methylbutyl formate 110-45-2 [1], 35073-27-9 [2], - Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H335 C CLP00/
607-019-00-9 methyl chloroformate 79-22-1 Flam. Liq. 2, Acute Tox. 2 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H225, H330, H312, H302, H314 CLP00/
607-020-00-4 ethyl chloroformate 541-41-3 Flam. Liq. 2, Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B H225, H330, H302, H314 CLP00/
607-021-00-X methyl acetate 79-20-9 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 CLP00/
607-022-00-5 ethyl acetate 141-78-6 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 CLP00/
607-023-00-0 vinyl acetate 108-05-4 Flam. Liq. 2, Carc. 2, Acute Tox. 4, STOT SE 3 H225, H351, H332, H335 D CLP00/ATP05
607-024-00-6 propyl acetate; [1] isopropyl acetate [2] 109-60-4 [1], 108-21-4 [2] Flam. Liq. 2, Eye Irrit. 2, STOT SE 3 H225, H319, H336 C CLP00/
607-025-00-1 n-butyl acetate 123-86-4 Flam. Liq. 3, STOT SE 3 H226, H336 CLP00/
607-026-00-7 sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] 105-46-4 [1], 110-19-0 [2], 540-88-5 [3] Flam. Liq. 2 H225 C CLP00/
607-027-00-2 methyl propionate 554-12-1 Flam. Liq. 2, Acute Tox. 4 * H225, H332 CLP00/
607-028-00-8 ethyl propionate 105-37-3 Flam. Liq. 2 H225 CLP00/
607-029-00-3 n-butyl propionate; [1] sec-butyl propionate; [2] tert-butyl propionate; [3] iso-butyl propionate 590-01-2 [1], 591-34-4 [2], 540-42-1 [3], - Flam. Liq. 3 H226 C CLP00/
607-030-00-9 propyl propionate 106-36-5 Flam. Liq. 3, Acute Tox. 4 * H226, H332 CLP00/
607-031-00-4 butyl butyrate 109-21-7 Flam. Liq. 3 H226 C CLP00/
607-032-00-X ethyl acrylate 140-88-5 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H225, H332, H312, H302, H319, H335, H315, H317 Skin Irrit. 2; H315: C ≥ 5 %, Eye Irrit. 2; H319: C ≥ 5 %, STOT SE 3; H335: C ≥ 5 % D CLP00/
607-033-00-5 n-butyl methacrylate 97-88-1 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H226, H319, H335, H315, H317 D CLP00/
607-034-00-0 methyl acrylate; methyl propenoate 96-33-3 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H225, H332, H312, H302, H319, H335, H315, H317 D CLP00/
607-035-00-6 methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate 80-62-6 Flam. Liq. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H225, H335, H315, H317 D CLP00/
607-036-00-1 2-methoxyethyl acetate; methylglycol acetate 110-49-6 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H360FD, H332, H312, H302 CLP00/
607-037-00-7 2-ethoxyethyl acetate; ethylglycol acetate 111-15-9 Flam. Liq. 3, Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H226, H360FD, H332, H312, H302 CLP00/ATP01
607-038-00-2 2-butoxyethyl acetate; butylglycol acetate 112-07-2 Acute Tox. 4 *, Acute Tox. 4 * H332, H312 CLP00/
607-039-00-8 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid 94-75-7 Acute Tox. 4 *, STOT SE 3, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H335, H318, H317, H412 CLP00/
607-040-00-3 salts of 2,4-D - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 A CLP00/
607-041-00-9 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid 93-76-5 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H315, H400, H410 CLP00/
607-042-00-4 salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid - Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H315, H400, H410 A CLP00/
607-043-00-X dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid 1918-00-9 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate [2] 2300-66-5 [1], 10007-85-9 [2] Eye Irrit. 2, Aquatic Chronic 3 H319, H412 CLP00/
607-045-00-0 dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid 120-36-5 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1 H312, H302, H315, H318 CLP00/
607-046-00-6 salts of dichlorprop - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 A CLP00/
607-047-00-1 fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid 93-72-1 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H400, H410 CLP00/
607-048-00-7 salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 A CLP00/
607-049-00-2 mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] 7085-19-0 [1], - [2] Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H318, H400, H410 M=100: CLP00/
607-050-00-8 salts of mecoprop - Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H318, H400, H410 A CLP00/
607-051-00-3 MCPA (ISO); 4-chloro-o-tolyloxyacetic acid 94-74-6 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H318, H400, H410 CLP00/ATP01
607-052-00-9 salts and esters of MCPA - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 A CLP00/ATP01
607-053-00-4 MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid 94-81-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-054-00-X salts and esters of MCPB - Acute Tox. 4 * H302 A CLP00/
607-055-00-5 endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate 129-67-9 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H301, H312, H319, H335, H315 CLP00/
607-056-00-0 warfarin (ISO); [1] (S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3] 81-81-2 [1], 5543-57-7 [2], 5543-58-8 [3] Repr. 1A, STOT RE 1, Aquatic Chronic 3 H360D ***, H372 **, H412 CLP00/
607-057-00-6 coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin 81-82-3 STOT RE 2 *, Aquatic Chronic 3 H373 **, H412 CLP00/
607-058-00-1 coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin 117-52-2 Acute Tox. 3 *, STOT RE 1, Aquatic Chronic 3 H301, H372 **, H412 CLP00/
607-059-00-7 coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 5836-29-3 Acute Tox. 1, Acute Tox. 2 *, STOT RE 1, Aquatic Chronic 3 H310, H300, H372 **, H412 CLP00/
607-060-00-2 dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) 66-76-2 STOT RE 1, Acute Tox. 4 *, Aquatic Chronic 2 H372 **, H302, H411 CLP00/
607-061-00-8 acrylic acid; prop-2-enoic acid 79-10-7 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A, Aquatic Acute 1 H226, H332, H312, H302, H314, H400 STOT SE 3; H335: C ≥ 1 % D CLP00/
607-062-00-3 n-butyl acrylate 141-32-2 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H226, H319, H335, H315, H317 D CLP00/
607-063-00-9 isobutyric acid 79-31-2 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
607-064-00-4 benzyl chloroformate 501-53-1 Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H314, H400, H410 STOT SE 3; H335: C ≥ 5 % CLP00/
607-065-00-X bromoacetic acid 79-08-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1 H331, H311, H301, H314, H317, H400 CLP00/ATP01
607-066-00-5 dichloroacetic acid 79-43-6 Skin Corr. 1A, Aquatic Acute 1 H314, H400 CLP00/
607-067-00-0 dichloroacetyl chloride 79-36-7 Skin Corr. 1A, Aquatic Acute 1 H314, H400 CLP00/
607-068-00-6 iodoacetic acid 64-69-7 Acute Tox. 3 *, Skin Corr. 1A H301, H314 CLP00/
607-069-00-1 ethyl bromoacetate 105-36-2 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H330, H310, H300 CLP00/
607-070-00-7 ethyl chloroacetate 105-39-5 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1 H331, H311, H301, H400 CLP00/
607-071-00-2 ethyl methacrylate 97-63-2 Flam. Liq. 2, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H225, H319, H335, H315, H317 D CLP00/
607-072-00-8 2-hydroxyethyl acrylate 818-61-1 Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1 H311, H314, H317, H400 *, Skin Sens. 1; H317: C ≥ 0,2 % D CLP00/
607-073-00-3 4-CPA (ISO); 4-chlorophenoxyacetic acid 122-88-3 Acute Tox. 4 * H302 CLP00/
607-074-00-9 chlorfenac (ISO); 2,3,6-trichlorophenylacetic acid 85-34-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-075-00-4 chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate 14437-17-3 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
607-076-00-X dodine (ISO); dodecylguanidinium acetate 2439-10-3 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H315, H400, H410 CLP00/
607-077-00-5 erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate 136-25-4 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-078-00-0 fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate 4301-50-2 Acute Tox. 1, Acute Tox. 2 * H310, H300 CLP00/
607-079-00-6 kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate 4234-79-1 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Chronic 2 H311, H302, H411 CLP00/
607-080-00-1 chloroacetyl chloride 79-04-9 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Skin Corr. 1A, Aquatic Acute 1 H331, H311, H301, H372 **, H314, H400 CLP00/
607-081-00-7 fluoroacetic acid 144-49-0 Acute Tox. 2 *, Aquatic Acute 1 H300, H400 CLP00/
607-082-00-2 fluoroacetates, soluble - Acute Tox. 2 *, Aquatic Acute 1 H300, H400 A CLP00/
607-083-00-8 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid 94-82-6 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-084-00-3 salts of 2,4-DB - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 A CLP00/
607-085-00-9 benzyl benzoate 120-51-4 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/ATP01
607-086-00-4 diallyl phthalate 131-17-9 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-088-00-5 methacrylic acid; 2-methylpropenoic acid 79-41-4 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H312, H302, H314 STOT SE 3; H335: C ≥ 1 % D CLP00/
607-089-00-0 propionic acid % 79-09-4 Skin Corr. 1B H314 Skin Corr. 1B; H314: C ≥ 25 %, Skin Irrit. 2; H319: 10 % ≤ C < 25 %, Eye Irrit. 2; H319: 10 % ≤ C < 25 %, STOT SE 3; H335: C ≥ 10 % B CLP00/
607-090-00-6 thioglycolic acid 68-11-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B H331, H311, H301, H314 * CLP00/
607-091-00-1 trifluoroacetic acid . . . % 76-05-1 Acute Tox. 4 *, Skin Corr. 1A, Aquatic Chronic 3 H332, H314, H412 * B CLP00/
607-092-00-7 methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] 547-64-8 [1], 2155-30-8 [2], 17392-83-5 [3], 27871-49-4 [4] Flam. Liq. 3, Eye Irrit. 2, STOT SE 3 H226, H319, H335 C CLP00/
607-093-00-2 propionyl chloride 79-03-8 Flam. Liq. 2, Skin Corr. 1B H225, H314 B D CLP00/
607-094-00-8 peracetic acid . . . % 79-21-0 Flam. Liq. 3, Org. Perox. D ****, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A, Aquatic Acute 1 H226, H242, H332, H312, H302, H314, H400 *, STOT SE 3; H335: C ≥ 1 % B D CLP00/
607-095-00-3 maleic acid 110-16-7 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H302, H319, H335, H315, H317 Skin Sens. 1; H317: C ≥ 0,1 % CLP00/ATP01
607-096-00-9 maleic anhydride 108-31-6 Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1 H302, H314, H334, H317 CLP00/
607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride 552-30-7 STOT SE 3, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H335, H318, H334, H317 CLP00/
607-098-00-X benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride 89-32-7 Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H318, H334, H317 CLP00/
607-099-00-5 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalic anhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] 85-43-8 [1], 935-79-5 [2], 2426-02-0 [3], 26266-63-7 [4] Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H334, H317, H412 C CLP00/
607-100-00-9 benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) 2421-28-5 Eye Irrit. 2, STOT SE 3 H319, H335 Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % CLP00/
607-101-00-4 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride 115-27-5 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 Skin Irrit. 2; H315: C ≥ 1 %, Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % CLP00/
607-102-00-X cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylic anhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] 85-42-7 [1], 13149-00-3 [2], 14166-21-3 [3] Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H318, H334, H317 C CLP00/
607-103-00-5 succinic anhydride 108-30-5 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H302, H319, H335 *, Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % CLP00/ATP01
607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 6053-68-5 Eye Irrit. 2, STOT SE 3 H319, H335 Eye Irrit. 2; H319: C ≥ 1 %, STOT SE 3; H335: C ≥ 1 % CLP00/
607-105-00-6 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1 ,2 ,3ß,6ß)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 129-64-6 [1], 826-62-0 [2], 2746-19-2 [3] Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H318, H334, H317 C CLP00/
607-106-00-1 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride 123748-85-6 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1 H302, H319, H335, H315, H334 STOT SE 3; H335: C ≥ 10 % C CLP00/
607-107-00-7 2-ethylhexyl acrylate 103-11-7 STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H335, H315, H317 D CLP00/
607-108-00-2 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3] 2918-23-2 [1], 999-61-1 [2], 25584-83-2 [3] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1 H331, H311, H301, H314, H317 *, Skin Sens. 1; H317: C ≥ 0,2 % C D CLP00/
607-109-00-8 hexamethylene diacrylate; hexane-1,6-diol diacrylate 13048-33-4 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-110-00-3 pentaerythritol triacrylate 3524-68-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-111-00-9 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate 15625-89-5 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-112-00-4 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate 2223-82-7 Acute Tox. 3 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H311, H319, H315, H317 * D CLP00/
607-113-00-X isobutyl methacrylate 97-86-9 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H226, H319, H335, H315, H317, H400 D CLP00/
607-114-00-5 ethylene dimethacrylate 97-90-5 STOT SE 3, Skin Sens. 1 H335, H317 STOT SE 3; H335: C ≥ 10 % D CLP00/
607-115-00-0 isobutyl acrylate 106-63-8 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1 H226, H332, H312, H315, H317 D CLP00/
607-116-00-6 cyclohexyl acrylate 3066-71-5 STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H335, H315, H411 STOT SE 3; H335: C ≥ 10 % D CLP00/
607-117-00-1 2,3-epoxypropyl acrylate; glycidyl acrylate 106-90-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1 H331, H311, H301, H314, H317 *, Skin Sens. 1; H317: C ≥ 0,2 % D CLP00/
607-118-00-7 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate 19485-03-1 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H312, H314, H317 D CLP00/
607-119-00-2 tetramethylene diacrylate; 1,4-butyleneglycol diacrylate 1070-70-8 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H312, H314, H317 D CLP00/
607-120-00-8 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate 4074-88-8 Acute Tox. 3 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H311, H319, H315, H317 *, Skin Sens. 1; H317: C ≥ 0,2 % D CLP00/
607-121-00-3 8,9,10-trinorborn-2-yl acrylate 10027-06-2 Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1 H312, H315, H317 D CLP00/
607-122-00-9 pentaerythritol tetraacrylate 4986-89-4 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-123-00-4 2,3-epoxypropyl methacrylate; glycidyl methacrylate 106-91-2 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H332, H312, H302, H319, H315, H317 D CLP00/
607-124-00-X 2-hydroxyethyl methacrylate 868-77-9 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-125-00-5 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate [2] 923-26-2 [1], 2761-09-3 [2] Eye Irrit. 2, Skin Sens. 1 H319, H317 C D CLP00/
607-126-00-0 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate 1680-21-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-127-00-6 2-diethylaminoethyl methacrylate 105-16-8 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H332, H319, H315, H317 D CLP00/
607-128-00-1 2-tert-butylaminoethyl methacrylate 3775-90-4 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 D CLP00/
607-129-00-7 ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] 97-64-3 [1], 687-47-8 [2] Flam. Liq. 3, STOT SE 3, Eye Dam. 1 H226, H335, H318 C CLP00/
607-130-00-2 pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] 628-63-7 [1], 123-92-2 [2], 626-38-0 [3], 624-41-9 [4], 84145-37-9 [5] Flam. Liq. 3 H226 C CLP00/
607-131-00-8 isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] 105-68-0 [1], 624-54-4 [2], 2438-20-2 [3] Flam. Liq. 3 H226 C CLP00/
607-132-00-3 2-dimethylaminoethyl methacrylate 2867-47-2 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H312, H302, H319, H315, H317 D CLP00/
607-133-00-9 monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex - Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H319, H335, H315, H411 STOT SE 3; H335: C ≥ 10 % A CLP00/
607-134-00-4 monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex - Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 STOT SE 3; H335: C ≥ 10 % A CLP00/
607-135-00-X butyric acid 107-92-6 Skin Corr. 1B H314 CLP00/
607-136-00-5 butyryl chloride 141-75-3 Flam. Liq. 2, Skin Corr. 1B H225, H314 CLP00/
607-137-00-0 methyl acetoacetate 105-45-3 Eye Irrit. 2 H319 CLP00/
607-138-00-6 butyl chloroformate; chloroformic acid butyl ester 592-34-7 Flam. Liq. 3, Acute Tox. 3 *, Skin Corr. 1B H226, H331, H314 CLP00/
607-139-00-1 2-chloropropionic acid 598-78-7 Acute Tox. 4 *, Skin Corr. 1A H302, H314 CLP00/
607-140-00-7 isobutyryl chloride 79-30-1 Flam. Liq. 2, Skin Corr. 1A H225, H314 CLP00/
607-141-00-2 oxydiethylene bis(chloroformate) 106-75-2 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H302, H315, H318, H411 CLP00/
607-142-00-8 propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate 109-61-5 Flam. Liq. 2, Acute Tox. 3 *, Skin Corr. 1B H225, H331, H314 CLP00/ATP01
607-143-00-3 valeric acid 109-52-4 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 CLP00/
607-144-00-9 adipic acid 124-04-9 Eye Irrit. 2 H319 CLP00/
607-145-00-4 methanesulphonic acid 75-75-2 Skin Corr. 1B H314 CLP00/
607-146-00-X fumaric acid 110-17-8 Eye Irrit. 2 H319 CLP00/
607-147-00-5 oxalic acid diethylester; diethyl oxalate 95-92-1 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
607-148-00-0 guanidinium chloride; guanadine hydrochloride 50-01-1 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2 H302, H319, H315 CLP00/
607-149-00-6 urethane (INN); ethyl carbamate 51-79-6 Carc. 1B H350 CLP00/
607-150-00-1 endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid 145-73-3 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H301, H312, H319, H335, H315 CLP00/
607-151-00-7 propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite 2312-35-8 Carc. 2, Acute Tox. 3 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H331, H315, H318, H400, H410 M = 10: CLP00/
607-152-00-2 2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid 50-31-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-153-00-8 benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid 3813-05-6 Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H319, H315, H412 CLP00/
607-154-00-3 ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO) 22212-55-1 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-155-00-9 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s 2079-00-7 Acute Tox. 2 * H300 CLP00/
607-156-00-4 chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate 80-33-1 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H400, H410 CLP00/
607-157-00-X 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin; difenacoum 56073-07-5 Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H300, H372 **, H400, H410 CLP00/
607-158-00-5 sodium salt of chloroacetic acid; sodium chloroacetate 3926-62-3 Acute Tox. 3 *, Skin Irrit. 2, Aquatic Acute 1 H301, H315, H400 CLP00/
607-159-00-0 chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate 510-15-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-160-00-6 isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) 51337-71-4 Acute Tox. 4 * H302 CLP00/
607-161-00-1 diethanolamine salt of 4-CPA - Acute Tox. 4 * H302 CLP00/
607-162-00-7 dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate [2] 75-99-0 [1], 127-20-8 [2] Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H315, H318, H412 CLP00/ATP01
607-163-00-2 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid 520-45-6 Acute Tox. 4 * H302 CLP00/
607-164-00-8 sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate 4418-26-2 Acute Tox. 4 * H302 CLP00/
607-165-00-3 diclofop-methyl (ISO); methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate 51338-27-3 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
607-166-00-9 medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate 2487-01-6 Acute Tox. 3 *, Acute Tox. 4 * H301, H312 CLP00/
607-167-00-4 sodium 3-chloroacrylate 4312-97-4 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
607-168-00-X dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome 83-59-0 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H311, H302, H400, H410 CLP00/
607-169-00-5 sodium fluoroacetate 62-74-8 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1 H330, H310, H300, H400 CLP00/
607-170-00-0 bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate 31895-22-4 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
607-172-00-1 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin; brodifacoum 56073-10-0 Acute Tox. 1, Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H372 **, H400, H410 CLP00/
607-173-00-7 dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-174-00-2 reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
607-175-00-8 methyl 2-(2-nitrobenzylidene)acetoacetate 39562-27-1 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-176-00-3 reaction mass of -3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl- -hydroxypoly(oxyethylene) and -3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl- -3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-177-00-9 tribenuron methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester; methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-methylureidosulfonyl)benzoate 101200-48-0 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M=100: CLP00/ATP01
607-178-00-4 methyl -((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate 83055-99-6 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-179-00-X (benzothiazol-2-ylthio)succinic acid 95154-01-1 Skin Sens. 1 H317 CLP00/
607-180-00-5 potassium 2-hydroxycarbazole-1-carboxylate 96566-70-0 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Chronic 3 H302, H319, H335, H412 CLP00/
607-181-00-0 3,5-dichloro-2,4-difluorobenzoyl fluoride 101513-70-6 Acute Tox. 3 *, Skin Corr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H331, H314, H302, H317, H412 CLP00/
607-182-00-6 methyl 3-sulphamoyl-2-thenoate - Skin Sens. 1 H317 CLP00/
607-183-00-1 zinc 2-hydroxy-5-C13-18alkylbenzoate - Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H319, H315, H411 CLP00/
607-184-00-7 S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate 85702-90-5 Flam. Liq. 3, Resp. Sens. 1, Skin Sens. 1 H226, H334, H317 CLP00/
607-185-00-2 ethyl trans-3-dimethylaminoacrylate 1117-37-9 Skin Sens. 1 H317 CLP00/
607-186-00-8 quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid 84087-01-4 Skin Sens. 1 H317 CLP00/
607-187-00-3 bis(2,2,6,6-tetramethyl-4-piperidyl) succinate 62782-03-0 Eye Irrit. 2, Aquatic Chronic 3 H319, H412 CLP00/
607-188-00-9 hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-189-00-4 trimethylenediaminetetraacetic acid 1939-36-2 Acute Tox. 4 *, Eye Dam. 1 H302, H318 CLP00/ATP01
607-190-00-X methyl acrylamidomethoxyacetate (containing 0,1 % acrylamid) 77402-03-0 Carc. 1B, Muta. 1B, Acute Tox. 4 *, Eye Irrit. 2 H350, H340, H302, H319 CLP00/
607-191-00-5 isobutyl 3,4-epoxybutyrate 100181-71-3 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
607-192-00-0 disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate 92511-22-3 Eye Dam. 1 H318 CLP00/
607-194-00-1 propylene carbonate 108-32-7 Eye Irrit. 2 H319 CLP00/
607-195-00-7 2-methoxy-1-methylethyl acetate 108-65-6 Flam. Liq. 3 H226 CLP00/ATP01
607-196-00-2 heptanoic acid 111-14-8 Skin Corr. 1B H314 CLP00/
607-197-00-8 nonanoic acid 112-05-0 Skin Irrit. 2, Eye Irrit. 2, Aquatic Chronic 3 H315, H319, H412 CLP00/ATP07
607-198-00-3 propyl 3,4,5-trihydroxybenzoate 121-79-9 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
607-199-00-9 octyl 3,4,5-trihydroxybenzoate 1034-01-1 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
607-200-00-2 dodecyl 3,4,5-trihydroxybenzoate 1166-52-5 Skin Sens. 1 H317 CLP00/
607-201-00-8 thiocarbonyl chloride 463-71-8 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H331, H302, H319, H335, H315 CLP00/
607-203-00-9 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate 80387-97-9 Repr. 1B, Skin Sens. 1, Aquatic Chronic 3 H360D ***, H317, H412 CLP00/
607-204-00-4 (chlorophenyl)(chlorotolyl)methane, mixed isomers - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-205-00-X methyl chloroacetate 96-34-4 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 3 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H226, H331, H301, H335, H315, H318 CLP00/
607-206-00-5 isopropyl chloroacetate 105-48-6 Flam. Liq. 3, Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H226, H301, H319, H335, H315 CLP00/
607-207-00-0 haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) 87237-48-7 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-208-00-6 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers 91853-67-7 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
607-209-00-1 reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate - Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
607-210-00-7 methyl acrylamidoglycolate (containing 0,1 % acrylamide) 77402-05-2 Carc. 1B, Muta. 1B, Skin Corr. 1B, Skin Sens. 1 H350, H340, H314, H317 CLP00/
607-211-00-2 methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate 6386-39-6 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-212-00-8 poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate - Skin Sens. 1 H317 CLP00/
607-213-00-3 ethyl 3,3-bis(tert-pentylperoxy)butyrate 67567-23-1 Org. Perox. D****, Flam. Liq. 3, Aquatic Chronic 2 H242, H226, H411 CLP00/ATP01
607-214-00-9 N,N-hydrazinodiacetic acid 19247-05-3 Acute Tox. 3 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H301, H373 **, H317, H412 CLP00/
607-215-00-4 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid 107551-67-7 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
607-216-00-X glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine - Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1 H330, H302, H314, H400 CLP00/ATP01
607-217-00-5 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate - Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
607-218-00-0 dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid 15165-67-0 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 CLP00/
607-219-00-6 bis(2-ethylhexyl) dithiodiacetate 62268-47-7 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
607-221-00-7 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid - Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
607-222-00-2 6-(2,3-dimethylmaleimido)hexyl methacrylate 63740-41-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-223-00-8 transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 118712-89-3 Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
607-224-00-3 methyl 2-(3-nitrobenzylidene)acetoacetate 39562-17-9 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
607-225-00-9 3-azidosulfonylbenzoic acid 15980-11-7 Self-React. C ****, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H241, H373 **, H318, H317 CLP00/
607-226-00-4 reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate - Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H315, H318, H317, H412 CLP00/
607-227-00-X potassium 2-amino-2-methylpropionate octahydrate 120447-91-8 Acute Tox. 4 *, Skin Corr. 1A H302, H314 CLP00/
607-228-00-5 bis(2-methoxyethyl) phthalate 117-82-8 Repr. 1B H360Df CLP00/
607-229-00-0 diethylcarbamoyl chloride 88-10-8 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H351, H332, H302, H319, H335, H315 CLP00/
607-230-00-6 2-ethylhexanoic acid 149-57-5 Repr. 2 H361d *** CLP00/
607-231-00-1 clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid 1702-17-6 Eye Dam. 1 H318 CLP00/ATP01
607-232-00-7 pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 55512-33-9 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
607-233-00-2 hexyl acrylate 2499-95-8 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H319, H335, H315, H317, H411 CLP00/
607-234-00-8 flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid 467-69-6 Aquatic Chronic 2 H411 CLP00/
607-235-00-3 mecrilate; methyl 2-cyanoacrylate 137-05-3 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 STOT SE 3; H335: C ≥ 10 % CLP00/
607-236-00-9 ethyl 2-cyanoacrylate 7085-85-0 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 STOT SE 3; H335: C ≥ 10 % CLP00/
607-237-00-4 benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole 72850-64-7 Aquatic Chronic 2 H411 CLP00/
607-238-00-X tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate 102851-06-9 Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H315, H400, H410 CLP00/
607-239-00-5 fenpropathrin (ISO); -cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate 39515-41-8 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H301, H312, H400, H410 CLP00/
607-240-00-0 cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalic anhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetra 1694-82-2 [1], 3425-89-6 [2], 5333-84-6 [3], 11070-44-3 [4], 26590-20-5 [5], 34090-76-1 [6], 42498-58-8 [7] Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H318, H334, H317 C CLP00/
607-241-00-6 hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalic anhydride [4] 19438-60-9 [1], 25550-51-0 [2], 48122-14-1 [3], 57110-29-9 [4] Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H318, H334, H317 C CLP00/
607-242-00-1 tetrachlorophthalic anhydride 117-08-8 Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H334, H317, H400, H410 CLP00/
607-243-00-7 sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 1982-69-0 [1], 25059-78-3 [2], 53404-28-7 [3] Aquatic Chronic 3 H412 CLP00/
607-244-00-2 isooctyl acrylate 29590-42-9 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H400, H410 STOT SE 3; H335: C ≥ 10 % CLP00/
607-245-00-8 tert-butyl acrylate 1663-39-4 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H225, H332, H312, H302, H335, H315, H317, H411 D CLP00/ATP01
607-246-00-3 allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester 96-05-9 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1 H226, H331, H312, H302, H400 CLP00/
607-247-00-9 dodecyl methacrylate 142-90-5 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H335, H315, H400, H410 STOT SE 3; H335: C ≥ 10 % CLP00/
607-248-00-4 naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate 132-67-2 Acute Tox. 4 * H302 CLP00/
607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 42978-66-5 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H319, H335, H315, H317, H411 STOT SE 3; H335: C ≥ 10 % CLP00/
607-250-00-5 4H-3,1-benzoxazine-2,4(1H)-dione 118-48-9 Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
607-251-00-0 2-methoxypropyl acetate 70657-70-4 Flam. Liq. 3, Repr. 1B, STOT SE 3 H226, H360D ***, H335 CLP00/
607-252-00-6 lambda-cyhalothrin (ISO); reaction mass of (S)- -cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)- -cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcycl 91465-08-6 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H301, H312, H400, H410 M=10000: CLP00/ATP01
607-253-00-1 cyfluthrin (ISO); -cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 68359-37-5 Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H300, H331, H400, H410 M=1000: CLP00/ATP01
607-254-00-7 -cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin 68359-37-5 Acute Tox. 2 *, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H400, H410 CLP00/
607-255-00-2 fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid 69377-81-7 Aquatic Chronic 3 H412 CLP00/
607-256-00-8 azoxystrobin (ISO); methyl (E)-2-{}{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}}-3-methoxyacrylate 131860-33-8 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H400, H410 CLP00/
607-257-00-3 isopropyl propionate 637-78-5 Flam. Liq. 2 H225 CLP00/
607-258-00-9 dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate 70950-45-7 Aquatic Chronic 4 H413 CLP00/
607-259-00-4 methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate 105560-93-8 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
607-260-00-X ethyl 2-(3-nitrobenzylidene)acetoacetate 39562-16-8 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
607-261-00-5 iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate 118832-72-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-262-00-0 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 86393-33-1 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
607-263-00-6 potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate - Self-heat. 2 ****, Aquatic Chronic 2 H252, H411 CLP00/
607-264-00-1 2-chloro-4-(methylsulfonyl)benzoic acid 53250-83-2 Eye Dam. 1 H318 CLP00/
607-265-00-7 ethyl-2-chloro-2,2-diphenylacetate 52460-86-3 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 CLP00/
607-266-00-2 reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid 130296-87-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-267-00-8 tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 33610-13-8 Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H334, H317, H412 CLP00/
607-268-00-3 2-methylpropyl (R)-2-hydroxypropanoate 61597-96-4 Eye Irrit. 2 H319 CLP00/
607-269-00-9 (R)-2-(4-hydroxyphenoxy)propanoic acid 94050-90-5 Eye Dam. 1 H318 CLP00/
607-270-00-4 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane 90498-90-1 Acute Tox. 4 * H312 CLP00/
607-271-00-X 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane 156324-82-2 Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
607-272-00-5 fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 81406-37-3 [1], 154486-27-8 [2] Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-273-00-0 ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate - Aquatic Chronic 3 H412 CLP00/
607-274-00-6 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate 54527-73-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-275-00-1 sodium benzoyloxybenzene-4-sulfonate 66531-87-1 Skin Sens. 1 H317 CLP00/
607-276-00-7 bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
607-277-00-2 reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
607-278-00-8 reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
607-279-00-3 reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-280-00-9 sodium 4-chloro-1-hydroxybutane-1-sulfonate 54322-20-2 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H302, H319, H317 CLP00/
607-281-00-4 reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates 127519-17-9 Aquatic Chronic 2 H411 CLP00/
607-282-00-X 2-acetoxymethyl-4-benzyloxybut-1-yl acetate 131266-10-9 Aquatic Chronic 3 H412 CLP00/
607-283-00-5 E-ethyl-4-oxo-4-phenylcrotonate 15121-89-8 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H315, H318, H317, H400, H410 CLP00/
607-284-00-0 reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triph 136213-76-8 Aquatic Chronic 2 H411 CLP00/
607-285-00-6 reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate - Skin Sens. 1 H317 CLP00/
607-286-00-1 reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate 141880-36-6 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-287-00-7 O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate - Aquatic Chronic 3 H412 CLP00/
607-288-00-2 Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively 148732-74-5 Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H319, H317, H412 CLP00/
607-289-00-8 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid 105488-33-3 Aquatic Chronic 4 H413 CLP00/
607-290-00-3 reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate - Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 CLP00/
607-291-00-9 dodecyl- -(C5/C6-cycloalkyl)alkyl carboxylate 104051-92-5 Aquatic Chronic 4 H413 CLP00/
607-292-00-4 reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
607-293-00-X reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
607-294-00-5 sodium 2-benzoyloxy-1-hydroxyethane-sulfonate - Skin Sens. 1 H317 CLP00/
607-295-00-0 reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-296-00-6 reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid - Aquatic Chronic 4 H413 CLP00/
607-297-00-1 (E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) 92761-26-7 Eye Dam. 1 H318 CLP00/
607-298-00-7 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate - Skin Sens. 1 H317 CLP00/
607-299-00-2 methyl 3-(acetylthio)-2-methyl-propanoate 97101-46-7 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
607-300-00-6 trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 - Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
607-301-00-1 reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-302-00-7 reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid - Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H315, H318, H317, H411 CLP00/
607-303-00-2 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 93107-30-3 Repr. 2, Aquatic Chronic 3 H361f ***, H412 CLP00/
607-304-00-8 fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 69806-50-4 Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H360D ***, H400, H410 CLP00/
607-305-00-3 fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 79241-46-6 Repr. 2, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H400, H410 CLP00/
607-306-00-9 chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate 84332-86-5 Carc. 2, Aquatic Chronic 2 H351, H411 CLP00/
607-307-00-4 vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione 50471-44-8 Carc. 2, Repr. 1B, Skin Sens. 1, Aquatic Chronic 2 H351, H360FD, H317, H411 CLP00/
607-308-00-X esters of 2,4-D - Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 A CLP00/
607-309-00-5 carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate 128639-02-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-310-00-0 kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate 143390-89-0 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
607-311-00-6 benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate 25059-80-7 Aquatic Chronic 2 H411 CLP00/
607-312-00-1 methoxyacetic acid 625-45-6 Repr. 1B, Acute Tox. 4 *, Skin Corr. 1B H360FD, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
607-313-00-7 neodecanoyl chloride 40292-82-8 Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B H330, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
607-314-00-2 ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate 26225-79-6 Aquatic Chronic 2 H411 CLP00/
607-315-00-8 glyphosate (ISO); N-(phosphonomethyl)glycine 1071-83-6 Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
607-316-00-3 glyphosate-trimesium; glyphosate-trimethylsulfonium 81591-81-3 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-317-00-9 bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP 117-81-7 Repr. 1B H360FD CLP00/
607-318-00-4 dibutyl phthalate; DBP 84-74-2 Repr. 1B, Aquatic Acute 1 H360Df, H400 CLP00/
607-319-00-X deltamethrin (ISO); (S)- -cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate 52918-63-5 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H400, H410 M=1000000: CLP00/ATP01
607-320-00-5 bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate 130066-57-8 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
607-321-00-0 (S)-methyl-2-chloropropionate 73246-45-4 Flam. Liq. 3, STOT RE 2 *, Eye Irrit. 2 H226, H373 **, H319 CLP00/
607-322-00-6 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid 107144-30-9 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-323-00-1 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate 123968-25-2 Aquatic Chronic 4 H413 CLP00/
607-324-00-7 reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine - Aquatic Chronic 4 H413 CLP00/
607-325-00-2 (S)-2-chloropropionic acid 29617-66-1 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H312, H302, H314 CLP00/
607-326-00-8 reaction mass of: isobutyl hydrogen 2-( -2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate 141847-13-4 Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
607-327-00-3 2-(2-iodoethyl)-1,3-propanediol diacetate 127047-77-2 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-328-00-9 methyl 4-bromomethyl-3-methoxybenzoate 70264-94-7 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 CLP00/
607-329-00-4 reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate - Skin Sens. 1 H317 CLP00/
607-330-00-X (S)-2,3-dihydro-1H-indole-2-carboxylic acid 79815-20-6 Repr. 2, STOT RE 2 *, Skin Sens. 1 H361f ***, H373 **, H317 CLP00/
607-331-00-5 reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane - Aquatic Chronic 4 H413 CLP00/
607-332-00-0 cyclopentyl chloroformate 50715-28-1 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H226, H331, H302, H373 **, H318, H317 CLP00/
607-333-00-6 reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-ß-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-ß-alaninate - Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H314, H400, H410 CLP00/
607-334-00-1 ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 100501-62-0 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-335-00-7 methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate 72619-32-0 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
607-336-00-2 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate 122760-85-4 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H315, H317, H411 CLP00/
607-337-00-8 di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate 125078-60-6 Flam. Liq. 3, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H226, H302, H315, H318, H411 CLP00/
607-338-00-3 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate 72531-53-4 Eye Irrit. 2, Skin Irrit. 2 H319, H315 CLP00/
607-339-00-9 2,3,4,5-tetrachlorobenzoylchloride 42221-52-3 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H302, H314, H317 CLP00/
607-340-00-4 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate - Aquatic Chronic 2 H411 CLP00/
607-341-00-X (9S)-9-amino-9-deoxyerythromycin 26116-56-3 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
607-342-00-5 4-chlorobutyl veratrate 69788-75-6 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-343-00-0 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) - Aquatic Chronic 4 H413 CLP00/
607-344-00-6 reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propi - STOT RE 2 * H373 ** CLP00/
607-345-00-1 potassium 2-(2,4-dichlorophenoxy)-(R)-propionate 113963-87-4 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 CLP00/
607-346-00-7 3-icosyl-4-henicosylidene-2-oxetanone 83708-14-9 Aquatic Chronic 4 H413 CLP00/
607-347-00-2 sodium (R)-2-(2,4-dichlorophenoxy)propionate 119299-10-4 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 CLP00/
607-348-00-8 magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) - Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 CLP00/
607-349-00-3 mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate - Aquatic Chronic 3 H412 CLP00/
607-350-00-9 bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane 136210-32-7 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-351-00-4 methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate 69184-17-4 Aquatic Chronic 2 H411 CLP00/
607-352-00-X 4,4'-oxydiphthalic anhydride 1823-59-2 Aquatic Chronic 3 H412 CLP00/
607-353-00-5 reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate 80657-64-3 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
607-354-00-0 ethyl 2-cyclohexylpropionate 2511-00-4 Aquatic Chronic 2 H411 CLP00/
607-355-00-6 p-tolyl 4-chlorobenzoate 15024-10-9 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
607-356-00-1 ethyl trans-2,2,6-trimethylcyclohexanecarboxylate - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
607-357-00-7 reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran 131766-73-9 Skin Sens. 1 H317 CLP00/
607-358-00-2 (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate 54275-93-3 Resp. Sens. 1 H334 CLP00/
607-359-00-8 (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate 76109-32-5 Resp. Sens. 1 H334 CLP00/
607-360-00-3 sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate 133167-77-8 Skin Sens. 1 H317 CLP00/
607-361-00-9 methyl (R)-2-(4-hydroxyphenoxy)propionate 96562-58-2 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
607-362-00-4 reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethy - Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H315, H318, H411 CLP00/
607-363-00-X methyl-3-methoxyacrylate 5788-17-0 Skin Sens. 1 H317 CLP00/
607-364-00-5 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione 134724-55-3 Aquatic Chronic 4 H413 CLP00/
607-365-00-0 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 119154-86-8 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H302, H314, H317 CLP00/
607-366-00-6 3,5-dimethylbenzoyl chloride 6613-44-1 Skin Corr. 1B, Skin Sens. 1 H314, H317 CLP00/
607-367-00-1 potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate 153352-59-1 Acute Tox. 4 * H302 CLP00/
607-368-00-7 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole 110895-43-7 Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H400, H410 CLP00/
607-369-00-2 reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid 147027-04-1 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 CLP00/
607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 41620-33-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 88150-62-3 Aquatic Chronic 4 H413 CLP00/
607-372-00-9 ethoxylated bis phenol A di-(norbornene carboxylate) - Aquatic Chronic 3 H412 CLP00/
607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 119738-06-6 Muta. 2, Repr. 1B, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H341, H360Df, H302, H373 **, H400, H410 CLP00/
607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 37441-29-5 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-375-00-5 reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 90035-08-8 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H372 **, H400, H410 CLP00/
607-376-00-0 benzyl 2,4-dibromobutanoate 23085-60-1 Repr. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f ***, H315, H317, H400, H410 CLP00/
607-377-00-6 trans-4-cyclohexyl-L-proline monohydrochloride 90657-55-9 Repr. 2, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H361f ***, H302, H315, H318, H317 CLP00/
607-378-00-1 ammonium (Z)- -methoxyimino-2-furylacetate 97148-39-5 Flam. Sol. 2 H228 T CLP00/
607-379-00-7 reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide - Aquatic Chronic 3 H412 CLP00/
607-380-00-2 reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate - Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H315, H318, H412 CLP00/
607-381-00-8 reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid - Aquatic Chronic 4 H413 CLP00/
607-382-00-3 2-((4-amino-2-nitrophenyl)amino)benzoic acid 117907-43-4 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
607-383-00-9 reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate 86403-32-9 Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H317, H400, H410 CLP00/
607-384-00-4 reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hyd 171090-93-0 Aquatic Chronic 4 H413 CLP00/
607-385-00-X Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate 125229-74-5 Aquatic Chronic 2 H411 CLP00/
607-386-00-5 reaction mass of: tetradecanoic acid (42.5-47.5 %); poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %) 174591-51-6 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 CLP00/
607-387-00-0 reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) 58856-63-6 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 CLP00/
607-388-00-6 4-ethylamino-3-nitrobenzoic acid 2788-74-1 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 CLP00/
607-389-00-1 trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate 119710-96-2 Acute Tox. 4 * H302 CLP00/
607-390-00-7 1,2,3,4-tetrahydro-6-nitro-quinoxaline 41959-35-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
607-391-00-2 dimethylcyclopropane-1,1-dicarboxylate 6914-71-2 Aquatic Chronic 3 H412 CLP00/
607-392-00-8 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate 88938-37-8 Aquatic Chronic 4 H413 CLP00/
607-393-00-3 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 106447-44-3 Skin Sens. 1 H317 CLP00/
607-394-00-9 5-methylpyrazine-2-carboxylic acid 5521-55-1 Eye Dam. 1 H318 CLP00/
607-395-00-4 reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate - Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H314, H317, H411 CLP00/
607-396-00-X bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate 147783-69-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-397-00-5 reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) - Repr. 2, Skin Sens. 1 H361f***, H317 CLP00/ATP01
607-398-00-0 ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate 125630-94-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-399-00-6 2,2-dimethyl 3-methyl-3-butenyl propanoate 104468-21-5 Skin Irrit. 2, Aquatic Chronic 3 H315, H412 CLP00/
607-400-00-X methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate 32750-89-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-401-00-5 ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate 88805-65-6 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H315, H318, H317 CLP00/
607-402-00-0 methyl N-(phenoxycarbonyl)-L-valinate 153441-77-1 Aquatic Chronic 3 H412 CLP00/
607-403-00-6 reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol - STOT RE 2 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H318, H400, H410 CLP00/
607-404-00-1 reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadi - Skin Sens. 1 H317 CLP00/
607-405-00-7 2-hexyldecyl-p-hydroxybenzoate 148348-12-3 Aquatic Chronic 2 H411 CLP00/
607-406-00-2 potassium 2,5-dichlorobenzoate 184637-62-5 Acute Tox. 4 *, Eye Dam. 1 H302, H318 CLP00/
607-407-00-8 ethyl 2-carboxy-3-(2-thienyl)propionate 143468-96-6 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H315, H318, H317 CLP00/
607-408-00-3 potassium N-(4-fluorophenyl)glycinate 184637-63-6 STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H373 **, H318, H317, H412 CLP00/
607-409-00-9 reaction mass of: (3R)-[1S-(1 , 2 , 6ß-((2S)-2-methyl-1-oxo-butoxy)-8a )hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus - Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-410-00-4 mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate 779343-34-9 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 CLP00/
607-411-00-X oxiranemethanol, 4-methylbenzene-sulfonate, (S)- 70987-78-9 Carc. 1B, Muta. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H350, H341, H318, H317, H411 CLP00/
607-412-00-5 ethyl 2-(1-cyanocyclohexyl)acetate 133481-10-4 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 3 H302, H373 **, H412 CLP00/
607-413-00-0 trans-4-phenyl-L-proline 96314-26-0 Repr. 2, Skin Sens. 1 H361f ***, H317 CLP00/
607-414-00-6 tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 88122-99-0 Aquatic Chronic 4 H413 CLP00/
607-415-00-1 poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl- , -dimethylbenzyl carbamate)-co-(maleicanhydride) - Flam. Sol. 1, Skin Sens. 1 H228, H317 T CLP00/
607-416-00-7 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-417-00-2 3-chloropropyl chloroformiate 628-11-5 Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H331, H302, H373**, H315, H318, H317 ATP01/
607-418-00-8 2-ethylhexyl 4-aminobenzoate 26218-04-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-419-00-3 (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid 166596-68-5 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
607-420-00-9 2,2-bis(hydroxymethyl)butanoic acid 10097-02-6 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
607-421-00-4 cypermethrin cis/trans +/- 40/60; (RS)- -cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 52315-07-8 Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H335, H400, H410 CLP00/
607-422-00-X -cypermethrin (ISO); racemate comprising (R)- -cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)- -cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 67375-30-8 Acute Tox. 3 *, STOT RE 2 *, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H301, H373**, H335, H400, H410 M=1000: CLP00/ATP01
607-423-00-5 esters of mecoprop and of mecoprop-P - Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 A CLP00/
607-424-00-0 trifloxystrobin (ISO); (E,E)- -methoxyimino-{}{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester 141517-21-7 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
607-425-00-6 metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate 57837-19-1 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 CLP00/
607-426-00-1 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] 84777-06-0 [1], - [2], 131-18-0 [3], 605-50-5 [4] Repr. 1B, Aquatic Acute 1 H360FD, H400 CLP00/
607-427-00-7 bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate 56634-95-8 Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H332, H302, H317, H400, H410 CLP00/
607-428-00-2 tetrasodium ethylene diamine tetraacetate 64-02-8 Acute Tox. 4 *, Eye Dam. 1 H302, H318 ATP01/
607-429-00-8 edetic acid; (EDTA) 60-00-4 Eye Irrit. 2 H319 ATP01/
607-430-00-3 BBP; benzyl butyl phthalate 85-68-7 Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H400, H410 CLP00/
607-431-00-9 prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 23031-36-9 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H302, H400, H410 CLP00/
607-432-00-4 S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] 87392-12-9 [1], 178961-20-1 [2] Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
607-433-00-X cypermethrin cis/trans +/- 80/20; (RS)- -cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 52315-07-8 Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H335, H315, H317, H400, H410 CLP00/
607-434-00-5 mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid 16484-77-8 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
607-435-00-0 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate 111969-64-3 STOT RE 2 *, Eye Dam. 1, Aquatic Chronic 2 H373 **, H318, H411 CLP00/
607-436-00-6 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
607-437-00-1 3-(4-aminophenyl)-2-cyano-2-propenoic acid 252977-62-1 Skin Sens. 1 H317 CLP00/
607-438-00-7 methyl-2-[(aminosulfonyl)methyl]benzoate 112941-26-1 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
607-439-00-2 methyl tetrahydro-2-furancarboxylate 37443-42-8 Eye Dam. 1 H318 CLP00/
607-440-00-8 methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate 144740-59-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
607-441-00-3 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid 167684-63-1 Aquatic Chronic 4 H413 CLP00/
607-442-00-9 benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate 87460-09-1 Eye Dam. 1 H318 CLP00/
607-444-00-X reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate 35541-81-2 Aquatic Chronic 4 H413 CLP00/
607-445-00-5 Iron (III) tris(4-methylbenzenesulfonate) 77214-82-5 Eye Dam. 1 H318 CLP00/
607-446-00-0 methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate 155522-12-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
607-447-00-6 sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate 156738-27-1 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
607-448-00-1 2,3,5,6-tetrafluorobenzoic acid 652-18-6 Skin Irrit. 2, Eye Dam. 1 H315, H318 CLP00/
607-449-00-7 reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4''' - Self-react. D ****, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H242, H317, H400, H410 CLP00/
607-450-00-2 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate 89604-92-2 Aquatic Chronic 4 H413 CLP00/
607-451-00-8 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt 161935-19-9 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
607-453-00-9 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) 172964-15-7 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
607-454-00-4 reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid 116193-72-7 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
607-455-00-X 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt 172890-93-6 Skin Sens. 1 H317 CLP00/
607-456-00-5 3-amino-4-chlorobenzoic acid, hexadecyl ester 143269-74-3 Aquatic Chronic 2 H411 CLP00/
607-457-00-0 tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{}{6-[4-(2-aminoethyl)piperazin-1-yl]}}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) 172277-97-3 Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
607-458-00-6 reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)o - Aquatic Chronic 2 H411 CLP00/
607-459-00-1 isopentyl 4-{}{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}}benzoate - Aquatic Chronic 4 H413 CLP00/
607-460-00-7 3-tridecyloxy-propyl-ammonium 9-octadecenoate 778577-53-0 STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H319, H315, H400, H410 CLP00/
607-461-00-2 reaction mass of: pentasodium 2-{}{4-{}{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}}-benzene-1,4-disulfonate; pentasodium 2-{}{4-{}{3-methyl-4-[ - Aquatic Chronic 3 H412 CLP00/
607-462-00-8 reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates 88230-35-7 Aquatic Chronic 2 H411 CLP00/
607-463-00-3 3-(phenothiazin-10-yl)propionic acid 362-03-8 Aquatic Chronic 2 H411 CLP00/
607-464-00-9 reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid - Aquatic Chronic 3 H412 CLP00/
607-465-00-4 tris(2-hydroxyethyl)ammonium 7-{}{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}}naphthalene-1,3-disulfonate 778583-04-3 Aquatic Chronic 3 H412 CLP00/
607-466-00-X reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3 - Aquatic Chronic 2 H411 CLP00/
607-467-00-5 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate 56533-00-7 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373 **, H314, H400, H410 CLP00/
607-468-00-0 reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6- - Skin Sens. 1 H317 CLP00/
607-469-00-6 disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate 120029-06-3 Aquatic Chronic 3 H412 CLP00/
607-470-00-1 potassium sodium 6,13-dichloro-3,10-bis{}{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 154336-20-6 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
607-471-00-7 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane 151900-44-6 Aquatic Chronic 4 H413 ATP01/
607-473-00-8 pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid 187412-41-5 Skin Sens. 1 H317 ATP01/
607-474-00-3 (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid 117573-89-4 Aquatic Chronic 4 H413 CLP00/
607-475-00-9 reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidoph 148878-18-6 Skin Sens. 1 H317 CLP00/
607-476-00-4 trisodium N,N-bis(carboxymethyl)-ß-alanine 129050-62-0 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 CLP00/
607-477-00-X (1 5 6 )-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
607-478-00-5 tetramethylammonium hydrogen phthalate 79723-02-7 Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1 H301, H373 **, H400 CLP00/
607-479-00-0 hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate 168689-49-4 Aquatic Chronic 4 H413 CLP00/
607-480-00-6 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters 68515-42-4 Repr. 1B H360Df CLP00/
607-481-00-1 reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate - Aquatic Chronic 4 H413 ATP01/
607-482-00-7 N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride 84793-24-8 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-483-00-2 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich 71888-89-6 Repr. 1B H360D*** ATP01/
607-484-00-8 ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl]ethylamino}propionate 221452-67-1 Aquatic Chronic 4 H413 ATP01/
607-485-00-3 (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate - Aquatic Chronic 4 H413 ATP01/
607-486-00-9 potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'-disulfonate 110081-40-8 Aquatic Chronic 3 H412 ATP01/
607-487-00-4 reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sul - Repr. 1B, Aquatic Chronic 3 H360D ***, H412 CLP00/
607-488-00-X ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate 147379-38-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-489-00-5 reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate 71302-79-9 Skin Sens. 1 H317 CLP00/
607-490-00-0 N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate - Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
607-491-00-6 reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6 - Carc. 2 H351 ATP01/
607-492-00-1 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate 141773-73-1 Aquatic Chronic 2 H411 CLP00/
607-493-00-7 methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate 78850-37-0 Eye Dam. 1 H318 CLP00/
607-494-00-2 bis(2-ethylhexyl)octylphosphonate 52894-02-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-495-00-8 sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate 168151-92-6 Skin Sens. 1 H317 CLP00/
607-496-00-3 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite 126050-54-2 Aquatic Chronic 4 H413 CLP00/
607-497-00-9 cerium oxide isostearate - Aquatic Chronic 4 H413 CLP00/
607-498-00-4 (E)-3,7-dimethyl-2,6-octadienylhexadecanoate 3681-73-0 Skin Irrit. 2, Aquatic Chronic 4 H315, H413 CLP00/
607-499-00-X bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
607-500-00-3 calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate - Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H315, H400, H410 CLP00/
607-501-00-9 reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives 192268-65-8 Aquatic Chronic 4 H413 CLP00/
607-502-00-4 (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate 178277-55-9 Skin Corr. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H314, H302, H411 CLP00/
607-503-00-X 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane 68957-94-8 Skin Corr. 1B H314 CLP00/
607-504-00-5 diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate - Repr. 1A, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H361f, H301, H373**, H400, H410 ATP01/
607-505-00-0 pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate - Aquatic Chronic 3 H412 CLP00/
607-506-00-6 reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfon - Aquatic Chronic 2 H411 CLP00/
607-507-00-1 potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate 187026-95-5 Eye Dam. 1 H318 CLP00/
607-508-00-7 disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] - Eye Dam. 1 H318 CLP00/
607-509-00-2 2-phenoxyethyl 4-aminobenzoate 88938-23-2 Aquatic Chronic 2 H411 ATP01/
607-510-00-8 (2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide 76646-91-8 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H302, H315, H318, H317 ATP01/
607-511-00-3 reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid - Eye Irrit. 2, Aquatic Chronic 2 H319, H411 ATP01/
607-512-00-9 trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate 182926-43-8 Aquatic Chronic 3 H412 CLP00/
607-513-00-4 reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodiu - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
607-514-00-X potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate 134841-35-3 Skin Sens. 1 H317 ATP01/
607-515-00-5 reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate 147732-60-3 Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
607-516-00-0 N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine 105996-54-1 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
607-517-00-6 (S)- -(acetylthio)benzenepropanoic acid 76932-17-7 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H302, H318, H317 CLP00/
607-518-00-1 3-oxoandrost-4-ene-17-ß-carboxylic acid 302-97-6 Repr. 1A, Aquatic Chronic 4 H361f, H413 ATP01/
607-519-00-7 poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] 176429-27-9 STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H335, H315, H318, H400, H410 ATP01/
607-520-00-2 reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-521-00-8 tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate 136210-30-5 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
607-522-00-3 sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate 184246-86-4 Aquatic Chronic 3 H412 ATP01/
607-523-00-9 reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6',13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
607-524-00-4 tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters - Aquatic Chronic 4 H413 ATP01/
607-525-00-X (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid 64485-90-1 Flam. Sol. 1****, Carc. 2, Aquatic Chronic 3 H228, H351, H412 ATP01/
607-526-00-5 cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane 15263-53-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
607-527-00-0 reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl) - STOT RE 2 * H373 ** CLP00/
607-528-00-6 (S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid 192725-50-1 Eye Dam. 1 H318 ATP01/
607-529-00-1 benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate 67299-45-0 Aquatic Chronic 3 H412 ATP01/
607-530-00-7 reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate 125643-61-0 Aquatic Chronic 4 H413 ATP01/
607-531-00-2 methyl 3-amino-4,6-dibromo-2-methyl-benzoate 119916-05-1 STOT RE 2 *, Aquatic Chronic 2 H373**, H411 ATP01/
607-532-00-8 (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt 167944-94-7 Aquatic Chronic 3 H412 ATP01/
607-533-00-3 pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-534-00-9 ethyl 2-(3-benzoylphenyl)propanoate 60658-04-0 Acute Tox. 3 *, STOT RE 1, Skin Sens. 1, Aquatic Chronic 2 H301, H372**, H317, H411 ATP01/
607-535-00-4 potassium 4-iodo-2-sulfonato-benzoic acid - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
607-536-00-X (2,6-xylyloxy) acetic acid 13335-71-2 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
607-537-00-5 isopropylammonium 2-(3-benzoylphenyl)propionate - Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 1, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H372**, H318, H400, H410 ATP01/
607-539-00-6 propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate 198705-81-6 Aquatic Chronic 4 H413 ATP01/
607-540-00-1 1-(mercaptomethyl)cyclopropylacetic acid 162515-68-6 Skin Corr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H314, H312, H302, H317, H411 ATP01/
607-541-00-7 [(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) 28698-31-9 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
607-542-00-2 methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-543-00-8 poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] 176429-22-4 STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H335, H315, H318, H400, H410 ATP01/
607-544-00-3 ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate 158585-86-5 Aquatic Chronic 3 H412 ATP01/
607-545-00-9 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate 94346-09-5 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
607-546-00-4 reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate 188070-47-5 Skin Sens. 1 H317 ATP01/
607-547-00-X 18-methylnonadecyl 2,2 -dimethylpropanoate 125496-22-2 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic H315, H317, H413 ATP01/
607-548-00-5 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate 154486-26-7 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
607-549-00-0 methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate 125778-19-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-550-00-6 2-amino-4-bromo-5-chlorobenzoic acid - Eye Dam. 1, Aquatic Chronic 3 H318, H410 ATP01/
607-551-00-1 tetrabutylammonium 2-amino-6-iodopurinate 156126-48-6 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H312, H302, H373**, H315, H318, H317, H411 ATP01/
607-552-00-7 hexadecyl 3-amino-4-isopropoxybenzoate - Aquatic Chronic 4 H413 ATP01/
607-553-00-2 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt - Eye Dam. 1 H318 ATP01/
607-554-00-8 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid 27624-67-5 Expl. 1.1, Eye Dam. 1, Aquatic Chronic 3 H201, H318, H412 ATP01/
607-555-00-3 1,1,3,3-tetramethylbutylperoxypivalate 22288-41-1 Flam. Liq. 2, Org. Perox. D, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H225, H242, H315, H317, H411 ATP01/
607-556-00-9 2-acetoxymethylene-4-acetylphenylacetate 24085-06-1 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H318, H317, H400, H410 ATP01/
607-557-00-4 salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid 169939-84-8 Skin Sens. 1 H317 ATP01/
607-558-00-X 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate 147027-10-9 Aquatic Chronic 2 H411 ATP01/
607-559-00-5 coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid 179986-09-5 Aquatic Chronic 4 H413 ATP01/
607-560-00-0 (R,S)-2-butyloctanedioic acid 50905-10-7 Eye Dam. 1 H318 ATP01/
607-561-00-6 sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate - Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
607-562-00-1 reaction mass of: (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate 98769-75-6 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
607-563-00-7 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid 171850-30-9 Aquatic Chronic 2 H411 ATP01/
607-564-00-2 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate 51178-75-7 Skin Sens. 1 H317 ATP01/
607-565-00-8 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate 88150-42-9 Acute Tox. 3 *, STOT RE 2 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H373**, H318, H400, H410 ATP01/
607-566-00-3 reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate - Aquatic Chronic 4 H413 ATP01/
607-567-00-9 potassium 3-iodo-6-methylbenzenesulfonate - Eye Dam. 1 H318 ATP01/
607-568-00-4 potassium 2-chloro-3-(benzyloxy)propionate 138666-92-9 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H302, H373**, H318, H317 ATP01/
607-569-00-X reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate - Skin Sens. 1 H317 ATP01/
607-570-00-5 sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate 71420-85-4 Skin Sens. 1 H317 ATP01/
607-571-00-0 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate 57374-49-9 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-572-00-6 diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate 162208-27-7 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373**, H317, H400, H410 ATP01/
607-573-00-1 reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate - Eye Dam. 1 H318 ATP01/
607-574-00-7 [1R-(1- ,2ß,5 )]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate 77341-67-4 Eye Dam. 1 H318 ATP01/
607-575-00-2 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt - STOT SE 3, Aquatic Chronic 3 H335, H412 ATP01/
607-576-00-8 branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-577-00-3 (2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H318, H317, H412 ATP01/
607-578-00-9 ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate - Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 4 H302, H373**, H413 ATP01/
607-579-00-4 diethyl[(p-ethoxyanilino)methylene]malonate 103976-28-9 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 ATP01/
607-580-00-X ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate 100491-29-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-581-00-5 ethyl 2-ethoxy-4-carboxymethylbenzoate 99469-99-5 Eye Dam. 1 H318 ATP01/
607-582-00-0 reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-yl - Aquatic Chronic 3 H412 ATP01/
607-583-00-6 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid 188907-52-0 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
607-584-00-1 trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate 215612-56-9 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
607-585-00-7 strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate - Skin Sens. 1 H317 ATP01/
607-586-00-2 dodecyl 3-amino-4-chlorobenzoate 6195-20-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
607-587-00-8 ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate 67914-69-6 Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H400, H410 ATP01/
607-588-00-3 reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
607-589-00-9 tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate 91788-83-9 STOT RE 1, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H372**, H302, H400, H410 ATP01/
607-590-00-4 hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate 210706-50-6 Aquatic Chronic 4 H413 ATP01/
607-591-00-X reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino) - Eye Dam. H318 ATP01/
607-592-00-5 di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate - Aquatic Chronic 4 H413 ATP01/
607-593-00-0 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate 159235-16-2 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
607-594-00-6 ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate 204254-96-6 STOT RE 2 *, Skin Sens. 1 H373**, H317 ATP01/
607-595-00-1 N-amidino-N-methylglycine-2-oxopropionate 208535-04-0 Eye Dam. 1 H318 ATP01/
607-596-00-7 ethyl 2-(4-phenoxyphenyl)lactate 132584-17-9 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
607-597-00-2 tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate - Eye Dam. 1 H318 ATP01/
607-598-00-8 trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate 212652-59-0 Eye Dam. 1 H318 ATP01/
607-599-00-3 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate 68860-54-8 Org. Perox. D, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H242, H317, H400, H410 ATP01/
607-600-00-7 (1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate - Aquatic Chronic 2 H411 ATP01/
607-601-00-2 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate 220410-74-2 Acute Tox. 4 * H302 ATP01/
607-602-00-8 ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate 122665-86-5 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
607-603-00-3 lithium sodium 4,4',4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate 193562-37-7 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-604-00-9 guanidinium benzoate 26739-54-8 Acute Tox. 4 * H302 ATP01/
607-605-00-4 methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate 144550-06-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-606-00-X (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid 86978-24-7 Acute Tox. 4 * H302 ATP01/
607-607-00-5 reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate) - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
607-608-00-0 pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-609-00-6 ethyl (3R)-4-cyano-3-hydroxybutanoate 141942-85-0 Eye Irrit. 2 H319 ATP01/
607-610-00-1 trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate - Skin Sens. 1 H317 ATP01/
607-611-00-7 methyl 3-amino-2,2,3-trimethylbutyrate 90886-53-6 Skin Corr. 1B, Acute Tox. 4 *, Aquatic Chronic 3 H314, H302, H412 ATP01/
607-612-00-2 reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate 182176-52-9 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1 H302, H373**, H318 ATP01/
607-613-00-8 reaction mass of: succinic acid, monopersuccinic acid, dipersuccinic acid, monomethyl ester of succinic acid, monomethyl ester of persuccinic acid, dimethyl succinate glutaric acid, monoperglutaric acid, diperglutaric acid, monomethyl ester of glutaric acid, monomethyl ester of perglutaric acid, dimethyl glutarate adipic acid, monoperadipic acid, diperadipic acid, monomethyl ester of adipic acid, monomethyl ester of peradipic acid, dimethyl adipate, hydrogen peroxide, methanol, water - Acute Tox. 4*, Acute Tox. 4*, Acute Tox. 4*, Skin Corr. 1B, STOT SE 2 H332, H312, H302, H314, H371 (eyes) ATP01/ATP05
607-614-00-3 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid 63562-33-4 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
607-615-00-9 reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance - Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H331, H302, H319, H317 ATP01/
607-616-00-4 2,4-dichloro-5-fluorobenzoylchloride 86393-34-2 STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H335, H315, H318, H317, H412 ATP01/
607-617-00-X bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate 10138-36-0 Skin Sens. 1 H317 ATP01/
607-618-00-5 menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt 130-37-0 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 ATP01/
607-619-00-0 menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) 73581-79-0 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 ATP01/
607-620-00-6 trisodium nitrilotriacetate 5064-31-3 Carc. 2, Acute Tox. 4 *, Eye Irrit. 2 H351, H302, H319 Carc. 2; H351: C ≥ 5 % ATP01/
607-621-00-1 milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] - Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H400, H410 M=100: ATP01/
607-622-00-7 2-ethylhexyl-2-ethylhexanoate 7425-14-1 Repr. 2 H361d*** ATP01/
607-623-00-2 diisobutyl phthalate 84-69-5 Repr. 1B H360Df Repr. 1B; H360Df: C ≥ 25%, Repr. 2; H361f: 5% ≤ C < 25% ATP01/
607-624-00-8 perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium 1763-23-1 [1], 2795-39-3 [2], 70225-14-8 [3], 29081-56-9 [4], 29457-72-5 [5] Carc. 2, Repr. 1B, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Lact., Aquatic Chronic 2 H351, H360D***, H372**, H332, H302, H362, H411 ATP01/
607-625-00-3 clodinafop-propargyl (ISO) 105512-06-9 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H317, H400, H410 Skin Sens. 1; H317: C ≥ 0,001 %, M=1: ATP01/
607-626-00-9 ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate 103112-35-2 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 ATP01/
607-627-00-4 [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate 162221-28-5 Skin Sens. 1 H317 ATP01/
607-628-00-X 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine 171054-89-0 Eye Dam. 1 H318 ATP01/
607-629-00-5 [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid 123599-82-6 Eye Irrit. 2 H319 ATP01/
607-630-00-0 acrylic acid, 3-(trimethoxysilyl)propyl ester 4369-14-6 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H332, H314, H317, H412 ATP01/
607-631-00-6 reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate - Skin Sens. 1 H317 ATP01/
607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide 111244-14-5 Aquatic Chronic 4 H413 ATP01/
607-633-00-7 trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate 341026-59-3 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-634-00-2 (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate 36394-75-9 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H302, H314, H317 ATP01/
607-635-00-8 trisodium N-(3-propionato)-l-aspartate 172737-80-3 Eye Dam. 1 H318 ATP01/
607-636-00-3 1-bromo-2-methylpropyl propionate 158894-67-8 Flam. Liq. 3, Carc. 2, Skin Corr. 1B, Skin Sens. 1 H226, H351, H314, H317 ATP01/
607-637-00-9 disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate 250688-43-8 Eye Dam. 1 H318 ATP01/
607-638-00-4 2-hydroxybenzoic acid 2-butyloctyl ester 190085-41-7 Aquatic Chronic 4 H413 ATP01/
607-639-00-X 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate 216698-07-6 Aquatic Chronic 4 H413 ATP01/
607-641-00-0 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid 43028-69-9 Acute Tox. 4 *, Skin Sens. 1 H302, H317 ATP01/
607-642-00-6 3,6,9-trithiaundecamethylene-1,11-dimethacrylate 141631-22-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
607-643-00-1 dimethyl (2S)-2-hydroxysuccinate 617-55-0 Flam. Liq. 3, Eye Dam. 1, Skin Sens. 1 H226, H318, H317 ATP01/
607-644-00-7 methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate 81752-87-6 Skin Irrit. 2 H315 ATP01/
607-645-00-2 tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate 243858-01-7 Eye Dam. 1 H318 ATP01/
607-646-00-8 d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate 124655-09-0 Acute Tox. 4 * H302 ATP01/
607-647-00-3 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane 143446-73-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1 H302, H317, H400 ATP01/
607-649-00-4 [3-(chlorocarbonyl)-2-methylphenyl]acetate 167678-46-8 Skin Corr. 1A, Skin Sens. 1 H314, H317 ATP01/
607-650-00-X 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate 145153-52-2 Skin Sens. 1 H317 ATP01/
607-651-00-5 sodium 2-(nonanoyloxy)benzenesulfonate 91125-43-8 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-652-00-0 ethyl N2-dodecanoyl-l-argininate hydrochloride 60372-77-2 Eye Dam. 1, Aquatic Acute 1 H318, H400 ATP01/
607-653-00-6 tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate 225786-91-4 Aquatic Chronic 2 H411 ATP01/
607-654-00-1 (S)-3-hydroxy- -butyrolactone 7331-52-4 Skin Sens. 1 H317 ATP01/
607-655-00-7 ethyl 6,8-dichlorooctanoate 1070-64-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-656-00-2 sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid 141250-43-3 Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
607-657-00-8 pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate 172399-10-9 Eye Dam. 1 H318 ATP01/
607-658-00-3 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt 371921-63-0 Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
607-659-00-9 pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid 321912-47-4 Eye Dam. 1 H318 ATP01/
607-660-00-4 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt 321679-52-1 Eye Dam. 1 H318 ATP01/
607-661-00-X 1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate 114772-40-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
607-662-00-5 methyl 2-(acetylamino)-3-chloropropionate 87333-22-0 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
607-663-00-0 bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate 127474-91-3 Aquatic Chronic 4 H413 ATP01/
607-664-00-6 methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate 393509-79-0 Eye Dam. 1, Aquatic Chronic 2 H318, H411 ATP01/
607-665-00-1 trans-methyl-2-ethyl-but-2-enoate 101226-85-1 Flam. Liq. 3 H226 ATP01/
607-666-00-7 (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid 88784-33-2 Eye Irrit. 2 H319 ATP01/
607-667-00-2 chloro-1-ethylcyclohexyl carbonate 99464-83-2 Muta. 2, Skin Sens. 1 H341, H317 ATP01/
607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane 42031-28-7 Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
607-669-00-3 methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate 376588-17-9 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
607-670-00-9 dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate 500791-70-8 STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373**, H318, H317, H400, H410 M=10: ATP01/
607-671-00-4 diethyl 1,4-cyclohexanedicarboxylate 72903-27-6 Aquatic Chronic 2 H411 ATP01/
607-672-00-X reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-673-00-5 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate - Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
607-675-00-6 reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
607-676-00-1 reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
607-677-00-7 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-l-valinate - STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H373**, H318, H317 ATP01/
607-678-00-2 reaction mass of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-679-00-8 reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl - Eye Dam. 1, Aquatic Chronic 2 H318, H411 ATP01/
607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate - Aquatic Chronic 4 H413 ATP01/
607-681-00-9 reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl - Aquatic Chronic 4 H413 ATP01/
607-682-00-4 complex reaction mass of Chinese gum rosin post reacted with acrylic acid 144413-22-9 Aquatic Chronic 4 H413 ATP01/
607-683-00-X reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) - Skin Sens. 1, Aquatic Chronic 2 H317, H411 ATP01/
607-684-00-5 alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts 243662-67-1 Skin Irrit. 2, Skin Sens. 1 H315, H317 ATP01/
607-685-00-0 ammonium 2-cocoyloxyethanesulfonate - Skin Irrit. 2, Eye Dam. 1 H315, H318 ATP01/
607-686-00-6 6,6'-bis(diazo-5,5',6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) - Self-react. C ****, Carc. 2 H242, H351 ATP01/
607-687-00-1 reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10%); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl} - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
607-688-00-7 (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride - Acute Tox. 4 * H302 ATP01/
607-689-00-2 reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate ("para-isomer" including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" including cis- and trans-isomers) - Aquatic Chronic 3 H412 ATP01/
607-690-00-8 dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) diimino]dihexanoate 255387-46-3 Skin Sens. 1 H317 ATP01/
607-691-00-3 magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear - Aquatic Chronic 4 H413 ATP01/
607-692-00-9 zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear - Aquatic Chronic 4 H413 ATP01/
607-693-00-4 hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate 302776-68-7 Aquatic Chronic 4 H413 ATP01/
607-694-00-X ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate 163520-33-0 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 ATP01/
607-696-00-0 pentyl formate 638-49-3 Flam. Liq. 3, Eye Irrit. 2, STOT SE 3 H226, H319, H335 C CLP00/
607-697-00-6 tert-butyl propionate 20487-40-5 Flam. Liq. 2 H225 C CLP00/
607-707-00-9 fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate 71283-80-2 STOT RE 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 (kidneys), H317, H400, H410 M=1, M=1 ATP07
607-708-00-4 octanoic acid 124-07-2 Skin Corr. 1C, Aquatic Chronic 3 H314, H412 ATP07
607-709-00-X decanoic acid 334-48-5 Skin Irrit. 2, Eye Irrit. 2, Aquatic Chronic 3 H315, H319, H412 ATP07
607-710-00-5 1,2-benzenedicarboxylic acid, dihexylester, branched and llinear 68515-50-4 Repr. 1B H360FD ATP07
607-711-00-0 spirotetramat (ISO); (5s,8s)-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec-3-en-4-yl ethyl carbonate 203313-25-1 Repr. 2, STOT SE 3, Eye Irrit. 2,Skin Sens. 1A, Aquatic Acute 1, Aquatic Chronic 1 H361fd, H335, H319, H317, H400, H410 M=1, M=1 ATP07
607-712-00-6 dodemorph acetate; 4-cyclodo-decyl-2,6-dimethylmorpholin-4-ium acetate 31717-87-0 Repr. 2, STOT RE 2, Skin Corr. 1C, Skin Sens. 1A, Aquatic Chronic 1 H361d, H373 (liver), H314, H317, H410 M=1 ATP07
607-713-00-1 fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate 134098-61-6 Acute Tox. 3, Acute Tox. 2, Skin Sens. 1B, Aquatic Acute 1, Aquatic Chronic 1 H301, H330, H317, H400, H410 M=100, M1000 ATP07
607-714-00-7 triflusulfuron-methyl; methyl2-({[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate 126535-15-7 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 M=100, M=10 ATP07
607-715-00-2 bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate 149877-41-8 STOT RE 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373, H317, H400, H410 M=1, M=1 ATP07
608-001-00-3 acetonitrile; cyanomethane 75-05-8 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2 H225, H332, H312, H302, H319 CLP00/
608-002-00-9 trichloroacetonitrile 545-06-2 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H331, H311, H301, H411 CLP00/
608-003-00-4 acrylonitrile 107-13-1 Flam. Liq. 2, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H225, H350, H331, H311, H301, H335, H315, H318, H317, H411 * D CLP00/
608-004-00-X 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin 75-86-5 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H400, H410 CLP00/
608-005-00-5 n-butyronitrile 109-74-0 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H225, H331, H311, H301 CLP00/ATP01
608-006-00-0 bromoxynil (ISO); 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol 1689-84-5 Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H330, H301, H317, H400, H410 M = 10: CLP00/
608-007-00-6 ioxynil (ISO); 4-hydroxy-3,5-diiodobenzonitrile 1689-83-4 Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H331, H301, H312, H373 **, H319, H400, H410 M = 10: CLP00/
608-008-00-1 chloroacetonitrile 107-14-2 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H331, H311, H301, H411 CLP00/
608-009-00-7 malononitrile 109-77-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 CLP00/
608-010-00-2 methacrylonitrile; 2-methyl-2-propene nitrile 126-98-7 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1 H225, H331, H311, H301, H317 *, Skin Sens. 1; H317: C ≥ 0,2 % D CLP00/
608-011-00-8 oxalonitrile; cyanogen 460-19-5 Press. Gas, Flam. Gas 1, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H220, H331, H400, H410 CLP00/ATP01
608-012-00-3 benzonitrile 100-47-0 Acute Tox. 4 *, Acute Tox. 4 * H312, H302 CLP00/
608-013-00-9 2-chlorobenzonitrile 873-32-5 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2 H312, H302, H319 CLP00/
608-014-00-4 chlorothalonil (ISO); tetrachloroisophthalonitrile 1897-45-6 Carc. 2, Acute Tox. 2 *, STOT SE 3, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H330, H335, H318, H317, H400, H410 M=10: CLP00/ATP01
608-015-00-X dichlobenil (ISO); 2,6-dichlorobenzonitrile 1194-65-6 Acute Tox. 4 *, Aquatic Chronic 2 H312, H411 CLP00/
608-016-00-5 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene 1897-41-2 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
608-017-00-0 bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate 1689-99-2 Repr. 2, Acute Tox. 3 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H331, H302, H317, H400, H410 M = 10: CLP00/
608-018-00-6 ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate 3861-47-0 Repr. 2, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H301, H319, H317, H400, H410 M = 10: CLP00/
608-019-00-1 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN 78-67-1 Self-react. C, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H242, H332, H302, H412 T CLP00/
608-020-00-7 diphenoxymethylenecyanamide 79463-77-7 Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
608-021-00-2 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile 76823-93-3 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
608-022-00-8 3,7-dimethyloctanenitrile 40188-41-8 Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H315, H317, H411 CLP00/
608-023-00-3 fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile 114369-43-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
608-024-00-9 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile 97460-76-9 Aquatic Chronic 4 H413 CLP00/
608-025-00-4 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile 117568-27-1 Aquatic Chronic 4 H413 CLP00/
608-026-00-X 3-cyano-3,5,5-trimethylcyclohexanone 7027-11-4 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H302, H373 **, H317, H412 CLP00/
608-027-00-5 reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile - Aquatic Chronic 2 H411 CLP00/
608-028-00-0 4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate 147374-67-2 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H373 **, H317, H411 CLP00/
608-029-00-6 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile 68612-94-2 Skin Sens. 1 H317 CLP00/
608-030-00-1 N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide 147741-93-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
608-031-00-7 2-benzyl-2-methyl-3-butenitrile 97384-48-0 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
608-032-00-2 acetamiprid (ISO); (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine 135410-20-7 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 ATP01/
608-033-00-8 N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide 75511-91-0 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
608-034-00-3 chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile 122453-73-0 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H302, H400, H410 M=100: CLP00/ATP01
608-035-00-9 (±)- -[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile - Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
608-036-00-4 3-(2-{}{4-[2-(4-cyanophenyl)vinyl]phenyl}}vinyl)benzonitrile 79026-02-1 Aquatic Chronic 4 H413 CLP00/
608-037-00-X reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
608-038-00-5 2,2,4-trimethyl-4-phenyl-butane-nitrile 75490-39-0 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
608-039-00-0 2-phenylhexanenitrile 3508-98-3 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 130755-46-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 138401-24-8 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
608-042-00-7 (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide 194602-27-2 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 ATP01/
608-043-00-2 3-(cis-3-hexenyloxy)propanenitril 142653-61-0 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H302, H400, H410 CLP00/
608-044-00-8 2-cyclohexylidene-2-phenylacetonitrile 10461-98-0 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 ATP01/
608-046-00-9 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile 77889-90-8 Aquatic Chronic 4 H413 ATP01/
608-047-00-4 2-piperidin-1-yl-benzonitrile 72752-52-4 Aquatic Chronic 2 H411 ATP01/
608-048-00-X 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile 152630-47-2 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H302, H373**, H317, H411 ATP01/
608-049-00-5 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile 157362-53-3 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
608-050-00-0 reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile - Aquatic Chronic 4 H413 ATP01/
608-051-00-6 (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 219861-18-4 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
608-052-00-1 (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 128173-52-4 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
608-053-00-7 (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 103146-25-4 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
608-054-00-2 (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 ATP01/
608-055-00-8 fipronil (ISO); 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile 120068-37-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H372**, H400, H410 M=10: ATP01/
608-056-00-3 N-methyl-N-cyanomethylmorpholiniummethylsulfate - Acute Tox. 4 *, Eye Dam. 1 H302, H318 ATP01/
608-057-00-9 4-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate 208538-34-5 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H302, H318, H317 ATP01/
608-058-00-4 esfenvalerate (ISO); (S)- -cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate 66230-04-4 Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H317, H400, H410 M=10000: CLP00/ATP01
608-059-00-X 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile 120068-79-3 Aquatic Chronic 2 H411 ATP01/
608-060-00-5 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile 138564-59-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
608-062-00-6 2-fluoro-4-hydroxybenzonitrile 82380-18-5 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
608-063-00-1 (S)- -hydroxy-3-phenoxy-benzeneacetonitrile 61826-76-4 Acute Tox. 3 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H318, H317, H400, H410 ATP01/
608-064-00-7 cyanomethyltrimethylammoniummethylsulfate - Aquatic Chronic 3 H412 ATP01/
608-065-00-2 salts of bromoxynil with the exception of those specified elsewhere in this Annex - Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H330, H301, H317, H400, H410 M = 10: A CLP00/
608-066-00-8 salts of ioxynil with the exception of those specified elsewhere in this Annex - Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H361d ***, H331, H301, H312, H373 **, H319, H400, H410 M = 10: A CLP00/
609-001-00-6 1-nitropropane 108-03-2 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H226, H332, H312, H302 * CLP00/
609-002-00-1 2-nitropropane 79-46-9 Flam. Liq. 3, Carc. 1B, Acute Tox. 4 *, Acute Tox. 4 * H226, H350, H332, H302 CLP00/
609-003-00-7 nitrobenzene 98-95-3 Carc. 2., Repr. 1B, Acute Tox. 3, Acute Tox. 3, Acute Tox. 3, STOT RE 1, Aquatic Chronic 3Carc. 2., Repr. 1B, Acute Tox. 3, Acute Tox. 3, Acute Tox. 3, STOT RE 1, Aquatic Chronic 3 H351, H360F, H301, H331, H311, H372 (blood), H412 CLP00/ATP05
609-004-00-2 dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] 25154-54-5 [1], 100-25-4 [2], 99-65-0 [3], 528-29-0 [4] Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H373 **, H400, H410 CLP00/
609-005-00-8 1,3,5-trinitrobenzene 99-35-4 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2, Aquatic Acute 1, Aquatic Chronic 1 H201, H330, H310, H300, H373**, H400, H410 CLP00/ATP01
609-006-00-3 4-nitrotoluene 99-99-0 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H331, H311, H301, H373 **, H411 CLP00/
609-007-00-9 2,4-dinitrotoluene; [1] dinitrotoluene [2] 121-14-2 [1], 25321-14-6 [2], - Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H361f***, H331, H311, H301, H373**, H400, H410 CLP00/ATP01
609-008-00-4 2,4,6-trinitrotoluene; TNT 118-96-7 Expl. 1.1, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H201, H331, H311, H301, H373 **, H411 CLP00/
609-009-00-X 2,4,6-trinitrophenol; picric acid 88-89-1 Expl. 1.1, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H201, H331, H311, H301 CLP00/ATP01
609-010-00-5 salts of picric acid - Unst. Expl, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H201, H331, H311, H301 T CLP00/
609-011-00-0 2,4,6-trinitroanisole 606-35-9 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H201, H332, H312, H302, H411 CLP00/
609-012-00-6 2,4,6-trinitro-m-cresol 602-99-3 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H201, H332, H312, H302 CLP00/
609-013-00-1 2,4,6-trinitro-m-xylene 632-92-8 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 * H201, H332, H312, H302, H373 ** CLP00/
609-015-00-2 4-nitrophenol; p-nitrophenol 100-02-7 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 * H332, H312, H302, H373 ** CLP00/
609-016-00-8 dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] 25550-58-7 [1], 71629-74-8 [2] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 CLP00/
609-018-00-9 2,4,6-trinitroresorcinol; styphnic acid 82-71-3 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H201, H332, H312, H302 CLP00/ATP01
609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate 15245-44-0 Unst. Expl, Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H200, H360Df, H332, H302, H373 **, H400, H410 1 CLP00/
609-019-01-1 lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate ( 20 % phlegmatiser) 15245-44-0 Expl. 1.1, Repr. 1A, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H201, H360Df, H332, H302, H373 **, H400, H410 1 CLP00/
609-020-00-X DNOC (ISO); 4,6-dinitro-o-cresol 534-52-1 Muta. 2, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H330, H310, H300, H315, H318, H317, H400, H410 CLP00/
609-021-00-5 sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] 2312-76-7 [1], 5787-96-2 [2] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 CLP00/
609-022-00-0 ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide 2980-64-5 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H310, H300, H373 **, H400, H410 CLP00/
609-023-00-6 dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which octyl is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups 39300-45-3 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H360D***, H332, H302, H373**, H315, H317, H400, H410 M=100: CLP00/ATP01
609-024-00-1 binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 485-31-4 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H360D ***, H312, H302, H400, H410 CLP00/
609-025-00-7 dinoseb (ISO); 6-sec-butyl-2,4-dinitrophenol 88-85-7 Repr. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H311, H301, H319, H400, H410 CLP00/
609-026-00-2 salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex - Repr. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H311, H301, H319, H400, H410 A CLP00/
609-027-00-8 dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate 63919-26-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
609-028-00-3 dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol 131-89-5 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 CLP00/
609-029-00-9 salts and esters of dinex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 A CLP00/
609-030-00-4 dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol 1420-07-1 Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H360D ***, H300, H311, H400, H410 CLP00/
609-031-00-X salts and esters of dinoterb - Repr. 1B, Acute Tox. 2 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H360D ***, H300, H311, H400, H410 A CLP00/
609-032-00-5 bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 13181-17-4 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
609-033-00-0 dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol 4097-36-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 CLP00/
609-034-00-6 salts and esters of dinosam - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H400, H410 A CLP00/
609-035-00-1 nitroethane 79-24-3 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 * H226, H332, H302 * CLP00/
609-036-00-7 nitromethane 75-52-5 Flam. Liq. 3, Acute Tox. 4 * H226, H302 * CLP00/
609-037-00-2 5-nitroacenaphthene 602-87-9 Carc. 1B H350 CLP00/
609-038-00-8 2-nitronaphthalene 581-89-5 Carc. 1B, Aquatic Chronic 2 H350, H411 CLP00/
609-039-00-3 4-nitrobiphenyl 92-93-3 Carc. 1B, Aquatic Chronic 2 H350, H411 CLP00/
609-040-00-9 nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether 1836-75-5 Carc. 1B, Repr. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H360D ***, H302, H400, H410 CLP00/
609-041-00-4 2,4-dinitrophenol 51-28-5 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1 H331, H311, H301, H373 **, H400 CLP00/
609-042-00-X pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 40487-42-1 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
609-043-00-5 quintozene (ISO); pentachloronitrobenzene 82-68-8 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
609-044-00-0 tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene 117-18-0 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
609-045-00-6 reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 8069-76-9 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
609-046-00-1 trifluralin (ISO) (containing < 0.5 ppm NPDA); , , -trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylan 1582-09-8 Carc. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H317, H400, H410 M=10: CLP00/ATP01
609-047-00-7 2-nitroanisole 91-23-6 Carc. 1B, Acute Tox. 4 * H350, H302 CLP00/
609-048-00-2 sodium 3-nitrobenzenesulphonate 127-68-4 Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
609-049-00-8 2,6-dinitrotoluene 606-20-2 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H350, H341, H361f ***, H331, H311, H301, H373 **, H412 CLP00/
609-050-00-3 2,3-dinitrotoluene 602-01-7 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H361f ***, H331, H311, H301, H373 **, H400, H410 CLP00/
609-051-00-9 3,4-dinitrotoluene 610-39-9 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H350, H341, H361f ***, H331, H311, H301, H373 **, H411 CLP00/
609-052-00-4 3,5-dinitrotoluene 618-85-9 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H350, H341, H361f ***, H331, H311, H301, H373 **, H412 CLP00/
609-053-00-X hydrazine-trinitromethane - Expl. 1.1 ****, Self-react. A, Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1 H201, H240, H350, H331, H301, H317 CLP00/
609-054-00-5 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] 66-56-8 [1], 329-71-5 [2], 573-56-8 [3], 577-71-9 [4], - [5] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H331, H311, H301, H373 **, H411 CLP00/
609-055-00-0 2,5-dinitrotoluene 619-15-8 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H350, H341, H361f ***, H331, H311, H301, H373 **, H411 CLP00/
609-056-00-6 2,2-dibromo-2-nitroethanol 69094-18-4 Expl. 1.1, Carc. 2, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H201, H351, H302, H373 **, H314, H317, H400, H410 *, STOT SE 3; H335: C ≥ 1 % T CLP00/
609-057-00-1 3-chloro-2,4-difluoronitrobenzene 3847-58-3 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H317, H400, H410 CLP00/
609-058-00-7 2-nitro-2-phenyl-1,3-propanediol 5428-02-4 STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H372 **, H312, H302, H317, H411 CLP00/
609-059-00-2 2-chloro-6-(ethylamino)-4-nitrophenol 131657-78-8 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
609-060-00-8 4-[(3-hydroxypropyl)amino]-3-nitrophenol 92952-81-3 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
609-061-00-3 (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime 94097-88-8 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
609-062-00-9 2-bromo-2-nitropropanol 24403-04-1 Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H311, H302, H373 **, H314, H317, H400, H410 CLP00/
609-063-00-4 2-[(4-chloro-2-nitrophenyl)amino]ethanol 59320-13-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
609-064-00-X mesotrione (ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione 104206-82-8 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
609-065-00-5 2-nitrotoluene 88-72-2 Carc. 1B, Muta. 1B, Repr. 2, Acute Tox. 4 *, Aquatic Chronic 2 H350, H340, H361f ***, H302, H411 CLP00/
609-066-00-0 lithium sodium 3-amino-10-{}{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 154212-58-5 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 2 ** H332, H312, H302, H371 ** CLP00/
609-067-00-6 sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine 156769-97-0 Skin Sens. 1 H317 CLP00/
609-068-00-1 musk xylene; 5-tert-butyl-2,4,6-trinitro-m-xylene 81-15-2 Expl. 1.1, Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H201, H351, H400, H410 T CLP00/
609-069-00-7 musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone 81-14-1 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 ATP01/
609-070-00-2 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene 130841-23-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 156137-33-6 Skin Sens. 1 H317 CLP00/
609-072-00-3 4-mesyl-2-nitrotoluene 1671-49-4 Repr. 2, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H361f***, H302, H317, H412 ATP01/
609-073-00-9 lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato]}-N'-(2-aminoethyl)piperazine - Skin Sens. 1 H317 ATP01/
610-001-00-3 trichloronitromethane; chloropicrin 76-06-2 Acute Tox. 2 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H330, H302, H319, H335, H315 CLP00/
610-002-00-9 1,1-dichloro-1-nitroethane 594-72-9 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 CLP00/
610-003-00-4 chlorodinitrobenzene - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 C CLP00/
610-004-00-X 2-chloro-1,3,5-trinitrobenzene 88-88-0 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H201, H330, H310, H300, H400, H410 CLP00/
610-005-00-5 1-chloro-4-nitrobenzene 100-00-5 Carc. 2, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H351, H341, H331, H311, H301, H373 **, H411 CLP00/
610-006-00-0 chloronitroanilines with the exception of those specified elsewhere in this Annex - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 2 H330, H310, H300, H373 **, H411 A C CLP00/
610-007-00-6 1-chloro-1-nitropropane 600-25-9 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 * CLP00/
610-008-00-1 2,6-dichloro-4-nitroanisole 17742-69-7 Acute Tox. 3 *, Aquatic Chronic 2 H301, H411 CLP00/
610-009-00-7 2-chloro-4-nitroaniline 121-87-9 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
610-010-00-2 2-bromo-1-(2-furyl)-2-nitroethylene 35950-52-8 Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H314, H317, H400, H410 CLP00/
611-001-00-6 azobenzene 103-33-3 Carc. 1B, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H332, H302, H373 **, H400, H410 CLP00/
611-002-00-1 azoxybenzene 495-48-7 Acute Tox. 4 *, Acute Tox. 4 * H332, H302 CLP00/
611-003-00-7 fenaminosulf (ISO); sodium 4-dimethylaminobenzenediazosulphonate 140-56-7 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Chronic 3 H301, H312, H412 CLP00/
611-004-00-2 methyl-ONN-azoxymethyl acetate; methyl azoxy methyl acetate 592-62-1 Carc. 1B, Repr. 1B H350, H360D *** CLP00/
611-005-00-8 disodium {}{5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}}cuprate(2-); CI Direct Brown 95 16071-86-6 Carc. 1B H350 CLP00/
611-006-00-3 4-o-tolylazo-o-toluidine; 4-amino-2',3-dimethylazobenzene; fast garnet GBC base; AAT; o-aminoazotoluene 97-56-3 Carc. 1B, Skin Sens. 1 H350, H317 CLP00/
611-007-00-9 tricyclazole (ISO); 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole 41814-78-2 Acute Tox. 4 * H302 CLP00/
611-008-00-4 4-aminoazobenzene; 4-phenylazoaniline 60-09-3 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
611-009-00-X sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) - Acute Tox. 4 *, Aquatic Chronic 3 H332, H412 CLP00/
611-010-00-5 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide 106359-94-8 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
611-011-00-0 N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-012-00-6 reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate 114565-65-0 Skin Sens. 1 H317 CLP00/
611-013-00-1 trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate 117409-78-6 Expl. 1.3 ****, Aquatic Chronic 2 H203, H411 CLP00/
611-014-00-7 (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide 115099-55-3 Skin Sens. 1 H317 CLP00/
611-015-00-2 tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 116889-78-2 Skin Sens. 1 H317 CLP00/
611-016-00-8 reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride - Skin Sens. 1 H317 CLP00/
611-017-00-3 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-018-00-9 tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate - Skin Sens. 1 H317 CLP00/
611-019-00-4 tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 106028-58-4 Skin Sens. 1 H317 CLP00/
611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 116340-05-7 Acute Tox. 3 *, Skin Sens. 1, Aquatic Chronic 3 H301, H317, H412 CLP00/
611-021-00-5 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate - Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Aquatic Chronic 4 H302, H373 **, H315, H413 CLP00/
611-022-00-0 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate - Self-react. C, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H242, H331, H301, H312, H373 **, H318, H317, H400, H410 T CLP00/
611-023-00-6 disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate - Skin Sens. 1 H317 CLP00/
611-024-00-1 Benzidine based azo dyes; 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex - Carc. 1B H350 A CLP00/
611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; C.I. Direct Black 38 1937-37-7 Carc. 1B, Repr. 2 H350, H361d *** CLP00/
611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; C.I. Direct Blue 6 2602-46-2 Carc. 1B, Repr. 2 H350, H361d *** CLP00/
611-027-00-8 disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28 573-58-0 Carc. 1B, Repr. 2 H350, H361d *** CLP00/
611-028-00-3 C,C'-azodi(formamide) 123-77-3 Resp. Sens. 1 H334 CLP00/ATP01
611-029-00-9 o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex - Carc. 1B H350 A H CLP00/
611-030-00-4 o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex - Carc. 1B H350 A H CLP00/
611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; C.I. Basic Red 9 569-61-9 Carc. 1B H350 CLP00/
611-032-00-5 1,4,5,8-tetraaminoanthraquinone; C.I. Disperse Blue 1 2475-45-8 Carc. 1B, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1 H350, H315, H318, H317 CLP00/
611-033-00-0 hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) 82027-60-9 Aquatic Chronic 2 H411 CLP00/
611-034-00-6 N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide 105076-77-5 Aquatic Chronic 4 H413 CLP00/
611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 107246-80-0 Aquatic Chronic 2 H411 CLP00/ATP01
611-036-00-7 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate - Skin Sens. 1 H317 CLP00/
611-037-00-2 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate 124584-00-5 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
611-038-00-8 trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate - Eye Irrit. 2 H319 CLP00/
611-039-00-3 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid 117715-57-8 Skin Sens. 1 H317 CLP00/
611-040-00-9 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid 115099-58-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
611-041-00-4 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide 98809-11-1 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
611-042-00-X trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate 136213-71-3 Aquatic Chronic 3 H412 CLP00/
611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')- -6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))- - Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis 117527-94-3 Aquatic Chronic 2 H411 CLP00/
611-045-00-6 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene - Aquatic Chronic 4 H413 CLP00/
611-046-00-1 4,4'-diamino-2-methylazobenzene 43151-99-1 Acute Tox. 3 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H373 **, H317, H400, H410 CLP00/
611-047-00-7 reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 111381-11-4 Aquatic Chronic 4 H413 CLP00/
611-048-00-2 reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 111381-12-5 Aquatic Chronic 4 H413 CLP00/
611-049-00-8 reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) 118658-98-3 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H373 **, H317, H412 CLP00/
611-050-00-3 reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4- - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-051-00-9 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride 136213-74-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
611-052-00-4 monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex - Aquatic Chronic 3 H412 CLP00/
611-053-00-X 2,2'-azobis[2-methylpropionamidine] dihydrochloride 2997-92-4 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
611-055-00-0 C.I. Disperse Yellow 3; N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 2832-40-8 Carc. 2, Skin Sens. 1 H351, H317 CLP00/
611-056-00-6 C.I. Solvent Yellow 14; 1-phenylazo-2-naphthol 842-07-9 Carc. 2, Muta. 2, Skin Sens. 1, Aquatic Chronic 4 H351, H341, H317, H413 CLP00/
611-057-00-1 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile 85136-74-9 Carc. 1B, Aquatic Chronic 4 H350, H413 CLP00/
611-058-00-7 (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 108225-03-2 Carc. 1B, Eye Dam. 1, Aquatic Chronic 2 H350, H318, H411 CLP00/
611-059-00-2 octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate 148878-21-1 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo] 187285-15-0 Eye Dam. 1 H318 CLP00/
611-061-00-3 disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate - Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
611-062-00-9 octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate - Skin Irrit. 2, Eye Dam. 1 H315, H318 CLP00/
611-063-00-4 trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) 164058-22-4 Carc. 1B H350 CLP00/
611-064-00-X 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol 124719-26-2 STOT RE 2 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H315, H400, H410 CLP00/
611-065-00-5 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol 111850-24-9 STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H319, H315, H317, H400, H410 CLP00/
611-066-00-0 tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 130201-57-9 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
611-067-00-6 reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-me - Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/ATP01
611-068-00-1 tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 85665-98-1 Aquatic Chronic 2 H411 CLP00/
611-069-00-7 N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline - Aquatic Chronic 2 H411 CLP00/
611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chr - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
611-071-00-8 tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate 131013-81-5 Acute Tox. 3 *, Aquatic Chronic 3 H301, H412 CLP00/
611-072-00-3 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride 118208-02-9 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 CLP00/
611-073-00-9 dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate 122630-55-1 Aquatic Chronic 4 H413 CLP00/
611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-m - Skin Sens. 1 H317 CLP00/
611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2- - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-076-00-5 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole 117584-16-4 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
611-077-00-0 dilithium disodium (5,5'-diamino-( -4,4'-dihydroxy-1:2- -2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2- -2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4- :N3',N4'- )]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) 126637-70-5 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
611-078-00-6 (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate 159604-94-1 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-079-00-1 disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate 147703-64-8 Eye Dam. 1 H318 CLP00/
611-080-00-7 sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate 147703-65-9 Skin Sens. 1 H317 CLP00/
611-081-00-2 tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) 141048-13-7 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
611-082-00-8 reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2 - Aquatic Chronic 2 H411 CLP00/
611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) - STOT RE 1, Skin Sens. 1, Aquatic Chronic 2 H372 **, H317, H411 CLP00/
611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-c - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate - Aquatic Chronic 3 H412 CLP00/
611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) - Aquatic Chronic 4 H413 CLP00/
611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate; trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)- - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
611-089-00-6 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate 136213-73-5 STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H317, H400, H410 CLP00/
611-090-00-1 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate 93672-52-7 Self-react. C, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H242, H302, H318, H317, H412 T CLP00/
611-091-00-7 sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate 134595-59-8 Skin Sens. 1 H317 CLP00/
611-092-00-2 tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate - Aquatic Chronic 2 H411 CLP00/
611-093-00-8 sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate 146177-84-6 Skin Sens. 1 H317 CLP00/
611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 143145-93-1 Aquatic Chronic 4 H413 CLP00/
611-095-00-9 hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide 89797-03-5 Aquatic Chronic 2 H411 CLP00/
611-096-00-4 methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate 149850-30-6 Skin Sens. 1 H317 CLP00/
611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-098-00-5 tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate 131013-83-7 Acute Tox. 3 *, Aquatic Chronic 3 H301, H412 CLP00/
611-099-00-0 (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride 118658-99-4 Carc. 1B, Aquatic Chronic 2 H350, H411 CLP00/
611-100-00-4 potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate 140876-13-7 Eye Dam. 1 H318 CLP00/
611-101-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide 104366-25-8 Skin Sens. 1 H317 CLP00/
611-102-00-5 reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfo - Aquatic Chronic 3 H412 ATP01/
611-103-00-0 trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2, - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-105-00-1 sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate 136213-75-7 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-106-00-7 hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate 157627-99-1 Eye Dam. 1 H318 CLP00/
611-107-00-2 potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate - Skin Sens. 1 H317 CLP00/
611-108-00-8 disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate 6527-62-4 Aquatic Chronic 3 H412 CLP00/
611-109-00-3 Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) - Aquatic Chronic 2 H411 CLP00/
611-110-00-9 tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene 124605-82-9 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-111-00-4 disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) - Skin Sens. 1 H317 CLP00/
611-112-00-X tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate - Skin Sens. 1 H317 CLP00/
611-113-00-5 lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) 149626-00-6 Aquatic Chronic 2 H411 CLP00/
611-114-00-0 lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) 149564-66-9 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
611-115-00-6 trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) 149564-65-8 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
611-116-00-1 reaction mass of: trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{}{4-chloro-6-[2-(2,6-dichloro-5-cyanopy - Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
611-117-00-7 1,3-bis{}{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}}propane lithium-, sodium salt 149850-29-3 Skin Sens. 1 H317 CLP00/
611-118-00-2 sodium 1,2-bis[4-[4-{}{4-(4-sulfophenylazo)-2-sulfophenylazo}}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt - Skin Sens. 1 H317 CLP00/
611-119-00-8 tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 148878-22-2 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
611-120-00-3 5-{}{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt 157707-94-3 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
611-121-00-9 Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; Main component 8 (isomer): asym. 1:2 Cr-com 30785-74-1 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
611-122-00-4 hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel 151436-99-6 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
611-123-00-X 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate 178452-66-9 Eye Dam. 1 H318 CLP00/
611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{}{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate; pentasodium 5- - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-125-00-0 reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-126-00-6 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride 174514-06-8 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
611-127-00-1 pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 G CLP00/
611-128-00-7 N,N'-bis{}{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt 171599-85-2 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid; 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 163879-69-4 Expl. 1.3 ****, Repr. 2, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H203, H361f ***, H373 **, H317, H411 CLP00/
611-130-00-8 tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate 183130-96-3 Eye Irrit. 2, Aquatic Chronic 3 H319, H412 CLP00/ATP01
611-131-00-3 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one 151798-26-4 Repr. 1B, Aquatic Chronic 4 H360D ***, H413 CLP00/
611-132-00-9 pentasodium bis{}{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III) 178452-71-6 Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
611-133-00-4 Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-134-00-X trisodium 2-{}{ [2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}}-4-sulfonatobenzoate, copper complex - Eye Dam. 1, Aquatic Chronic 2 H318, H411 CLP00/
611-135-00-5 Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt - Eye Dam. 1, Aquatic Chronic 3 H318, H412 CLP00/
611-136-00-0 2-{}{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}}-2-aminopropyl formate - Repr. 2, Eye Dam. 1, Aquatic Chronic 2 H361f ***, H318, H411 CLP00/
611-137-00-6 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole 159038-16-1 Aquatic Chronic 4 H413 CLP00/
611-138-00-1 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole 152828-25-6 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
611-139-00-7 reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride - Eye Dam. 1, Aquatic Chronic 2 H318, H411 ATP01/
611-140-00-2 azafenidin (ISO); 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one 68049-83-2 Repr. 1B, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Df, H373 **, H400, H410 M = 1000: CLP00/
611-141-00-8 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
611-142-00-3 product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and furt - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-143-00-9 reaction mass of: trisodium 2-(2-[ -(2-carboxylato- -O-4-sulfonatophenylazo)benzylidene]hydrazino- -N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[ -(2-carboxylato- -O-4-sulfonatophenylazo)benzylidene]hydrazino- - Eye Dam. 1 H318 ATP01/
611-144-00-4 reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, 214362-06-8 Eye Dam. 1 H318 ATP01/
611-145-00-X reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulf - Eye Dam. 1 H318 ATP01/
611-146-00-5 reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentaso - Aquatic Chronic 2 H411 ATP01/
611-147-00-0 sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate 205764-96-1 Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
611-148-00-6 reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
611-149-00-1 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate 193486-83-8 Aquatic Chronic 2 H411 ATP01/
611-150-00-7 tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate - Eye Irrit. 2, Aquatic Chronic 3 H319, H412 ATP01/
611-151-00-2 chrysoidine; 4-(phenylazo)benzene-1,3-diamine 495-54-5 Muta. 2, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H341, H302, H315, H400, H410 ATP01/
611-152-00-8 chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate; [3] chrysoidine-p-dodecy 532-82-1 [1], 75660-25-2 [2], 79234-33-6 [3], 63681-54-9 [4], 83968-67-6 [5], 84196-22-5 [6] Muta. 2, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H302, H315, H318, H400, H410 ATP01/
611-153-00-3 chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1] chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4 85407-90-5 [1], 94247-67-3 [2] Muta. 2, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1 H341, H302, H315, H318 ATP01/
611-154-00-9 trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate 92408-46-3 Aquatic Chronic 3 H412 ATP01/
611-155-00-4 4,4'-oxybis(benzenesulfonylazide) 7456-68-0 Expl. 1.1****, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H201, H373**, H400, H410 ATP01/
611-156-00-X triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate 221354-37-6 Repr. 2, STOT RE 2 *, Aquatic Chronic 2 H361f***, H373**, H411 ATP01/
611-157-00-5 benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate 243869-48-9 Eye Irrit. 2, Aquatic Chronic 3 H319, H412 ATP01/
611-158-00-0 reaction product of: 2,3,4,2',3',4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride - ****, Aquatic Chronic 4 ****, H413 ATP01/
611-159-00-6 disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-160-00-1 reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'',4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'',6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane w - ****, Aquatic Chronic 4 ****, H413 ATP01/
611-161-00-7 trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) - Eye Dam. 1 H318 ATP01/
611-162-00-2 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
611-163-00-8 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate - Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 2 H302, H318, H411 ATP01/
611-164-00-3 reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile; 2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2,2'-dimethyl-2,2'-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2'-(2'-meth - Self React D, Acute Tox. 4 *, Aquatic Chronic 2 H242, H302, H411 ATP01/
611-165-00-9 reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo - Aquatic Chronic 3 H412 ATP01/
611-166-00-4 reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsul - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-167-00-X sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II) - Aquatic Chronic 3 H412 ATP01/
611-168-00-5 reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzo - Eye Dam. 1 H318 ATP01/
611-169-00-0 sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate - Aquatic Chronic 3 H412 ATP01/
611-170-00-6 reaction mass of: trisodium 2-((1-(2-hydroxy- -O-5-(2-sulfonatoethansulfonyl)phenylazo- -N2)-1-phenylmethyl)azo- -N1)-4-sulfonatobenzoate(5-)- -O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy- -O-phenylazo- -N2)-1-phenylmethyl)azo- -N1)-4-sulfo - Aquatic Chronic 3 H412 ATP01/
611-171-00-1 reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5- - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-172-00-7 reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate - Self-react. C****, Repr. 2, Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 3 H242, H361f***, H302, H373**, H412 ATP01/
611-173-00-2 reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(v - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
611-174-00-8 reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-ch 457624-86-1 Eye Dam. 1 H318 ATP01/
611-175-00-3 reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-tr - Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
611-176-00-9 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate - Self-react. C****, Aquatic Chronic 2 H242, H411 ATP01/
611-177-00-4 reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1, 508202-43-5 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
611-178-00-X reaction mass of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsul - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
611-179-00-5 reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1 - Eye Dam. 1, Skin Sens. 1 H318, H317 ATP01/
611-180-00-0 iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts - Aquatic Chronic 2 H411 ATP01/
612-001-00-9 mono-methylamine; [1] di-methylamine; [2] tri-methylamine [3] 74-89-5 [1], 124-40-3 [2], 75-50-3 [3] Flam. Gas 1, Press. Gas, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H220, H332, H335, H315, H318 *, Skin Irrit. 2; H315: C ≥ 5 %, Eye Dam. 1; H318: C ≥ 5 %, Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %, STOT SE 3; H335: C ≥ 5 % U 5 CLP00/
612-001-01-6 mono-methylamine ... %; [1] di-methylamine ... %; [2] tri-methylamine ... % [3] 74-89-5 [1], 124-40-3 [2], 75-50-3 [3] Flam. Liq. 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H224, H332, H302, H314 *, STOT SE 3; H335: C ≥ 5 % B CLP00/
612-002-00-4 ethylamine 75-04-7 Flam. Gas 1, Press. Gas, Eye Irrit. 2, STOT SE 3 H220, H319, H335 U CLP00/
612-003-00-X diethylamine 109-89-7 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H225, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 1 % CLP00/
612-004-00-5 triethylamine 121-44-8 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H225, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 1 % CLP00/
612-005-00-0 butylamine 109-73-9 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H225, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 1 % CLP00/
612-006-00-6 ethylenediamine; 1,2-diaminoethane 107-15-3 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1 H226, H312, H302, H314, H334, H317 CLP00/
612-007-00-1 2-aminopropane; isopropylamine 75-31-0 Flam. Liq. 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H224, H319, H335, H315 CLP00/
612-008-00-7 aniline 62-53-3 Carc. 2, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H351, H341, H331, H311, H301, H372 **, H318, H317, H400 *, STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,2 % ≤ C < 1 % CLP00/
612-009-00-2 salts of aniline - Carc. 2, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H351, H341, H331, H311, H301, H372 **, H318, H317, H400 *, STOT RE 1; H372: C ≥ 1 %, STOT RE 2; H373: 0,2 % ≤ C < 1 % A CLP00/
612-010-00-8 chloroanilines, with exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 C CLP00/
612-011-00-3 4-nitrosoaniline 659-49-4 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 CLP00/
612-012-00-9 o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] 88-74-4 [1], 99-09-2 [2], 100-01-6 [3] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H331, H311, H301, H373 **, H412 C CLP00/
612-013-00-4 3-aminobenzene sulphonic acid; metanilic acid 121-47-1 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 CLP00/
612-014-00-X sulphanilic acid; 4-aminobenzenesulphonic acid 121-57-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H319, H315, H317 CLP00/
612-015-00-5 N-methylaniline 100-61-8 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 CLP00/
612-016-00-0 N,N-dimethylaniline 121-69-7 Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H351, H331, H311, H301, H411 CLP00/
612-017-00-6 N-methyl-N-2,4,6-tetranitroaniline; tetryl 479-45-8 Expl. 1.1, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 H201, H331, H311, H301, H373** CLP00/ATP01
612-018-00-1 bis(2,4,6-trinitrophenyl)amine; hexyl 131-73-7 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2, Aquatic Chronic 2 H201, H330, H310, H300, H373**, H411 CLP00/ATP01
612-019-00-7 dipicrylamine, ammonium salt 2844-92-0 Expl. 1.1, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2, Aquatic Chronic 2 H201, H330, H310, H300, H373**, H411 CLP00/ATP01
612-020-00-2 1-naphthylamine 134-32-7 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
612-022-00-3 2-naphthylamine 91-59-8 Carc. 1A, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 Carc. 1A; H350: C ≥ 0,01 % CLP00/
612-023-00-9 phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] phenylhydrazinium sulphate (2:1) [4] 100-63-0 [1], 59-88-1 [2], 27140-08-5 [3], 52033-74-6 [4] Carc. 1B, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H350, H341, H331, H311, H301, H372 **, H319, H315, H317, H400 CLP00/
612-024-00-4 m-toluidine; 3-aminotoluene 108-44-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1 H331, H311, H301, H373 **, H400 CLP00/
612-025-00-X nitrotoluidines, with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H331, H311, H301, H373 **, H411 C CLP00/
612-026-00-5 diphenylamine 122-39-4 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H373 **, H400, H410 CLP00/
612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex; dimethyl anilines with the exception of those specified elsewhere in this Annex - Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H331, H311, H301, H373 **, H411 C CLP00/
612-028-00-6 p-phenylenediamine 106-50-3 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H319, H317, H400, H410 CLP00/
612-029-00-1 benzene-1,4-diamine dihydrochloride; p-phenylenediamine dihydrochloride 624-18-0 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H319, H317, H400, H410 CLP00/
612-030-00-7 2-methyl-p-phenylenediamine sulphate [1] 615-50-9 [1], 6369-59-1 [2] Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H301, H332, H312, H317, H411 CLP00/
612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1] 4-amino-N,N-dimethylaniline; 3-amino-N,N'-dimethylaniline [2] 2836-04-6 [1], 99-98-9 [2] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H331, H311, H301 C CLP00/
612-032-00-8 N,N,N',N'-tetramethyl-p-phenylenediamine 100-22-1 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 CLP00/
612-033-00-3 2-aminophenol 95-55-6 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 * H341, H332, H302 CLP00/
612-034-00-9 2-amino-4,6-dinitrophenol; picramic acid 96-91-3 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H201, H332, H312, H302, H412 CLP00/ATP01
612-034-01-6 2-amino-4,6-dinitrophenol; picramic acid; [ 20 % water] 96-91-3 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H332, H312, H302, H412 G CLP00/
612-035-00-4 2-methoxyaniline; o-anisidine 90-04-0 Carc. 1B, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 * H350, H341, H331, H311, H301 CLP00/
612-036-00-X 3,3'-dimethoxybenzidine; o-dianisidine 119-90-4 Carc. 1B, Acute Tox. 4 * H350, H302 CLP00/
612-037-00-5 salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine - Carc. 1B, Acute Tox. 4 * H350, H302 A CLP00/
612-038-00-0 2-nitro-p-anisidine; 4-methoxy-2-nitroaniline 96-96-8 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 3 H330, H310, H300, H373 **, H412 CLP00/
612-039-00-6 2-ethoxyaniline; o-phenetidine 94-70-2 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 * H331, H311, H301, H373 ** CLP00/
612-040-00-1 2,4-dinitroaniline 97-02-9 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Chronic 2 H330, H310, H300, H373 **, H411 CLP00/
612-041-00-7 4,4'-bi-o-toluidine 119-93-7 Carc. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 CLP00/
612-042-00-2 benzidine; 1,1'-biphenyl-4,4'-diamine; 4,4'-diaminobiphenyl; biphenyl-4,4'-ylenediamine 92-87-5 Carc. 1A, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 Carc. 1A; H350: C ≥ 0,01 % CLP00/
612-043-00-8 N,N'-dimethylbenzidine 2810-74-4 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H332, H312, H302 CLP00/
612-044-00-3 N,N'-diacetylbenzidine 613-35-4 Carc. 1B, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H350, H341, H332, H312, H302 CLP00/ATP01
612-046-00-4 allylamine 107-11-9 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H225, H331, H311, H301, H411 CLP00/
612-047-00-X benzylamine 100-46-9 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 CLP00/
612-048-00-5 dipropylamine 142-84-7 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H225, H332, H312, H302, H314 STOT SE 3; H335: C ≥ 1 % CLP00/
612-049-00-0 di-n-butylamine; [1] di-sec-butylamine [2] 111-92-2 [1], 626-23-3 [2] Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H226, H332, H312, H302 CLP00/
612-050-00-6 cyclohexylamine 108-91-8 Flam. Liq. 3, Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H226, H361f***, H312, H302, H314 CLP00/ATP01
612-051-00-1 4,4'-diaminodiphenylmethane; 4,4'-methylenedianiline 101-77-9 Carc. 1B, Muta. 2, STOT SE 1, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H350, H341, H370 **, H373 **, H317, H411 CLP00/
612-052-00-7 (S)-sec-butylamine; (S)-2-aminobutane; [1] (R)-sec-butylamine; (R)-2-aminobutane; [2] sec-butylamine; 2-aminobutane [3] 513-49-5 [1], 13250-12-9 [2], 13952-84-6 [3] Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A, Aquatic Acute 1 H225, H332, H302, H314, H400 C CLP00/
612-053-00-2 N-ethylaniline 103-69-5 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 * H331, H311, H301, H373 ** CLP00/
612-054-00-8 N,N-diethylaniline 91-66-7 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 2 H331, H311, H301, H373 **, H411 * CLP00/
612-055-00-3 N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3] 611-21-2 [1], 696-44-6 [2], 623-08-5 [3] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H331, H311, H301, H373 **, H412 C CLP00/
612-056-00-9 N,N-dimethyl-p-toluidine; [1] N,N-dimethyl-m-toluidine; [2] N,N-dimethyl-o-toluidine [3] 99-97-8 [1], 121-72-2 [2], 609-72-3 [3] Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Aquatic Chronic 3 H331, H311, H301, H373 **, H412 * C CLP00/
612-057-00-4 piperazine; [solid] 110-85-0 Repr. 2, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1 H361fd, H314, H334, H317 CLP00/ATP01
612-057-01-1 piperazine; [liquid] 110-85-0 Repr. 2, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1 H361fd, H314, H334, H317 ATP01/
612-058-00-X 2,2'-iminodiethylamine; diethylenetriamine 111-40-0 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H312, H302, H314, H317 CLP00/
612-059-00-5 3,6-diazaoctanethylenediamin; triethylenetetramine 112-24-3 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H312, H314, H317, H412 CLP00/
612-060-00-0 3,6,9-triazaundecamethylenediamine; tetraethylenepentamine 112-57-2 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H312, H302, H314, H317, H411 CLP00/
612-061-00-6 3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane 109-55-7 Flam. Liq. 3, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H226, H302, H314, H317 CLP00/
612-062-00-1 3-aminopropyldiethylamine; N,N-diethyl-1,3-diaminopropane 104-78-9 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H226, H312, H302, H314, H317 CLP00/
612-063-00-7 3,3'-iminodi(propylamine); dipropylenetriamine 56-18-8 Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1A, Skin Sens. 1 H330, H311, H302, H314, H317 CLP00/
612-064-00-2 3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine 4067-16-7 Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 CLP00/
612-065-00-8 polyethlyenepolyamines with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H314, H317, H400, H410 CLP00/
612-066-00-3 dicyclohexylamine 101-83-7 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H400, H410 CLP00/
612-067-00-9 3-aminomethyl-3,5,5-trimethylcyclohexylamine 2855-13-2 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H312, H302, H314, H317, H412 CLP00/
612-068-00-4 3,3'-dichlorobenzidine; 3,3'-dichlorobiphenyl-4,4'-ylenediamine 91-94-1 Carc. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H312, H317, H400, H410 CLP00/
612-069-00-X salts of 3,3'-dichlorobenzidine; salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine - Carc. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H312, H317, H400, H410 A CLP00/
612-070-00-5 salts of benzidine 531-85-1, 531-86-2, 21136-70-9, 36341-27-2 Carc. 1A, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 A CLP00/
612-071-00-0 salts of 2-naphthylamine 553-00-4, 612-52-2 Carc. 1A, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 A CLP00/
612-072-00-6 biphenyl-4-ylamine; xenylamine; 4-aminobiphenyl 92-67-1 Carc. 1A, Acute Tox. 4 * H350, H302 CLP00/
612-073-00-1 salts of biphenyl-4-ylamine; salts of xenylamine; salts of 4-aminobiphenyl - Carc. 1A, Acute Tox. 4 * H350, H302 A CLP00/
612-074-00-7 benzyldimethylamine 103-83-3 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 3 H226, H332, H312, H302, H314, H412 CLP00/
612-075-00-2 2-aminoethyldimethylamine; 2-dimethylaminoethylamine 108-00-9 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H225, H312, H302, H314 CLP00/
612-076-00-8 ethyldimethylamine 598-56-1 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H225, H332, H302, H314 CLP00/ATP01
612-077-00-3 dimethylnitrosoamine; N-nitrosodimethylamine 62-75-9 Carc. 1B, Acute Tox. 2 *, Acute Tox. 3 *, STOT RE 1, Aquatic Chronic 2 H350, H330, H301, H372 **, H411 Carc. 1B; H350: C ≥ 0,001 % CLP00/
612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline; 4,4'-methylene bis(2-chloroaniline) 101-14-4 Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 CLP00/
612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline; salts of 4,4'-methylenebis(2-chloroaniline) - Carc. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H400, H410 A CLP00/
612-080-00-X 4-amino-N,N-diethylaniline; N,N-diethyl-p-phenylendiamine 93-05-0 Acute Tox. 3 *, Skin Corr. 1B H301, H314 CLP00/
612-081-00-5 salts of 4,4'-bi-o-toluidine; salts of 3,3'-dimethylbenzidine; salts of o-tolidine 612-82-8, 64969-36-4, 74753-18-7 Carc. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 A CLP00/
612-082-00-0 thiourea; thiocarbamide 62-56-6 Carc. 2, Repr. 2, Acute Tox. 4 *, Aquatic Chronic 2 H351, H361d ***, H302, H411 CLP00/
612-083-00-6 1-methyl-3-nitro-1-nitrosoguanidine 70-25-7 Carc. 1B, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H350, H332, H319, H315, H411 Carc. 1B; H350: C ≥ 0,01 % CLP00/ATP01
612-084-00-1 dapsone; 4,4'-diamino diphenyl sulfone 80-08-0 Acute Tox. 4 * H302 CLP00/
612-085-00-7 4,4'-methylenedi-o-toluidine 838-88-0 Carc. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H317, H400, H410 CLP00/
612-086-00-2 amitraz (ISO); N,N-bis(2,4-xylyliminomethyl) methylamine 33089-61-1 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373 **, H317, H400, H410 M = 10: CLP00/
612-087-00-8 guazatine (ISO) 108173-90-6 Acute Tox. 2 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H312, H302, H335, H315, H318, H400, H410 CLP00/
612-088-00-3 simazine (ISO); 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 122-34-9 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
612-089-00-9 1,5-naphthylenediamine 2243-62-1 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
612-090-00-4 2,2'-(nitrosoimino)bisethanol 1116-54-7 Carc. 1B H350 CLP00/
612-091-00-X o-toluidine; 2-aminotoluene 95-53-4 Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Aquatic Acute 1 H350, H331, H301, H319, H400 CLP00/
612-092-00-5 N,N'-(2,2-dimethylpropylidene)hexamethylenediamine 1000-78-8 Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
612-093-00-0 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline 104147-32-2 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
612-094-00-6 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride 113674-95-6 STOT RE 1, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H372**, H302, H373**, H318, H317, H400, H410 CLP00/ATP01
612-095-00-1 benzyl-2-hydroxydodecyldimethylammonium benzoate 113694-52-3 Skin Corr. 1B, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H314, H302, H400, H410 CLP00/
612-096-00-7 4,4'-carbonimidoylbis[N,N-dimethylaniline] 492-80-8 Carc. 2, Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 2 H351, H302, H319, H411 CLP00/
612-097-00-2 salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] - Carc. 2, Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 2 H351, H302, H319, H411 A CLP00/
612-098-00-8 nitrosodipropylamine 621-64-7 Carc. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 Carc. 1B; H350: C ≥ 0,001 % CLP00/ATP01
612-099-00-3 4-methyl-m-phenylenediamine; 2,4-toluenediamine 95-80-7 Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H350, H341, H361f***, H301, H312, H373**, H317, H411 CLP00/ATP01
612-100-00-7 propylenediamine 78-90-0 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1A H226, H312, H302, H314 CLP00/
612-101-00-2 methenamine; hexamethylenetetramine 100-97-0 Flam. Sol. 2, Skin Sens. 1 H228, H317 CLP00/ATP01
612-102-00-8 N,N-bis(3-aminopropyl)methylamine 105-83-9 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B H331, H311, H302, H314 CLP00/
612-103-00-3 N,N,N',N'-tetramethylethylenediamine 110-18-9 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H225, H332, H302, H314 CLP00/
612-104-00-9 hexamethylenediamine 124-09-4 Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Corr. 1B H312, H302, H335, H314 CLP00/
612-105-00-4 2-piperazin-1-ylethylamine 140-31-8 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H312, H302, H314, H317, H412 CLP00/
612-106-00-X 2,6-diethylaniline 579-66-8 Acute Tox. 4 * H302 CLP00/
612-107-00-5 1-phenylethylamine; [1] Dl- -methylbenzylamine [2] 98-84-0 [1], 618-36-0 [2] Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 CLP00/
612-108-00-0 3-aminopropyltriethoxysilane 919-30-2 Acute Tox. 4 *, Skin Corr. 1B H302, H314 CLP00/
612-109-00-6 bis(2-dimethylaminoethyl)(methyl)amine 3030-47-5 Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B H311, H302, H314 CLP00/
612-110-00-1 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) 6864-37-5 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1A, Aquatic Chronic 2 H331, H311, H302, H314, H411 CLP00/
612-111-00-7 2-methyl-m-phenylenediamine; 2,6-toluenediamine 823-40-5 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H341, H312, H302, H317, H411 CLP00/
612-112-00-2 p-anisidine; 4-methoxyaniline 104-94-9 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, STOT RE 2 *, Aquatic Acute 1 H330, H310, H300, H373 **, H400 CLP00/
612-113-00-8 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine 106264-79-3 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
612-114-00-3 R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate - Flam. Sol. 1, Skin Sens. 1, Aquatic Chronic 3 H228, H317, H412 CLP00/
612-115-00-9 dimethyldioctadecylammonium hydrogen sulfate 123312-54-9 Eye Irrit. 2, Aquatic Chronic 4 H319, H413 CLP00/
612-116-00-4 C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate 68132-19-4 Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H314, H317, H400, H410 CLP00/
612-117-00-X C12-14-tert-alkylamine, methylphosphonic acid salt 119415-07-5 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H302, H314, H411 CLP00/
612-118-00-5 A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
612-119-00-0 benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate - Skin Irrit. 2, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H400, H410 CLP00/
612-120-00-6 aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline 74070-46-5 Carc. 2, Skin Sens. 1A, Aquatic Acute 1, Aquatic Chronic 1 H351, H317, H400, H410 M=100, M=10 CLP00/ATP05
612-121-00-1 amines, polyethylenepoly-; HEPA 68131-73-7 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H314, H317, H400, H410 CLP00/
612-122-00-7 hydroxylamine ....% [> 55 % in aqueous solution] 7803-49-8 Unst. Expl., Met. Corr. 1, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H200, H290, H351, H312, H302, H373**, H335, H315, H318, H317, H400 B CLP00/ATP01
612-122-01-4 hydroxylamine ...% [ 55% in aqueous solution] 7803-49-8 Met. Corr. 1, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H290, H351, H312, H302, H373**, H335, H315, H318, H317, H400 B ATP01/
612-123-00-2 hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; hydroxylamine sulfate (2:1) [2] 5470-11-1 [1], 10039-54-0 [2] Met. Corr. 1, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H290, H351, H312, H302, H373**, H319, H315, H317, H400 CLP00/ATP01
612-124-00-8 N,N,N-trimethylanilinium chloride 138-24-9 Acute Tox. 3 *, Acute Tox. 3 * H311, H301 CLP00/
612-125-00-3 2-methyl-p-phenylenediamine; 2,5-toluenediamine 95-70-5 Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H301, H332, H312, H317, H411 CLP00/
612-126-00-9 toluene-2,4-diammonium sulphate; 4-methyl-m-phenylenediamine sulfate 65321-67-7 Carc. 1B, Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H350, H301, H312, H319, H317, H411 CLP00/
612-127-00-4 3-aminophenol 591-27-5 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H332, H302, H411 CLP00/
612-128-00-X 4-aminophenol 123-30-8 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H341, H332, H302, H400, H410 CLP00/
612-129-00-5 diisopropylamine 108-18-9 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H225, H332, H302, H314 STOT SE 3; H335: C ≥ 5 % CLP00/
612-130-00-0 2,6-diamino-3,5-diethyltoluene; 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] 2,4-diamino-3,5-diethyltoluene; 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] 2095-01-4 [1], 2095-02-5 [2], 68479-98-1 [3] Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373 **, H319, H400, H410 C CLP00/
612-131-00-6 didecyldimethylammonium chloride 7173-51-5 Acute Tox. 4 *, Skin Corr. 1B H302, H314 CLP00/
612-132-00-1 N,N'-diphenyl-p-phenylenediamine; N,N'-diphenyl-1,4-benzenediamine 74-31-7 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 25646-77-9 Acute Tox. 3 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H373 **, H317, H400, H410 CLP00/
612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 25646-71-3 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
612-135-00-8 N-2-naphthylaniline; N-phenyl-2-naphthylamine 135-88-6 Carc. 2, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H351, H319, H315, H317, H411 CLP00/
612-136-00-3 N-isopropyl-N'-phenyl-p-phenylenediamine 101-72-4 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 Skin Sens. 1; H317: C ≥ 0,1 % CLP00/
612-137-00-9 4-chloroaniline 106-47-8 Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H331, H311, H301, H317, H400, H410 CLP00/
612-138-00-4 furalaxyl (ISO); methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate 57646-30-7 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
612-139-00-X mefenacet (ISO); 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 73250-68-7 Aquatic Chronic 2 H411 CLP00/
612-140-00-5 quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides 63449-41-2 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1 H312, H302, H314, H400 CLP00/
612-141-00-0 4,4'-methylenebis(2-ethylaniline); 4,4'-methylenebis(2-ethylbenzeneamine) 19900-65-3 Carc. 2, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H400, H410 CLP00/
612-142-00-6 biphenyl-2-ylamine 90-41-5 Carc. 2, Acute Tox. 4 *, Aquatic Chronic 3 H351, H302, H412 CLP00/
612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride 2051-79-8 Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H319, H317, H400, H410 CLP00/
612-144-00-7 flumetralin (ISO); N-(2-chloro-6-fluorobenzyl)-N-ethyl- , , -trifluoro-2,6-dinitro-p-toluidine 62924-70-3 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H317, H400, H410 CLP00/
612-145-00-2 o-phenylenediamine 95-54-5 Carc. 2, Muta. 2, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H341, H301, H332, H312, H319, H317, H400, H410 CLP00/
612-146-00-8 o-phenylenediamine dihydrochloride 615-28-1 Carc. 2, Muta. 2, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H341, H301, H332, H312, H319, H317, H400, H410 CLP00/
612-147-00-3 m-phenylenediamine 108-45-2 Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H331, H311, H301, H319, H317, H400, H410 CLP00/
612-148-00-9 m-phenylenediamine dihydrochloride 541-69-5 Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H331, H311, H301, H319, H317, H400, H410 CLP00/
612-149-00-4 1,3-diphenylguanidine 102-06-7 Repr. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H361f ***, H302, H319, H335, H315, H411 CLP00/
612-150-00-X spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine 118134-30-8 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H315, H317, H400, H410 CLP00/
612-151-00-5 methyl-phenylene diamine; diaminotoluene; [technical product reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] - Carc. 1B, Muta. 2, Repr. 2, Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H350, H341, H361f***, H301, H312, H373**, H319, H317, H411 CLP00/ATP01
612-152-00-0 N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine 62478-82-4 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1A, Aquatic Chronic 3 H226, H332, H302, H373 **, H314, H412 CLP00/
612-153-00-6 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride 132885-85-9 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 CLP00/
612-154-00-1 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] 95235-29-3 Aquatic Chronic 4 H413 CLP00/
612-155-00-7 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene 93071-94-4 Aquatic Chronic 4 H413 CLP00/
612-156-00-2 reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
612-157-00-8 (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride - Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H373 **, H318, H317, H411 CLP00/
612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; 4-dodecylsalicylaldoxime - Aquatic Chronic 4 H413 CLP00/
612-159-00-9 Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid - Acute Tox. 4 *, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H400, H410 CLP00/
612-160-00-4 p-toluidine; 4-aminotoluene; [1] toluidinium chloride; [2] toluidine sulphate (1:1) [3] 106-49-0 [1], 540-23-8 [2], 540-25-0 [3] Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H351, H331, H311, H301, H319, H317, H400 CLP00/
612-161-00-X 2,6-xylidine; 2,6-dimethylaniline 87-62-7 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 2 H351, H332, H312, H302, H335, H315, H411 CLP00/
612-162-00-5 dimethyldioctadecylammonium chloride; DODMAC 107-64-2 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
612-163-00-0 metalaxyl-M (ISO); mefenoxam; (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester 70630-17-0 Acute Tox. 4 *, Eye Dam. 1 H302, H318 CLP00/
612-164-00-6 2-butyl-2-ethyl-1,5-diaminopentane 137605-95-9 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H312, H302, H373 **, H314, H317, H412 CLP00/
612-165-00-1 N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine 65181-78-4 Aquatic Chronic 2 H411 CLP00/
612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 114765-88-7 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 CLP00/
612-167-00-2 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride - Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H373 **, H318, H317, H411 CLP00/
612-168-00-8 3,5-dichloro-2,6-difluoropyrdine-4-amine 2840-00-8 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H312, H302, H411 CLP00/
612-169-00-3 bis(N-methyl-N-phenylhydrazine)sulfate 618-26-8 Flam. Liq. 2, STOT RE 1, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H225, H372**, H302, H318, H317, H400, H410 ATP01/
612-170-00-9 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime - Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
612-171-00-4 N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane 130728-76-6 Muta. 2, Skin Sens. 1, Aquatic Chronic 2 H341, H317, H411 CLP00/
612-172-00-X 4,4'-methylenebis(N,N'-dimethylcyclohexanamine 13474-64-1 Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1A, Aquatic Chronic 3 H302, H373 **, H314, H412 CLP00/
612-173-00-5 lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate 125328-86-1 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
612-174-00-0 4,4-dimethoxybutylamine 19060-15-2 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 3 H302, H314, H317, H412 CLP00/
612-175-00-6 2-(O-aminooxy)ethylamine dihydrochloride 37866-45-8 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
612-176-00-1 Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine 143747-73-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
612-177-00-7 2-naphthylamino-6-sulfomethylamide 104295-55-8 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H373 **, H317, H411 CLP00/
612-178-00-2 1,4,7,10-tetraazacyclododecane disulfate 112193-77-8 Acute Tox. 4 *, STOT SE 3, Eye Dam. 1, Aquatic Chronic 3 H302, H335, H318, H412 CLP00/
612-179-00-8 1-(2-propenyl)pyridinium chloride 25965-81-5 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
612-180-00-3 3-aminobenzylamine 4403-70-7 Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 2 H302, H314, H411 CLP00/
612-181-00-9 2-phenylthioaniline 1134-94-7 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
612-182-00-4 1-ethyl-1-methylmorpholinium bromide 65756-41-4 Muta. 2 H341 CLP00/
612-183-00-X 1-ethyl-1-methylpyrrolidinium bromide 69227-51-6 Muta. 2 H341 CLP00/
612-184-00-5 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one 89331-94-2 Aquatic Chronic 3 H412 CLP00/
612-185-00-0 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide 59493-72-0 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
612-186-00-6 bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate 149057-64-7 STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H318, H317, H400, H410 CLP00/
612-187-00-1 2,3,4-trifluoroaniline 3862-73-5 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H312, H302, H373 **, H315, H318, H411 CLP00/
612-188-00-7 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) 107934-68-9 Aquatic Chronic 2 H411 CLP00/
612-189-00-2 4-amino-2-(aminomethyl)phenol dihydrochloride 135043-64-0 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
612-190-00-8 4,4'-methylenebis(2-isopropyl-6-methylaniline) 16298-38-7 STOT RE 2 *, Aquatic Chronic 2 H373 **, H411 CLP00/
612-191-00-3 Polymer of allylamine hydrochloride 71550-12-4 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
612-192-00-9 2-isopropyl-4-(N-methyl)aminomethylthiazole 154212-60-9 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 2 H312, H302, H315, H318, H411 CLP00/
612-193-00-4 3-methylaminomethylphenylamine 18759-96-1 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H314, H317, H400, H410 CLP00/
612-194-00-X 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride 141890-30-4 Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H318, H400, H410 CLP00/
612-195-00-5 bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate 160236-81-7 Acute Tox. 4 *, Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H318, H400, H410 CLP00/
612-196-00-0 4-chloro-o-toluidine; [1] 4-chloro-o-toluidine hydrochloride [2] 95-69-2 [1], 3165-93-3 [2] Carc. 1B, Muta. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H350, H341, H331, H311, H301, H400, H410 CLP00/
612-197-00-6 2,4,5-trimethylaniline; [1] 2,4,5-trimethylaniline hydrochloride [2] 137-17-7 [1], 21436-97-5 [2] Carc. 1B, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H350, H331, H311, H301, H411 CLP00/
612-198-00-1 4,4'-thiodianiline and its salts 139-65-1 Carc. 1B, Acute Tox. 4 *, Aquatic Chronic 2 H350, H302, H411 CLP00/
612-199-00-7 4,4'-oxydianiline and its salts; p-aminophenyl ether 101-80-4 Carc. 1B, Muta. 1B, Repr. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 2 H350, H340, H361f ***, H331, H311, H301, H411 CLP00/
612-200-00-0 2,4-diaminoanisole; 4-methoxy-m-phenylenediamine; [1] 2,4-diaminoanisole sulphate [2] 615-05-4 [1], 39156-41-7 [2] Carc. 1B, Muta. 2, Acute Tox. 4 *, Aquatic Chronic 2 H350, H341, H302, H411 CLP00/
612-201-00-6 N,N,N',N'-tetramethyl-4,4'-methylendianiline 101-61-1 Carc. 1B, Aquatic Acute 1, Aquatic Chronic 1 H350, H400, H410 CLP00/
612-202-00-1 3,4-dichloroaniline 95-76-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H318, H317, H400, H410 CLP00/
612-203-00-7 C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3%, chain = C8: 15%-70%, chain = C10: 30%-85%, chain > C10: <3%) - Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2 H312, H302, H315 ATP01/
612-204-00-2 C.I. Basic Violet 3; 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 548-62-9 Carc. 2, Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H318, H400, H410 CLP00/
612-205-00-8 C.I. Basic Violet 3 with 0.1 % of Michler's ketone (EC no. 202-027-5) 548-62-9 Carc. 1B, Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H302, H318, H400, H410 CLP00/
612-206-00-3 famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione 131807-57-3 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H400, H410 CLP00/
612-207-00-9 4-ethoxyaniline; p-phenetidine 156-43-4 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H341, H332, H312, H302, H319, H317 CLP00/
612-208-00-4 N-methylbenzene-1,2-diammonium hydrogen phosphate - Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
612-209-00-X 6-methoxy-m-toluidine; p-cresidine 120-71-8 Carc. 1B, Acute Tox. 4 * H350, H302 CLP00/
612-210-00-5 5-nitro-o-toluidine; [1] 5-nitro-o-toluidine hydrochloride [2] 99-55-8 [1], 51085-52-0 [2] Carc. 2, Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Aquatic Chronic 3 H351, H331, H311, H301, H412 CLP00/
612-211-00-0 N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide 170292-97-4 Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
612-212-00-6 2,6-dichloro-4-trifluoromethylaniline 24279-39-8 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H315, H317, H400, H410 CLP00/
612-213-00-1 isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine 148348-13-4 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 CLP00/
612-214-00-7 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine 89114-90-9 Aquatic Chronic 4 H413 CLP00/
612-215-00-2 3-chloro-2-(isopropylthio)aniline 179104-32-6 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
612-216-00-8 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt 19450-38-5 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
612-217-00-3 1-methoxy-2-propylamine 37143-54-7 Flam. Liq. 2, Skin Corr. 1B, Acute Tox. 4 *, Aquatic Chronic 3 H225, H314, H302, H412 CLP00/
612-219-00-4 (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride - Aquatic Chronic 3 H412 ATP01/
612-220-00-X N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine 153719-38-1 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 ATP01/
612-221-00-5 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride 4274-38-8 Skin Corr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1 H314, H332, H312, H302, H373**, H317, H400 ATP01/
612-222-00-0 cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine 104860-26-6 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H373**, H318, H400, H410 ATP01/
612-223-00-6 N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine 186450-73-7 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
612-224-00-1 N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine 121246-28-4 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
612-225-00-7 1,4,7,10-tetraazacyclododecane 294-90-6 Skin Corr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H314, H312, H302, H400, H410 ATP01/
612-226-00-2 3-(2'-phenoxyethoxy)propylamine 6903-18-0 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H302, H315, H318, H412 ATP01/
612-227-00-8 benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride 120606-08-8 Acute Tox. 4 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H318, H400, H410 ATP01/
612-228-00-3 reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N,N,N'-tris-b - Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT SE 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H226, H332, H312, H302, H371, H318, H317, H412 ATP01/
612-229-00-9 mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine 110235-47-7 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 ATP01/
612-230-00-4 N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide - Skin Corr. 1A, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 ATP01/
612-231-00-X 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride 164288-56-6 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
612-232-00-5 reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid 186148-38-9 Aquatic Chronic 3 H412 ATP01/
612-237-00-2 hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] 10046-00-1 [1], 20845-01-6 [2], 19098-16-9 [3], 53933-48-5 [4] Expl. 1.1, Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H201, H351, H312, H302, H373**, H319, H315, H317, H400 T ATP01/
612-238-00-8 (3-chloro-2-hydroxypropyl) trimethylammonium chloride ...% 3327-22-8 Carc. 2, Aquatic Chronic 3 H351, H412 B ATP01/
612-239-00-3 biphenyl-3,3',4,4'-tetrayltetraamine; diaminobenzidine 91-95-2 Carc. 1B, Muta. 2 H350, H341 ATP01/
612-240-00-9 pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline 53112-28-0 Aquatic Chronic 2 H411 ATP01/
612-241-00-4 piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] 6094-40-2 [1], 142-64-3 [2], 1951-97-9 [3] Repr. 2, Eye Irrit. 2, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H361fd, H319, H315, H334, H317, H412 ATP01/
612-242-00-X cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine 121552-61-2 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M=10: ATP01/
612-243-00-5 (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate 79617-97-3 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 M=10: ATP01/
612-244-00-0 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride 87691-88-1 Repr. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f***, H302, H319, H317, H400, H410 ATP01/
612-245-00-6 2-ethylphenylhydrazine hydrochloride 19398-06-2 Carc. 2, STOT RE 1, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H372**, H302, H318, H317, H400, H410 M=10: ATP01/
612-246-00-1 (2-chloroethyl)(3-hydroxypropyl)ammonium chloride 40722-80-3 Carc. 1B, Muta. 1B, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H350, H340, H373**, H317, H412 ATP01/
612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide 152828-23-4 STOT RE 1, Acute Tox. 4 *, Aquatic Chronic 3 H372**, H302, H412 ATP01/
612-248-00-2 reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) - Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 4 H315, H317, H413 ATP01/
612-249-00-8 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride 159939-85-2 Repr. 2, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H361f***, H302, H314, H317, H411 ATP01/
612-250-00-3 chloro-N,N-dimethylformiminium chloride 3724-43-4 Repr. 1B, Acute Tox. 4 *, Skin Corr. 1A H360D***, H302, H314 ATP01/
612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 51229-78-8 Flam. Sol. 2, Repr. 2, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H228, H361d***, H302, H315, H317, H411 ATP01/
612-252-00-4 imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine 138261-41-3 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 ATP01/
612-253-00-X 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0.5 % formamide (EC No 200-842-0)] 199327-61-2 Aquatic Chronic 3 H412 ATP01/
612-253-01-7 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing 0.5 % formamide (EC No 200-842-0) ] 199327-61-2 Repr. 1B, Aquatic Chronic 3 H360D***, H412 ATP01/
612-254-00-5 reaction products of diisopropanolamine with formaldehyde (1:4) 220444-73-5 Carc. 2, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H351, H302, H314, H317, H411 ATP01/
612-255-00-0 1-(3-methoxypropyl)-4-piperidinamine 179474-79-4 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B, Aquatic Chronic 3 H312, H302, H314, H412 ATP01/
612-256-00-6 benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate 137864-22-3 Acute Tox. 4 *, Skin Sens. 1 H302, H317 ATP01/
612-257-00-1 tripropylammonium dihydrogenphosphate 35687-90-2 Acute Tox. 4 * H302 ATP01/
612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine 227085-51-0 Eye Dam. 1 H318 ATP01/
612-261-00-3 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline 121451-05-6 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 M=10: ATP01/
612-265-00-5 bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate 191617-13-7 Aquatic Chronic 3 H412 ATP01/
612-266-00-0 3-chloro-4-(3-fluorobenzyloxy)aniline 202197-26-0 Muta. 2, Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H341, H302, H373**, H400, H410 ATP01/
612-267-00-6 bis(hydrogenated tallow C16-18-alkyl)hydroxylamine - Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
612-269-00-7 reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benz - Aquatic Chronic 4 H413 ATP01/
612-270-00-2 (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride - Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H302, H317, H412 ATP01/
612-271-00-8 reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate 160987-57-5 Aquatic Chronic 4 H413 ATP01/
612-272-00-3 ammonium ( -6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate - Aquatic Chronic 2 H411 ATP01/
612-273-00-9 alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride - Acute Tox. 4 *, Skin Corr. 1A, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H400, H410 ATP01/
612-274-00-4 (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H318, H317, H412 ATP01/
612-275-00-X fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil 206565-89-1 Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H318, H317, H400, H410 M=10: ATP01/
612-276-00-5 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts 500717-36-2 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
612-277-00-0 reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-( 586372-44-3 Eye Dam. 1 H318 ATP01/
612-278-00-6 ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide 1239-45-8 Muta. 2, Acute Tox. 2 *, Acute Tox. 4 * H341, H330, H302 ATP01/
612-279-00-1 (R,S)-2-amino-3,3-dimethylbutane amide 144177-62-8 Repr. 2, STOT RE 2 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H361f***, H373**, H319, H315, H317 ATP01/
612-280-00-7 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine 132-32-1 Carc. 1B H350 CLP00/ATP02
613-001-00-1 ethyleneimine; aziridine 151-56-4 Flam. Liq. 2, Carc. 1B, Muta. 1B, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Skin Corr. 1B, Aquatic Chronic 2 H225, H350, H340, H330, H310, H300, H314, H411 D CLP00/
613-002-00-7 pyridine 110-86-1 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H225, H332, H312, H302 * CLP00/
613-003-00-2 1,2,3,4-tetranitrocarbazole 6202-15-9 Expl. 1.1, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 * H201, H332, H312, H302 CLP00/ATP01
613-004-00-8 crimidine (ISO); 2-chloro-6-methylpyrimidin-4-yldimethylamine 535-89-7 Acute Tox. 2 * H300 CLP00/
613-007-00-4 desmetryne (ISO); 6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine 1014-69-3 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
613-008-00-X dazomet (ISO); tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione 533-74-4 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H400, H410 CLP00/
613-009-00-5 2,4,6-trichloro-1,3,5-triazine; cyanuric chloride 108-77-0 Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1 H330, H302, H314, H317 STOT SE 3; H335: C ≥ 5 % CLP00/
613-010-00-0 ametryn (ISO); 2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine 834-12-8 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=100: CLP00/ATP01
613-011-00-6 amitrole (ISO); 1,2,4-triazol-3-ylamine 61-82-5 Repr. 2, STOT RE 2 *, Aquatic Chronic 2 H361d ***, H373 **, H411 CLP00/
613-012-00-1 bentazone (ISO); 3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 25057-89-0 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H302, H319, H317, H412 CLP00/
613-013-00-7 cyanazine (ISO); 2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile 21725-46-2 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-014-00-2 ethoxyquin (ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline 91-53-2 Acute Tox. 4 * H302 CLP00/
613-015-00-8 fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate 14255-88-0 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
613-016-00-3 fuberidazole (ISO); 2-(2-furyl)-1H-benzimidazole 3878-19-1 Carc. 2, Acute Tox. 4, STOT RE 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H373 (Herz), H317, H400, H410, M=1 CLP00/ATP03
613-017-00-9 bis (8-hydroxyquinolinium) sulphate 134-31-6 Acute Tox. 4 * H302 CLP00/
613-018-00-4 morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion 7411-47-4 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 3 H302, H319, H335, H315, H412 CLP00/
613-019-00-X thioquinox (ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline 93-75-4 Acute Tox. 4 * H302 CLP00/
613-020-00-5 tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine 24602-86-6 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H360D ***, H332, H302, H315, H400, H410 CLP00/
613-021-00-0 dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile 3347-22-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-022-00-6 pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 A CLP00/
613-023-00-1 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1 [S*(Z)],3ß]]-chrysanthemate; pyrethrin I 121-21-1 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 CLP00/
613-024-00-7 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1 [S*(Z)](3ß)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; pyrethrin II 121-29-9 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 CLP00/
613-025-00-2 cinerin I; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 25402-06-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-026-00-8 cinerin II; 3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate 121-20-0 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-027-00-3 piperidine 110-89-4 Flam. Liq. 2, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B H225, H331, H311, H314 * CLP00/
613-028-00-9 morpholine 110-91-8 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H226, H332, H312, H302, H314 CLP00/
613-029-00-4 dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid 2782-57-2 Ox. Sol. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H272, H302, H319, H335, H400, H410 T CLP00/
613-030-00-X troclosene potassium; [1] troclosene sodium [2] 2244-21-5 [1], 2893-78-9 [2] Ox. Sol. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H272, H302, H319, H335, H400, H410 *, STOT SE 3; H335: C ≥ 10 %, EUH031: C ≥ 10 % G CLP00/ATP01
613-030-01-7 troclosene sodium, dihydrate 51580-86-0 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H335, H400, H410 CLP00/
613-031-00-5 symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion 87-90-1 Ox. Sol. 2, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Aquatic Acute 1, Aquatic Chronic 1 H272, H302, H319, H335, H400, H410 CLP00/
613-032-00-0 methyl-2,3,5,6-tetrachloro-4-pyridylsulphone; 2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine 13108-52-6 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1 H312, H302, H319, H317 CLP00/
613-033-00-6 2-methylaziridine; propyleneimine 75-55-8 Flam. Liq. 2, Carc. 1B, Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Eye Dam. 1, Aquatic Chronic 2 H225, H350, H330, H310, H300, H318, H411 Carc. 1B; H350: C ≥ 0,01 % CLP00/
613-034-00-1 1,2-dimethylimidazole 1739-84-0 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1 H302, H315, H318 CLP00/
613-035-00-7 1-methylimidazole 616-47-7 Acute Tox. 4 *, Acute Tox. 4 *, Skin Corr. 1B H312, H302, H314 CLP00/
613-036-00-2 2-methylpyridine; 2-picoline 109-06-8 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3 H226, H332, H312, H302, H319, H335 CLP00/
613-037-00-8 4-methylpyridine; 4-picoline 108-89-4 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H226, H311, H332, H302, H319, H335, H315 CLP00/
613-038-00-3 6-phenyl-1,3,5-triazine-2,4-diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine 91-76-9 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
613-039-00-9 ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol 96-45-7 Repr. 1B, Acute Tox. 4 * H360D ***, H302 CLP00/
613-040-00-4 azaconazole (ISO); 1-{}{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}}-1H-1,2.4-triazole 60207-31-0 Acute Tox. 4 * H302 CLP00/
613-041-00-X morpholine-4-carbonyl chloride 15159-40-7 Carc. 2, Eye Irrit. 2, Skin Irrit. 2 H351, H319, H315 CLP00/
613-042-00-5 imazalil (ISO); 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 35554-44-0 Carc. 2, Acute Tox. 3, Acute Tox. 4, Eye Dam. 1, Aquatic Chronic 1 H315, H301, H332, H318, H410 M=10 CLP00/ATP07
613-043-00-0 imazalil sulphate (ISO) powder; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 58594-72-2 [1], 83918-57-4 [2] Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
613-043-01-8 imazalil sulphate (ISO), aqueous solution; 1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 58594-72-2 [1], 83918-57-4 [2] Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H317, H400, H410 Skin Corr. 1B; H314: C ≥ 50 %, Skin Irrit. 2; H315: 30 % ≤ C < 50 %, Eye Dam. 1; H318: 15 % ≤ C < 50 %, Eye Irrit. 2; H319: 5 % ≤ C < 15 % CLP00/
613-044-00-6 captan (ISO); 1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide 133-06-2 Carc. 2, Acute Tox. 3 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H351, H331, H318, H317, H400 M=10: CLP00/ATP01
613-045-00-1 folpet (ISO); N-(trichloromethylthio)phthalimide 133-07-3 Carc. 2, Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H351, H332, H319, H317, H400 M=10: CLP00/ATP01
613-046-00-7 captafol (ISO); 1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide 2425-06-1 Carc. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H350, H317, H400, H410 CLP00/
613-047-00-2 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate; dimetilan (ISO) 644-64-4 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 CLP00/
613-048-00-8 carbendazim (ISO); methyl benzimidazol-2-ylcarbamate 10605-21-7 Muta. 1B, Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H340, H360FD, H400, H410 CLP00/
613-049-00-3 benomyl (ISO); methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate 17804-35-2 Muta. 1B, Repr. 1B, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H340, H360FD, H335, H315, H317, H400, H410 M = 10: CLP00/
613-050-00-9 carbadox (INN); methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide 6804-07-5 Flam. Sol. 1, Carc. 1B, Acute Tox. 4 * H228, H350, H302 T CLP00/
613-051-00-4 molinate (ISO); S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate 2212-67-1 Carc. 2, Repr. 2, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H361f ***, H332, H302, H373 **, H317, H400, H410 M = 100: CLP00/
613-052-00-X trifenmorph (ISO); 4-tritylmorpholine 1420-06-0 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-053-00-5 anilazine (ISO); 2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline 101-05-3 Eye Irrit. 2, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H315, H400, H410 CLP00/
613-054-00-0 thiabendazol (ISO); 2-(thiazole-4-yl)benzimidazole 148-79-8 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-056-00-1 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate; difenzoquat methyl sulfate 43222-48-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-057-00-7 dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine 1593-77-7 Repr. 2, STOT RE 2, Skin Corr. 1C, Skin Sens. 1A, Aquatic Acute 1, Aquatic Chronic 1 H361d, H373 (liver), H314, H317, H400, H410 M=1 , M=1 CLP00/ATP07
613-058-00-2 permethrin (ISO); m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 52645-53-1 Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H317, H400, H410 M = 1000: CLP00/
613-059-00-8 profluralin (ISO); N-(cyclopropylmethyl)- , , -trifluoro-2,6-dinitro-N-propyl-p-toluidine 26399-36-0 Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H400, H410 CLP00/
613-060-00-3 resmethrin (ISO); 5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate 10453-86-8 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=1000: CLP00/ATP01
613-061-00-9 6-(1 ,5aß,8aß,9-pentahydroxy-7ß-isopropyl-2ß,5ß,8ß-trimethylperhydro-8b ,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania 15662-33-6 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
613-062-00-4 sabadilla (ISO); veratrine 8051-02-3 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H319, H335, H315 CLP00/
613-063-00-X secbumeton (ISO); 2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 26259-45-0 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H400, H410 CLP00/
613-064-00-5 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane; sesamex 51-14-9 Acute Tox. 4 * H302 CLP00/
613-065-00-0 simetryn (ISO); 2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine 1014-70-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-066-00-6 terbumeton (ISO); 2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 33693-04-8 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-067-00-1 propazine (ISO); 2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine 139-40-2 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
613-068-00-7 atrazine (ISO); 2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine 1912-24-9 STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H317, H400, H410 CLP00/
613-069-00-2 -caprolactam 105-60-2 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2 H332, H302, H319, H335, H315 CLP00/
613-070-00-8 propylenethiourea 2122-19-2 Repr. 2, Acute Tox. 4 *, Aquatic Chronic 3 H361d ***, H302, H412 CLP00/
613-071-00-3 2-fluoro-5-trifluoromethylpyridine 69045-82-5 Flam. Liq. 3, Skin Sens. 1, Aquatic Chronic 3 H226, H317, H412 CLP00/
613-072-00-9 N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine 91273-04-0 Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H314, H317, H411 CLP00/
613-073-00-4 N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine 10357-99-0 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H373 **, H317, H411 CLP00/
613-074-00-X 3-(3-methylpent-3-yl)isoxazol-5-ylamine 82560-06-3 Acute Tox. 3 *, Acute Tox. 3 *, Eye Dam. 1, Aquatic Chronic 3 H331, H301, H318, H412 CLP00/
613-075-00-5 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 89415-87-2 Ox. Sol. 1 ****, Acute Tox. 3 *, Skin Corr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1 H271, H331, H314, H302, H317, H400 CLP00/
613-076-00-0 3-chloro-5-trifluoromethyl-2-pyridylamine 79456-26-1 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
613-077-00-6 reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine - Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 2 H302, H319, H411 CLP00/
613-078-00-1 N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine 106990-43-6 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-079-00-7 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers - Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H315, H317, H400, H410 CLP00/
613-080-00-2 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione 105254-85-1 Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 CLP00/
613-081-00-8 1-butyl-2-methylpyridinium bromide 26576-84-1 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
613-082-00-3 2-methyl-1-pentylpyridinium bromide - Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H312, H302, H412 CLP00/
613-083-00-9 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate - Skin Corr. 1B, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H373 **, H317, H400, H410 CLP00/
613-084-00-4 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate 106359-93-7 Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H400, H410 CLP00/
613-085-00-X reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione - Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-086-00-5 caffeine 58-08-2 Acute Tox. 4 * H302 CLP00/
613-087-00-0 tetrahydrothiophene 110-01-0 Flam. Liq. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H225, H332, H312, H302, H319, H315, H412 CLP00/
613-088-00-6 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one 2634-33-5 Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1 H302, H315, H318, H317, H400 Skin Sens. 1; H317: C ≥ 0,05 % CLP00/
613-089-00-1 diquat dibromide; [1] diquat dichloride; [2] 6,7-dihydrodipyrido[1,2- :2',1'-c]pyrazinediylium dihydroxide [3] 85-00-7 [1], 4032-26-2 [2], 94021-76-8 [3] Acute Tox. 2 *, STOT RE 1, Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H372 **, H302, H319, H335, H315, H317, H400, H410 CLP00/
613-090-00-7 paraquat dichloride; 1,1-dimethyl-4,4'-bipyridinium dichloride; [1] paraquat dimethylsulfate; 1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 1910-42-5 [1], 2074-50-2 [2] Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H330, H311, H301, H372 **, H319, H335, H315, H400, H410 CLP00/
613-091-00-2 morfamquat dichloride; [1] morfamquat sulfate [2] 4636-83-3 [1], 29873-36-7 [2] Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Aquatic Chronic 3 H302, H319, H335, H315, H412 CLP00/
613-092-00-8 1,10-phenanthroline 66-71-7 Acute Tox. 3 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H400, H410 CLP00/
613-093-00-3 hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 85153-92-0 Resp. Sens. 1, Skin Sens. 1 H334, H317 CLP00/
613-094-00-9 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine 5248-39-5 Acute Tox. 4 *, STOT RE 2 * H302, H373 ** CLP00/
613-095-00-4 sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate 92484-48-5 Eye Dam. 1 H318 CLP00/
613-096-00-X 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine 62096-63-3 Acute Tox. 4 * H302 CLP00/
613-097-00-5 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 111298-82-9 Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H334, H317, H412 CLP00/
613-098-00-0 N-(n-octyl)-2-pyrrolidone 2687-94-7 Skin Corr. 1B, Aquatic Chronic 2 H314, H411 CLP00/
613-099-00-6 1-dodecyl-2-pyrrolidone 2687-96-9 Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H317, H400, H410 CLP00/
613-100-00-X 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione - Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
613-101-00-5 N-tert-pentyl-2-benzothiazolesulfenamide 110799-28-5 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
613-102-00-0 dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine 110488-70-5 Aquatic Chronic 2 H411 CLP00/
613-103-00-6 sodium 5-n-butylbenzotriazole 118685-34-0 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H302, H314, H317, H411 CLP00/
613-104-00-1 5-tert-butyl-3-isoxazolylamine hydrochloride - Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Aquatic Chronic 3 H302, H373 **, H318, H412 CLP00/
613-105-00-7 hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) 124537-30-0 Acute Tox. 3 *, Skin Sens. 1, Aquatic Chronic 3 H301, H317, H412 CLP00/
613-106-00-2 tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate - Skin Sens. 1 H317 CLP00/
613-107-00-8 hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate 76508-02-6 Eye Irrit. 2 H319 CLP00/
613-108-00-3 benzothiazole-2-thiol 149-30-4 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-109-00-9 bis(piperidinothiocarbonyl) disulphide 94-37-1 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1 H319, H335, H315, H317 CLP00/
613-110-00-4 dimepiperate (ISO); S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate 61432-55-1 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
613-111-00-X 1,2,4-triazole 288-88-0 Repr. 2, Acute Tox. 4 *, Eye Irrit. 2 H361d ***, H302, H319 CLP00/
613-112-00-5 octhilinone (ISO); 2-octyl-2H-isothiazol-3-one 26530-20-1 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H302, H314, H317, H400, H410 Skin Sens. 1; H317: C ≥ 0,05 % CLP00/
613-113-00-0 2-(morpholinothio)benzothiazole 102-77-2 Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H319, H315, H317, H411 CLP00/
613-114-00-6 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol; 1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine 4719-04-4 Acute Tox. 4 *, Skin Sens. 1 H302, H317 Skin Sens. 1; H317: C ≥ 0,1 % CLP00/
613-115-00-1 hymexazol (ISO); 3-hydroxy-5-methylisoxazole 10004-44-1 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 CLP00/
613-116-00-7 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing 0.1% (w/w) of particles with an aerodynamic diameter of below 50 m] 731-27-1 Acute Tox. 2 *, STOT RE 1, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H330, H372**, H319, H335, H315, H317, H400 M=10: CLP00/ATP01
613-116-01-4 tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0.1% (w/w) of particles with an aerodynamic diameter of below 50 m] 731-27-1 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H319, H335, H315, H317, H400 M=10: ATP01/
613-117-00-2 diniconazole (ISO); (E)-ß-[(2,4-dichlorophenyl)methylene]- -(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol; (E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol 76714-88-0 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-118-00-8 flubenzimine (ISO); N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline 37893-02-0 Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H319, H400, H410 CLP00/
613-119-00-3 (benzothiazol-2-ylthio)methyl thiocyanate; TCMTB 21564-17-0 Acute Tox. 2 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H302, H319, H315, H317, H400, H410 CLP00/
613-120-00-9 bioresmethrin (ISO); (5-benzylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 28434-01-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=1000: CLP00/ATP01
613-121-00-4 chlorsulfuron (ISO); 2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide 64902-72-3 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-122-00-X diclobutrazole (ISO); (R*, R*)-(±)-ß-[(2,4-dichlorophenyl)methyl]- -(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol 75736-33-3 Eye Irrit. 2, Aquatic Chronic 2 H319, H411 CLP00/
613-123-00-5 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem 33813-20-6 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-124-00-0 fenpropimorph (ISO); cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 67564-91-4 Repr. 2, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Chronic 2 H361d ***, H302, H315, H411 CLP00/
613-125-00-6 hexythiazox (ISO); trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide 78587-05-0 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-126-00-1 imazapyr (ISO); 2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate 81334-34-1 Eye Irrit. 2, Aquatic Chronic 3 H319, H412 CLP00/
613-127-00-7 1,1-dimethylpiperidinium chloride; mepiquat chloride 24307-26-4 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
613-128-00-2 prochloraz (ISO); N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide 67747-09-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-129-00-8 metamitron (ISO); 4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one 41394-05-2 Acute Tox. 4 *, Aquatic Acute 1 H302, H400 CLP00/
613-131-00-9 pyroquilon (ISO); 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one 57369-32-1 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
613-132-00-4 hexazinone (ISO); 3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione 51235-04-2 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H400, H410 CLP00/
613-133-00-X etridiazole (ISO); 5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 2593-15-9 Carc. 2, Acute Tox. 4, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H317, H400, H410 M=1000 , M=1000 CLP00/ATP07
613-134-00-5 myclobutanil (ISO); 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile 88671-89-0 Repr. 2, Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 2 H361d ***, H302, H319, H411 CLP00/
613-135-00-0 di(benzothiazol-2-yl) disulphide 120-78-5 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-136-00-6 N-cyclohexylbenzothiazole-2-sulphenamide 95-33-0 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-137-00-1 methabenzthiazuron (ISO); 1-(1,3-benzothiazol-2-yl)1,3-dimethylurea 18691-97-9 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-138-00-7 quinoxyfen (ISO); 5,7-dichloro-4-(4-fluorophenoxy)quinoline 124495-18-7 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-139-00-2 metsulfuron-methyl (ISO); 2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid 74223-64-6 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=1000: CLP00/ATP01
613-140-00-8 cycloheximide (ISO); 4-{}{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}}piperidine-2,6-dione 66-81-9 Muta. 2, Repr. 1B, Acute Tox. 2 *, Aquatic Chronic 2 H341, H360D ***, H300, H411 CLP00/
613-141-00-3 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone 93686-63-6 Aquatic Chronic 4 H413 CLP00/
613-142-00-9 trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate - Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-143-00-4 1-(3-phenylpropyl)-2-methylpyridinium bromide 10551-42-5 Acute Tox. 4 *, Eye Irrit. 2, Aquatic Chronic 3 H302, H319, H412 CLP00/
613-144-00-X Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate 125139-08-4 Aquatic Chronic 3 H412 CLP00/
613-145-00-5 (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate 77497-97-3 Aquatic Chronic 2 H411 CLP00/
613-146-00-0 N-ethyl-N-methylpiperidinium iodide 4186-71-4 Acute Tox. 4 *, Aquatic Chronic 2 H302, H411 CLP00/
613-147-00-6 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine 111681-72-2 Eye Dam. 1 H318 CLP00/
613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 143683-23-2 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
613-149-00-7 pyridaben (ISO); 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 96489-71-3 Acute Tox. 3, Acute Tox. 3, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H400, H410 M=1000 , M=1000 CLP00/ATP07
613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione - Aquatic Chronic 4 H413 CLP00/
613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 104218-44-2 Aquatic Chronic 4 H413 CLP00/
613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 89392-03-0 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-153-00-9 2,3,5-trichloropyridine 16063-70-0 Aquatic Chronic 3 H412 CLP00/
613-154-00-4 2-amino-4-chloro-6-methoxypyrimidine 5734-64-5 Acute Tox. 4 * H302 CLP00/
613-155-00-X 5-chloro-2,3-difluoropyridine 89402-43-7 Flam. Liq. 3, Acute Tox. 4 *, Aquatic Chronic 3 H226, H302, H412 CLP00/
613-156-00-5 2-butyl-4-chloro-5-formylimidazole 83857-96-9 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-157-00-0 2,4-diamino-5-methoxymethylpyrimidine 54236-98-5 Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2 H302, H373 **, H319 CLP00/
613-158-00-6 2,3-dichloro-5-trifluoromethyl-pyridine 69045-84-7 Acute Tox. 4 *, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H332, H302, H318, H317, H411 CLP00/
613-159-00-1 fenazaquin (ISO); 4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline 120928-09-8 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H332, H400, H410 CLP00/
613-160-00-7 (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide 125224-62-6 Skin Sens. 1 H317 CLP00/
613-161-00-2 2,4-diamino-6-hydroxymethylpteridinehydrobromide 76145-91-0 STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 3 H373**, H317, H412 ATP01/
613-162-00-8 (6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide 100988-63-4 Muta. 2, Skin Sens. 1, Aquatic Chronic 2 H341, H317, H411 ATP01/
613-163-00-3 azimsulfuron (ISO); 1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea 120162-55-2 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=1000: CLP00/ATP01
613-164-00-9 flufenacet (ISO); N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide 142459-58-3 Acute Tox. 4 *, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H317, H400, H410 M=100: CLP00/ATP01
613-165-00-4 flupyrsulfuron-methyl-sodium (ISO); methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt 144740-54-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=100: CLP00/ATP01
613-166-00-X flumioxazin (ISO); N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide 103361-09-7 Repr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H360D***, H400, H410 M=1000: CLP00/ATP01
613-167-00-5 reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]; and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]; and 2-methyl-4-isothiazolin-3-one [EC 55965-84-9 Acute Tox. 3 *, Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H311, H301, H314, H317, H400, H410 Skin Corr. 1B; H314: C ≥ 0,6 %, Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %, Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %, Skin Sens. 1; H317: C ≥ 0,0015 % CLP00/
613-168-00-0 1-vinyl-2-pyrrolidone 88-12-0 Carc. 2, Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, STOT SE 3, Eye Dam. 1 H351, H332, H312, H302, H373 **, H335, H318 D CLP00/
613-169-00-6 9-vinylcarbazole 1484-13-5 Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H341, H312, H302, H315, H317, H400, H410 M=100: CLP00/ATP01
613-170-00-1 2,2-ethylmethylthiazolidine 694-64-4 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
613-171-00-7 hexaconazole (ISO); (RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol 79983-71-4 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 CLP00/
613-172-00-2 5-chloro-1,3-dihydro-2H-indol-2-one 17630-75-0 Repr. 2, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 3 H361f ***, H302, H317, H412 CLP00/
613-173-00-8 fluquinconazole (ISO); 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one 136426-54-5 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H372 **, H312, H315, H400, H410 CLP00/
613-174-00-3 tetraconazole (ISO); (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 112281-77-3 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 2 H332, H302, H411 CLP00/ATP01
613-175-00-9 epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 133855-98-8 Carc. 2, Repr. 1B, Aquatic Chronic 2 H351, H360Df, H411 CLP00/ATP05
613-176-00-4 2-methyl-2-azabicyclo[2.2.1]heptane 4524-95-2 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1B H226, H312, H302, H373 **, H314 CLP00/
613-177-00-X 8-amino-7-methylquinoline 5470-82-6 Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H312, H302, H317, H411 CLP00/
613-178-00-5 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine 137796-06-6 Skin Corr. 1B, Skin Sens. 1 H314, H317 STOT SE 3; H335: C ≥ 5 % CLP00/
613-179-00-0 lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide 111337-53-2 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Chronic 2 H302, H314, H317, H411 CLP00/
613-180-00-6 N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide 3741-80-8 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-181-00-1 5,5-dimethyl-perhydro-pyrimidin-2-one -(4-trifluoromethylstyryl)- -(4-trifluoromethyl)cinnamylidenehydrazone 67485-29-4 STOT RE 1, Acute Tox. 4 *, Eye Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H372 **, H302, H319, H400, H410 CLP00/
613-182-00-7 1-(1-naphthylmethyl)quinolinium chloride 65322-65-8 Carc. 2, Muta. 2, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H351, H341, H302, H315, H318, H412 CLP00/
613-183-00-2 reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one - STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H400, H410 CLP00/
613-184-00-8 nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate - Eye Irrit. 2, Skin Sens. 1 H319, H317 CLP00/
613-185-00-3 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one 82633-79-2 Acute Tox. 3 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H301, H318, H317, H400, H410 CLP00/
613-186-00-9 (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate 76855-69-1 Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 2 H319, H317, H411 CLP00/
613-187-00-4 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene - Skin Sens. 1 H317 ATP01/
613-188-00-X 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone 116256-11-2 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
613-189-00-5 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane 52667-88-6 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
613-190-00-0 disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate 149530-93-8 Acute Tox. 4 *, Skin Sens. 1 H302, H317 CLP00/
613-191-00-6 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 143860-04-2 Repr. 1B, Skin Corr. 1B, Aquatic Acute 1, Aquatic Chronic 1 H360F ***, H314, H400, H410 CLP00/
613-192-00-1 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane 151860-15-0 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
613-193-00-7 pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate - Aquatic Chronic 2 H411 CLP00/
613-194-00-2 6,13-dichloro-3,10-bis{}{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt 163062-28-0 Eye Dam. 1 H318 CLP00/
613-195-00-8 2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one) 18600-59-4 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
613-196-00-3 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt 168113-78-8 Eye Dam. 1 H318 CLP00/
613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 187547-46-2 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-198-00-4 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine 145963-84-4 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 3 H302, H373**, H412 ATP01/
613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione; reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine - Carc. 1B, Repr. 1B, Skin Sens. 1, Aquatic Chronic 3 H350, H360D ***, H317, H412 CLP00/
613-200-00-3 Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts - Eye Dam. 1 H318 CLP00/
613-201-00-9 (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole 143322-57-0 Repr. 2, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361f ***, H372 **, H332, H302, H317, H400, H410 CLP00/
613-202-00-4 pymetrozine (ISO); (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one 123312-89-0 Carc. 2, Aquatic Chronic 3 H351, H412 CLP00/
613-203-00-X pyraflufen-ethyl (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] 129630-19-9 [1], 129630-17-7 [2] Aquatic Acute 1, Aquatic Chronic 1 H400, H410 M=1000: CLP00/ATP01
613-204-00-5 oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one; 5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one 39807-15-3 Repr. 1A, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360Fd, H373**, H400, H410 M=1000: CLP00/ATP01
613-205-00-0 propiconazole (ISO); (±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole 60207-90-1 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
613-206-00-6 fenamidone (ISO); (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one 161326-34-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-208-00-7 imazamox (ISO); (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid 114311-32-9 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-209-00-2 cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride 63645-17-0 Acute Tox. 3 *, STOT RE 2 *, Skin Sens. 1, Aquatic Chronic 2 H301, H373 **, H317, H411 CLP00/
613-210-00-8 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 88128-57-8 STOT RE 2 *, Aquatic Chronic 3 H373 **, H412 CLP00/
613-211-00-3 N-methyl-4-(p-formylstyryl)pyridinium methylsulfate 74401-04-0 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
613-212-00-9 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) 133467-41-1 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
613-213-00-4 cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline 120807-02-5 Aquatic Chronic 3 H412 CLP00/
613-214-00-X N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide 147613-95-4 Aquatic Chronic 4 H413 CLP00/
613-215-00-5 2-chloromethyl-3,4-dimethoxypyridinium chloride 72830-09-2 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Skin Irrit. 2, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H312, H302, H373 **, H315, H318, H317, H411 CLP00/
613-216-00-0 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole 162208-01-7 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-217-00-6 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine 73754-27-5 Aquatic Chronic 4 H413 CLP00/
613-218-00-1 6-hydroxyindole 2380-86-1 Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H302, H318, H317, H411 CLP00/
613-219-00-7 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole 79185-77-6 Skin Irrit. 2, Aquatic Chronic 2 H315, H411 CLP00/
613-220-00-2 trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide 147086-81-5 Acute Tox. 4 * H302 CLP00/
613-221-00-8 2-chloro-5-methyl-pyridine 18368-64-4 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Aquatic Chronic 3 H312, H302, H315, H412 CLP00/
613-222-00-3 4-(1-oxo-2-propenyl)-morpholine 5117-12-4 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H302, H373 **, H318, H317 CLP00/
613-223-00-9 N-isopropyl-3-(4-fluorophenyl)-1H-indole 93957-49-4 Aquatic Chronic 4 H413 CLP00/
613-224-00-4 2,5-dimercaptomethyl-1,4-dithiane 136122-15-1 Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H317, H400, H410 CLP00/
613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. - STOT RE 2 *, Aquatic Chronic 4 H373 **, H413 CLP00/
613-226-00-5 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride 163831-67-2 Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 CLP00/
613-227-00-0 (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 99199-90-3 Skin Sens. 1, Aquatic Chronic 2 H317, H411 CLP00/
613-228-00-6 (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 793669-26-8 Aquatic Chronic 2 H411 CLP00/
613-229-00-1 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine 106917-31-1 Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H315, H317, H400, H410 ATP01/
613-230-00-7 florasulam (ISO); 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; pyrimidine-2-sulfonanilide 145701-23-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
613-231-00-2 2,6-diamino-3-((pyridine-3-yl)azo)pyridine 28365-08-4 Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 2 H302, H373**, H411 ATP01/
613-232-00-8 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide 163269-30-5 Acute Tox. 3 *, STOT RE 2 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H373**, H318, H400, H410 ATP01/
613-233-00-3 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane 56552-15-9 Eye Dam. 1 H318 CLP00/
613-234-00-9 imidazo[1,2-b]pyridazin hydrochloride 18087-70-2 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 ATP01/
613-235-00-4 2,3-dihydro-2,2-dimethyl-1H-perimidine 6364-17-6 Acute Tox. 4*, STOT RE 2 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H317, H400, H410 ATP01/
613-236-00-X 2-chloro-3-trifluoromethylpyridine 65753-47-1 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 1, Skin Corr. 1B, Aquatic Chronic 3 H311, H301, H372**, H314, H412 ATP01/
613-237-00-5 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine 133949-92-5 Aquatic Chronic 4 H413 ATP01/
613-238-00-0 sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate 81992-66-7 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 ATP01/
613-239-00-6 2-[3-(methylamino)propyl]-1H-benzimidazole 64137-52-6 Eye Dam. 1, Aquatic Chronic 3 H318, H412 ATP01/
613-241-00-7 3-(2H-tetrazol-5-yl)pyridine 3250-74-6 Eye Dam. 1 H318 ATP01/
613-242-00-2 reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts 191877-09-5 Eye Dam. 1 H318 ATP01/
613-243-00-8 4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) 182235-14-9 Aquatic Chronic 2 H411 ATP01/
613-244-00-3 5,7-dichloro-4-hydroxyquinoline 21873-52-9 Aquatic Chronic 2 H411 ATP01/
613-245-00-9 2-fluoro-6-trifluoromethylpyridine 94239-04-0 Flam. Liq. 3, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H226, H332, H302, H412 ATP01/
613-246-00-4 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine 103577-66-8 Aquatic Chronic 3 H412 ATP01/
613-247-00-X 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole 107786-36-7 Aquatic Chronic 4 H413 ATP01/
613-248-00-5 3,4-dimethyl-1H-pyrazole 2820-37-3 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
613-249-00-0 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate 155601-30-2 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 ATP01/
613-250-00-6 reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine - Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H318, H317, H412 ATP01/
613-251-00-1 (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole 180637-89-2 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1 H302, H373**, H318, H317 ATP01/
613-253-00-2 2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3.5) - Skin Irrit. 2, Aquatic Chronic 2 H315, H411 ATP01/
613-254-00-8 forchlorfenuron (ISO); 1-(2-chloro-4-pyridyl)-3-phenylurea 68157-60-8 Carc. 2, Aquatic Chronic 2 H351, H411 ATP01/
613-255-00-3 reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){[2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl](sulfamoyl)}(sulfonatophthalocyaninato)]copper(II) - Eye Dam. 1 H318 ATP01/
613-256-00-9 3'5'-anhydro thymidine 38313-48-3 Aquatic Chronic 3 H412 ATP01/
613-257-00-4 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-ß-alaninate 170222-39-6 Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
613-258-00-X reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; 4-chloro-5-methylbenzotriazole sodium salt; 5-chloro-4-methylbenzotriazole sodium salt 202420-04-0 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 ATP01/
613-259-00-5 reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate 72963-72-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 ATP01/
613-260-00-0 (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin - Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H400, H410 ATP01/
613-261-00-6 pyrazole-1-carboxamidine monohydrochloride 4023-02-3 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H373**, H318, H317, H412 ATP01/
613-262-00-1 disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene 180850-95-7 Eye Dam. 1 H318 ATP01/
613-263-00-7 monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate - Skin Sens. 1 H317 ATP01/
613-266-00-3 2-chloro-5-chloromethylthiazole 105827-91-6 Acute Tox. 3 *, Skin Corr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H311, H314, H302, H317, H411 ATP01/
613-267-00-9 thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine 153719-23-4 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=10: ATP01/
613-268-00-4 (4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine 151213-39-7 Skin Corr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Aquatic Chronic 2 H314, H332, H302, H373**, H411 ATP01/
613-269-00-X 2-thiazolidinylidenecyanamide 26364-65-8 Acute Tox. 4*, STOT RE 2 *, Aquatic Chronic 3 H302, H373**, H412 ATP01/
613-270-00-5 5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide 113171-13-4 Aquatic Chronic 3 H412 ATP01/
613-271-00-0 tritosulfuron (ISO) (containing 0,02% AMTT); 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing 0,02% AMTT) 142469-14-5 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 M=10: ATP01/
613-272-00-6 pyraclostrobin (ISO); methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate - Acute Tox. 3 *, Skin Irrit. 2, Aquatic Acute 1, Aquatic Chronic 1 H331, H315, H400, H410 M=100: ATP01/
613-273-00-1 tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine 192439-46-6 Aquatic Chronic 2 H411 ATP01/
613-274-00-7 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate 140623-89-8 Skin Corr. 1B, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H314, H302, H317, H400, H410 ATP01/
613-275-00-2 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride 93076-03-0 Acute Tox. 3 *, STOT SE 2, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H301, H371**, H373**, H318, H317, H411 ATP01/
613-276-00-8 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one 98377-35-6 Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
613-277-00-3 (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one - Aquatic Chronic 4 H413 ATP01/
613-278-00-9 (3-aminophenyl)pyridin-3-ylmethanone 79568-06-2 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373**, H400, H410 ATP01/
613-279-00-4 2-ethyl-2,3-dihydro-2-methyl-1H-perimidine 43057-68-7 Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H400, H410 ATP01/
613-280-00-X tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea 7226-23-5 Repr. 2, Acute Tox. 4 *, Eye Dam. 1 H361f***, H302, H318 ATP01/
613-281-00-5 quinoline 91-22-5 Carc. 1B, Muta. 2, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H350, H341, H312, H302, H319, H315, H411 ATP01/
613-282-00-0 triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol 131983-72-7 Aquatic Chronic 2 H411 ATP01/
613-283-00-6 ketoconazole; 1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone 65277-42-1 Repr. 1B, Acute Tox. 3 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H360F***, H301, H373**, H400, H410 ATP01/
613-284-00-1 metconazole (ISO); (1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol 125116-23-6 Repr. 2, Acute Tox. 4 *, Aquatic Chronic 2 H361d***, H302, H411 ATP01/
613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] 2592-95-2 [1], 123333-53-9 [2] Expl. 1.3 H203 ATP01/
613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0.5 % N,N-dimethylformamide (EC no 200-679-5)] 183196-57-8 Skin Sens. 1 H317 ATP01/
613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing 0.5 % N,N-dimethylformamide (EC No 200-679-5)] 183196-57-8 Repr. 1B, Skin Sens. 1 H360D***, H317 ATP01/
613-287-00-8 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole 160194-26-3 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
613-288-00-3 1,3-bis(dimethylcarbamoyl)-imidazolium chloride 135756-61-5 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
613-289-00-9 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole 142623-48-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
613-290-00-4 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride 189012-93-9 Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H318, H317, H400, H410 ATP01/
613-291-00-X 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one 106461-41-0 STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H373**, H400, H410 ATP01/
613-292-00-5 N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine 26157-73-3 Muta. 2, Aquatic Chronic 3 H341, H412 ATP01/
613-293-00-0 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester 444065-11-6 Aquatic Chronic 4 H413 ATP01/
613-294-00-6 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester 379268-96-9 Aquatic Chronic 4 H413 ATP01/
613-295-00-1 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride 363138-44-7 Acute Tox. 4 *, Eye Dam. 1, Aquatic Chronic 3 H302, H318, H412 ATP01/
613-296-00-7 pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate - Skin Sens. 1, Aquatic Chronic 3 H317, H412 ATP01/
613-297-00-2 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole - Flam. Liq. 3, Acute Tox. 4 *, Aquatic Chronic 2 H226, H302, H411 ATP01/
613-298-00-8 bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate - STOT RE 2 *, Eye Dam. 1, Aquatic Chronic 2 H373**, H318, H411 ATP01/
613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; - Eye Dam. 1 H318 ATP01/
613-300-00-7 1-imidazol-1-yl-octadecan-2-ol - Skin Sens. 1, Aquatic Chronic 4 H317, H413 ATP01/
613-301-00-2 dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate - Aquatic Chronic 4 H413 ATP01/
613-302-00-8 disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate 243858-60-8 Eye Dam. 1 H318 ATP01/
613-303-00-3 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine 95737-68-1 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
613-304-00-9 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide 138937-28-7 Acute Tox. 4 *, Eye Dam. 1 H302, H318 ATP01/
613-305-00-4 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole 3147-77-1 Aquatic Chronic 4 H413 ATP01/
613-306-00-X (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate 82911-69-1 Acute Tox. 4 *, Skin Sens. 1, Aquatic Chronic 2 H302, H317, H411 ATP01/
613-307-00-5 clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine 210880-92-5 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 M=10: ATP01/
613-308-00-0 2-amino-5-methylthiazole 7305-71-7 Acute Tox. 4 *, STOT RE 2 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H373**, H400, H410 ATP01/
613-309-00-6 1-methyl-3-phenyl-1-piperazine 5271-27-2 Acute Tox. 4 *, Acute Tox. 4 *, Skin Irrit. 2, Eye Dam. 1, Aquatic Chronic 3 H312, H302, H315, H318, H412 ATP01/
613-310-00-1 (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride 105813-13-6 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 ATP01/
613-311-00-7 methyl-5-nitrophenyl-guanidine 152460-07-6 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Chronic 3 H302, H319, H317, H412 ATP01/
613-312-00-2 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride - Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H302, H318, H317, H412 ATP01/
613-313-00-8 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione 173838-67-0 Aquatic Chronic 3 H412 ATP01/
613-314-00-3 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one 7693-82-5 Aquatic Acute 1, Aquatic Chronic 1 H400, H410 ATP01/
613-315-00-9 tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate - Acute Tox. 4 *, Aquatic Chronic 3 H332, H412 ATP01/
613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate); (TAZ) 52234-82-9 Muta. 2, Eye Dam. 1, Skin Sens. 1 H341, H318, H317 CLP00/ATP02
613-319-00-0 imidazole 288-32-4 Repr. 1B, Acute Tox. 4, Skin Corr. 1C H360D, H302, H314 ATP07
613-320-00-6 lenacil (ISO); 3-cyclohexyl-6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione 2164-08-1 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 M=10, M=10 ATP07
614-001-00-4 nicotine (ISO); 3-(N-methyl-2-pyrrolidinyl)pyridine 54-11-5 Acute Tox. 1, Acute Tox. 3 *, Aquatic Chronic 2 H310, H301, H411 CLP00/
614-002-00-X salts of nicotine - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 *, Aquatic Chronic 2 H330, H310, H300, H411 A CLP00/
614-003-00-5 strychnine 57-24-9 Acute Tox. 1, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H310, H300, H400, H410 CLP00/
614-004-00-0 salts of strychnine - Acute Tox. 2 *, Acute Tox. 2 *, Aquatic Acute 1, Aquatic Chronic 1 H330, H300, H400, H410 A CLP00/
614-005-00-6 colchicine 64-86-8 Muta. 1B, Acute Tox. 2 * H340, H300 CLP00/ATP01
614-006-00-1 brucine; 2,3-dimethoxystrychnine 357-57-3 Acute Tox. 2 *, Acute Tox. 2 *, Aquatic Chronic 3 H330, H300, H412 CLP00/
614-007-00-7 brucine sulphate; [1] brucine nitrate; [2] Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 4845-99-2 [1], 5786-97-0 [2], 68239-26-9 [3], 68310-42-9 [4] Acute Tox. 2 *, Acute Tox. 2 *, Aquatic Chronic 3 H330, H300, H412 A CLP00/
614-008-00-2 aconitine 302-27-2 Acute Tox. 2 *, Acute Tox. 2 * H330, H300 CLP00/
614-009-00-8 salts of aconitine - Acute Tox. 2 *, Acute Tox. 2 * H330, H300 A CLP00/
614-010-00-3 atropine 51-55-8 Acute Tox. 2 *, Acute Tox. 2 * H330, H300 CLP00/
614-011-00-9 salts of atropine - Acute Tox. 2 *, Acute Tox. 2 * H330, H300 A CLP00/
614-012-00-4 hyoscyamine 101-31-5 Acute Tox. 2 *, Acute Tox. 2 * H330, H300 CLP00/
614-013-00-X salts of hyoscyamine - Acute Tox. 2 *, Acute Tox. 2 * H330, H300 A CLP00/
614-014-00-5 hyoscine 51-34-3 Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H330, H310, H300 CLP00/
614-015-00-0 salts of hyoscine - Acute Tox. 2 *, Acute Tox. 1, Acute Tox. 2 * H330, H310, H300 A CLP00/
614-016-00-6 pilocarpine 92-13-7 Acute Tox. 2 *, Acute Tox. 2 * H330, H300 CLP00/
614-017-00-1 salts of pilocarpine - Acute Tox. 2 *, Acute Tox. 2 * H330, H300 A CLP00/
614-018-00-7 papaverine 58-74-2 Acute Tox. 4 * H302 CLP00/
614-019-00-2 salts of papaverine - Acute Tox. 4 * H302 A CLP00/
614-020-00-8 physostigmine 57-47-6 Acute Tox. 2 *, Acute Tox. 2 * H330, H300 CLP00/
614-021-00-3 salts of physostigmine - Acute Tox. 2 *, Acute Tox. 2 * H330, H300 A CLP00/
614-022-00-9 digitoxin 71-63-6 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 * H331, H301, H373 ** CLP00/
614-023-00-4 ephedrine 299-42-3 Acute Tox. 4 * H302 CLP00/
614-024-00-X salts of ephedrine - Acute Tox. 4 * H302 A CLP00/
614-025-00-5 ouabain 630-60-4 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 * H331, H301, H373 ** CLP00/
614-026-00-0 strophantin-K 11005-63-3 Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 * H331, H301, H373 ** CLP00/
614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(ß-D-glucopyranosyloxy)-8,14-dihydroxy-, (3ß, 6ß)-; red squill; scilliroside 507-60-8 Acute Tox. 2 * H300 CLP00/
614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; 2-ethylhexyl di-D-glucopyranoside - Eye Dam. 1 H318 CLP00/
614-029-00-7 constitutional isomers of penta-O-allyl-ß-D-fructofuranosyl- -D-glucopyranoside; constitutional isomers of hexa-O-allyl-ß-D-fructofuranosyl- -D-glucopyranoside; constitutional isomers of hepta-O-allyl-ß-D-fructofuransoyl- -D-glucopyranoside 68784-14-5 Acute Tox. 4 * H302 CLP00/
615-001-00-7 methyl isocyanate 624-83-9 Flam. Liq. 2, Repr. 2, Acute Tox. 2 *, Acute Tox. 3 *, Acute Tox. 3 *, Resp. Sens. 1, Skin Sens. 1, STOT SE 3, Skin Irrit. 2, Eye Dam. 1 H225, H361d***, H330, H311, H301, H334, H317, H335, H315, H318 CLP00/ATP01
615-002-00-2 methyl isothiocyanate 556-61-6 Acute Tox. 3 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H331, H301, H314, H317, H400, H410 CLP00/
615-003-00-8 thiocyanic acid 463-56-9 Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H332, H312, H302, H412 CLP00/
615-004-00-3 salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H332, H312, H302, H412 A CLP00/ATP01
615-005-00-9 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate; [1] 2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate; [2] o-(p-isocyanatobenzyl)phenyl isocyanate; diphenylmethane-2,4'-diisocyanate; [3] methylenediphenyl 101-68-8 [1], 2536-05-2 [2], 5873-54-1 [3], 26447-40-5 [4] Carc. 2, Acute Tox. 4 *, STOT RE 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1 H351, H332, H373**, H319, H335, H315, H334, H317 Eye Irrit. 2; H319: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 %, Resp. Sens. 1; H334: C ≥ 0,1 %, STOT SE 3; H335: C ≥ 5 % C 2 CLP00/ATP01
615-006-00-4 2-methyl-m-phenylene diisocyanate; toluene-2,4-di-isocyanate; [1] 4-methyl-m-phenylene diisocyanate; toluene-2,6-di-isocyanate; [2] m-tolylidene diisocyanate; toluene-diisocyanate [3] 91-08-7 [1], 584-84-9 [2], 26471-62-5 [3] Carc. 2, Acute Tox. 2 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H351, H330, H319, H335, H315, H334, H317, H412 Resp. Sens. 1; H334: C ≥ 0,1 % C CLP00/
615-007-00-X 1,5-naphthylene diisocyanate 3173-72-6 Acute Tox. 4 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Aquatic Chronic 3 H332, H319, H335, H315, H334, H412 CLP00/
615-008-00-5 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate 4098-71-9 Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 2 H331, H319, H335, H315, H334, H317, H411 *, Resp. Sens. 1; H334: C ≥ 0,5 %, Skin Sens.1; H317: C ≥ 0,5 % 2 CLP00/
615-009-00-0 4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate 5124-30-1 Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1 H331, H319, H335, H315, H334, H317 *, Resp. Sens. 1; H334: C ≥ 0,5 %, Skin Sens. 1; H317: C ≥ 0,5 % 2 CLP00/
615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 16938-22-0 [1], 15646-96-5 [2] Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1 H331, H319, H335, H315, H334 *, Resp. Sens. 1; H334: C ≥ 0,5 %, Skin Sens. 1; H317: C ≥ 0,5 % C 2 CLP00/
615-011-00-1 hexamethylene-di-isocyanate 822-06-0 Acute Tox. 3 *, Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1, Skin Sens. 1 H331, H319, H335, H315, H334, H317 *, Resp. Sens. 1; H334: C ≥ 0,5 %, Skin Sens. 1; H317: C ≥ 0,5 % 2 CLP00/
615-012-00-7 4-isocyanatosulphonyltoluene; tosyl isocyanate 4083-64-1 Eye Irrit. 2, STOT SE 3, Skin Irrit. 2, Resp. Sens. 1 H319, H335, H315, H334 Eye Irrit.; H319: C ≥ 5 %, STOT SE 3; H335: C ≥ 5 %, Skin Irrit. 2; H315: C ≥ 5 % CLP00/
615-013-00-2 cyanamide; carbanonitril 420-04-2 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H301, H312, H319, H315, H317 CLP00/
615-014-00-8 tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate 7276-58-6 Acute Tox. 4 * H302 CLP00/
615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; isobornyl thiocyanoacetate 115-31-1 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
615-016-00-9 potassium cyanate 590-28-3 Acute Tox. 4 * H302 CLP00/
615-017-00-4 calcium cyanamide 156-62-7 Acute Tox. 4 *, STOT SE 3, Eye Dam. 1 H302, H335, H318 CLP00/
615-018-00-X 2-(2-butoxyethoxy)ethyl thiocyanate 112-56-1 Flam. Liq. 3, Acute Tox. 3 *, Acute Tox. 3 * H226, H311, H301 CLP00/
615-019-00-5 dicyclohexylcarbodiimide 538-75-0 Acute Tox. 3 *, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H311, H302, H318, H317 CLP00/
615-020-00-0 methylene dithiocyanate 6317-18-6 Acute Tox. 2 *, Acute Tox. 3 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1 H330, H301, H314, H317, H400 CLP00/
615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; TGIC 2451-62-9 Muta. 1B, Acute Tox. 3 *, Acute Tox. 3 *, STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 3 H340, H331, H301, H373 **, H318, H317, H412 CLP00/
615-022-00-1 methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate 79277-18-2 STOT RE 2 *, Resp. Sens. 1, Skin Sens. 1 H373**, H334, H317 CLP00/ATP01
615-023-00-7 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate 83056-32-0 Flam. Liq. 3, Muta. 2, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Resp. Sens. 1 H226, H341, H332, H373 **, H318, H334 CLP00/
615-024-00-2 2-phenylethylisocyanate 1943-82-4 Acute Tox. 3 *, Acute Tox. 4 *, Skin Corr. 1A, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 2 H331, H302, H314, H334, H317, H411 CLP00/
615-025-00-8 4,4'-ethylidenediphenyl dicyanate 47073-92-7 Acute Tox. 4 *, Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H302, H373 **, H318, H400, H410 CLP00/
615-026-00-3 4,4'-methylenebis(2,6-dimethylphenyl cyanate) 101657-77-6 Skin Sens. 1, Aquatic Chronic 3 H317, H412 CLP00/
615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 77375-79-2 Acute Tox. 4 *, STOT RE 2 *, Eye Dam. 1, Resp. Sens. 1, Skin Sens. 1 H302, H373**, H318, H334, H317 CLP00/ATP01
615-029-00-X 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane - Acute Tox. 2 *, Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 3 H330, H302, H314, H334, H317, H412 CLP00/
615-030-00-5 alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Chronic 3 H332, H312, H302, H412 A CLP00/ATP01
615-031-00-0 thallium thiocyanate 3535-84-0 Acute Tox. 2 *, Acute Tox. 2 *, Acute Tox. 4 *, STOT RE 2, Aquatic Chronic 2 H330, H300, H312, H373**, H411 CLP00/ATP01
615-032-00-6 metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex - Acute Tox. 4 *, Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H332, H312, H302, H400, H410 A CLP00/ATP01
615-033-00-1 reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0.097) - Aquatic Chronic 4 H413 ATP01/
615-034-00-7 reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) - Aquatic Chronic 4 H413 ATP01/
615-035-00-2 reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14) 122886-55-9 Aquatic Chronic 4 H413 ATP01/
615-036-00-8 reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) - Aquatic Chronic 4 H413 ATP01/
615-037-00-3 reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) - Aquatic Chronic 4 H413 ATP01/
615-038-00-9 reaction product of toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2) - Aquatic Chronic 4 H413 ATP01/
615-039-00-4 reaction product of diphenylmethanediisocyanate, toluenediisocyanate ( reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) - Aquatic Chronic 4 H413 ATP01/
615-044-00-1 4-chlorophenylisocyanate 104-12-1 Acute Tox. 2 *, Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Eye Dam. 1, Resp. Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H330, H302, H335, H315, H318, H334, H400, H410 ATP01/
615-045-00-7 4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) - Resp. Sens. 1, Skin Sens. 1, Aquatic Chronic 4 H334, H317, H413 ATP01/
616-001-00-X N,N-dimethylformamide; dimethyl formamide 68-12-2 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2 H360D ***, H332, H312, H319 CLP00/
616-002-00-5 2-fluoroacetamide 640-19-7 Acute Tox. 2 *, Acute Tox. 3 * H300, H311 CLP00/
616-003-00-0 acrylamide; prop-2-enamide 79-06-1 Carc. 1B, Muta. 1B, Repr. 2, Acute Tox. 3 *, STOT RE 1, Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Skin Sens. 1 H350, H340, H361f ***, H301, H372 **, H332, H312, H319, H315, H317 D CLP00/
616-004-00-6 allidochlor (ISO); N,N-diallylchloroacetamide 93-71-0 Acute Tox. 4 *, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 2 H312, H302, H319, H315, H411 CLP00/
616-005-00-1 chlorthiamid (ISO); 2,6-dichloro (thiobenzamide) 1918-13-4 Acute Tox. 4 * H302 CLP00/
616-006-00-7 dichlofluanid (ISO); N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulfamide 1085-98-9 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1 H332, H319, H317, H400 M=10: CLP00/ATP01
616-007-00-2 diphenamid (ISO); N,N-dimethyl-2,2-diphenylacetamide 957-51-7 Acute Tox. 4 *, Aquatic Chronic 3 H302, H412 CLP00/
616-008-00-8 propachlor (ISO); 2-chloro-N-isopropylacetanilide; -chloro-N-isopropylacetanilide 1918-16-7 Acute Tox. 4 *, Eye Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H319, H317, H400, H410 CLP00/
616-009-00-3 propanil (ISO); 3',4'-dichloropropionanilide 709-98-8 Acute Tox. 4 *, Aquatic Acute 1 H302, H400 M=10: CLP00/ATP01
616-010-00-9 tosylchloramide sodium 127-65-1 Acute Tox. 4 *, Skin Corr. 1B, Resp. Sens. 1 H302, H314, H334 CLP00/
616-011-00-4 N,N-dimethylacetamide 127-19-5 Repr. 1B, Acute Tox. 4 *, Acute Tox. 4 * H360D ***, H332, H312 Repr. 1B; H360D: C ≥ 5 % CLP00/
616-012-00-X N-(dichlorofluoromethylthio)phthalimide; N-(fluorodichloromethylthio)phthalimide 719-96-0 Skin Irrit. 2 H315 CLP00/
616-013-00-5 butyraldehyde oxime 110-69-0 Acute Tox. 3 *, Acute Tox. 4 *, Eye Irrit. 2 H311, H302, H319 CLP00/
616-014-00-0 2-butanone oxime; ethyl methyl ketoxime; ethyl methyl ketone oxime 96-29-7 Carc. 2, Acute Tox. 4 *, Eye Dam. 1, Skin Sens. 1 H351, H312, H318, H317 CLP00/
616-015-00-6 alachlor (ISO); 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 15972-60-8 Carc. 2, Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H351, H302, H317, H400, H410 M=10: CLP00/
616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide 5836-73-7 Acute Tox. 2 * H300 CLP00/
616-017-00-7 cartap hydrochloride 15263-52-2 Acute Tox. 4 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H312, H302, H400, H410 CLP00/
616-018-00-2 N,N-diethyl-m-toluamide; deet 134-62-3 Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H302, H319, H315, H412 CLP00/
616-019-00-8 perfluidone (ISO); 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide 37924-13-3 Acute Tox. 4 *, Eye Irrit. 2 H302, H319 CLP00/
616-020-00-3 tebuthiuron (ISO); 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 34014-18-1 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
616-021-00-9 thiazafluron (ISO); 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 25366-23-8 Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H302, H400, H410 CLP00/
616-022-00-4 acetamide 60-35-5 Carc. 2 H351 CLP00/
616-023-00-X N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide - Skin Irrit. 2, Skin Sens. 1 H315, H317 CLP00/
616-024-00-5 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide 54942-74-4 Aquatic Chronic 4 H413 CLP00/
616-025-00-0 valinamide 20108-78-5 Repr. 2, Eye Irrit. 2, Skin Sens. 1 H361f ***, H319, H317 CLP00/
616-026-00-6 thioacetamide 62-55-5 Carc. 1B, Acute Tox. 4 *, Eye Irrit. 2, Skin Irrit. 2, Aquatic Chronic 3 H350, H302, H319, H315, H412 CLP00/
616-027-00-1 tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate - Skin Sens. 1 H317 CLP00/
616-028-00-7 N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 108673-51-4 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
616-029-00-2 N,N'-ethylenebis(vinylsulfonylacetamide) 66710-66-5 Eye Dam. 1, Skin Sens. 1 H318, H317 CLP00/
616-030-00-8 ethidimuron (ISO); 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 30043-49-3 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
616-031-00-3 dimethachlor (ISO); 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide 50563-36-5 Acute Tox. 4 *, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H317, H400, H410 CLP00/
616-032-00-9 diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide 83164-33-4 Aquatic Chronic 3 H412 CLP00/
616-033-00-4 cyprofuram (ISO); N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 69581-33-5 Acute Tox. 3 *, Acute Tox. 4 *, Aquatic Acute 1, Aquatic Chronic 1 H301, H312, H400, H410 CLP00/
616-034-00-X pyracarbolid (ISO); 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 24691-76-7 Aquatic Chronic 3 H412 CLP00/
616-035-00-5 cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 57966-95-7 Repr. 2, Acute Tox. 4, STOT RE 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H361fd, H302, H373 (Blut, Thymusdrüse), H317, H400, H410 M=1, M=1" CLP00/ATP06
616-036-00-0 2-chloracetamide 79-07-2 Repr. 2, Acute Tox. 3 *, Skin Sens. 1 H361f ***, H301, H317 Skin Sens. 1; H317: C ≥ 0,1 % CLP00/
616-037-00-6 acetochlor (ISO); 2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide 34256-82-1 Acute Tox. 4 *, STOT SE 3, Skin Irrit. 2, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H332, H335, H315, H317, H400, H410 CLP00/
616-038-00-1 (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride 88918-84-7 Eye Dam. 1, Skin Sens. 1, Aquatic Chronic 2 H318, H317, H411 CLP00/
616-039-00-7 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide 117827-06-2 Skin Sens. 1 H317 CLP00/
616-040-00-2 potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide 97888-41-0 Eye Dam. 1 H318 CLP00/
616-041-00-8 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide 101664-25-9 Aquatic Chronic 4 H413 CLP00/
616-042-00-3 N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide 142859-67-4 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
616-043-00-9 isoxaben (ISO); N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 82558-50-7 Aquatic Chronic 4 H413 CLP00/
616-044-00-4 N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide - Aquatic Chronic 2 H411 CLP00/
616-045-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide 122371-93-1 Skin Sens. 1, Aquatic Chronic 4 H317, H413 CLP00/
616-046-00-5 N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide - Aquatic Acute 1, Aquatic Chronic 1 H400, H410 CLP00/
616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide; 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide - Skin Sens. 1 H317 CLP00/
616-048-00-6 3'-trifluoromethylisobutyranilide 1939-27-1 STOT RE 2 *, Aquatic Chronic 2 H373 **, H411 CLP00/
616-049-00-1 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide 99141-89-6 Aquatic Chronic 4 H413 CLP00/
616-050-00-7 lufenuron (ISO); N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 103055-07-8 Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H317, H400, H410 CLP00/
616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene - Aquatic Chronic 4 H413 CLP00/
616-052-00-8 formamide 75-12-7 Repr. 1B H360D *** CLP00/
616-053-00-3 N-methylacetamide 79-16-3 Repr. 1B H360D *** CLP00/
616-054-00-9 iprodione (ISO); 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 36734-19-7 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
616-055-00-4 propyzamide (ISO); 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 23950-58-5 Carc. 2, Aquatic Acute 1, Aquatic Chronic 1 H351, H400, H410 CLP00/
616-056-00-X N-methylformamide 123-39-7 Repr. 1B, Acute Tox. 4 * H360D ***, H312 CLP00/
616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N - Carc. 1B, Muta. 2, STOT RE 2 * H350, H341, H373 ** CLP00/
616-058-00-0 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene 119462-56-5 STOT RE 2 *, Eye Dam. 1, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H373 **, H318, H317, H400, H410 CLP00/
616-059-00-6 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide 121487-83-0 Aquatic Chronic 4 H413 CLP00/
616-060-00-1 Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) - Acute Tox. 4 *, Skin Corr. 1B, Skin Sens. 1, Aquatic Acute 1, Aquatic Chronic 1 H302, H314, H317, H400, H410 CLP00/
616-061-00-7 N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide 124172-53-8 Eye Irrit. 2, Aquatic Chronic 3 H319, H412 CLP00/
616-062-00-2 N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide 70693-57-1 Skin Corr. 1B, Aquatic Chronic 3 H314, H412 CLP00/
616-063-00-8 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione 106917-30-0 Acute Tox. 3 *, Acute Tox. 4 *, STOT RE 2 *, Skin Corr. 1A, Aquatic Acute 1, Aquatic Chronic 1 H331, H302, H373 **, H314, H400, H410 CLP00/
616-064-00-3 N-tert-butyl-3-methylpicolinamide 32998-95-1 Aquatic Chronic 3 H412 CLP00/
616-065-00-9 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea 79881-89-3 Acute Tox. 4 *, STOT RE 2 * H302, H373 ** CLP00/
616-066-00-4 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone 115662-06-1 Repr. 2 H361f *** CLP00/
616-067-00-X dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate 92683-20-0 Aquatic Chronic 4 H413 CLP00/
616-068-00-5 potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate 174393-75-0 Skin Sens. 1 H317 CLP00/
616-069-00-0 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide 110560-22-0 Aquatic Chronic 4 H413 CLP00/
616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea - Aquatic Chronic 4 H413 <